PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Lagatie, O; Ediage, EN; Pikkemaat, JA; Djuardi, Y; Stuyver, LJ				Lagatie, Ole; Ediage, Emmanuel Njumbe; Pikkemaat, Jeroen A.; Djuardi, Yenny; Stuyver, Lieven J.			2-methyl butyramide, a previously identified urine biomarker for Ascaris lumbricoides, is not present in infected Indonesian individuals	PARASITES & VECTORS			English	Letter						Ascaris lumbricoides; Soil-transmitted helminths; Biomarker; Urine; 2-methyl butyramide; 2-methyl valeramide	HELMINTH INFECTIONS	Previous reports suggest that the 2-methyl butyramide and 2-methyl valeramide metabolites of Ascaris lumbricoides in urine of infected individuals could be considered as urinary biomarkers for active infection. We have developed an LC-MS method with a detection limit of 10 ng/mL using synthetic chemicals as reference material. Urine samples (n = 21) of infected individuals were analyzed for the presence of these metabolites, but they were not detected in any of the samples. Furthermore, the recorded H-1-NMR spectrum for reference 2-methyl butyramide did not match with the spectrum that was described for the Ascaris metabolite. Based on these two observations, we concluded that the urinary biomarkers that were detected for A. lumbricoides infection are not 2-methyl butyramide nor 2-methylvaleramide. New discovery efforts will be required to identify the structure of these metabolite biomarkers in urine of infected individuals.	[Lagatie, Ole; Stuyver, Lieven J.] Janssen R&D, Janssen Diagnost, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Ediage, Emmanuel Njumbe] Janssen R&D, Bioanal, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Pikkemaat, Jeroen A.] Janssen R&D, Pharmaceut Dev & Mfg Sci, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Djuardi, Yenny] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia	Lagatie, O (reprint author), Janssen R&D, Janssen Diagnost, Turnhoutseweg 30, B-2340 Beerse, Belgium.	olagatie@its.jnj.com		Lagatie, Ole/0000-0002-0638-1313			DEJONGE N, 1990, T ROY SOC TROP MED H, V84, P815, DOI 10.1016/0035-9203(90)90094-U; HALL A, 1990, EXP PARASITOL, V70, P35, DOI 10.1016/0014-4894(90)90083-O; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; O'Connell EM, 2016, AM J TROP MED HYG, V95, P508, DOI 10.4269/ajtmh.16-0266; Tahapary DL, 2015, BMC INFECT DIS, V15, P1, DOI 10.1186/s12879-015-0873-4; van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004	7	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 29	2017	10								629	10.1186/s13071-017-2600-z				3	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FR7GG	WOS:000419235100004	29284514	DOAJ Gold, Green Published			2019-03-26
J	Gower, CM; Gehre, F; Marques, SR; Lamberton, PHL; Lwambo, NJ; Webster, JP				Gower, Charlotte M.; Gehre, Florian; Marques, Sara R.; Lamberton, Poppy H. L.; Lwambo, Nicholas J.; Webster, Joanne P.			Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme	PARASITES & VECTORS			English	Article						Density-dependence; Neglected tropical diseases; Schistosomiasis; Population genetics; Drug resistance; Praziquantel	PRAZIQUANTEL; PARASITES; TRANSMISSION; HIERFSTAT; EFFICACY; IMPACT	"Background: Schistosoma mansoni is a parasite of profound medical importance. Current control focusses on mass praziquantel (PZQ) treatment of populations in endemic areas, termed Preventative Chemotherapy (PC). Large-scale PC programmes exert prolonged selection pressures on parasites with the potential for, direct and/or indirect, emergence of drug resistance. Molecular methods can help monitor genetic changes of schistosome populations over time and in response to drug treatment, as well as estimate adult worm burdens through parentage analysis. Furthermore, methods such as in vitro drug sensitivity assays help phenotype in vivo parasite genotypic drug efficacy. Methods: We conducted combined in vitro PZQ efficacy testing with population genetic analyses of S. mansoni collected from children from two schools in 2010, five years after the introduction of a National Control Programme. Children at one school had received four annual PZQ treatments and the other school had received two mass treatments in total. We compared genetic differentiation, indices of genetic diversity, and estimated adult worm burden from parasites collected in 2010 with samples collected in 2005 (before the control programme began) and in 2006 (six months after the first PZQ treatment). Using 2010 larval samples, we also compared the genetic similarity of those with high and low in vitro sensitivity to PZQ. Results: We demonstrated that there were individual parasites with reduced PZQ susceptibility in the 2010 collections, as evidenced by our in vitro larval behavioural phenotypic assay. There was no evidence, however, that miracidia showing phenotypically reduced susceptibility clustered together genetically. Molecular analysis also demonstrated a significant reduction of adult worm load over time, despite little evidence of reduction in parasite infection intensity, as measured by egg output. Genetic diversity of infections did not reduce over time, despite changes in the genetic composition of the parasite populations. Conclusions: Genotypic and phenotypic monitoring did not indicate a selective sweep, as may be expected if PZQ treatment was selecting a small number of related ""resistant"" parasites, but there was evidence of genetic changes at the population level over time. Genetic data were used to estimate adult worm burdens, which unlike parasite infection intensity, showed reductions over time, suggesting the relaxation of negative density-dependent constraints on parasite fecundity with PZQ treatment. We thereby demonstrated that density-dependence in schistosome populations may complicate evaluation and monitoring of control programmes."	[Gower, Charlotte M.; Webster, Joanne P.] Univ London, Royal Vet Coll, Ctr Endem Emerging & Exot Dis, London AL9 7TA, England; [Gower, Charlotte M.; Gehre, Florian; Lamberton, Poppy H. L.; Webster, Joanne P.] Imperial Coll, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Gehre, Florian] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Marques, Sara R.] Imperial Coll, Fac Med, Dept Life Sci, London, England; [Lamberton, Poppy H. L.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Lamberton, Poppy H. L.] Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Lwambo, Nicholas J.] Mwanza Res Ctr, Natl Inst Med Res, Mwanza, Tanzania	Gower, CM (reprint author), Univ London, Royal Vet Coll, Ctr Endem Emerging & Exot Dis, London AL9 7TA, England.; Gower, CM (reprint author), Imperial Coll, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	c.gower@imperial.ac.uk		Lamberton, Poppy/0000-0003-1048-6318	Royal Society Dorothy Hodgkin Clore Fellowship	This work was supported by a Royal Society Dorothy Hodgkin Clore Fellowship to CMG. PZQ and albendazole was supplied by the Schistosomiasis Control Initiative and the National Schistosomiasis Control Programme.	Aemero M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0297-6; Anderson RM, 2016, ADV PARASIT, V94, P199, DOI 10.1016/bs.apar.2016.06.003; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P53; Barbosa LM, 2016, INT J PARASITOL, V46, P343, DOI 10.1016/j.ijpara.2016.01.007; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233; CHEEVER AW, 1968, AM J TROP MED HYG, V17, P38, DOI 10.4269/ajtmh.1968.17.38; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Crellen T, 2016, CLIN INFECT DIS, V63, P1151, DOI 10.1093/cid/ciw506; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; FELSENSTEIN J, PHYLIP PHYLOGENY INF; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8278.2004.00828.x; Goudet J., FSTAT COMPUTER PROGR; Gower CM, 2007, PARASITOLOGY, V134, P523, DOI 10.1017/S0031182006001685; Gower CM, 2011, PARASITOLOGY, V138, P978, DOI 10.1017/S0031182011000722; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Huyse T, 2013, INFECT GENET EVOL, V18, P100, DOI 10.1016/j.meegid.2013.05.007; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Lamberton PH, 2014, PLOS NEGLECT TROP D, V8, P3139; Lamberton PHL, 2010, AM J TROP MED HYG, V83, P1340, DOI 10.4269/ajtmh.2010.10-0413; Lelo AE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003221; Liang YS, 2001, INT J PARASITOL, V31, P1227, DOI 10.1016/S0020-7519(01)00246-6; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Norton AJ, 2010, AM J TROP MED HYG, V83, P951, DOI 10.4269/ajtmh.2010.10-0283; Rudge JW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000340; Steinauer ML, 2009, INT J PARASITOL, V39, P1157, DOI 10.1016/j.ijpara.2009.02.019; Wang JL, 2003, GENETICS, V163, P429; Webster JP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0434; Webster JP, 2008, EVOL APPL, V1, P66, DOI 10.1111/j.1752-4571.2007.00012.x; William S, 2001, INT J PARASITOL, V31, P1093, DOI 10.1016/S0020-7519(01)00215-6; World Health Organization, 2012, ACC WORK OV GLOB IMP; Zwang J, 2014, PLOS NEGLECT TROP D, V20, P3286	35	3	3	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 2	2017	10								593	10.1186/s13071-017-2533-6				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FO6HX	WOS:000416965200003	29197426	DOAJ Gold, Green Published			2019-03-26
J	Rahmouni, C; Vanhove, MPM; Simkova, A				Rahmouni, Chahrazed; Vanhove, Maarten P. M.; Simkova, Andrea			Underexplored diversity of gill monogeneans in cichlids from Lake Tanganyika: eight new species of Cichlidogyrus Paperna, 1960 (Monogenea: Dactylogyridae) from the northern basin of the lake, with remarks on the vagina and the heel of the male copulatory organ	PARASITES & VECTORS			English	Article						Africa; Burundi; Cichlidae; Cyprichromini; Ectodini; Eretmodini; Platyhelminthes; Monogenea; Cichlidogyrus	LEONE WEST-AFRICA; FRESH-WATER FISH; GENUS CICHLIDOGYRUS; ANCYROCEPHALIDAE MONOGENEA; CONGENERIC MONOGENEANS; PARASITE DIVERSITY; TELEOSTEI; PISCES; SAROTHERODON; PHYLOGENY	Background: Lake Tanganyika harbours the most diverse cichlid assemblage of the Great African Lakes. Considering its cichlid flocks consist of approximately 250 endemic species, we can hypothesize a high species-richness in their often quite host-specific monogenean ectoparasites belonging to Cichlidogyrus Paperna, 1960. Yet, only 24 species were described from Tanganyikan hosts and some host tribes have never been investigated for monogeneans. This study presents the first parasitological examination of species of the tribes Cyprichromini (Cyprichromis microlepidotus (Poll, 1956)), Eretmodini (Eretmodus marksmithi Burgess, 2012 and Tanganicodus irsacae Poll, 1950) and Ectodini (Aulonocranus dewindti (Boulenger, 1899)). Specimens of the ectodine Ophthalmotilapia nasuta (Poll & Matthes, 1962) from which four Cichlidogyrus spp. have been previously described from more southern localities were also studied. Further, we discuss the haptor configuration in Tanganyikan Cichlidogyrus spp. and highlight the morphological diversity of the vagina, and that of the heel, a sclerotized part of the male copulatory organ, absent in some species of Cichlidogyrus. Methods: Cichlidogyrus spp. were isolated from gills and fixed using GAP. Haptoral and genital hard parts were measured and drawn by means of a phase contrast microscopic examination. Results: We describe eight new species: Cichlidogyrus milangelnari n. sp. on C. microlepidotus; C. jeanloujustinei n. sp. on E. marksmithi; C. evikae n. sp. on T. irsacae; C. aspiralis n. sp., C. glacicremoratus n. sp. and C. rectangulus n. sp. on O. nasuta; and C. pseudoaspiralis n. sp. and C. discophonum n. sp. on A. dewindti. Three haptoral morphotypes were recognized among the new species. Species of Cichlidogyrus from closely related hosts exhibited the same morphotypes. Geographical variation in Cichlidogyrus spp. fauna as observed in O. nasuta and three morphotypes were distinguished. Finally, we listed 111 Cichlidogyrus species, of which 27 and three Tanganyikan species lack sclerotized vagina and heel, respectively, just like 19 and seven species outside of the lake. Conclusions: Haptoral and genital features in the Tanganyikan Cichlidogyrus fauna reflect the phylogenetic relationships of their cichlid hosts. It seems that several lineages of Cichlidogyrus spp. exist in Lake Tanganyika but further studies are necessary to confirm this hypothesis and answer questions related to Lake Tanganyika and its cichlids.	[Rahmouni, Chahrazed; Vanhove, Maarten P. M.; Simkova, Andrea] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CZ-61137 Brno, Czech Republic; [Vanhove, Maarten P. M.] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Capac Biodivers & Sustainable Dev CEBioS, Vautierstr 29, B-1000 Brussels, Belgium; [Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Charles Deberiotstr 32, B-3000 Leuven, Belgium; [Vanhove, Maarten P. M.] Hasselt Univ, Ctr Environm Sci, Res Grp Zool Biodivers & Toxicol, B-3590 Diepenbeek, Belgium	Rahmouni, C (reprint author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CZ-61137 Brno, Czech Republic.	rahmouni.chahrazed@gmail.com			Czech Science Foundation - European Centre of Ichtyoparasitology (ECIP) [P505/12/G112]	This research was funded by the Czech Science Foundation project no. P505/12/G112 - European Centre of Ichtyoparasitology (ECIP).	Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; BIRGI E, 1986, ANN PARASIT HUM COMP, V61, P521, DOI 10.1051/parasite/1986615521; BIRGI E, 1983, B SOC ZOOL FR, V108, P101; Bukinga FM, 2012, PARASITOL RES, V111, P2049, DOI 10.1007/s00436-012-3052-1; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; DOSSOU C, 1984, ANN SCI NAT ZOOL, V6, P101; DOSSOU C, 1982, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V44, P295; DOUELLOU L, 1993, SYST PARASITOL, V25, P159, DOI 10.1007/BF00007007; ERGENS R, 1981, FOLIA PARASIT, V28, P205; Froese R., FISHBASE; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; Gregoir AF, 2015, FRESHWATER BIOL, V60, P323, DOI 10.1111/fwb.12492; Gussev AV, 1983, NAUK LENINGR, V48; Hanssens M, 1999, ZOOL J LINN SOC-LOND, V125, P487, DOI 10.1111/j.1096-3642.1999.tb00602.x; Hizelle J. D., 1936, American Midland Naturalist, V17, P785; Jorissen MWP, 2018, J HELMINTHOL, V92, P417, DOI 10.1017/S0022149X17000712; Kmentova N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39605; Kmentova N, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1696-x; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; Koblmuller S, 2004, J MOL EVOL, V58, P79, DOI 10.1007/s00239-003-2527-1; Konings A., 2015, TANGANYIKA CICHLIDS; KRITSKY DC, 1986, P HELM SOC WASH, V53, P1; Maan ME, 2013, SEMIN CELL DEV BIOL, V24, P516, DOI 10.1016/j.semcdb.2013.05.003; Malmberg G., 1957, Skr Sverig Fisk Foren, V1956, P19; MANDENG FDM, 2015, PARASIT VECTORS, V8; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Meyer BS, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140498; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Musilova N, 2009, ZOOTAXA, P47; N'Douba Valentin, 1997, Journal of African Zoology, V111, P429; Nevado B, 2011, MOL BIOL EVOL, V28, P2253, DOI 10.1093/molbev/msr043; Paperna I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA I, 1969, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V31, P840; PAPERNA I, 1964, ISRAEL J ZOOL, V13, P1; Paperna I, 1968, BAMIDGEH B FISH CULT, V20, P80; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; PAPERNA ILAN, 1965, BAMIDGEH, V17, P107; Pariselle A, 1998, FOLIA PARASIT, V45, P275; PARISELLE A, 1995, PARASITE, V2, P203, DOI 10.1051/parasite/199502s2203; PARISELLE A, 1994, SYST PARASITOL, V29, P229, DOI 10.1007/BF00009678; Pariselle A, 2004, PARASITE, V11, P359, DOI 10.1051/parasite/2004114359; Pariselle A, 1997, SYST PARASITOL, V38, P221, DOI 10.1023/A:1005803202543; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; Pariselle A, 2003, FOLIA PARASIT, V50, P195, DOI 10.14411/fp.2003.035; PARISELLE A, 1995, SYST PARASITOL, V30, P187, DOI 10.1007/BF00010469; Pariselle A., 2011, INT J EVOL BIOL, V2011, DOI DOI 10.4061/2011/471480; Pariselle A, 2015, CONTRIB ZOOL, V84, P25; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle A, 2014, ZOOTAXA, V3881, P258, DOI 10.11646/zootaxa.3881.3.4; Pariselle A, 2013, ZOOTAXA, V3599, P78, DOI 10.11646/zootaxa.3599.1.7; Pariselle Antoine, 2003, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Poulin R, 2002, INT J PARASITOL, V32, P245, DOI 10.1016/S0020-7519(01)00329-0; Pouyaud L, 2006, MOL PHYLOGENET EVOL, V38, P242; Price C. E., 1967, Revue de Zoologie et de Botanique Africaines, V76, P137; Price C. E., 1969, Revue de Zoologie et de Botanique Africaines, V79, P117; Rehulkova E, 2013, PARASITOL RES, V112, P1399, DOI 10.1007/s00436-013-3291-9; Simkova A, 2008, J FISH BIOL, V73, P2210, DOI 10.1111/j.1095-8649.2008.02064.x; Simkova A, 2006, EVOLUTION, V60, P1023, DOI 10.1554/05-521.1; Snoeks J, 2000, ADV ECOL RES, V31, P17, DOI 10.1016/S0065-2504(00)31005-4; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Takahashi T, 2011, INT J EVOLUTIONARY B, V2011, DOI DOI 10.4061/2011/620754; Takahashi T, 2016, MOL PHYLOGENET EVOL, V100, P234, DOI 10.1016/j.ympev.2016.04.012; Van Steenberge M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124474; Van Steenberge M, 2011, ACTA ICHTHYOL PISCAT, V41, P201, DOI 10.3750/AIP2011.41.3.08; Vanhove MPM, 2016, TRENDS PARASITOL, V32, P820, DOI 10.1016/j.pt.2016.07.002; Vanhove MPM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13669; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vanhove MPM, 2012, THESIS; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x	71	2	2	2	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 2	2017	10								591	10.1186/s13071-017-2460-6				21	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FO6HX	WOS:000416965200001	29197419	DOAJ Gold, Green Published			2019-03-26
J	Nkanga, MSN; Longo-Mbenza, B; Vandenberghe, P; Verdonck, F; Tchokonte-Nana, V; Nlandu, NC; Miakassissa, RLM; Kazadi, PRB; Katawandja, AL; Ngwidiwo, JB; Mufuta, NJP; Solo, KT; Beia, MACO				Nkanga, Mireille Solange Nganga; Longo-Mbenza, Benjamin; Vandenberghe, Peter; Verdonck, Fons; Tchokonte-Nana, Venant; Nlandu, Nkama Claude; Miakassissa, Roth Laure Mapapa; Kazadi, Paul Roger Beia; Katawandja, Antoine Lufimbo; Ngwidiwo, Jacques Bikaula; Mufuta, Ntolo Jean-Pierre; Solo, Kuanda Thomas; Beia, Mbombo Aurore Cecilia Orphee			Feasibility of iFISH patterns in hematologic malignancies among Congolese patients at Kinshasa University clinics	ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE			English	Article								Objective: To analyze the feasibility of detecting Ph-1 in leukemia patients in the Kinshasa University Clinics in the Democratic Republic of Congo, at KU Leuven, Belgium. Methods: Bone marrow and peripheral blood samples with chronic myeloid leukemia, acute myeloid leukemia or acute leukocytes leukemia were obtained from 32 patients in Kinshasa University clinics in the Democratic Republic of Congo and transferred to KU Leuven in Belgium for iFISH feasibility. Ph-1 was detected by using a remote analysis of interphase fluorescence in situ hybridization (iFISH). Results: Out of the 32 patients involved in this study, 65.6% (n = 21) of the cases were successfully tested, of which 52.4% (n = 11) were iFISH positives for the variant t(9; 22) (presence of Ph-1) in chronic myeloid leukemia samples and 47.6% (n = 10) negatives in all subtypes of hematological malignancies. However, there was a female predominance in chronic myeloid leukemia samples Ph-1-positives by iFISH, whereas no sexual influence was observed on acute subtypes of leukemia. Conclusions: iFISH analysis is feasible on samples obtained from remote sites in the Democratic Republic of Congo. However, the optimization of the sample storage is necessary to further improve iFISH's performance.	[Nkanga, Mireille Solange Nganga; Katawandja, Antoine Lufimbo; Ngwidiwo, Jacques Bikaula; Beia, Mbombo Aurore Cecilia Orphee] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Longo-Mbenza, Benjamin] Univ President Kasa Vubu, Boma, DEM REP CONGO; [Vandenberghe, Peter; Verdonck, Fons] Katholieke Univ Leuven, UZ Gasthuisberg, Leuven, Belgium; [Tchokonte-Nana, Venant] Stellenbosch Univ, Fac Med & Hlth Sci, Stellenbosch, South Africa; [Miakassissa, Roth Laure Mapapa] Univ Hosp Brazzaville, Pediatr Serv, Brazzaville, DEM REP CONGO; [Mufuta, Ntolo Jean-Pierre] Ngaliema Clin, Kinshasa, DEM REP CONGO; [Solo, Kuanda Thomas] Univ Kinshasa, Reg Ctr Nucl Studies Kinshasa, Kinshasa, DEM REP CONGO	Tchokonte-Nana, V (reprint author), Stellenbosch Univ, Fac Med & Hlth Sci, Stellenbosch, South Africa.	venant@sun.ac.za		Tchokonte-Nana, Venant/0000-0003-2240-3735			Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Asif M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00124; Avet-Loiseau H., 2007, SPECTRA BIOL, V26, P82; Chinese Society of Hematology Chinese Medical Association, 2016, Zhonghua Xue Ye Xue Za Zhi, V37, P846, DOI 10.3760/cma.j.issn.0253-2727.2016.10.004; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Demyda-Peyras S, 2013, CYTOGENET GENOME RES, V141, P277, DOI 10.1159/000351225; Diagnekpo T, 1992, MED AFR NOIRE, V39, P268; Diallo D A, 2005, Mali Med, V20, P1; DRACH J, 1995, BLOOD, V86, P3915; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Errahhali ME, 2016, BMC CANCER, P159; Hossain MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-438; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Kantarjian HM, 2006, BLOOD, V108, P1835, DOI 10.1182/blood-2006-02-004325; Lee YK, 2002, INT J HEMATOL, V76, P180, DOI 10.1007/BF02982582; Marum JE, 2016, THER ADV HEMATOL, V7, P237, DOI 10.1177/2040620716657994; Mashinda KD, 2012, ANN AFR MED, V6, P1087; Mireille NN, 2017, J INNOV RES HEAL SCI, V2, P345; Mounkaila B, 1996, MED AFR NOIRE, V43, P8; Mufuta JP, 2014, RMJ, V71, P5; Najfeld V., 2008, MOL GENETIC PATHOLOG, P303; Nkanga MSN, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3547-3; Nwannadi IA, 2011, J EPIDEMIOL, V9, P2; Omoti CE, 2012, PAN AFR MED J, V11; Palandri F, 2009, CLIN CANCER RES, V15, P1059, DOI 10.1158/1078-0432.CCR-08-1195; Sabatini E, 2010, PATHOLOGICA, V102, P83; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Sarwar Sohail, 2015, J Ayub Med Coll Abbottabad, V27, P371; Schmid C, 2005, J CLIN ONCOL, V23, P5675, DOI 10.1200/JCO.2005.07.061; Sreekantaiah C, 2007, CYTOGENET GENOME RES, V118, P284, DOI 10.1159/000108312; Wang JN, 2016, ADV CARDIOVASC DIS, V37, P412; Zamecnikova A, 2010, EXPERT REV HEMATOL, V3, P45, DOI [10.1586/ehm.09.66, 10.1586/EHM.09.66]; Zhou H, 2015, PROTEIN CELL, V6, P403, DOI 10.1007/s13238-015-0143-7	33	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2221-1691	2588-9222		ASIAN PAC J TROP BIO	Asian Pac. Trop. Biomed.	DEC	2017	7	12					1116	1119		10.1016/j.apjtb.2017.10.014				4	Tropical Medicine	Tropical Medicine	FR6YT	WOS:000419214100010		DOAJ Gold			2019-03-26
J	Fontes, ANB; Lima, LNGC; Mota, RMS; Almeida, RLF; Pontes, MA; Goncalves, HD; Frota, CC; Vissa, VD; Brennan, PJ; Guimaraes, RJPS; Kendall, C; Kerr, LRFS; Suffys, PN				Fontes, Amanda N. B.; Lima, Luana N. G. C.; Mota, Rosa M. S.; Almeida, Rosa L. F.; Pontes, Maria A.; Goncalves, Heitor de S.; Frota, Cristiane C.; Vissa, Varalakshmi D.; Brennan, Patrick J.; Guimaraes, Ricardo J. P. S.; Kendall, Carl; Kerr, Ligia R. F. S.; Suffys, Philip N.			Genotyping of Mycobacterium leprae for better understanding of leprosy transmission in Fortaleza, Northeastern Brazil	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SHORT TANDEM REPEATS; MOLECULAR EPIDEMIOLOGY; NORTHERN INDIA; RISK-FACTORS; SKIN BIOPSY; STRAINS; POPULATION; REGION; DIVERSITY; CHINA	Leprosy is endemic in large part of Brazil with 28,761 new patients in 2015, the second largest number worldwide and reaches 9/10.000 in highly endemic regions and 2.7/10.000 in the city of Fortaleza, Ceara A, Northeast Brazil. For better understanding of risk factors for leprosy transmission, we conducted an epidemiologic study supplemented by 17 locus VNTR and SNP 1-4 typing of Mycobacterium leprae in skin biopsy samples from new multibacillary (MB) patients diagnosed at a reference center in 2009 and 2010. Among the 1,519 new patients detected during the study period, 998 (65.7%) were MB and we performed DNA extraction and genotyping on 160 skin biopsy samples, resulting in 159 (16%) good multilocus VNTR types. Thirty-eight of these patients also provided VNTR types from M. leprae in nasal swabs. The SNP-Type was obtained for 157 patients and 87% were of type 4. Upon consideration all VNTR markers, 156 different genotypes and three pairs with identical genotypes were observed; no epidemiologic relation could be observed between individuals in these pairs. Considerable variability in differentiating index (DI) was observed between the different markers and the four with highest DI [(AT) 15, (TA) 18, (AT) 17 and (GAA) 21] frequently demonstrated differences in copy number when comparing genotypes from both type of samples. Excluding these markers from analysis resulted in 83 genotypes, 20 of which included 96 of the patients (60.3%). These clusters were composed of two (n = 8), three (n = 6), four (n = 1), five (n = 2), six (n = 1), 19 (n = 1) and 23 (n = 23) individuals and suggests that recent transmission is contributing to the maintenance of leprosy in Fortaleza. When comparing epidemiological and clinical variables among patients within clustered or with unique M. leprae genotypes, a positive bacterial index in skin biopsies and knowledge of working with someone with the disease were significantly associated with clustering. A tendency to belong to a cluster was observed with later notification of disease (mean value of 3.4 months) and having disability grade 2. A tendency for lack of clustering was observed for patients who reported to have lived with another leprosy case but this might be due to lack of inclusion of household contacts in the study. Although clusters were spread over the city, kernel analysis revealed that some of the patients belonging to the two major clusters were spatially related to some neighborhoods that report poverty and high disease incidence in children. Finally, inclusion of genotypes from nasal swabs might be warranted. A major limitation of the study is that sample size of 160 patients from a two year period represents only 15% of the new patients and this could have weakened statistical outcomes. This is the first molecular epidemiology study of leprosy in Brazil and although the high clustering level suggests that recent transmission is the major cause of disease in Fortaleza; the existence of two large clusters needs further investigation.	[Fontes, Amanda N. B.; Suffys, Philip N.] Oswaldo Cruz Inst, Lab Mol Biol Appl Mycobacteria, Rio De Janeiro, Brazil; [Lima, Luana N. G. C.] State Hlth Off, Dept Pathol, Fortaleza, Ceara, Brazil; [Mota, Rosa M. S.] Univ Fed Ceara, Dept Stat & Appl Math, Fortaleza, Ceara, Brazil; [Almeida, Rosa L. F.] Univ Fortaleza, Post Grad Program Publ Hlth, Fortaleza, Ceara, Brazil; [Pontes, Maria A.; Goncalves, Heitor de S.] State Hlth Off, Reference Ctr Dermatol Dona Libania, Fortaleza, Ceara, Brazil; [Frota, Cristiane C.] Univ Fed Ceara, Dept Pathol, Fortaleza, Ceara, Brazil; [Vissa, Varalakshmi D.; Brennan, Patrick J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Guimaraes, Ricardo J. P. S.] Evandro Chagas Inst, Lab Geoproc, Belem, Para, Brazil; [Kendall, Carl] Tulane Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Kendall, Carl; Kerr, Ligia R. F. S.] Univ Fed Ceara, Coll Med, Dept Community Hlth, Fortaleza, Ceara, Brazil; [Suffys, Philip N.] Trop Inst Med, Mycobacteriol Unit, Dept Biomed Sci, Antwerp, Belgium	Suffys, PN (reprint author), Oswaldo Cruz Inst, Lab Mol Biol Appl Mycobacteria, Rio De Janeiro, Brazil.; Suffys, PN (reprint author), Trop Inst Med, Mycobacteriol Unit, Dept Biomed Sci, Antwerp, Belgium.	psuffys@gmail.com	Almeida, Rosa/M-7962-2018; Frota, Cristiane/M-7424-2018; Guimaraes, Ricardo/F-7182-2015; KERR, LIGIA/F-9250-2012	Almeida, Rosa/0000-0001-6423-543X; Frota, Cristiane/0000-0003-0018-7736; Guimaraes, Ricardo/0000-0002-5767-4765; KERR, LIGIA/0000-0003-4941-408X	Ministerio de Ciencia e Tecnologia (MCT)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio de Saude (MS)- Secretaria de Ciencia, Tecnologia e Insumos Estrategicos (SCTIE)-Departamento de Ciencia e Tecnologia (DECIT) [410573/2006-0]; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) [CI1-0050-00057.01.00/11-003/2011 PNP-0058-00121.01.01/11-007/201]; Damien Foundation-International Federation of Anti-Leprosy Associations (ILEP); National Institute of Health NIH (NIH)/ National Institute of Allergy and Infectious Diseases (NIAID) [AI 47197]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Programa Estrategico de Apoio a Pesquisa em Saude (PAPES) [407624/2012-0]	"This project was supported by the following funding agencies: ""Ministerio de Ciencia e Tecnologia (MCT)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio de Saude (MS)- Secretaria de Ciencia, Tecnologia e Insumos Estrategicos (SCTIE)-Departamento de Ciencia e Tecnologia (DECIT) (410573/2006-0)(LRFSKP); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) (CI1-0050-00057.01.00/11-003/2011 PNP-0058-00121.01.01/11-007/201)(LRFSKP); Damien Foundation-International Federation of Anti-Leprosy Associations (ILEP) (PNS); National Institute of Health NIH (NIH)/ National Institute of Allergy and Infectious Diseases (NIAID) (grant AI 47197) (PJB VDV PNS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Programa Estrategico de Apoio a Pesquisa em Saude (PAPES) (407624/2012-0) (PNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Araujo S, 2016, CLIN INFECT DIS; Ferreira SMB, 2011, REV SAUDE PUBL, V45, P756, DOI 10.1590/s0034-89102011005000043; Boletim Epidemiologico Hanseniase, 2016, COORD PROM PROT SAUD; Bratschi MW, 2015, LEPROSY REV, V86, P142; Brito Aline Lima, 2016, Rev. bras. epidemiol., V19, P194, DOI 10.1590/1980-5497201600010017; Fontes ANB, 2012, MEM I OSWALDO CRUZ, V107, P143, DOI 10.1590/S0074-02762012000900021; Fontes ANB, 2009, LEPROSY REV, V80, P302; Cardona-Castro N, LEPR REV, V80, P316; Cardona-Castro N, 2013, INFECT GENET EVOL, V14, P375, DOI 10.1016/j.meegid.2012.12.015; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; De Lamano LR, 2013, 18 INT LEPR C BRUSS, P158; Ferreira MLLT, 2008, CAD SAUDE COLETIVA, V16, P243; Fine PEM, 1997, AM J EPIDEMIOL, V146, P91; FRANCOPAREDES C, 2016, ANN CLIN MICROB ANTI, V15, P45825; Frota CC, 2010, T ROY SOC TROP MED H, V104, P490, DOI 10.1016/j.trstmh.2010.03.006; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Lima LNGC, 2015, MEM I OSWALDO CRUZ, V110, P898, DOI 10.1590/0074-02760150178; Groathouse NA, 2004, J CLIN MICROBIOL, V42, P1666, DOI 10.1128/JCM.42.4.1666-1672.2004; HARTSKEERL RA, 1989, J GEN MICROBIOL, V135, P2357; Heukelbach J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001031; IBGE, 2017, CID CEAR FORT; Kazda J., 2000, ECOLOGY MYCOBACTERIU; Kerr-Pontes LRS, 2006, INT J EPIDEMIOL, V35, P994, DOI 10.1093/ije/dyl072; Kerr-Pontes LRS, 2004, INT J EPIDEMIOL, V33, P262, DOI 10.1093/ije/dyh002; Kimura M, 2009, J CLIN MICROBIOL, V47, P1757, DOI 10.1128/JCM.02019-08; Lavania M, 2007, INFECT GENET EVOL, V7, P627, DOI 10.1016/j.meegid.2007.05.011; Lavania M, 2015, INFECT GENET EVOL, V36, P256, DOI 10.1016/j.meegid.2015.10.001; Lavania M, 2011, INDIAN J MED RES, V133, P618; Li W, 2011, ANTIMICROB AGENTS CH, V55, P5384, DOI 10.1128/AAC.05236-11; LIESACK W, 1990, LETT APPL MICROBIOL, V11, P96, DOI 10.1111/j.1472-765X.1990.tb01285.x; Lima LNGC, 2016, LEPROSY REV, V87, P486; Matsuoka M, 2000, INT J LEPROSY, V68, P121; Matsuoka M, 2009, LEPROSY REV, V80, P322; Monot M, 2005, SCIENCE, V308, P1040, DOI [10.1126/science/1109759, 10.1126/science.1109759]; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Montenegro ACD, 2004, MEM I OSWALDO CRUZ, V99, P683, DOI 10.1590/S0074-02762004000700003; Murto M, 2013, PLOS NEGLECT TROP D, V7, pe2422; Phetsuksiri B, 2012, JPN J INFECT DIS, V65, P52; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rocha AD, 2012, J CLIN MICROBIOL, V50, P1912, DOI 10.1128/JCM.06561-11; Rocha AD, 2011, J MED MICROBIOL, V60, P1441, DOI 10.1099/jmm.0.029389-0; Rosa PS, 2013, 18 INT LEPR C BRUSS, P139; Sakamuri RM, 2009, LEPROSY REV, V80, P272; Sakamuri RM, 2009, J CLIN MICROBIOL, V47, P2844, DOI 10.1128/JCM.02021-08; Santos SM, 2007, TEXTOS BASICOS SAU B, V3; SESA-Secretaria da Saude do Estado do Ceara, 2014, INF EP HAN; Sharma R, 2015, EMERG INFECT DIS, V21, P2127, DOI 10.3201/eid2112.150501; Shin YC, 2000, J CLIN MICROBIOL, V38, P4535; Shinde V, 2009, LEPROSY REV, V80, P290; Singh P, 2011, ANTIMICROB AGENTS CH, V55, P2971, DOI 10.1128/AAC.00201-11; Srisungnam S, 2009, LEPROSY REV, V80, P280; Suffys PN, 2013, 18 INT LEPR C BRUSS, P156; Truman R, 2004, J CLIN MICROBIOL, V42, P2558, DOI 10.1128/JCM.42.6.2558-2565.2004; van Beers SM, 1999, INT J LEPROSY, V67, P119; Visschedijk J, 2000, TROP MED INT HEALTH, V5, P388, DOI 10.1046/j.1365-3156.2000.00572.x; Weng XM, 2007, J CLIN MICROBIOL, V45, P1728, DOI 10.1128/JCM.00018-07; Weng XM, 2013, INFECT GENET EVOL, V14, P361, DOI 10.1016/j.meegid.2012.12.009; Weng XM, 2011, INFECT GENET EVOL, V11, P363, DOI 10.1016/j.meegid.2010.11.014; Xing Y, 2009, LEPROSY REV, V80, P261; Young SK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000214; Zhang LF, 2005, J CLIN MICROBIOL, V43, P5221, DOI 10.1128/JCM.43.10.5221-5229.2005	62	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2017	11	12							e0006117	10.1371/journal.pntd.0006117				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FR5LR	WOS:000419108500028	29244821	DOAJ Gold, Green Published			2019-03-26
J	Ponte-Sucre, A; Gamarro, F; Dujardin, JC; Barrett, MP; Lopez-Velez, R; Garcia-Hernandez, R; Pountain, AW; Mwenechanya, R; Papadopoulou, B				Ponte-Sucre, Alicia; Gamarro, Francisco; Dujardin, Jean-Claude; Barrett, Michael P.; Lopez-Velez, Rogelio; Garcia-Hernandez, Raquel; Pountain, Andrew W.; Mwenechanya, Roy; Papadopoulou, Barbara			Drug resistance and treatment failure in leishmaniasis: A 21st century challenge	PLOS NEGLECTED TROPICAL DISEASES			English	Review							AMPHOTERICIN-B RESISTANCE; PROTOZOAN PARASITE LEISHMANIA; ABC-TRANSPORTER MRPA; VISCERAL LEISHMANIASIS; DONOVANI PROMASTIGOTES; CUTANEOUS LEISHMANIASIS; MILTEFOSINE RESISTANCE; ANTIMONY-RESISTANT; MEGLUMINE ANTIMONIATE; SODIUM STIBOGLUCONATE	"Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem. Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system. Pentavalent antimonials have been used successfully worldwide for the treatment of leishmaniasis since the first half of the 20th century, but the last 10 to 20 years have witnessed an increase in clinical resistance, e.g., in North Bihar in India. In this review, we discuss the meaning of ""resistance"" related to leishmaniasis and discuss its molecular epidemiology, particularly for Leishmania donovani that causes visceral leishmaniasis. We also discuss how resistance can affect drug combination therapies. Molecular mechanisms known to contribute to resistance to antimonials, amphotericin B, and miltefosine are also outlined."	[Ponte-Sucre, Alicia] Univ Cent Venezuela, Inst Expt Med, Luis Razetti Sch Med, Dept Physiol Sci,Lab Mol Physiol, Caracas, Venezuela; [Gamarro, Francisco; Garcia-Hernandez, Raquel] Spanish Natl Res Council IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Biochem & Mol Pharmacol, Granada, Spain; [Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, Mol Parasitol Unit, Antwerp, Belgium; [Barrett, Michael P.; Pountain, Andrew W.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Lopez-Velez, Rogelio] Ramon & Cajal Univ Hosp, Dept Infect Dis, Natl Referral Unit Trop Dis, Madrid, Spain; [Mwenechanya, Roy] Univ Zambia, Sch Vet Med, Dept Biomed Sci, Lusaka, Zambia; [Papadopoulou, Barbara] CHU Quebec Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada; [Papadopoulou, Barbara] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada	Ponte-Sucre, A (reprint author), Univ Cent Venezuela, Inst Expt Med, Luis Razetti Sch Med, Dept Physiol Sci,Lab Mol Physiol, Caracas, Venezuela.; Papadopoulou, B (reprint author), CHU Quebec Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada.; Papadopoulou, B (reprint author), Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada.	aiponte@gmail.com; barbara.papadopoulou@crchudequebec.ulaval.ca		Pountain, Andrew/0000-0001-9651-5145	Canadian Institutes of Health Research [MOP-12182]; Spanish Grant Proyecto de Excelencia, Junta de Andalucia [CTS-7282]; Wellcome Trust [104111/Z/14/Z]; Alexander von Humboldt Foundation, Germany;  [SAF2015-68042-R]	Research reported in this publication was supported by the Canadian Institutes of Health Research operating grant MOP-12182 awarded to BP; the Spanish Grant Proyecto de Excelencia, Junta de Andalucia Ref. CTS-7282 awarded to FG; the Spanish Grant SAF2015-68042-R awarded to FG; the Wellcome Trust (104111/Z/14/Z) awarded to MPB; and the Alexander von Humboldt Foundation, Germany awarded to APS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354; Al-Mohammed HI, 2005, ANTIMICROB AGENTS CH, V49, P3274, DOI 10.1128/AAC.49.8.3274-3280.2005; Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; Andrade-Narvaez FJ, 2016, MEM I OSWALDO CRUZ, V111, P599, DOI 10.1590/0074-02760160138; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Azas N, 2001, PARASITE, V8, P335, DOI 10.1051/parasite/2001084335; Barratt G, 2009, CURR DRUG METAB, V10, P247, DOI 10.2174/138920009787846332; Berg M, 2015, ANTIMICROB AGENTS CH, V59, P2242, DOI 10.1128/AAC.04231-14; Berg M, 2013, PARASITOLOGY, V140, P1492, DOI 10.1017/S0031182013000140; Bhandari V, 2014, ANTIMICROB AGENTS CH, V58, P2580, DOI 10.1128/AAC.01574-13; BHATTACHARYYA T, 2014, PLOS NEGLECT TROP D, V8, P45825; Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355; Brochu C, 2003, ANTIMICROB AGENTS CH, V47, P3073, DOI 10.1128/AAC.47.10.3073-3079.2003; Brotherton MC, 2014, INT J PARASITOL-DRUG, V4, P126, DOI 10.1016/j.ijpddr.2014.05.002; Castanys S., 2013, DRUG RESISTANCE LEIS; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Coelho AC, 2003, MOL BIOCHEM PARASIT, V130, P83, DOI 10.1016/S0166-6851(03)00162-2; COELHO AC, 2012, PLOS NEGLECT TROP D, V6, P45825; Cojean S, 2012, EMERG INFECT DIS, V18, P704, DOI 10.3201/eid1804.110841; Coutinho Sergio G, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS173; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI [10.1128/CMR.19.1.111-126.2006, 10.4103/0974-777X.62887]; Das M, 2013, FEBS J, V280, P4807, DOI 10.1111/febs.12449; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/BSE0510031, 10.1042/bse0510031]; Deep DK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005641; Dickens NJ, 2017, PLOS NEGLECT TROP D, V11; Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Dorlo TPC, 2012, ANTIMICROB AGENTS CH, V56, P3864, DOI 10.1128/AAC.00292-12; Dumetz F, 2017, MBIO, V8, DOI [10.1128/mBio.00599-17, 10.1128/mbio.00599-17]; Eichenberger A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2192-4; El Fadili K, 2005, ANTIMICROB AGENTS CH, V49, P1988, DOI 10.1128/AAC.49.5.1988-1993.2005; Fernandez-Prada C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005171; Forastiero A, 2013, ANTIMICROB AGENTS CH, V57, P4769, DOI 10.1128/AAC.00477-13; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Garcia-Hernandez R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003704; GARCIAHERNANDEZ R, 2012, PLOS NEGL TROP DIS, V6, P45825; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Hartley MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00099; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; Hefnawy A, 2017, TRENDS PARASITOL, V33, P162, DOI 10.1016/j.pt.2016.11.003; Hendrickx S, 2016, J ANTIMICROB CHEMOTH, V71, P1914, DOI 10.1093/jac/dkw096; Imamura H, 2016, ELIFE, V5, DOI 10.7554/eLife.12613; Jhingran A, 2009, MOL BIOCHEM PARASIT, V164, P111, DOI 10.1016/j.molbiopara.2008.12.007; Kulshrestha A, 2014, PARASITOL RES, V113, P1171, DOI 10.1007/s00436-014-3755-6; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P6172, DOI 10.1128/AAC.02834-14; Kundig C, 1999, NUCLEIC ACIDS RES, V27, P3653, DOI 10.1093/nar/27.18.3653; Laffitte Marie-Claude N, 2016, F1000Res, V5, P2350, DOI 10.12688/f1000research.9218.1; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136; Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436; Lux H, 2000, MOL BIOCHEM PARASIT, V111, P1, DOI 10.1016/S0166-6851(00)00278-4; Machado PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000912; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Mannaert A, 2012, TRENDS PARASITOL, V28, P370, DOI 10.1016/j.pt.2012.06.003; Manzano JI, 2013, ANTIMICROB AGENTS CH, V57, P3719, DOI 10.1128/AAC.00211-13; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Martinez-Valencia AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005713; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; Melaku Y, 2007, AM J TROP MED HYG, V77, P89, DOI 10.4269/ajtmh.2007.77.89; Mishra J, 2013, EXP PARASITOL, V135, P397, DOI 10.1016/j.exppara.2013.08.004; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Mohebali M, 2007, ACTA TROP, V103, P33, DOI 10.1016/j.actatropical.2007.05.005; Mondal D, 2014, LANCET GLOB HEALTH, V2, pE51, DOI 10.1016/S2214-109X(13)70118-9; Mondelaers A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154101; Morizot G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004304; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674; Newton PN, 2010, TRENDS PHARMACOL SCI, V31, P99, DOI 10.1016/j.tips.2009.11.005; OMOLLO R, 2011, TRIALS, V12, P45825; OSTYN B, 2011, PLOS NEGLECT TROP D, V5, P45825; Ostyn B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100220; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Perea A, 2016, ANTIMICROB AGENTS CH, V60, P3489, DOI 10.1128/AAC.02813-15; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Perez-Victoria JM, 2001, ANTIMICROB AGENTS CH, V45, P2468, DOI 10.1128/AAC.45.9.2468-2474.2001; Perry MR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003518; Perry MR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001227; Ponte-Sucre A, 2013, DRUG RESISTANCE LEIS, P431; Ponte-Sucre A., 2003, KINETOPLASTID BIOL D, V28, P2, DOI DOI 10.1186/1475-9292-2-14; Pourshafie M, 2004, ANTIMICROB AGENTS CH, V48, P2409, DOI 10.1128/AAC.48.7.2409-2414.2004; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Rai K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005420; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; Rakotomanga M, 2005, ANTIMICROB AGENTS CH, V49, P2677, DOI 10.1128/AAC.49.7.2677-2686.2005; Ramos H, 1996, J MEMBRANE BIOL, V152, P65, DOI 10.1007/s002329900086; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06; Romero GAS, 2001, AM J TROP MED HYG, V65, P456, DOI 10.4269/ajtmh.2001.65.456; Roychoudhury J, 2008, INDIAN J BIOCHEM BIO, V45, P16; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Singh N, 2006, INDIAN J MED RES, V123, P411; Sinha PK, 2014, LANCET GLOB HEALTH, V2, pE7, DOI 10.1016/S2214-109X(13)70151-7; SOKOLANDERSON M, 1988, ANTIMICROB AGENTS CH, V32, P702, DOI 10.1128/AAC.32.5.702; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Srivastava P, 2011, J CLIN MICROBIOL, V49, P3088, DOI 10.1128/JCM.00173-11; Srivastava S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1969-z; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Sterkers Y, 2014, TRENDS PARASITOL, V30, P429, DOI 10.1016/j.pt.2014.07.002; Sundar S, 2000, CLIN INFECT DIS, V31, P1110, DOI 10.1086/318122; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; Sundar S, 2011, T ROY SOC TROP MED H, V105, P115, DOI 10.1016/j.trstmh.2010.10.008; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Sundar Shyam, 2007, Ther Clin Risk Manag, V3, P733; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Vacchina P, 2016, ANTIMICROB AGENTS CH, V60, P4089, DOI 10.1128/AAC.00478-16; Valencia C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001656; van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556; van Griensven J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004495; Vanaerschot M, 2014, FEMS MICROBIOL REV, V38, P41, DOI 10.1111/1574-6976.12032; Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004; Verma S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2318-8; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Wasunna M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004880; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003; Zerpa O, 2013, DRUG RESISTANCE LEIS, P199; Zerpa O, 2009, GAZETA MED BAHIA S3, V79, P30; 2010, WHO TECHNICAL REPORT, V949, P1	140	48	48	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2017	11	12							e0006052	10.1371/journal.pntd.0006052				24	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FR5LR	WOS:000419108500008	29240765	DOAJ Gold, Green Published			2019-03-26
J	Dao, TTH; Nguyen, TTG; Gabriel, S; Bui, KL; Dorny, P; Le, TH				Thanh Thi Ha Dao; Thanh Thi Giang Nguyen; Gabriel, Sarah; Khanh Linh Bui; Dorny, Pierre; Thanh Hoa Le			Updated molecular phylogenetic data for Opisthorchis spp. (Trematoda: Opisthorchioidea) from ducks in Vietnam	PARASITES & VECTORS			English	Article						Mitochondrial gene; Ribosomal transcription unit; Opisthorchis sp BD2013; Opisthorchiid; 18S rDNA; 28S rDNA; Phylogenetic analysis	COMPLETE MITOCHONDRIAL GENOMES; CLONORCHIS-SINENSIS TREMATODA; RIBOSOMAL DNA-SEQUENCES; AVIAN LIVER FLUKE; FAMILIES OPISTHORCHIIDAE; DIGENEA FASCIOLIDAE; FASCIOLOPSIS-BUSKI; GENE ORGANIZATION; VIVERRINI; PLATYHELMINTHES	"Background: An opisthorchiid liver fluke was recently reported from ducks (Anas platyrhynchos) in Binh Dinh Province of Central Vietnam, and referred to as ""Opisthorchis viverrini-like"". This species uses common cyprinoid fishes as second intermediate hosts as does Opisthorchis viverrini, with which it is sympatric in this province. In this study, we refer to the liver fluke from ducks as ""Opisthorchis sp. BD2013"", and provide new sequence data from the mitochondrial (mt) genome and the nuclear ribosomal transcription unit. A phylogenetic analysis was conducted to clarify the basal taxonomic position of this species from ducks within the genus Opisthorchis (Digenea: Opisthorchiidae). Methods: Adults and eggs of liver flukes were collected from ducks, metacercariae from fishes (Puntius brevis, Rasbora aurotaenia, Esomus metallicus) and cercariae from snails (Bithynia funiculata) in different localities in Binh Dinh Province. From four developmental life stage samples (adults, eggs, metacercariae and cercariae), the complete cytochrome b (cob), nicotinamide dehydrogenase subunit 1 (nad1) and cytochrome c oxidase subunit 1 (cox1) genes, and near-complete 18S and partial 28S ribosomal DNA (rDNA) sequences were obtained by PCR-coupled sequencing. The alignments of nucleotide sequences of concatenated cob + nad1 + cox1, and of concatenated 18S + 28S were separately subjected to phylogenetic analyses. Homologous sequences from other trematode species were included in each alignment. Results: Phylogenetic trees were inferred from concatenated (cob + nad1 + cox1) nucleotide sequences and combined 18S + 28S nucleotide sequences of five Opisthorchis sp. BD2013 samples and additional reference taxa. Both trees demonstrated the anticipated clustering of taxa within the superfamily Opisthorchioidea, the paraphyly of the genus Opisthorchis and the sister-species relationship of Opisthorchis sp. BD2013 with O. viverrini. Conclusions: While it is likely that Opisthorchis sp. BD2013 is distinct from O. viverrini, it is clearly a sister taxon of O. viverrini within the limited number of Opisthorchis species for which appropriate sequence data are available. The new sequences provided here will assist the diagnosis and the taxonomic clarification of the opisthorchiid species."	[Thanh Thi Ha Dao; Thanh Thi Giang Nguyen] Natl Inst Vet Res, 86 Truong Chinh St, Hanoi, Vietnam; [Thanh Thi Ha Dao; Thanh Thi Giang Nguyen; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium; [Thanh Thi Ha Dao; Dorny, Pierre] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, 133 Salisburylaan, B-9820 Merelbeke, Belgium; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, 133 Salisburylaan, B-9820 Merelbeke, Belgium; [Khanh Linh Bui] Vietnam Natl Univ Agr, Dept Parasitol, Fac Vet Med, Hanoi, Vietnam; [Thanh Hoa Le] Inst Biotechnol, Dept Immunol, 18 Hoang Quoc Viet Rd, Hanoi, Vietnam; [Thanh Hoa Le] Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, 18 Hoang Quoc Viet Rd, Hanoi, Vietnam	Dorny, P (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.; Dorny, P (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, 133 Salisburylaan, B-9820 Merelbeke, Belgium.	pdorny@itg.be		Dorny, Pierre/0000-0001-5381-7987	Directorate General for Development Cooperation (DGD) Belgium, through the individual PhD Programme (THT Dao) of the Institute of Tropical Medicine Belgium under the DGD-ITM [3, 4]	This work was funded by the Directorate General for Development Cooperation (DGD) Belgium, through the individual PhD Programme (THT Dao) of the Institute of Tropical Medicine Belgium under the DGD-ITM Framework agreements 3 and 4.	Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; Dao TH, 2014, J HELMINTHOL, V88, P441, DOI 10.1017/S0022149X13000400; Doanh PN, 2016, T ROY SOC TROP MED H, V110, P13, DOI 10.1093/trstmh/trv103; Dorny P, 2015, J HELMINTHOL, V89, P257, DOI 10.1017/S0022149X13000722; Dao HTT, 2017, ACTA TROP, V170, P120, DOI 10.1016/j.actatropica.2017.02.028; JOHNSTON DA, 1993, PARASITOLOGY, V107, P147, DOI 10.1017/S0031182000067251; Kostadinova A, 2014, ADV EXP MED BIOL, V766, P21, DOI 10.1007/978-1-4939-0915-5_2; Le NT, 2000, FAUNA OF VIETNAM, P236; Le TH, 2004, T ROY SOC TROP MED H, V98, P193, DOI 10.1016/S0035-9203(03)00022-1; Le TH, 2001, PARASITOLOGY, V123, P609, DOI 10.1017/S0031182001008733; Lee D, 2013, KOREAN J PARASITOL, V51, P719, DOI 10.3347/kjp.2013.51.6.719; Littlewood DTJ, 2006, MOL PHYLOGENET EVOL, V39, P452, DOI 10.1016/j.ympev.2005.12.012; Liu GH, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-150; Lockyer AE, 2003, PARASITOLOGY, V126, P203, DOI 10.1017/S0031182002002792; Lotfy WM, 2008, AM J TROP MED HYG, V79, P248, DOI 10.4269/ajtmh.2008.79.248; Ma J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2039-2; Ma J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1699-7; Na L, 2016, INFECT GENET EVOL, V39, P45, DOI 10.1016/j.meegid.2016.01.010; Nawa Y, 2015, J HELMINTHOL, V89, P255, DOI 10.1017/S0022149X13000709; Olson PD, 2003, INT J PARASITOL, V33, P733, DOI 10.1016/S0020-7519(03)00049-3; OSHMARIN P. G., 1970, Trematodes of domestic and wild birds in the Democratic Republic of Viet Nam. Helminths of animals in south-eastern Asia., P5; Petney TN, 2013, INT J PARASITOL, V43, P1031, DOI 10.1016/j.ijpara.2013.07.007; Pornruseetairatn S, 2016, PARASITOL RES, V115, P1123, DOI 10.1007/s00436-015-4843-y; Scholz T, 2008, KEYS TREMATODA, V3, P9; Shekhovtsov SV, 2010, PARASITOL INT, V59, P100, DOI 10.1016/j.parint.2009.10.012; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan ND, 2017, J VET SCI TECHN, V3, P58; Thaenkham U, 2012, PARASITOL INT, V61, P90, DOI 10.1016/j.parint.2011.06.004; Thaenkham U, 2011, PARASITOL INT, V60, P521, DOI 10.1016/j.parint.2011.07.015; Thaenkham U, 2010, PARASITOL INT, V59, P460, DOI 10.1016/j.parint.2010.06.009; Le TH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1968-0; Dao TTH, 2016, KOREAN J PARASITOL, V54, P357, DOI 10.3347/kjp.2016.54.3.357; Dao TTH, 2016, ACTA TROP, V157, P151, DOI 10.1016/j.actatropica.2016.01.029; Tkach VV, 2016, INT J PARASITOL, V46, P171, DOI 10.1016/j.ijpara.2015.11.001	35	4	4	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 21	2017	10								575	10.1186/s13071-017-2514-9				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FN6IA	WOS:000416116300003	29157282	DOAJ Gold, Green Published			2019-03-26
J	Chembensofu, M; Mwape, KE; Van Damme, I; Hobbs, E; Phiri, IK; Masuku, M; Zulu, G; Colston, A; Willingham, AL; Devleesschauwer, B; Van Hul, A; Chota, A; Speybroeck, N; Berkvens, D; Dorny, P; Gabriel, S				Chembensofu, Mwelwa; Mwape, K. E.; Van Damme, I.; Hobbs, E.; Phiri, I. K.; Masuku, M.; Zulu, G.; Colston, A.; Willingham, A. L.; Devleesschauwer, B.; Van Hul, A.; Chota, A.; Speybroeck, N.; Berkvens, D.; Dorny, P.; Gabriel, S.			Re-visiting the detection of porcine cysticercosis based on full carcass dissections of naturally Taenia solium infected pigs	PARASITES & VECTORS			English	Article						Taenia solium; Cysticercosis; Pig carcass; Dissection; Liver; Antigen ELISA; Tongue palpation	PREVALENCE; DIAGNOSIS; ANTIGENS; TANZANIA; NECROPSY; WESTERN	Background: Taenia solium is a neglected zoonotic parasite. The performances of existing tools for the diagnosis of porcine cysticercosis need further assessment, and their shortcomings call for alternatives. The objective of this study was to evaluate the performance of tongue palpation and circulating antigen detection for the detection of porcine cysticercosis in naturally infected pigs of slaughter age compared to full carcass dissections (considered the gold standard). Additionally, alternative postmortem dissection procedures were investigated. A total of 68 rural pigs of slaughter age randomly selected in the Eastern Province of Zambia were dissected. Dissections were conducted on full carcasses (or half carcass in case cysticerci were already detected in the first half), including all the organs. Total cysticercus counts, location and stages were recorded and collected cysticerci were identified morphologically and molecularly. All sera were analysed with the B158/B60 antigen detecting ELISA (Ag-ELISA). Results: Key findings were the high occurrence of T. solium infected pigs (56%) and the presence of T. solium cysticerci in the livers of 26% of infected animals. More than half of the infected carcasses contained viable cysticerci. Seven carcasses had T. hydatigena cysticerci (10%), out of which five carcasses were co-infected with T. hydatigena and T. solium; two carcasses (3%) had only T. hydatigena cysticerci. Compared to full carcass dissection, the specificity of the Ag-ELISA to detect infected carcasses was estimated at 67%, the sensitivity at 68%, increasing to 90% and 100% for the detection of carcasses with one or more viable cysticerci, and more than 10 viable cysts, respectively. Tongue palpation only detected 10% of the cases, half carcass dissection 84%. Selective dissection of the diaphragm, tongue and heart or masseters can be considered, with an estimated sensitivity of 71%, increasing to 86% in carcasses with more than 10 cysticerci. Conclusions: Depending on the aim of the diagnosis, a combination of Ag-ELISA and selective dissection, including investigating the presence of T. hydatigena, can be considered. Full carcass dissection should include the dissection of the liver, kidneys, spleen and lungs, and results should be interpreted carefully, as small cysticerci can easily be overlooked.	[Chembensofu, Mwelwa; Chota, A.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, POB 32379, Lusaka, Zambia; [Mwape, K. E.; Phiri, I. K.; Masuku, M.] Univ Zambia, Sch Vet Med, Dept Clin Studies, POB 32379, Lusaka, Zambia; [Van Damme, I.; Hobbs, E.; Dorny, P.; Gabriel, S.] Univ Ghent, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Hobbs, E.; Willingham, A. L.] Ross Univ, Sch Vet Med, Hlth Ctr Zoonoses & Trop Vet Med 1, POB 334, Basseterre, St Kitts, St Kitts & Nevi; [Hobbs, E.; Van Hul, A.; Berkvens, D.; Dorny, P.] Inst Trop Med, Dept Biomed Sci, Kronenburgstr 25, B-2000 Antwerp, Belgium; [Zulu, G.] Minist Hlth, Dist Med Off, POB 30205, Lusaka, Zambia; [Colston, A.] Global Alliance Livestock Vet Med, POB 52773-00100, Nairobi, Kenya; [Devleesschauwer, B.] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Rue Juliette Wytsman 14, B-1050 Brussels, Belgium; [Speybroeck, N.] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Sch Publ Hlth, 1200 Woluwe St Lambert, Brussels, Belgium	Gabriel, S (reprint author), Univ Ghent, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	sarah.gabriel@ugent.be	Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892	Institute of Tropical Medicine, Antwerp via Flemish Ministry of Research; Ross University School of Veterinary Medicine; Bill AMP; Melinda Gates Foundation; UK aid from UK Government through GALVmed; Institute of Tropical Medicine in Antwerp, Belgium; University of Pretoria, Pretoria, South Africa	The study received financial support from the Institute of Tropical Medicine, Antwerp via the Flemish Ministry of Research. Funding for the PhD study was provided by the Ross University School of Veterinary Medicine. Support was also obtained from the Belgian Cooperation in the framework of the Institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium, and the University of Pretoria, Pretoria, South Africa. This publication is also based on research funded in part by the Bill & Melinda Gates Foundation and with UK aid from the UK Government through GALVmed. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation nor the UK Government.	Assana E, 2010, INT J PARASITOL, V40, P515, DOI 10.1016/j.ijpara.2010.01.006; Boa ME, 2002, VET PARASITOL, V106, P155, DOI 10.1016/S0304-4017(02)00037-7; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dermauw V, 2016, VET PARASITOL, V230, P9, DOI 10.1016/j.vetpar.2016.10.022; Donadeu M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005875; Dorny P, 2017, VET PARASITOL, V245, P39, DOI 10.1016/j.vetpar.2017.08.008; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Flecker RH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005282; Gabriel S, 2017, ACTA TROP, V165, P252, DOI 10.1016/j.actatropica.2016.04.010; GONZALEZ AE, 1990, AM J TROP MED HYG, V43, P194, DOI 10.4269/ajtmh.1990.43.194; Jayashi CM, 2014, VET PARASITOL, V199, P42, DOI 10.1016/j.vetpar.2013.10.004; Lightowlers MW, 2016, PARASITE IMMUNOL, V38, P158, DOI 10.1111/pim.12291; Lightowlers MW, 2015, INT J PARASITOL, V45, P815, DOI 10.1016/j.ijpara.2015.08.004; Murrell KD, 2005, WHO OIE FAO GUIDELIN, P57; Mwape KE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003972; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Phiri IK, 2006, J HELMINTHOL, V80, P69, DOI 10.1079/JOH2005314; Sciutto E, 1998, VET PARASITOL, V79, P299, DOI 10.1016/S0304-4017(98)00180-0; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; SOKAL R, 1981, BIOMETRY PRINCIPALS; Trevisan C, 2017, ACTA TROP, V165, P141, DOI 10.1016/j.actatropica.2015.12.021; World Health Organisation (WHO), 2015, EST GLOB BURD FOODB; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9	26	3	3	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 16	2017	10								572	10.1186/s13071-017-2520-y				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FM8RB	WOS:000415356100002	29145875	DOAJ Gold			2019-03-26
J	Muzyamba, C; Groot, W; Tomini, SM; Pavlova, M				Muzyamba, Choolwe; Groot, Wim; Tomini, Sonila M.; Pavlova, Milena			The usefulness of traditional birth attendants to women living with HIV in resource-poor settings: the case of Mfuwe, Zambia	TROPICAL MEDICINE AND HEALTH			English	Article						Maternal health; Traditional birth attendants (TBAs); HIV/aids		"Background: Although there is increased attention on the role of trained traditional birth attendants (TBAs) in maternal care, most of the research has mainly focused on providing evidence of the relevance of trained TBAs to women in general without a specific focus on women who are HIV positive, despite them being most vulnerable. Therefore, the aim of this study is to fill this gap by assessing the relevance of trained TBAs to women living with HIV in resource-poor settings by using Zambia as a case study. Methods: Our data collection consisted of two focus group discussions, one involving HIV-positive women utilizing trained TBAs and the other with women not utilizing TBAs. Additionally, in-depth interviews were conducted with trained TBAs and health workers. Thematic analysis was used to analyze the data. Results: In general, women living with HIV positively characterized the services of TBAs. In the face of an inefficient health system, trained TBAs were seen to be useful in providing efficient, cheap and quality care, counseling, and referral and logistical support, including treatment adherence support. Conclusion: In Zambia, trained TBAs and professional care are not mutually exclusive but complementary. There is no doubt that HIV-positive women need professionals to handle complications and offer antiretroviral treatment to ensure prevention of mother to child transmission (PMTCT). However, additional ""soft"" services offered by trained TBAs are equally important in the promotion of maternal health care among HIV-positive women. Thus, it seems there is more to gain by systematically allowing trained TBAs to work alongside professionals in a well-coordinated and complementary manner."	[Muzyamba, Choolwe; Tomini, Sonila M.] Maastricht Univ, Maastricht Grad Sch Governance UNU Merit, Maastricht, Netherlands; [Muzyamba, Choolwe] A9 Marshlands Village,POB 32379, Lusaka, Zambia; [Groot, Wim; Pavlova, Milena] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, CAPHRI,Med Ctr, Maastricht, Netherlands; [Groot, Wim] Maastricht Univ, Top Inst Evidence Based Educ Res TIER, Maastricht, Netherlands; [Tomini, Sonila M.] Univ Liege, Dept Econ, Liege, Belgium	Muzyamba, C (reprint author), Maastricht Univ, Maastricht Grad Sch Governance UNU Merit, Maastricht, Netherlands.; Muzyamba, C (reprint author), A9 Marshlands Village,POB 32379, Lusaka, Zambia.	muzyamba@merit.unu.edu	Pavlova, Milena/B-4778-2011	Pavlova, Milena/0000-0002-6082-8446				0	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1348-8945	1349-4147		TROP MED HEALTH	Trop. Med. Health	NOV 13	2017	45								37	10.1186/s41182-017-0076-3				8	Tropical Medicine	Tropical Medicine	FM4FD	WOS:000414967100001	29158723	DOAJ Gold, Green Published			2019-03-26
J	Klotz, C; Soba, B; Skvarc, M; Gabriel, S; Robertson, LJ				Klotz, Christian; Soba, Barbara; Skvarc, Miha; Gabriel, Sarah; Robertson, Lucy J.			A European network for food-borne parasites (Euro-FBP): meeting report on 'Analytical methods for food-borne parasites in human and veterinary diagnostics and in food matrices'	PARASITES & VECTORS			English	Article						Food-borne parasites; Diagnosis; Multi-pathogen detection; Euro-FBP; CYSTINET	CRYPTOSPORIDIUM	Food-borne parasites (FBPs) are a neglected topic in food safety, partly due to a lack of awareness of their importance for public health, especially as symptoms tend not to develop immediately after exposure. In addition, methodological difficulties with both diagnosis in infected patients and detection in food matrices result in under-detection and therefore the potential for underestimation of their burden on our societies. This, in consequence, leads to lower prioritization for basic research, e.g. for development new and more advanced detection methods for different food matrices and diagnostic samples, and thus a vicious circle of neglect and lack of progress is propagated. The COST Action FA1408, A European Network for Foodborne Parasites (Euro-FBP) aims to combat the impact of FBP on public health by facilitating the multidisciplinary cooperation and partnership between groups of researchers and between researchers and stakeholders. The COST Action TD1302, the European Network for cysticercosis/taeniosis, CYSTINET, has a specific focus on Taenia solium and T. saginata, two neglected FBPs, and aims to advance knowledge and understanding of these zoonotic disease complexes via collaborations in a multidisciplinary scientific network. This report summarizes the results of a meeting within the Euro-FBP consortium entitled 'Analytical methods for food-borne parasites in human and veterinary diagnostics and in food matrices' and of the joined Euro-FBP and CYSTINET meeting.	[Klotz, Christian] Robert Koch Inst, Dept Infect Dis, Mycot & Parasit Agents & Mycobacteria Unit 16, Seestr 10, D-13353 Berlin, Germany; [Soba, Barbara; Skvarc, Miha] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Robertson, Lucy J.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Fac Vet Med, POB 8146 Dep, N-0033 Oslo, Norway	Klotz, C (reprint author), Robert Koch Inst, Dept Infect Dis, Mycot & Parasit Agents & Mycobacteria Unit 16, Seestr 10, D-13353 Berlin, Germany.	klotzc@rki.de			"COST (European Cooperation in Science and Technology) Action FA1408 ""A European Network for Foodborne Parasites: Euro-FBP""; COST (European Cooperation in Science and Technology) Action TD1302 ""European Network on Taeniosis/Cysticercosis: CYSTINET"""	"The meeting was supported by COST (European Cooperation in Science and Technology) Actions FA1408 ""A European Network for Foodborne Parasites: Euro-FBP"" and TD1302 ""European Network on Taeniosis/Cysticercosis: CYSTINET""."	[Anonymous], TD1302 COST; [Anonymous], FA1408 COST; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Bouwknegt M, 2017, EURO SURVEI IN PRESS; Chalmers R, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.37.30338; Chalmers RM, 2015, J MED MICROBIOL, V64, P688, DOI 10.1099/jmm.0.000089; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; Hohweyer J, 2016, FOOD MICROBIOL, V57, P36, DOI 10.1016/j.fm.2016.01.002; Opsteegh M, 2016, EFSA SUPP PUBL, V13, P294, DOI [10.2903/sp.efsa.2016.EN-996, DOI 10.2903/SP.EFSA.2016.EN-996]; Opsteegh M, 2016, EFSA SUPPORTING PUBL, V13, DOI [10.2903/sp.efsa.2016.EN-995, DOI 10.2903/SP.EFSA.2016.EN-995]; Ortega YR, 2017, FOODBORNE PARASITES; Rossi P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1532-3; STAJNER T, 2016, MEDICINE BALTIMORE, V95; Troell K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2815-y; van Dommelen L, 2012, J CLIN MICROBIOL, V50, P1818, DOI 10.1128/JCM.06355-11	15	0	0	3	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 9	2017	10								559	10.1186/s13071-017-2506-9				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FM2AY	WOS:000414786900005	29122002	DOAJ Gold, Green Published			2019-03-26
J	Di Luca, M; Toma, L; Severini, F; Boccolini, D; D'Avola, S; Todaro, D; Stancanelli, A; Antoci, F; La Russa, F; Casano, S; Sotera, SD; Carraffa, E; Versteirt, V; Schaffner, F; Romi, R; Torina, A				Di Luca, Marco; Toma, Luciano; Severini, Francesco; Boccolini, Daniela; D'Avola, Salvatore; Todaro, Diego; Stancanelli, Alessandra; Antoci, Francesco; La Russa, Francesco; Casano, Sandro; Sotera, Salvatore D.; Carraffa, Eugenio; Versteirt, Veerle; Schaffner, Francis; Romi, Roberto; Torina, Alessandra			First record of the invasive mosquito species Aedes (Stegomyia) albopictus (Diptera: Culicidae) on the southernmost Mediterranean islands of Italy and Europe	PARASITES & VECTORS			English	Article						Aedes albopictus; First record; Invasive mosquito; Entry routes; Lampedusa; Linosa; Pantelleria; Italy	DENGUE VIRUS; INFECTION; CROATIA	Background: Aedes albopictus, a known worldwide vector of several mosquito-borne disease pathogens including dengue, chikungunya and Zika viruses, was introduced into Europe in the late 1970s through global trade. First recorded in northern Italy in 1990, this mosquito species has rapidly spread throughout the country, where it was responsible for an outbreak of chikungunya in 2007 that affected more than 200 people. As part of the VectorNet project, which is aimed at improving preparedness and responsiveness for animal and human vector-borne diseases in Europe, a mosquito targeted study was carried out on the three southernmost Italian islands. The objective was to verify the current European southern distribution limits of Ae. albopictus and the potential occurrence of other invasive mosquito species, in the light of the introduction of high risk for vector-borne disease pathogens into Europe via migration flows. Results: In the summer 2015, six surveys for container-breeding mosquitoes were carried out by setting up a network of oviposition traps and BG Sentinel traps in selected areas on the islands of Pantelleria, Lampedusa and Linosa. Aedes albopictus was found on all three islands under investigation. The consequences on public health with regard to the presence of this mosquito vector and the migrant people entering the country from Africa and the Middle East are also discussed here. Conclusions: The detection of the Asian tiger mosquito on these islands, which represent the last European strip of land facing Africa, has important implications for public health policy and should prompt the national authorities to implement tailored surveillance activities and reinforce plans for preparedness strategies in such contexts.	[Di Luca, Marco; Toma, Luciano; Severini, Francesco; Boccolini, Daniela; Romi, Roberto] Ist Super Sanita, Dept Infect Dis, Unit Vectorborne Dis, Rome, Italy; [D'Avola, Salvatore; Todaro, Diego] ASP Trapani, Unit Anim Hlth Serv, Dept Vet Prevent, Pantelleria, Italy; [Stancanelli, Alessandra; Antoci, Francesco; La Russa, Francesco; Torina, Alessandra] Ist Zooprofilatt Sperimentale Sicilia, Lab Entomol & Environm Vectors Control, Palermo, Italy; [Casano, Sandro] City Council Pantelleria, Pantelleria, Italy; [Carraffa, Eugenio] City Council Lampedusa & Linosa, Linosa, Italy; [Versteirt, Veerle] Avia GIS, Risschotlei 33, B-2980 Zoersel, Belgium; [Schaffner, Francis] Francis Schaffner Consultancy, Riehen, Switzerland; [Schaffner, Francis] Univ Zurich, Switzerland & Inst Parasitol, Zurich, Switzerland	Di Luca, M (reprint author), Ist Super Sanita, Dept Infect Dis, Unit Vectorborne Dis, Rome, Italy.	marco.diluca@iss.it		Torina, Alessandra/0000-0003-1555-8309; Schaffner, Francis/0000-0001-9166-7617	"VectorNet; ECDC; EFSA [OC/EFSA/AHAW/2013/02]; European Commission Framework Program Seven Award ""InfraVec"" [228421]; Elanco Animal Health [BIOIT140021]"	"This study was supported by VectorNet and its funding agencies ECDC and EFSA (contract number OC/EFSA/AHAW/2013/02). FS was partially funded by the European Commission Framework Program Seven Award ""InfraVec"" (project number 228421), and by Elanco Animal Health (project number BIOIT140021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Adhami J, 1987, REV MJEKESORE, V1, P13; Barcelo Carlos, 2015, Journal of the European Mosquito Control Association, V33, P1; Bengoa Mikel, 2016, Journal of the European Mosquito Control Association, V34, P5; Buhagiar Joseph A., 2009, European Mosquito Bulletin, V27, P65; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Cuffaro S, 2008, PARASSITOLOGIA, V50, P145; Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318; Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108; Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223; European Centre for Disease Prevention and Control, 2012, GUID SURV INV MOSQ E; Gatt Paul, 2009, European Mosquito Bulletin, V27, P56; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Knudsen A. B., 1995, Parassitologia (Rome), V37, P91; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Madon MB, 2002, J VECTOR ECOL, V27, P149; Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661; Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Miquel Margalida, 2013, Journal of the European Mosquito Control Association, V31, P8; Pasta L, 2015, EPIDEMIOL PREV, V39, P55; Prestileo Tullio, 2013, Infez Med, V21, P21; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Romi R, 2008, EUR INF DIS, V2, P98; Romi Roberto, 1997, Fragmenta Entomologica, V29, P1; Sabatini A, 1990, PARASSITOLOGIA, V32, p30l; Schaffner F. G., 2001, MOSQUITOES EUROPE ID; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2; Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; Torina A., 2006, Parassitologia (Rome), V48, P145	35	1	1	5	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 2	2017	10								543	10.1186/s13071-017-2488-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FL6BX	WOS:000414331300002	29096677	DOAJ Gold, Green Published			2019-03-26
J	Botero-Garcia, CA; Faccini-Martinez, AA; Uribe, E; Calixto, OJ; Perez-Diaz, CE; Osejo-Diago, PP; Franco-Maz, PG				Andres Botero-Garcia, Carlos; Adolfo Faccini-Martinez, Alvaro; Uribe, Erika; Calixto, Omar-Javier; Eduardo Perez-Diaz, Carlos; Pablo Osejo-Diago, Pedro; Gabriel Franco-Maz, Pedro			Epididymo-orchitis caused by Histoplasma capsulatum in a Colombian patient	REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL			English	Article						Histoplasma; Epididymitis; Orchitis; Colombia		Although histoplasmosis is generally a self-limited disease, disseminated infection can occur in patients lacking effective cell-mediated immunity, reaching virtually every organ, even the genitourinary tract in rare cases. We report a case of epididymo-orchitis in an immunocompetent 38-year-old bricklayer from the rural area of Villeta, Cundinamarca, Colombia. The patient presented with testicular pain and macroscopic scrotal changes requiring a left orchiectomy, with microbiological isolation and molecular confirmation of Histoplasma capsulatum.	[Andres Botero-Garcia, Carlos] Hosp Militar Cent GREINMIL, Grp Invest Enfermedades Infecciosas, Bogota, Colombia; [Adolfo Faccini-Martinez, Alvaro] Univ Fed Espirito Santo, Hlth Sci Ctr, Postgrad Program Infect Dis, Vitoria, ES, Brazil; [Adolfo Faccini-Martinez, Alvaro] Asociac Colombiana Infectol, Comm Trop Med Zoonoses & Travel Med, Bogota, Colombia; [Uribe, Erika; Eduardo Perez-Diaz, Carlos] Serv & Asesorias Infectol, Bogota, Colombia; [Calixto, Omar-Javier] Hasselt Univ, Brussels, Belgium; [Eduardo Perez-Diaz, Carlos] Hosp Univ Samaritana, Infect Dis Dept, Bogota, Colombia; [Pablo Osejo-Diago, Pedro; Gabriel Franco-Maz, Pedro] Hosp Univ Samaritana, Pathol Dept, Bogota, Colombia; [Gabriel Franco-Maz, Pedro] Univ Nacl Colombia, Sch Med, Bogota, Colombia	Faccini-Martinez, AA (reprint author), Univ Fed Espirito Santo, Hlth Sci Ctr, Postgrad Program Infect Dis, Vitoria, ES, Brazil.	afaccini@gmail.com					Arango M, 2011, BIOMEDICA, V31, P344, DOI 10.1590/S0120-41572011000300007; Baig WW, 2011, TRANSPL INFECT DIS, V13, P489, DOI 10.1111/j.1399-3062.2011.00660.x; Friskel E, 2000, CLIN INFECT DIS, V31, P189, DOI 10.1086/313904; Horwath MC, 2015, FUTURE MICROBIOL, V10, P967, DOI [10.2217/FMB.15.25, 10.2217/fmb.15.25]; Kauffman CA, 2007, CLIN MICROBIOL REV, V20, P115, DOI 10.1128/CMR.00027-06; Kiggundu Reuben, 2016, Autops Case Rep, V6, P27, DOI 10.4322/acr.2016.048; Robayo CAM, 2014, COLOMB MEDICA, V45, P186; Neder L, 2015, REV BRAS REUMATOL, V55, P414, DOI 10.1016/j.rbr.2014.12.013; Negroni R, 2011, BIOMEDICA, V31, P301, DOI 10.7705/biomedica.v31i3.597; Randhawa HS, 1995, MYCOPATHOLOGIA, V131, P173, DOI 10.1007/BF01102897; Sizemore TC, 2013, RHEUMATOL INT, V33, P2963, DOI 10.1007/s00296-013-2816-y; Tichindelean C, 2009, AM J MED SCI, V338, P238, DOI 10.1097/MAJ.0b013e3181a779fa	12	0	0	0	3	SOC BRASILEIRA MEDICINA TROPICAL	BRASILIA	UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356, BRASILIA, DF 70919-970, BRAZIL	0037-8682			REV SOC BRAS MED TRO	Rev. Soc. Bras. Med. Trop.	NOV-DEC	2017	50	6					868	870		10.1590/0037-8682-0267-2017				3	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FT2CF	WOS:000422945300023	29340471	DOAJ Gold			2019-03-26
J	Toledo, ME; Vanlerberghe, V; Rosales, JP; Mirabal, M; Cabrera, P; Fonseca, V; Padron, TG; Menzies, MP; Montada, D; Van der Stuyft, P				Eugenia Toledo, Maria; Vanlerberghe, Veerle; Popa Rosales, Julio; Mirabal, Mayelin; Cabrera, Pedro; Fonseca, Viviana; Gomez Padron, Tania; Perez Menzies, Mirtha; Montada, Domingo; Van der Stuyft, Patrick			The additional benefit of residual spraying and insecticide-treated curtains for dengue control over current best practice in Cuba: Evaluation of disease incidence in a cluster randomized trial in a low burden setting with intensive routine control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							AEDES-AEGYPTI CONTROL; VECTOR CONTROL; PYRETHROID RESISTANCE; VIRUS TRANSMISSION; INCREMENTAL COST; EFFICACY; DELTAMETHRIN; EPIDEMIC; THAILAND; SANTIAGO	Background Aedes control interventions are considered the cornerstone of dengue control programmes, but there is scarce evidence on their effect on disease. We set-up a cluster randomized controlled trial in Santiago de Cuba to evaluate the entomological and epidemiological effectiveness of periodical intra-and peri-domiciliary residual insecticide (deltamethrin) treatment (RIT) and long lasting insecticide treated curtains (ITC). Methodology/Principal findings Sixty three clusters (around 250 households each) were randomly allocated to two intervention (RIT and ITC) and one control arm. Routine Aedes control activities (entomological surveillance, source reduction, selective adulticiding, health education) were applied in the whole study area. The outcome measures were clinical dengue case incidence and immature Aedes infestation. Effectiveness of tools was evaluated using a generalized linear regression model with a negative binomial link function. Despite significant reduction in Aedes indices (Rate Ratio (RR) 0.54 (95% CI 0.32-0.89) in the first month after RIT, the effect faded out over time and dengue incidence was not reduced. Overall, in this setting there was no protective effect of RIT or ITC over routine in the 17months intervention period, with for house index RR of 1.16 (95% CI 0.96-1.40) and 1.25 (95% CI 1.03-1.50) and for dengue incidence RR of 1.43 (95% CI 1.08-1.90) and 0.96 (95% CI 0.72-1.28) respectively. The monthly dengue incidence rate (IR) at cluster level was best explained by epidemic periods (Incidence Rate Ratio (IRR) 5.50 (95% CI 4.14-7.31)), the IR in bordering houseblocks (IRR 1.03 (95% CI 1.02-1.04)) and the IR pre-intervention (IRR 1.02 (95% CI 1.00-1.04)). Conclusions Adding RIT to an intensive routine Aedes control programme has a transient effect on the already moderate low entomological infestation levels, while ITC did not have any effect. For both interventions, we didn't evidence impact on disease incidence. Further studies are needed to evaluate impact in settings with high Aedes infestation and arbovirus case load.	[Eugenia Toledo, Maria; Montada, Domingo] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Vanlerberghe, Veerle; Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Popa Rosales, Julio; Cabrera, Pedro; Fonseca, Viviana; Perez Menzies, Mirtha] Prov Ctr Surveillance & Vector Control, Santiago De Cuba, Cuba; [Mirabal, Mayelin] Ctr Vaccines Res & Prod, Finlay Inst, Havana, Cuba; [Gomez Padron, Tania] Prov Ctr Epidemiol, Santiago De Cuba, Cuba; [Van der Stuyft, Patrick] Univ Ghent, Ghent, Belgium	Toledo, ME (reprint author), Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba.	mariaeugenia@ipk.sld.cu		Vanlerberghe, Veerle/0000-0002-6531-0793	Institute of Tropical Medicine; Belgian Directorate General for Development Co-operation	This study received partial funding from the framework agreement between the Institute of Tropical Medicine and the Belgian Directorate General for Development Co-operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Agwu EJ, 2016, ACTA TROP, V161, P18, DOI 10.1016/j.actatropica.2016.05.005; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; Anshebo GY, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-80; Baly A, 2016, REV SOC BRAS MED TRO, V49, P418, DOI 10.1590/0037-8682-0368-2015; Baly A, 2016, TROP MED INT HEALTH, V21, P597, DOI 10.1111/tmi.12693; Baly A, 2011, AM J TROP MED HYG, V84, P747, DOI 10.4269/ajtmh.2011.10-0532; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Cattand P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P451; CDC, SURV CONTR AED AEG A; Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Christofferson RC, 2015, VACCINE, V33, P7069, DOI 10.1016/j.vaccine.2015.09.114; CIPAC, CIPAC4907 HPLC; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373; Faria NR, 2016, PLOS CURR, V8; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; KO YC, 1992, AM J EPIDEMIOL, V136, P214, DOI 10.1093/oxfordjournals.aje.a116487; Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423; Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424; Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; PAHO, 2016, QUEST ANSW VECT CONT; Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201; Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588; Ritchie S. A., 2002, Dengue Bulletin, V26, P7; Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Singer M., 2016, GLOB PUBLIC HEALTH, P1; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Thammapalo S, 2012, J TROP MED, DOI 10.1155/2012/652564; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; Toledo ME, 2011, TROP MED INT HEALTH, V16, P744, DOI 10.1111/j.1365-3156.2011.02762.x; Valdés G Luis, 2002, Rev Cubana Med Trop, V54, P220; Vanlerberghe V, 2011, TROP MED INT HEALTH, V16, P162, DOI 10.1111/j.1365-3156.2010.02668.x; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Vanlerberghe V, 2017, REV PANAM SALUD PUBL, P41; Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; WHO, 2009, WHOHTMNTDDEN2009; WHO, 2004, WHOCDSCPEPVC200410; Wilder-Smith A, 2016, EXPERT REV VACCINES, V15, P437, DOI 10.1586/14760584.2016.1143366; Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015; World Health Organization, 1998, TEST PROC INS RES MO; World Health Organization, 2002, WHOCDSWHOPES20026; World Health Organization, 2006, WHOCDSNTDWHOPESGCDPP; World Health Organization (WHO), 1981, WHOVBC81806; 2015, VACCINE, V33, P76	59	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2017	11	11							e0006031	10.1371/journal.pntd.0006031				19	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FO4RM	WOS:000416832800021	29117180	DOAJ Gold, Green Published			2019-03-26
J	Nina, PM; Mugisha, S; Leirs, H; Basuta, GI; Van Damme, P				Nina, Pius Mbuya; Mugisha, Samuel; Leirs, Herwig; Basuta, Gilbert Isabirye; Van Damme, Patrick			Brucellosis in cattle and micro-scale spatial variability of pastoral household income from dairy production in south western Uganda	ACTA TROPICA			English	Article						Brucellosis; Spatial pattern; Dairy production; Household income; Uganda	MBURO NATIONAL-PARK; ZOONOTIC TUBERCULOSIS; BOVINE BRUCELLOSIS; AFRICAN BUFFALO; RISK-FACTORS; WILDLIFE; DISEASES; AREAS; PERCEPTION; INTERFACE	Brucellosis in cattle and humans has received world-wide research attention as a neglected and reemerging zoonotic disease with many routes of transmission. Studies of brucellosis in Uganda have emphasized occupational exposures and also revealed variations in prevalence levels by region and cattle production systems. To date, research linking pastoralist household income from dairy production to brucellosis and its transmission risk pathways do not exist in Uganda. We assessed whether spatial differences in unit milk prices can be explained by brucellosis prevalence in cattle along a distance gradient from Lake Mburo National Park in Uganda. Semi-structured interviews administered to 366 randomly selected household heads were supplemented with serological data on brucellosis in cattle. Statistical analysis included Pearson correlation test, multiple regression and analysis of variance (ANOVA) using SPSS version 17. Serological results showed that 44% of cattle blood samples were sero-positive for brucellosis. The results obtained from interviews put the statistical mean of household reported cattle abortions at 5.39 (5.08-5.70 at 95% CI, n=366). Post -hoc analysis of variance revealed that both sero-positive cattle and reported cattle abortions significantly were much lower when moving outwards from the park boundary (p <0.05), while the price of milk increased significantly (p <0.05) along the same distance gradient. Further studies should identify public and private partnerships needed to create and strengthen good zoonotic brucellosis management practices at the nexus of wildlife and livestock in Uganda. (C) 2016 Elsevier B.V. All rights reserved.	[Nina, Pius Mbuya; Van Damme, Patrick] Univ Ghent, Fac Biosci Engn, Dept Plant Prod, Ghent, Belgium; [Nina, Pius Mbuya; Mugisha, Samuel; Basuta, Gilbert Isabirye] Makerere Univ, Dept Biol, Coll Nat Sci, Kampala, Uganda; [Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, Antwerp, Belgium; [Nina, Pius Mbuya] Int Univ East Africa, Dept Environm Sci & Management, Kampala, Uganda; [Van Damme, Patrick] Czech Univ Life Sci, Fac Trop AgriSci, Prague, Czech Republic	Nina, PM (reprint author), Makerere Univ, Dept Biol, Coll Nat Sci, Kampala, Uganda.	ninapius@yahoo.co.uk	Van Damme, Patrick/H-6693-2018	Van Damme, Patrick/0000-0002-2548-633X	International Development Research Centre (IDRC_CANADA) [106152-001]; VLIR-UOS via HEFS Platform harvest call [ZIUS2013VOA0902]	We would like to return our appreciation and gratitude to the pastoralist communities around Lake Mburo National Park in Uganda for their cooperation. This study was supported by funding from International Development Research Centre (IDRC_CANADA) through zoonotic project number 106152-001 in the Department of Biology, Makerere University. The collection of data was carried out with the help of veterinary assistants and research assistants whose efforts are greatly appreciated. We also wish to thank Dr. Richard Apecu of Mbarara University for the laboratory work and Dr. Joseph Ssebuliba for guidance on statistical analysis. The final manuscript preparation was done at the University of Antwerp, Belgium, supported by VLIR-UOS via HEFS Platform harvest call (ZIUS2013VOA0902).	Alton G. G., 1988, TECHNIQUES BRUCELLOS; Averbeck C, 2009, AFR J ECOL, V47, P756, DOI 10.1111/j.1365-2028.2009.01076.x; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Corbel M., 1998, FERTILITY INFERTILIT, P190; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; DAVIS DS, 1990, J WILDLIFE DIS, V26, P360, DOI 10.7589/0090-3558-26.3.360; FAO, 2009, STAT FOOD AGR; Faye B., 2005, PREV VET MED, V67, p267 , DOI DOI 10.1016/J.PREVETMED.2004.11.002; Godfroid J, 2013, REV SCI TECH OIE, V32, P27; Godfroid J, 2002, VET MICROBIOL, V90, P135, DOI 10.1016/S0378-1135(02)00217-1; Gomo C., 2011, TROP ANIM HLTH PROD, V5, P1; GRADWELL DV, 1977, J S AFR VET ASSOC, V48, P41; Grunert KG, 2005, EUR REV AGRIC ECON, V32, P369, DOI 10.1093/eurrag/jbi011; HERR S, 1981, ONDERSTEPOORT J VET, V48, P133; Holt H. R., 2011, BMC PUBLIC HLTH, V341; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kabagambe EK, 2001, PREV VET MED, V52, P91, DOI 10.1016/S0167-5877(01)00251-3; Kalema-Zikusoka G., 2005, PRELIMINARY INVESTIG; Kansiime C., 2010, ZOONOTIC PATHOGENS F; Kungu J. M., 2010, AFR J ANIM BIOMED SC, V5, P36; Lobb AE, 2007, FOOD QUAL PREFER, V18, P384, DOI 10.1016/j.foodqual.2006.04.004; Lopes L. B., 2010, Open Veterinary Science Journal, V4, P72; Mangen M. J., 2002, 8 FAO; Marcotty T, 2009, ANN TROP MED PARASIT, V103, P401, DOI 10.1179/136485909X451771; Mugisha S., 2011, 106152001 IDRC, P25; Muma JB, 2007, PREV VET MED, V80, P306, DOI 10.1016/j.prevetmed.2007.03.003; Muma JB, 2006, TROP ANIM HEALTH PRO, V38, P195, DOI 10.1007/s11250-006-4320-9; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Mwebe R, 2011, TROP ANIM HEALTH PRO, V43, P603, DOI 10.1007/s11250-010-9739-3; Mwiine F. N., 2004, THESIS; Nabukenya I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-901; Nakavuma J., 1999, UGANDA J AGR SCI, V4, P13; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Nasinyama G, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.3; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Nina P. M., 2015, INT J BIOL RES, V3, P12; Nizeyimana G, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.943; Ocaido M, 1996, S AFR J WILDL RES, V26, P133; Ocaido M, 2009, TROP ANIM HEALTH PRO, V41, P731, DOI 10.1007/s11250-008-9245-z; Olsen S, 2010, VET CLIN N AM-FOOD A, V26, P15, DOI 10.1016/j.cvfa.2009.10.006; Onwujekwe OE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-67; Rannestad OT, 2006, J TROP ECOL, V22, P675, DOI 10.1017/S0266467406003610; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; TESSARO SV, 1986, CAN VET J, V27, P119; Verbeke W, 2007, ANAL CHIM ACTA, V586, P2, DOI 10.1016/j.aca.2006.07.065; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; WHO, 2006, CONTR NEGL ZOON DIS	48	2	2	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2017	175				SI		130	137		10.1016/j.actatropica.2016.11.030				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FJ3DZ	WOS:000412612000015	27894608				2019-03-26
J	Siling, K; Dierickx, S; Mwesigwa, J; D'Alessandro, U; Grietens, KP				Siling, Katja; Dierickx, Susan; Mwesigwa, Julia; D'Alessandro, Umberto; Grietens, Koen Peeters			IGNORING PEOPLE `WHO ARE NOT THERE' MAY MITIGATE SUCCESS OF MASS DRUG ADMINISTRATION FOR MALARIA: FINDINGS FROM A MIXED-METHOD STUDY IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Siling, Katja; Grietens, Koen Peeters] Inst Trop Med Antwerp, Antwerp, Belgium; [Dierickx, Susan] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Mwesigwa, Julia; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		20	7	7						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501020					2019-03-26
J	Dermauw, V; Carabin, H; Ganaba, R; Cisse, A; Gabriel, S; Tarnagda, Z; Dorny, P; Millogo, A				Dermauw, Veronique; Carabin, Helene; Ganaba, Rasmane; Cisse, Assana; Gabriel, Sarah; Tarnagda, Zekiba; Dorny, Pierre; Millogo, Athanase			TAENIA SOLIUM CYSTICERCOSIS SEROCONVERSION AND SEROREVERSION CUMULATIVE INCIDENCE IN A LARGE-SCALE COMMUNITY TRIAL IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dermauw, Veronique; Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Antwerp, Belgium; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Ganaba, Rasmane] AFRICSante, Bobo Dioulasso, Burkina Faso; [Cisse, Assana] Inst Res Hlth Sci, Bobo Dioulasso, Burkina Faso; [Tarnagda, Zekiba] Inst Res Hlth Sci, Bobo Dioulasso, Belgium; [Millogo, Athanase] Univ Ouagadougou, Bobo Dioulasso, Belgium								0	0	0	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		32	11	12						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501032					2019-03-26
J	Colebunders, R; Tepage, F; Mandro, M; Pfarr, K; Kashama, JM; Levick, B; Rossy, D; Tagoto, A; Laudisoit, A				Colebunders, Robert; Tepage, Floribert; Mandro, Michel; Pfarr, Kenneth; Kashama, Jean Marie; Levick, Bethanie; Rossy, Deogratias; Tagoto, Alliance; Laudisoit, Anne			HIGH PREVALENCE OF EPILEPSY IN ONCHOCERCIASIS ENDEMIC REGIONS IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC)	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Colebunders, Robert; Laudisoit, Anne] Univ Antwerp, Antwerp, Belgium; [Tepage, Floribert] Programme Natl Iutte Onchocercose, Kisangani, DEM REP CONGO; [Mandro, Michel; Rossy, Deogratias] Prov Hlth Div Ituri, Bunia, DEM REP CONGO; [Pfarr, Kenneth] Univ Hosp Bonn, Bonn, Germany; [Kashama, Jean Marie] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Levick, Bethanie] Univ Liverpool, Liverpool, Merseyside, England; [Tagoto, Alliance] Minist Hlth, Kisangani, DEM REP CONGO			Pfarr, Kenneth/X-9175-2018	Pfarr, Kenneth/0000-0003-3096-2465				0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		52	17	18						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501052					2019-03-26
J	Denoeud-Ndam, L; Dicko, A; Baudin, E; Guindo, O; Grandesso, F; Diawara, H; Sissoko, S; Sanogo, K; Traore, S; Keta, S; Barry, A; de Smet, M; Lasry, E; Smit, M; Wiesner, L; Barnes, KI; Djimde, AA; Grais, RF; Doumbo, OK; Etard, JF				Denoeud-Ndam, Lise; Dicko, Alassane; Baudin, Elisabeth; Guindo, Ousmane; Grandesso, Francesco; Diawara, Halimatou; Sissoko, Sibiri; Sanogo, Koualy; Traore, Seydou; Keta, Sekouba; Barry, Amadou; de Smet, Martin; Lasry, Estrella; Smit, Michiel; Wiesner, Lubbe; Barnes, Karen I.; Djimde, Abdoulaye A.; Grais, Rebecca F.; Doumbo, Ogobara K.; Etard, Jean-Francois			CLINICAL EFFICACY OF ARTEMETHER-LUMEFANTRINE IN RELATION TO DRUG EXPOSURE IN CHILDREN WITH UNCOMPLICATED SEVERE ACUTE MALNUTRITION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Denoeud-Ndam, Lise; Baudin, Elisabeth; Grandesso, Francesco; Grais, Rebecca F.; Etard, Jean-Francois] Epicentre, Paris, France; [Dicko, Alassane; Diawara, Halimatou; Sissoko, Sibiri; Sanogo, Koualy; Traore, Seydou; Keta, Sekouba; Barry, Amadou; Djimde, Abdoulaye A.; Doumbo, Ogobara K.] Malaria Res & Training Ctr, Bamako, Mali; [Guindo, Ousmane] Epicentre, Niamey, Niger; [de Smet, Martin] Med Sans Frontieres, Brussels, Belgium; [Lasry, Estrella] Med Sans Frontieres, Paris, France; [Smit, Michiel; Wiesner, Lubbe] Univ Cape Town, Div Clin Pharmacol, Cape Town, South Africa; [Barnes, Karen I.] WorldWide Antimalarial Resistance Network, Oxford, England								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		67	23	23						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501067					2019-03-26
J	Silber, S; Diro, E; Workneh, N; Mekonnen, Z; Levecke, B; Steinmann, P; Umulisa, I; Engelen, M; Baeten, B; Hu, P; Friedman, A; Baseman, A; Mrus, J				Silber, Steven; Diro, Ermias; Workneh, Netsanet; Mekonnen, Zeleke; Levecke, Bruno; Steinmann, Peter; Umulisa, Irenee; Engelen, Marc; Baeten, Benny; Hu, Peter; Friedman, Andrew; Baseman, Alan; Mrus, Joseph			EFFICACY AND SAFETY OF A SINGLE-DOSE MEBENDAZOLE 500 MG CHEWABLE TABLET IN THE TREATMENT OF ASCARIS LUMBRICOIDES AND TRICHURIS TRICHIURA INFECTION IN PEDIATRIC PATIENTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 STUDY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Silber, Steven; Hu, Peter; Friedman, Andrew; Baseman, Alan; Mrus, Joseph] Janssen Res & Dev LLC, Raritan, NJ USA; [Diro, Ermias] Univ Gondar, Gondar, Ethiopia; [Workneh, Netsanet; Mekonnen, Zeleke] Jimma Univ, Jimma, Ethiopia; [Levecke, Bruno] Univ Ghent, Merelbeke, Belgium; [Steinmann, Peter] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Steinmann, Peter] Univ Basel, Basel, Switzerland; [Umulisa, Irenee] Rwanda Biomed Ctr, Kingali, Rwanda; [Engelen, Marc; Baeten, Benny] Janssen Pharmaceut NV, Beerse, Belgium								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		82	28	28						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501082					2019-03-26
J	Gave, A; Manrique, P; Alava, F; Sanchez, D; Tenorio, R; Serra, E; Rosanas, A; Gonzalez, I; Ding, X; Gamboa, D				Gave, Anthony; Manrique, Paulo; Alava, Freddy; Sanchez, Daniel; Tenorio, Roy; Serra, Elisa; Rosanas, Anna; Gonzalez, Iveth; Ding, Xavier; Gamboa, Dionicia			ASSESSMENT OF LOOP MEDIATED ISOTHERMAL DNA AMPLIFICATION (LAMP) METHOD FOR ASYMPTOMATIC MALARIA SCREENING IN THE PERUVIAN AMAZON SETTINGS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Gave, Anthony; Manrique, Paulo; Alava, Freddy; Sanchez, Daniel; Tenorio, Roy; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Lima, Peru; [Serra, Elisa; Rosanas, Anna] Inst Trop Med, Antwerp, Belgium; [Gonzalez, Iveth] Caucaseco Sci Res Cente, Cali, Colombia; [Ding, Xavier] FIND Diag, Geneva, Switzerland								0	0	0	2	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		268	84	84						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501268					2019-03-26
J	Bannister-Tyrrell, M; Xa, NX; Dung, VKA; Duong, TT; Ngoc, NTH; Rovira-Vallbona, E; Erhart, A; Rosanas-Urgell, A; Grietens, KP				Bannister-Tyrrell, Melanie; Nguyen Xuan Xa; Vu Khac Anh Dung; Tran Thanh Duong; Nguyen Thi Hong Ngoc; Rovira-Vallbona, Eduard; Erhart, Annette; Rosanas-Urgell, Anna; Grietens, Koen Peeters			FINDING THE LAST FEW CASES: MOST EXPOSED INDIVIDUALS LESS LIKELY TO PARTICIPATE IN MALARIA SCREENING IN A PRE-ELIMINATION SETTING IN VIETNAM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Bannister-Tyrrell, Melanie; Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Nguyen Xuan Xa; Vu Khac Anh Dung; Tran Thanh Duong; Nguyen Thi Hong Ngoc] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, Annette] MRC, Fajara, Gambia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		305	95	95						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501305					2019-03-26
J	Dorny, P; Ouedraogo, B; Dermauw, V; Cisse, A; Millogo, A; Tarnagda, Z; Ganaba, R; Carabin, H; Gabriel, S				Dorny, Pierre; Ouedraogo, Boubacar; Dermauw, Veronique; Cisse, Assana; Millogo, Athanase; Tarnagda, Zekiba; Ganaba, Rasmane; Carabin, Helene; Gabriel, Sarah			A CROSS-SECTIONAL ABATTOIR STUDY ON TAENIA HYDATIGENA INFECTIONS IN PIGS IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dorny, Pierre; Dermauw, Veronique; Gabriel, Sarah] Inst Trop Med, Antwerp, Belgium; [Ouedraogo, Boubacar; Ganaba, Rasmane] AFRICSante, Bobo Dioulasso, Burkina Faso; [Cisse, Assana; Tarnagda, Zekiba] Res Inst Hlth Sci, Bobo Dioulasso, Burkina Faso; [Millogo, Athanase] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		444	138	138						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501444					2019-03-26
J	O'Neal, SE; Moyano, LM; Ayvar, V; Vilchez, P; Gamboa, R; Muro, C; Dorny, P; Gilman, RH; Gonzalez, AE; Garcia, HH				O'Neal, Seth E.; Maria Moyano, Luz; Ayvar, Viterbo; Vilchez, Percy; Gamboa, Ricardo; Muro, Claudio; Dorny, Pierre; Gilman, Robert H.; Gonzalez, Armando E.; Garcia, Hector H.		Cysticercosis Working Grp Peru	NEUROCYSTICERCOSIS AND EPILEPSY AMONG PEOPLE LIVING NEARBY PIGS HEAVILY-INFECTED WITH CYSTICERCOSIS IN RURAL ENDEMIC PERU	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[O'Neal, Seth E.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [O'Neal, Seth E.] Portland State Univ, Portland, OR 97207 USA; [Maria Moyano, Luz; Ayvar, Viterbo; Vilchez, Percy; Gamboa, Ricardo; Muro, Claudio] Univ Peruana Cayetano Heredia, Ctr Global Hlth Tumbes, Tumbes, Peru; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru; [Cysticercosis Working Grp Peru] Univ Peruana Cayetano Heredia, Lima, Peru								0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		446	139	139						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501446					2019-03-26
J	Hubner, MP; Quirynen, L; Lachau-Durand, S; Engelen, M; Hoerauf, A				Huebner, Marc P.; Quirynen, Ludo; Lachau-Durand, Sophie; Engelen, Marc; Hoerauf, Achim			EFFICACY OF SINGLE AND REPEATED ORAL AND SUBCUTANEOUS DOSES OF FLUBENDAZOLE IN LITOMOSOIDES SIGMODONTIS INFECTED JIRDS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Huebner, Marc P.; Hoerauf, Achim] Univ Hosp Bonn, Bonn, Germany; [Quirynen, Ludo; Lachau-Durand, Sophie; Engelen, Marc] Janssen Pharmaceut, Beerse, Belgium			Hubner, Marc/W-9529-2018	Hubner, Marc/0000-0001-8885-418X				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		485	153	153						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502008					2019-03-26
J	Sjoberg, H; Pionnier, N; Steven, A; Alyyoussi, G; Quirynen, L; Engelen, M; Baeten, B; Ward, SA; Taylor, MJ; Turner, JD				Sjoberg, Hanna; Pionnier, Nicolas; Steven, Andrew; Alyyoussi, Ghaith; Quirynen, Ludo; Engelen, Marc; Baeten, Benny; Ward, Stephen A.; Taylor, Mark J.; Turner, Joseph D.			LACK OF SIGNIFICANT MICROFILARICIDAL EFFICACY OF PARENTERAL OR ORAL BIOAVAILABLE FLUBENDAZOLE FORMULATIONS IN A BRUGIA MALAYI MICROFILARAEMIC MOUSE MODEL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Sjoberg, Hanna; Pionnier, Nicolas; Steven, Andrew; Alyyoussi, Ghaith; Ward, Stephen A.; Taylor, Mark J.; Turner, Joseph D.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Quirynen, Ludo; Engelen, Marc; Baeten, Benny] Janssen Pharmaceut, Beerse, Belgium			Ward, Steve/G-6003-2015	Ward, Steve/0000-0003-2331-3192				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		486	153	153						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502009					2019-03-26
J	Biamonte, M; Van Dorst, B; Lagatie, O; Canestrelli, I; Ji, YC; Stuyver, L				Biamonte, Marco; Van Dorst, Bieke; Lagatie, Ole; Canestrelli, Ilona; Ji, Yongchang; Stuyver, Lieven			INTEGRATING NOVEL PEPTIDES AND REPORTER NANOPARTICLES IN A RAPID TEST FOR ONCHOCERCIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Biamonte, Marco; Canestrelli, Ilona; Ji, Yongchang] Drugs & Diagnost Trop Dis, San Diego, CA USA; [Van Dorst, Bieke; Lagatie, Ole; Stuyver, Lieven] Janssen Diagnost, Beerse, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		495	156	156						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502018					2019-03-26
J	Lagatie, O; Verheyen, A; Nijs, E; Van Dorst, B; Debrah, LB; Debrah, A; Stuyver, LJ				Lagatie, Ole; Verheyen, Ann; Nijs, Erik; Van Dorst, Bieke; Debrah, Linda Batsa; Debrah, Alex; Stuyver, Lieven J.			IMMUNOREACTIVITY OF AN ONCHOCERCA VOLVULUS LINEAR EPITOPE IN INDIVIDUALS FROM DIFFERENT REGIONS IN GHANA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Lagatie, Ole; Verheyen, Ann; Nijs, Erik; Van Dorst, Bieke; Stuyver, Lieven J.] Janssen Diagnost, Beerse, Belgium; [Debrah, Linda Batsa] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Debrah, Alex] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Kumasi, Ghana								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		496	156	157						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502019					2019-03-26
J	Irani, J; Ronse, M; Njamnshi, AK; Hendy, A; Siling, K; Kamgno, J; Colebunders, B; Verdonck, T; O'Neill, S; Grietens, KP				Irani, Julia; Ronse, Maya; Njamnshi, Alfred K.; Hendy, Adam; Siling, Katja; Kamgno, Joseph; Colebunders, Bob; Verdonck, Tine; O'Neill, Sarah; Grietens, Koen P.			HEALTH-SEEKING BEHAVIOR FOR EPILEPSY IN AN ONCHOCERCIASIS ENDEMIC AREA OF CAMEROON	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Irani, Julia; Ronse, Maya; Hendy, Adam; Siling, Katja; Verdonck, Tine; O'Neill, Sarah; Grietens, Koen P.] Inst Trop Med, Antwerp, Belgium; [Njamnshi, Alfred K.] Univ Yaounde I, Yaounde, Cameroon; [Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis, Yaounde, Cameroon; [Colebunders, Bob] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		510	161	161						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502033					2019-03-26
J	Lagatie, O; Van Dorst, B; Stuyver, LJ				Lagatie, Ole; Van Dorst, Bieke; Stuyver, Lieven J.			ONCHOCERCA VOLVULUS PROTEOME-WIDE LINEAR EPITOPE SCANNING USING HIGH-DENSITY PEPTIDE MICROARRAYS AND CONFIRMATION OF IMMUNODOMINANT MOTIFS BY ELISA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Lagatie, Ole; Van Dorst, Bieke; Stuyver, Lieven J.] Janssen Diagnost, Beerse, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		600	188	188						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502123					2019-03-26
J	Hamer, DH; Barbre, K; Anderson, S; Barnett, ED; Boggild, A; Bottieau, E; Brunette, G; Caumes, E; Cetron, M; Chen, LH; Eperon, G; Gautret, P; Goorhuis, A; Grobusch, MP; Hagmann, S; Hynes, N; Kozarsky, P; Jespersen, S; Libman, M; Lopez-Velez, R; Malvy, D; Mockenhaupt, F; Molina, I; Perret, C; Rothe, C; Schlagenhauff, P; Schwartz, E; Van Genderen, P; Wilder-Smith, A; Esposito, D				Hamer, Davidson H.; Barbre, Kira; Anderson, Susan; Barnett, Elizabeth D.; Boggild, Andrea; Bottieau, Emmanuel; Brunette, Gary; Caumes, Eric; Cetron, Marty; Chen, Lin H.; Eperon, Gilles; Gautret, Philippe; Goorhuis, Abraham; Grobusch, Martin P.; Hagmann, Stefan; Hynes, Noreen; Kozarsky, Phyllis; Jespersen, Sanne; Libman, Michael; Lopez-Velez, Rogelio; Malvy, Denis; Mockenhaupt, Frank; Molina, Israel; Perret, Cecilia; Rothe, Camilla; Schlagenhauff, Patricia; Schwartz, Eli; Van Genderen, Perry; Wilder-Smith, Annelies; Esposito, Doug			ZIKA VIRUS DISEASE AMONG TRAVELERS RETURNING FROM THE AMERICAS BETWEEN JANUARY 2013 AND FEBRUARY 2016: A GEOSENTINEL ANALYSIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Barbre, Kira] Task Force Global Hlth, Decatur, GA USA; [Anderson, Susan] Palo Alto Med Fdn, Travel Med & Emergency Urgent Care, Palo Alto, CA USA; [Barnett, Elizabeth D.] Boston Med Ctr, Maxwell Finland Lab Infect Dis, Boston, MA USA; [Boggild, Andrea] Toronto Gen Hosp, Ctr Travel & Trop Med, Toronto, ON, Canada; [Bottieau, Emmanuel] Inst Trop Med, Antwerp, Belgium; [Brunette, Gary; Cetron, Marty; Esposito, Doug] Ctr Dis Control & Prevent, Atlanta, GA USA; [Caumes, Eric] Hop La Pitie Salpetriere, Serv Malad Infect & Trop, Paris, France; [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MD USA; [Eperon, Gilles] Geneva Univ Hosp, Div Trop & Humanitarian Med, Travel & Trop Med, Geneva, Switzerland; [Gautret, Philippe] Hop Nord Marseille, Infect & Trop Dis Unit, Marseille, France; [Goorhuis, Abraham; Grobusch, Martin P.] Univ Amsterdam, Ctr Trop & Travel Med, Amsterdam, Netherlands; [Hagmann, Stefan] Bronx Lebanon Hosp Ctr, Div Pediat Infect Dis, Bronx, NY 10456 USA; [Hynes, Noreen] Johns Hopkins Univ, Sch Med, Div Infect Dis, Geog Med Ctr, Baltimore, MD 21205 USA; [Kozarsky, Phyllis] TravelWell, Atlanta, GA USA; [Jespersen, Sanne] Aarhus Univ Hostpital, Dept Infect Dis, Arrhus, Denmark; [Libman, Michael] McGill Univ, Ctr Trop Dis, Montreal Gen Hosp, Montreal, PQ, Canada; [Lopez-Velez, Rogelio] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, Unidad Med Trop, Madrid, Spain; [Malvy, Denis] Hop St Andre, Sante Voyages & Med Trop Niveau, Bordeaux, France; [Mockenhaupt, Frank] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Molina, Israel] Hosp Gen Valle Hebron, Anexos Planta 6, Barcelona, Spain								0	1	1	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		691	218	218						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502214					2019-03-26
J	Mofid, LS; Casapia, M; Aguilar, E; Silva, H; Montresor, A; Rahme, E; Fraser, WD; Marquis, GS; Vercruysse, J; Allen, L; Blouin, B; Razuri, H; Pezo, L; Gyorkos, TW				Mofid, Layla S.; Casapia, Martin; Aguilar, Eder; Silva, Hermann; Montresor, Antonio; Rahme, Elham; Fraser, William D.; Marquis, Grace S.; Vercruysse, Jozef; Allen, Lindsay; Blouin, Brittany; Razuri, Hugo; Pezo, Lidsky; Gyorkos, Theresa W.			MATERNAL POSTPARTUM DEWORMING AS A MEANS OF IMPROVING INFANT GROWTH AND MORBIDITY IN AREAS ENDEMIC FOR SOIL-TRANSMITTED HELMINTHIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Mofid, Layla S.; Blouin, Brittany; Gyorkos, Theresa W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Casapia, Martin; Pezo, Lidsky] Asociac Civil Selva Amazon, Iquitos, Peru; [Aguilar, Eder; Silva, Hermann] Hosp Iquitos Cesar Garayar Garcia, Iquitos, Peru; [Montresor, Antonio] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Rahme, Elham; Razuri, Hugo] McGill Univ, Hlth Ctr, Div Clin Epidemiol, Res Inst, Montreal, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ, Canada; [Marquis, Grace S.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Allen, Lindsay] Univ Calif Davis, USDA, ARS Western Human Nutr Res Ctr, Davis, CA 95616 USA								0	0	0	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		701	221	221						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502224					2019-03-26
J	Cromwell, EA; Stoddard, ST; Barker, C; Meshnick, S; Messer, W; Van Rie, A; Morrison, AC; Scott, TW				Cromwell, Elizabeth A.; Stoddard, Steven T.; Barker, Chris; Meshnick, Steven; Messer, William; Van Rie, Annelies; Morrison, Amy C.; Scott, Thomas W.			THE RELATIONSHIP BETWEEN ENTOMOLOGICAL INDICATORS OF AEDES AEGYPTI ABUNDANCE AND DENGUE INFECTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Cromwell, Elizabeth A.; Meshnick, Steven] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Stoddard, Steven T.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Barker, Chris; Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Davis, CA 95616 USA; [Messer, William] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Van Rie, Annelies] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		807	253	253						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502330					2019-03-26
J	Zavala, GA; Doak, CM; Portrait, F; Garcia, OP; Rosado, JL; Jarquin, T; Polman, K; Campos-Ponce, M				Zavala, Gerardo A.; Doak, Colleen M.; Portrait, France; Garcia, Olga P.; Rosado, Jorge L.; Jarquin, Tatiana; Polman, Katja; Campos-Ponce, Maiza			IS INTESTINAL PARASITE INFECTION ASSOCIATED WITH OBESITY? AN ECOLOGICAL ANALYSIS IN MEXICO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Zavala, Gerardo A.; Doak, Colleen M.; Portrait, France; Campos-Ponce, Maiza] VU Amsterdam Univ, Amsterdam, Netherlands; [Garcia, Olga P.; Rosado, Jorge L.; Jarquin, Tatiana] Univ Autonoma Queretaro, Queretaro, Mexico; [Polman, Katja] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		809	254	254						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502332					2019-03-26
J	Ravinetto, R; Van Assche, K; Pouget, C; Caudron, JM; Cann, JM; Melotte, V; Giralt, AN; Meessen, B				Ravinetto, Raffaella; Van Assche, Kerlijn; Pouget, Corinne; Caudron, Jean-Michel; Cann, Jean-Michel; Melotte, Vera; Giralt, Ariadna Nebot; Meessen, Bruno			THE IMPACT OF LOCAL DISTRIBUTORS ON THE QUALITY OF MEDICINES IN RESOURCE-LIMITED SETTINGS: FIELD-BASED RECOMMENDATIONS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Ravinetto, Raffaella; Van Assche, Kerlijn; Pouget, Corinne; Caudron, Jean-Michel; Cann, Jean-Michel; Melotte, Vera; Giralt, Ariadna Nebot; Meessen, Bruno] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		818	257	257						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502341					2019-03-26
J	Gryseels, C; Uk, S; Suon, S; Set, S; Delvaux, T; Lek, D; Ouk, V; Grietens, KP				Gryseels, Charlotte; Uk, Sambunny; Suon, Sokha; Set, Srun; Delvaux, Therese; Lek, Dysoley; Ouk, Vichea; Grietens, Koen Peeters			CAN WE TARGET MOBILE POPULATIONS WITH AN INTEGRATED DISEASE CONTROL APPROACH? A QUALITATIVE STUDY ON RISK BEHAVIOR FOR MALARIA AND HIV ALONG THE THAI-CAMBODIA BORDER	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Gryseels, Charlotte; Delvaux, Therese; Grietens, Koen Peeters] Inst Trop Med Antwerp, Antwerp, Belgium; [Uk, Sambunny; Suon, Sokha; Set, Srun; Lek, Dysoley] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Ouk, Vichea] Natl Ctr HIV AIDS Dermatol & STD, Phnom Penh, Cambodia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		827	260	260						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502350					2019-03-26
J	Payne, R; Silk, SE; Elias, SC; Miura, K; Diouf, A; Alanine, DG; Jin, J; Labbe, GM; Brian, IJ; Poulton, ID; Griffiths, O; Edwards, NJ; Berrie, E; Siani, L; Douglas, AD; Roberts, R; Vekemans, J; Nugent, F; Hill, AV; Long, CA; Lawrie, AM; Draper, SJ				Payne, Ruth; Silk, Sarah E.; Elias, Sean C.; Miura, Kazutoyo; Diouf, Ababacar; Alanine, Daniel G.; Jin, Jing; Labbe, Genevieve M.; Brian, Iona J.; Poulton, Ian D.; Griffiths, Oliver; Edwards, Nick J.; Berrie, Eleanor; Siani, Loredana; Douglas, Alexander D.; Roberts, Rachel; Vekemans, Johan; Nugent, Fay; Hill, Adrian V.; Long, Carole A.; Lawrie, Alison M.; Draper, Simon J.			SAFETY AND IMMUNOGENICITY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE CHAD63-MVA RH5 IN A PHASE IA CLINICAL TRIAL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Payne, Ruth; Silk, Sarah E.; Elias, Sean C.; Alanine, Daniel G.; Jin, Jing; Labbe, Genevieve M.; Brian, Iona J.; Poulton, Ian D.; Griffiths, Oliver; Edwards, Nick J.; Douglas, Alexander D.; Roberts, Rachel; Nugent, Fay; Hill, Adrian V.; Lawrie, Alison M.; Draper, Simon J.] Univ Oxford, Oxford, England; [Miura, Kazutoyo; Diouf, Ababacar; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Berrie, Eleanor] Clin Biomfg Facil, Oxford, England; [Siani, Loredana] Reithera Srl, Rome, Italy; [Vekemans, Johan] GSK Vaccines, Rixensart, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1000	313	313						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502523					2019-03-26
J	Sing'oei, VC; Otieno, L; Oneko, M; Otieno, W; Abuodha, J; Odero, C; Mendoza, Y; Andagalu, B; Owino, N; Ivinson, K; Otsyula, N; Oziemkowska, M; Otieno, A; Otieno, K; Cowden, J; Kariuki, S; Oyieko, J; Slutsker, L; Lievens, M; Ogutu, B; Hamel, MJ				Sing'oei, Valentine C.; Otieno, Lucas; Oneko, Martina; Otieno, Walter; Abuodha, Joseph; Odero, Chris; Mendoza, Yolanda; Andagalu, Ben; Owino, Nobert; Ivinson, Karen; Otsyula, Nekoye; Oziemkowska, Maria; Otieno, Allan; Otieno, Kephas; Cowden, Jessica; Kariuki, Simon; Oyieko, Janet; Slutsker, Laurence; Lievens, Marc; Ogutu, Bernhards; Hamel, Mary J.			ANTIBODY RESPONSES TO HEPATITIS B SURFACE ANTIGEN FOLLOWING ADMINISTRATION OF RTS, S/ASO1E TO HIV-INFECTED AFRICAN INFANTS AND CHILDREN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Sing'oei, Valentine C.; Otieno, Lucas; Otieno, Walter; Andagalu, Ben; Otsyula, Nekoye; Otieno, Allan; Cowden, Jessica; Oyieko, Janet; Ogutu, Bernhards] US Army, Med Res Directorate, Walter Reed Project, Kenya Med Res Intitute, Kisumu, Kenya; [Oneko, Martina; Abuodha, Joseph; Odero, Chris; Owino, Nobert; Oziemkowska, Maria; Otieno, Kephas; Kariuki, Simon; Hamel, Mary J.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Kisumu, Kenya; [Mendoza, Yolanda; Lievens, Marc] GlaxoSmithKline, Wavre, Belgium; [Ivinson, Karen] PATH Malaria Vaccine Initiat, Washington, WA USA; [Slutsker, Laurence] US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1009	316	316						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502532					2019-03-26
J	Levecke, B; Ghebretinsae, AH; Anderson, RM; Berkvens, D; Vlaminck, J; Devleesschauwer, B; Speybroeck, N; Vercruysse, J; Van Aelst, S				Levecke, Bruno; Ghebretinsae, Aklilu H.; Anderson, Roy M.; Berkvens, Dirk; Vlaminck, Johnny; Devleesschauwer, Brecht; Speybroeck, Niko; Vercruysse, Jozef; Van Aelst, Stefan			GUIDANCE IN DESIGNING SURVEYS FOR MONITORING SURVEYS FOR MONITORING THE PROGRESS OF SCHOOL-BASED DEWORMING PROGRAMS TO CONTROL SOIL-TRANSMITTED HELMINTHIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Levecke, Bruno; Ghebretinsae, Aklilu H.; Vlaminck, Johnny; Vercruysse, Jozef] Univ Ghent, Merelbeke, Belgium; [Anderson, Roy M.] Imperial Coll, London, England; [Berkvens, Dirk] Inst Trop Med, Antwerp, Belgium; [Devleesschauwer, Brecht] Sci Inst Publ Hlth, Brussels, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Brussels, Belgium; [Van Aelst, Stefan] KU Leuven Univ Leuven, Leuven, Belgium; [Van Aelst, Stefan] Univ Ghent, Ghent, Belgium			Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1136	356	356						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502659					2019-03-26
J	Mwesigwa, J; Achan, J; Affara, M; Sainey, C; Worwui, A; Grietens, KP; Van Geertruyden, JP; D'Alessandro, U				Mwesigwa, Julia; Achan, Jane; Affara, Muna; Sainey, Cessay; Worwui, Archibald; Grietens, Koen Peeters; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			IMPACT OF MASS DRUG ADMINISTRATION WITH DIHYDROARTEMISININ-PIPERAQUINE ON MALARIA TRANSMISSION IN A HIGHLY SEASONAL TRANSMISSION SETTING IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Mwesigwa, Julia] Univ Antwerp, Gambia & Epidemiol Global Hlth Inst, Med Res Council Unit, Banjul, Gambia; [Achan, Jane; Affara, Muna; Sainey, Cessay; Worwui, Archibald; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, Antwerp, Belgium; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, Banjul, Gambia			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1218	382	382						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502740					2019-03-26
J	Dierickx, S; Siling, K; Mwesigwa, J; Gryseels, C; Jaiteh, F; Gerrets, R; D'Alessandro, U; Peeters, KG				Dierickx, Susan; Siling, Katja; Mwesigwa, Julia; Gryseels, Charlotte; Jaiteh, Fatou; Gerrets, Rene; D'Alessandro, Umberto; Peeters, Koen Grietens			THE RELEVANCE OF OUTDOOR RESTING AND SLEEPING FOR BED NET USE IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dierickx, Susan] Vrije Univ Brussel, Brussels, Belgium; [Siling, Katja; Gryseels, Charlotte; Peeters, Koen Grietens] Inst Trop Med, Antwerp, Belgium; [Mwesigwa, Julia; Jaiteh, Fatou; D'Alessandro, Umberto] MRC, Fajara, Gambia; [Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1286	404	404						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502808					2019-03-26
J	Bebell, LM; Ngonzi, J; Bazira, J; Fajardo, Y; Boatin, AA; Boatin, AA; Jacquemyn, Y; van Geertruyden, JP; Schiff, SJ; Riley, LE; Bangsberg, DR; Boum, Y				Bebell, Lisa M.; Ngonzi, Joseph; Bazira, Joel; Fajardo, Yarine; Boatin, Adeline A.; Boatin, Adeline A.; Jacquemyn, Yves; van Geertruyden, Jean-Pierre; Schiff, Steven J.; Riley, Laura E.; Bangsberg, David R.; Boum, Yap			POSTPARTUM INFECTION AT A UGANDAN REGIONAL REFERRAL HOSPITAL: MICROBIOLOGY AND ANTIMICROBIAL RESISTANCE PATTERNS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Bebell, Lisa M.; Boatin, Adeline A.; Boatin, Adeline A.; Riley, Laura E.; Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ngonzi, Joseph; Bazira, Joel; Fajardo, Yarine] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Jacquemyn, Yves; van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium; [Schiff, Steven J.] Penn State Univ, Hershey, PA USA; [Boum, Yap] Epictr Res Base, Mbarara, Uganda			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1293	406	406						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502815					2019-03-26
J	Wright, D; Giza, M; Rampling, T; Zeltina, A; Bowyer, G; Powlson, J; Venkatraman, N; Imoukhuede, E; Payne, R; Nicosia, A; Sullivan, N; Graham, B; Volkmann, A; Ballou, WR; Gilbert, S; Hill, A; Ewer, K				Wright, Danny; Giza, Mark; Rampling, Tommy; Zeltina, Antra; Bowyer, Georgina; Powlson, Jonathan; Venkatraman, Navin; Imoukhuede, Egeruan; Payne, Ruth; Nicosia, Alfredo; Sullivan, Nancy; Graham, Barney; Volkmann, Ariane; Ballou, W. Ripley; Gilbert, Sarah; Hill, Adrian; Ewer, Katie			IDENTIFICATION OF HUMAN T CELL EPITOPES IN THE EBOLAVIRUS GLYCOPROTEIN FOLLOWING VACCINATION WITH CHAD3 EBO Z GP AND MVA BN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Wright, Danny; Giza, Mark; Rampling, Tommy; Bowyer, Georgina; Powlson, Jonathan; Venkatraman, Navin; Imoukhuede, Egeruan; Payne, Ruth; Nicosia, Alfredo; Gilbert, Sarah; Hill, Adrian; Ewer, Katie] Univ Oxford, Jenner Inst, Oxford, England; [Zeltina, Antra] Univ Oxford, STRUBI, Oxford, England; [Sullivan, Nancy; Graham, Barney] NIH, Bldg 10, Bethesda, MD 20892 USA; [Volkmann, Ariane] Bavarian Nordic, Martinried, Germany; [Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium			Ewer, Katie/B-4328-2011	Ewer, Katie/0000-0001-9827-9836				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1311	412	412						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502834					2019-03-26
J	Lin, LY; Lyke, KE; Jarman, RG; Eckels, KH; Lepine, E; Collard, A; McArthur, MA; Keiser, P; De La Barrera, R; Innis, BL; Thomas, SJ; Schmidt, AC				Lin, Leyi; Lyke, Kirsten E.; Jarman, Richard G.; Eckels, Kenneth H.; Lepine, Edith; Collard, Alix; McArthur, Monica A.; Keiser, Paul; De La Barrera, Rafael; Innis, Bruce L.; Thomas, Stephen J.; Schmidt, Alexander C.			SAFETY AND IMMUNOGENICITY OF AN AS03(B)-ADJUVANTED DENGUE PURIFIED INACTIVATED VACCINE ADMINISTERED ON THREE SCHEDULES TO HEALTHY US ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Lin, Leyi; Jarman, Richard G.; Eckels, Kenneth H.; Keiser, Paul; De La Barrera, Rafael; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Lyke, Kirsten E.; McArthur, Monica A.] Univ Maryland, Ctr Vaccine Dev, Inst Global Hlth, Baltimore, MD 21201 USA; [Lepine, Edith; Innis, Bruce L.] GlaxoSmithKline Vaccines, Rockville, MD USA; [Collard, Alix; Schmidt, Alexander C.] GlaxoSmithKline Vaccines, Rixensart, Belgium								0	0	0	3	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1350	424	425						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502873					2019-03-26
J	Cromwell, EA; Stoddard, ST; Barker, CM; Meshnick, S; Van Rie, A; Messer, W; Morrison, AC; Scott, TW; Serre, M				Cromwell, Elizabeth A.; Stoddard, Steven T.; Barker, Chris M.; Meshnick, Steven; Van Rie, Annelies; Messer, William; Morrison, Amy C.; Scott, Thomas W.; Serre, Marc			APPLICATION OF BAYESIAN MAXIMUM ENTROPY TO ESTIMATE THE ASSOCIATION BETWEEN ADULT AEDES AEGYPTI DENSITY AND SIX-MONTH RISK OF DENGUE VIRUS SEROCONVERSION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Cromwell, Elizabeth A.; Meshnick, Steven; Serre, Marc] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Stoddard, Steven T.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Barker, Chris M.; Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Davis, CA 95616 USA; [Van Rie, Annelies] Univ Antwerp, Antwerp, Belgium; [Messer, William] Oregon Hlth & Sci Univ, Portland, OR 97201 USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1433	449	450						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502956					2019-03-26
J	Canavati, SE; Lawpoolsri, S; Quintero, CE; Ly, P; Nguon, C; Pukrittayakamee, S; Sintasath, D; Singhasivanon, P; Grietens, KP; Whittaker, MA				Canavati, Sara E.; Lawpoolsri, Saranath; Quintero, Cesia E.; Ly, Po; Nguon, Chea; Pukrittayakamee, Sasithon; Sintasath, David; Singhasivanon, Pratap; Grietens, Koen Peeters; Whittaker, Maxine Anne			VILLAGE MALARIA WORKER PERFORMANCE KEY TO THE ELIMINATION OF ARTEMISININ-RESISTANT MALARIA: A WESTERN CAMBODIA HEALTH SYSTEM ASSESSMENT	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Canavati, Sara E.; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Canavati, Sara E.; Quintero, Cesia E.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Lawpoolsri, Saranath; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Ly, Po; Nguon, Chea] Minist Hlth, Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Pukrittayakamee, Sasithon] Burnet Inst, Ctr Biomed Res, Bangkok, Thailand; [Sintasath, David] Mahidol Univ, Fac Trop Med, Malaria Consortium Asia, Bangkok, Thailand; [Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Antwerp, Belgium; [Whittaker, Maxine Anne] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Whittaker, Maxine Anne] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld, Australia; [Whittaker, Maxine Anne] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1544	484	484						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503097					2019-03-26
J	Bannister-Tyrrell, M; Grietens, KP				Bannister-Tyrrell, Melanie; Grietens, Koen Peeters			DEFINING THE MICRO-EPIDEMIOLOGY OF MALARIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Bannister-Tyrrell, Melanie; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1583	497	497						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503137					2019-03-26
J	Chaudhury, S; Ockenhouse, CF; Regules, JA; Dutta, S; Wallqvist, A; Jongert, E; Paris, R; Waters, NC; Lemiale, F; Bergmann-Leitner, ES				Chaudhury, Sidhartha; Ockenhouse, Christian F.; Regules, Jason A.; Dutta, Sheetij; Wallqvist, Anders; Jongert, Erik; Paris, Robert; Waters, Norman C.; Lemiale, Franck; Bergmann-Leitner, Elke S.			THE BIOLOGICAL FUNCTION OF ANTIBODIES INDUCED BY THE RTS,S/AS01 MALARIA VACCINE CANDIDATE IS DETERMINED BY THEIR FINE SPECIFICITY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Chaudhury, Sidhartha; Wallqvist, Anders] Telemed & Adv Technol Res Ctr, Biotechnol High Performance Comp Software Applica, Ft Detrick, MD USA; [Ockenhouse, Christian F.; Lemiale, Franck] PATH Malaria Vaccine Initiat, Washington, DC USA; [Regules, Jason A.] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA; [Dutta, Sheetij; Paris, Robert; Waters, Norman C.; Bergmann-Leitner, Elke S.] Walter Reed Army Inst, Silver Spring, MD USA; [Jongert, Erik] GlaxoSmithKline Vaccine, Rixensart, Belgium			Bergmann-Leitner, Elke/B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1605	503	504						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503159					2019-03-26
J	Early, AM; Gilbert, PB; Lievens, M; MacInnis, B; Ockenhouse, CF; Volkman, SK; Wirth, DF; Neafsey, DE				Early, Angela M.; Gilbert, Peter B.; Lievens, Marc; MacInnis, Bronwyn; Ockenhouse, Christian F.; Volkman, Sarah K.; Wirth, Dyann F.; Neafsey, Daniel E.		RTS S Clinical Trials Partnership	USING DEEP POPULATION SEQUENCING TO INVESTIGATE IMMUNE-BASED SELECTION ON ANTIGENIC LOCI IN PLASMODIUM FALCIPARUM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Early, Angela M.; MacInnis, Bronwyn; Neafsey, Daniel E.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lievens, Marc] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Ockenhouse, Christian F.] PATH Malaria Vaccine Initiat, Washington, DC USA; [Volkman, Sarah K.; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA								0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1619	508	508						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503173					2019-03-26
J	Dutta, S; Dlugosz, L; Miura, K; Long, C; Hoyt, N; Franco, D; Vanloubbeeck, Y; Waters, NC; Batchelor, A				Dutta, Sheetij; Dlugosz, Lisa; Miura, Kazutoyo; Long, Carol; Hoyt, Nathan; Franco, David; Vanloubbeeck, Yannick; Waters, Norman C.; Batchelor, Adrian			OVERCOMING DIVERSITY OF AMA1: EVIDENCE OF POLYMORPHISM DILUTION MEDIATED REFOCUSING OF RESPONSES TOWARDS CONSERVED EPITOPES IN RHESUS MONKEYS VACCINATED WITH QUADVAX+AS01	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dutta, Sheetij; Dlugosz, Lisa; Hoyt, Nathan; Waters, Norman C.; Batchelor, Adrian] Walter Reed Army Inst Res, Silver Spring, MD USA; [Miura, Kazutoyo; Long, Carol] NIAID, NIH, Rockville, MD USA; [Franco, David] GlaxoSmithKline Vaccines, Rixensaart, Belgium; [Vanloubbeeck, Yannick] GlaxoSmithKline Vaccines, Vanloubbeeck, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1643	515	515						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503197					2019-03-26
J	Irani, J; Ronse, M; Njamnshi, AK; Hendy, A; Boussinesq, M; Kamgno, J; Colebunders, B; Siling, K; Verdonck, T; Grietens, KP; O'Neill, S				Irani, Julia; Ronse, Maya; Njamnshi, Alfred K.; Hendy, Adam; Boussinesq, Michel; Kamgno, Joseph; Colebunders, Bob; Siling, Katja; Verdonck, Tine; Grietens, Koen Peeters; O'Neill, Sarah			NODDING SYNDROME/EPILEPSY IN THE SANAGA RIVER BASIN (CAMEROON): AN UNNOTICED EPIDEMIC?	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Irani, Julia; Ronse, Maya; Hendy, Adam; Siling, Katja; Verdonck, Tine; Grietens, Koen Peeters; O'Neill, Sarah] Inst Trop Med, Antwerp, Belgium; [Njamnshi, Alfred K.] Univ Yaounde I, Yaounde, Cameroon; [Boussinesq, Michel] IRD, Montpellier, France; [Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis CRFilMT, Yaounde, Cameroon; [Colebunders, Bob] Univ Antwerp, Antwerp, Belgium								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1705	535	535						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503259					2019-03-26
J	Afolabi, MO; McGrath, N; D'Alessandro, U; Kampmann, B; Imoukhuede, E; Ravinetto, R; Alexander, N; Larson, HJ; Chandramohan, D; Bojang, K				Afolabi, Muhammed O.; McGrath, Nuala; D'Alessandro, Umberto; Kampmann, Beate; Imoukhuede, Egeruan; Ravinetto, Raffaella; Alexander, Neal; Larson, Heidi J.; Chandramohan, Daniel; Bojang, Kalifa			MULTIMEDIA TOOL FOR OBTAINING INFORMED CONSENT IN THE GAMBIA: A MIXED METHOD STUDY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Afolabi, Muhammed O.; D'Alessandro, Umberto; Kampmann, Beate; Bojang, Kalifa] MRC, Banjul, Gambia; [McGrath, Nuala] Univ Southampton, Southampton, Hants, England; [Imoukhuede, Egeruan] Univ Oxford, Oxford, England; [Ravinetto, Raffaella] Inst Trop Med, Antwerp, Belgium; [Alexander, Neal; Larson, Heidi J.; Chandramohan, Daniel] London Sch Hyg & Trop Med, London, England								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1809	566	566						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503363					2019-03-26
J	Trindade, S; Rijo-Ferreira, F; Carvalho, T; Pinto-Neves, D; Guegan, F; Aresta-Branco, F; Bento, F; Young, SA; Pinto, A; Van den Abbeele, J; Ribeiro, RM; Dias, S; Smith, TK; Figueiredo, LM				Trindade, Sandra; Rijo-Ferreira, Filipa; Carvalho, Tania; Pinto-Neves, Daniel; Guegan, Fabien; Aresta-Branco, Francisco; Bento, Fabio; Young, Simon A.; Pinto, Andreia; Van den Abbeele, Jan; Ribeiro, Ruy M.; Dias, Sergio; Smith, Terry K.; Figueiredo, Luisa M.			ADIPOSE TISSUE IS A MAJOR RESERVOIR OF FUNCTIONALLY DISTINCT TRYPANOSOMA BRUCEI PARASITES	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Trindade, Sandra; Rijo-Ferreira, Filipa; Carvalho, Tania; Pinto-Neves, Daniel; Guegan, Fabien; Aresta-Branco, Francisco; Bento, Fabio; Pinto, Andreia; Dias, Sergio; Figueiredo, Luisa M.] Inst Med Mol, Lisbon, Portugal; [Young, Simon A.; Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Van den Abbeele, Jan] Inst Trop Med Antwerp, Antwerp, Belgium; [Ribeiro, Ruy M.] Los Alamos Natl Lab, Los Alamos, NM USA				Young, Simon/0000-0003-1072-905X				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1932	606	606						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503486					2019-03-26
J	da Luz, RI; Linsuke, S; Lutumba, P; Hasker, E; Boelaert, M				da Luz, R. Inocencio; Linsuke, S.; Lutumba, P.; Hasker, E.; Boelaert, M.			Assessment of schistosomiasis and soil-transmitted helminths prevalence in school-aged children and opportunities for integration of control in local health services in Kwilu Province, the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						NTD; parasites; helminths; schistosomiasis; MNT; parasites; helminthes; schistosomiase	INTERNATIONAL SURVEY	ObjectiveTo determine the prevalence of schistosomiasis (SCH) and soil-transmitted helminths (STH) in the Democratic Republic of Congo, and to assess the capacity of the local health centres for diagnosis and treatment. MethodsCross-sectional school-based survey in two health districts in the Province of Kwilu. We collected a stool and a urine sample for parasitological examination. Urine filtration and duplicate Kato-Katz thick smears were used for the diagnosis of SCH. Health centres were evaluated using a structured questionnaire. ResultsIn total, 526 children participated in the study and the overall prevalence of Schistosoma mansoni infection was 8.9% (95% CI: 3.5-13.2) in both districts. The prevalence was higher in Mosango (11.7%; 95% CI: 8.9-14.8) than Yasa Bonga district (6.2%; 95% CI: 1.1-11.4). Urine filtration showed that Schistosoma haematobium infection was not present. The combined STH infection prevalence was 58.1% in both districts; hookworm infection was the most common STH found in 52.9% (95% CI: 29.3-62.4) of subjects, followed by Ascaris lumbricoides 9.3% (95% CI: 5.8-15.5) and Trichuris trichiura 2.1% (95% CI: 0.9-4.9). Mixed STH infections were observed as well as SCH-STH coinfection. ConclusionFurther mapping of both SCH and STH burden is needed, and coverage of preventive chemotherapy in school-aged children should be increased. ObjectifDeterminer la prevalence de la schistosomiase (SCH) et des helminthes transmises par le sol (HTS) dans la Republique Democratique du Congo et evaluer la capacite des centres de sante locaux pour le diagnostic et le traitement. MethodesEnquete transversale menee en milieu scolaire dans deux districts de sante dans la province de Kwilu. Nous avons recueilli un echantillon de selles et un d'urine pour un examen parasitologique. La filtration d'urine et les frottis epais de Kato-Katz dupliques ont ete utilises pour le diagnostic de la SCH. Les centres de sante ont ete evalues a l'aide d'un questionnaire structure. ResultatsAu total, 526 enfants ont participe a l'etude et la prevalence globale de l'infection a S. mansoni etait de 8,9% (IC95%: 3,5 a 13,2) dans les deux districts. La prevalence etait plus elevee dans le district de Mosango (11,7%; IC95%: 8,9 a 14,8) que dans celui de Yasa Bonga (6,2%; IC95%: 01,01 a 11,04). La filtration d'urine a montre que l'infection par S. haematobium n'etait pas presente. La prevalence combinee de la STH etait de 58,1% dans les deux districts; l'ankylostomiase etait la STH la plus repandue trouvee chez 52,9% (IC95%: 29,3 a 62,4) des sujets, suivi par A. lumbricoides 9,3% (IC95%: 5,8 a 15,5) et T. trichiura 2,1% (IC95%: 0,9-4,9). Des infections a STH mixtes ainsi que des coinfections SCH/HTS ont ete observees. ConclusionLa cartographie de la SCH et des HTS est necessaire, et la couverture de la chimiotherapie preventive chez les enfants d'age scolaire devrait etre augmentee.	[da Luz, R. Inocencio; Hasker, E.; Boelaert, M.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium; [Linsuke, S.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO	da Luz, RI (reprint author), Inst Trop Med, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	rinocencio@itg.be	Inocencio da Luz, Raquel/L-9676-2016	Inocencio da Luz, Raquel/0000-0002-2870-0311; Boelaert, Marleen/0000-0001-8051-6776	Margaret A. Cargill Philanthropies	We thank the Margaret A. Cargill Philanthropies for funding the study. We thank the Medecin Chef de Zone from Mosango and Yasa Bonga and their team for facilitating the study in their Health District. Finally, we thank the school directors for their cooperation and all the parents and children who participated in the study.	[Anonymous], 2016, Wkly Epidemiol Rec, V91, P585; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DAZO BC, 1974, B WORLD HEALTH ORGAN, V51, P399; de Silva N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000655; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Kabore A, 2017, ACTA TROP, V166, P177, DOI 10.1016/j.actatropica.2016.11.023; Kane RA, 2003, PARASITOLOGY, V127, P131, DOI 10.1017/S0031182003003421; Knoblauch AM, 2016, T ROY SOC TROP MED H, V110, P424, DOI 10.1093/trstmh/trw040; Linsuke S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003387; Madinga J, 2017, ACTA TROP, V171, P186, DOI 10.1016/j.actatropica.2017.03.019; Madinga J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1206-6; MATANGILA JR, 2014, PLOS ONE, V0009; Montresor A, 2011, LUTTE CONTRE HELMINT; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P243; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; Statistique INdl, 2015, ANN STAT 2014 STAT I; Stothard JR, 2014, PARASITOLOGY, V141, P1947, DOI 10.1017/S0031182014001152; WHO, 2006, PREV CHEM HUM HELM C, P74; WHO, 2011, WHONMHNHDMNM111; WHO, PREV CHEM TRANSM CON; WHO, 2013, SCHIST PROGR REP 200	22	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2017	22	11					1442	1450		10.1111/tmi.12965				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FL6IC	WOS:000414347400010	28853206	Bronze			2019-03-26
J	Masha, SC; Cools, P; Crucitti, T; Sanders, EJ; Vaneechoutte, M				Masha, Simon C.; Cools, Piet; Crucitti, Tania; Sanders, Eduard J.; Vaneechoutte, Mario			Molecular typing of Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T-vaginalis viruses	PARASITES & VECTORS			English	Article						Trichomonas vaginalis; Trichomonas vaginalis viruses; actin gene; Typing; Kilifi; Kenya	DOUBLE-STRANDED-RNA; FEMALE SEX WORKERS; VIRAL-INFECTION; DSRNA VIRUS; WOMEN; PREVALENCE; KENYA; POLYMORPHISM; SENSITIVITY; DIAGNOSIS	Background: The protozoan parasite Trichomonas vaginalis is the most common non-viral, sexually transmitted pathogen. Although T. vaginalis is highly prevalent among women in Kenya, there is lack of data regarding genetic diversity of isolates currently in circulation in Kenya. Methods: Typing was performed on 22 clinical isolates of T. vaginalis collected from women attending the antenatal care clinic at Kilifi County Hospital, Kenya, in 2015. Genotyping followed a previously proposed restriction fragment length polymorphism (RFLP) scheme, which involved in silico cleavage of the amplified actin gene by HindII, MseI and RsaI restriction enzymes. Phylogenetic analysis of all the sequences was performed to confirm the results obtained by RFLP-analysis and to assess the diversity within the RFLP genotypes. Additionally, we determined carriage of the four different types of Trichomonas vaginalis viruses (TVVs) by polymerase chain reaction. Results: In silico RFLP-analysis revealed five actin genotypes; 50.0% of the isolates were of actin genotype E, 27.3% of actin genotype N, 13.6% of actin genotype G and 4.5% of actin genotypes I and P. Phylogenetic analysis was in agreement with the RFLP-analysis, with the different actin genotypes clustering together. Prevalence of TVVs was 43.5% (95% confidence interval, CI: 23.2-65.5). TVV1 was the most prevalent, present in 39.1% of the strains and 90% of the T. vaginalis isolates which harbored TVVs had more than one type of TVV. None of the isolates of actin genotype E harbored any TVV. Conclusion: The presence of five actin genotypes in our study suggests notable diversity among T. vaginalis isolates occurring among pregnant women in Kilifi, Kenya. Isolates of the most prevalent actin genotype E lacked TVVs. We found no association between T. vaginalis genotype, carriage of TVVs and symptoms. Further studies with higher number of strains should be conducted in order to corroborate these results.	[Masha, Simon C.; Sanders, Eduard J.] Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, POB 230-80108, Kilifi, Kenya; [Masha, Simon C.; Cools, Piet; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, De Pintelaan 185, B-9000 Ghent, Belgium; [Masha, Simon C.] Pwani Univ, Fac Pure & Appl Sci, Dept Biol Sci, POB 195-80108, Kilifi, Kenya; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Natl Str 155, B-2000 Antwerp, Belgium	Masha, SC (reprint author), Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, POB 230-80108, Kilifi, Kenya.; Masha, SC (reprint author), Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, De Pintelaan 185, B-9000 Ghent, Belgium.; Masha, SC (reprint author), Pwani Univ, Fac Pure & Appl Sci, Dept Biol Sci, POB 195-80108, Kilifi, Kenya.	schengo@kemri-wellcome.org	Masha, Simon/R-4419-2017	Masha, Simon/0000-0002-6283-2430	Belgian Development Cooperation through VLIR-UOS; Wellcome Trust [077092]	This research has been supported by a PhD Scholarship for SCM from the Belgian Development Cooperation through VLIR-UOS. The Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP) at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). The funders had no role in the in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. The views expressed here are those of the authors and do not necessarily represent the views of the Belgian Development Cooperation, or the Wellcome Trust.	Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006; Conrad MD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001573; Crucitti T, 2008, CLIN MICROBIOL INFEC, V14, P844, DOI 10.1111/j.1469-0691.2008.02034.x; Drouin G, 1995, J MOL EVOL, V41, P841, DOI 10.1007/BF00173163; Fichorova R, 2017, RES MICROBIOL, V168, P882, DOI 10.1016/j.resmic.2017.03.005; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Fraga Jorge, 2005, Braz J Infect Dis, V9, P521, DOI 10.1590/S1413-86702005000600012; Fraga J, 2011, EXP PARASITOL, V127, P593, DOI 10.1016/j.exppara.2010.09.005; Gomih-Alakija A, 2014, J CLIN MICROBIOL, V52, P3660, DOI 10.1128/JCM.00850-14; Goodman RP, 2011, J VIROL, V85, P4258, DOI 10.1128/JVI.00220-11; Goodman RP, 2011, ARCH VIROL, V156, P171, DOI 10.1007/s00705-010-0832-8; Heidary S, 2013, IRAN J PARASITOL, V8, P60; Hokororo A, 2015, SEX TRANSM INFECT, V91, P473, DOI 10.1136/sextrans-2014-051952; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; Kaul P, 2004, PARASITOL INT, V53, P255, DOI 10.1016/j.parint.2004.02.003; Kerubo E, 2016, SEX TRANSM INFECT, V92, P251, DOI 10.1136/sextrans-2015-052371; KHOSHNAN A, 1994, J VIROL, V68, P4035; KRIEGER JN, 1984, SEX TRANSM DIS, V11, P100, DOI 10.1097/00007435-198404000-00011; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Luo L, 2016, INT J STD AIDS, V27, P469, DOI 10.1177/0956462415585449; Malla N, 2011, INDIAN J MED MICROBI, V29, P152, DOI 10.4103/0255-0857.81801; Masha SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175166; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Momeni Z, 2015, EXP PARASITOL, V159, P259, DOI 10.1016/j.exppara.2015.10.011; Nakubulwa Sarah, 2015, BMC Res Notes, V8, P573, DOI 10.1186/s13104-015-1545-6; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Provenzano D, 1997, ARCH VIROL, V142, P939, DOI 10.1007/s007050050130; Rivera WL, 2017, J MICROBIOL IMMUNOL, V50, P669, DOI 10.1016/j.jmii.2015.07.016; Sangkomkamhang US, 2015, COCHRANE DB SYST REV, V2; Silver BJ, 2014, SEX TRANSM DIS, V41, P369, DOI 10.1097/OLQ.0000000000000134; Sorvillo F, 1998, LANCET, V351, P213, DOI 10.1016/S0140-6736(05)78181-2; Swygard H, 2004, SEX TRANSM INFECT, V80, P91, DOI 10.1136/sti.2003.005124; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TORIAN BE, 1988, J PROTOZOOL, V35, P273, DOI 10.1111/j.1550-7408.1988.tb04343.x; Unger JA, 2015, SEX TRANSM DIS, V42, P637, DOI 10.1097/OLQ.0000000000000355; Upcroft JA, 2006, INT J PARASITOL, V36, P821, DOI 10.1016/j.ijpara.2006.02.018; VOHRA H, 1991, INDIAN J MED RES-A, V93, P37; WANG AL, 1986, P NATL ACAD SCI USA, V83, P7956, DOI 10.1073/pnas.83.20.7956; Weber B, 2003, J CLIN PATHOL, V56, P542, DOI 10.1136/jcp.56.7.542; Wendel KA, 2002, J INFECT DIS, V186, P558, DOI 10.1086/341832	42	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 30	2017	10								537	10.1186/s13071-017-2496-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FL3WS	WOS:000414157300002	29084570	DOAJ Gold, Green Published			2019-03-26
J	Drakeley, C; Abdulla, S; Agnandji, ST; Fernandes, JF; Kremsner, P; Lell, B; Mewono, L; Bache, BE; Mihayo, MG; Juma, O; Tanner, M; Tahita, MC; Tinto, H; Diallo, S; Lompo, P; D'Alessandro, U; Ogutu, B; Otieno, L; Otieno, S; Otieno, W; Oyieko, J; Asante, KP; Dery, DBE; Adjei, G; Adeniji, E; Atibilla, D; Owusu-Agyei, S; Greenwood, B; Gesase, S; Lusingu, J; Mahende, C; Mongi, R; Segeja, M; Adjei, S; Agbenyega, T; Agyekum, A; Ansong, D; Bawa, JT; Boateng, HO; Dandalo, L; Escamilla, V; Hoffman, I; Maenje, P; Martinson, F; Carter, T; Leboulleux, D; Kaslow, DC; Usuf, E; Pircon, JY; Bahmanyar, ER				Drakeley, Chris; Abdulla, Salim; Agnandji, Selidji Todagbe; Fernandes, Jose Francisco; Kremsner, Peter; Lell, Bertrand; Mewono, Ludovic; Bache, Bache Emmanuel; Mihayo, Michael Gabriel; Juma, Omar; Tanner, Marcel; Tahita, Marc Christian; Tinto, Halidou; Diallo, Salou; Lompo, Palpouguini; D'Alessandro, Umberto; Ogutu, Bernhards; Otieno, Lucas; Otieno, Solomon; Otieno, Walter; Oyieko, Janet; Asante, Kwaku Poku; Dery, Dominic Bon-Ereme; Adjei, George; Adeniji, Elisha; Atibilla, Dorcas; Owusu-Agyei, Seth; Greenwood, Brian; Gesase, Samwel; Lusingu, John; Mahende, Coline; Mongi, Robert; Segeja, Method; Adjei, Samuel; Agbenyega, Tsiri; Agyekum, Alex; Ansong, Daniel; Bawa, John Tanko; Boateng, Harry Owusu; Dandalo, Leonard; Escamilla, Veronica; Hoffman, Irving; Maenje, Peter; Martinson, Francis; Carter, Terrell; Leboulleux, Didier; Kaslow, David C.; Usuf, Effua; Pircon, Jean-Yves; Bahmanyar, Edith Roset			Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries	MALARIA JOURNAL			English	Article						Epidemiology; Malaria; Transmission; Prevalence; Plasmodium falciparum; Anaemia	INSECTICIDE-TREATED BEDNETS; PARASITE PREVALENCE; BURKINA-FASO; TRANSMISSION INTENSITY; ASYMPTOMATIC PARASITEMIA; WESTERN KENYA; CHILDREN; MORBIDITY; MORTALITY; COVERAGE	Background: Plasmodium falciparum prevalence (PfPR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS, S/AS01 candidate malaria vaccine Phase III trial and estimated PfPR over <= 4 standardized cross-sectional surveys. Methods: This epidemiology study (NCT01190202) was conducted in 8 sites from 6 countries (Burkina Faso, Gabon, Ghana, Kenya, Malawi, and Tanzania), between March 2011 and December 2013. Participants were enrolled in a 2:1:1 ratio according to age category:6 months-4 years, 5-19 years, and >= 20 years, respectively, per year and per centre. All sites carried out surveys 1-3 while survey 4 was conducted only in 3 sites. Surveys were usually performed during the peak malaria parasite transmission season, in one home visit, when medical history and malaria risk factors/prevention measures were collected, and a blood sample taken for rapid diagnostic test, microscopy, and haemoglobin measurement. PfPR was estimated by site and age category. Results: Overall, 6401 (survey 1), 6411 (survey 2), 6400 (survey 3), and 2399 (survey 4) individuals were included in the analyses. In the 6 months-4 years age group, the lowest prevalence (assessed using microscopy) was observed in 2 Tanzanian centres (4.6% for Korogwe and 9.95% for Bagamoyo) and Lambarene, Gabon (6.0%), while the highest PfPR was recorded for Nanoro, Burkina Faso (52.5%). PfPR significantly decreased over the 3 years in Agogo (Ghana), Kombewa (Kenya), Lilongwe (Malawi), and Bagamoyo (Tanzania), and a trend for increased PfPR was observed over the 4 surveys for Kintampo, Ghana. Over the 4 surveys, for all sites, PfPR was predominantly higher in the 5-19 years group than in the other age categories. Occurrence of fever and anaemia was associated with high P. falciparum parasitaemia. Univariate analyses showed a significant association of anti-malarial treatment in 4 surveys (odds ratios [ORs]: 0.52, 0.52, 0.68, 0.41) and bed net use in 2 surveys (ORs:0.63, 0.68, 1.03, 1.78) with lower risk of malaria infection. Conclusion: Local PfPR differed substantially between sites and age groups. In children 6 months-4 years old, a significant decrease in prevalence over the 3 years was observed in 4 out of the 8 study sites.	[Drakeley, Chris; D'Alessandro, Umberto; Owusu-Agyei, Seth; Greenwood, Brian] London Sch Hyg & Trop Med, London, England; [Abdulla, Salim; Mihayo, Michael Gabriel; Juma, Omar; Tanner, Marcel] Bagamoyo Dist Hosp, Ifakara Inst Hlth, Bagamoyo Res & Training Ctr, POB 74, Bagamoyo, Tanzania; [Agnandji, Selidji Todagbe; Fernandes, Jose Francisco; Lell, Bertrand; Mewono, Ludovic; Bache, Bache Emmanuel] Albert Schweitzer Hosp, Lambarene, Gabon; [Agnandji, Selidji Todagbe; Fernandes, Jose Francisco; Kremsner, Peter; Lell, Bertrand; Mewono, Ludovic; Bache, Bache Emmanuel] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Basel, Switzerland; [Tahita, Marc Christian; Tinto, Halidou; Diallo, Salou; Lompo, Palpouguini] Inst Rech Sci Sante, Nanoro, Burkina Faso; [D'Alessandro, Umberto; Usuf, Effua] Gambia, Med Res Council Unit, Banjul, Gambia; [Ogutu, Bernhards; Otieno, Lucas; Otieno, Solomon; Otieno, Walter; Oyieko, Janet] KEMRI Walter Reed Project, Kombewa, Kenya; [Asante, Kwaku Poku; Dery, Dominic Bon-Ereme; Adjei, George; Adeniji, Elisha; Atibilla, Dorcas; Owusu-Agyei, Seth; Greenwood, Brian] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Gesase, Samwel; Lusingu, John; Mahende, Coline; Mongi, Robert; Segeja, Method] Natl Inst Med Res, Korogwe, Tanzania; [Adjei, Samuel; Agbenyega, Tsiri; Agyekum, Alex; Ansong, Daniel; Bawa, John Tanko] Kwame Nkrumah Univ Sci & Technol, Agogo, Ghana; [Dandalo, Leonard; Escamilla, Veronica; Hoffman, Irving; Maenje, Peter; Martinson, Francis] Univ North Carolina Project, Lilongwe, Malawi; [Carter, Terrell; Leboulleux, Didier; Kaslow, David C.] PATH Malaria Vaccine Initiat, Washington, DC USA; [Usuf, Effua; Pircon, Jean-Yves; Bahmanyar, Edith Roset] GSK Vaccines, Wavre, Belgium	Abdulla, S (reprint author), Bagamoyo Dist Hosp, Ifakara Inst Hlth, Bagamoyo Res & Training Ctr, POB 74, Bagamoyo, Tanzania.	sabdulla@ihi.or.tz		Tinto, Halidou/0000-0002-0472-3586; Atibilla, Dorcas/0000-0002-0462-0499	GlaxoSmithKline Biologicals SA (GSK) - GSK; GlaxoSmithKline Biologicals SA (GSK) - PATH Malaria Vaccine Initiative (MVI)	The study was sponsored by GlaxoSmithKline Biologicals SA (GSK) and funded by both GSK and the PATH Malaria Vaccine Initiative (MVI). GSK also funded all costs associated with the development and the publishing of the present manuscript.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1654-4; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Buchwald AG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1686-2; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Clinical S., 2015, LANCET, V386, P31; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Diallo A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1715-1; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Idris ZM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36958; International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 1996, GUID IND E6 GOOD CLI, V38-42, P50; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; Lengeler C., 2004, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD000363.pub2/abstract;jsessionid=23CE1FBBFA0C06D2841A1BBC3EE93F02.f02t02, DOI 10.1002/14651858.CD000363.PUB2]; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1603/0022-2585(2006)043[0428:IOSUOI]2.0.CO;2; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/ERI.13.45, 10.1586/eri.13.45]; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-3; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Ministry of Health Republic of Ghana., 2010, STAND TREATM GUID; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Mwingira F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-433; Namountougou M, 2012, ACTA TROP, V7, P48412, DOI DOI 10.1371/J0URNAL.P0NE.0048412; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; Olumese P, 2016, ACCESS SMC M TRANSF, DOI [10.1002/14651858.CD000363.pub2, DOI 10.1002/14651858.CD000363.PUB2]; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Parr JB, 2016, AM J TROP MED HYG, V95, P373, DOI 10.4269/ajtmh.16-0156; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Shaukat AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-122; Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stoltzfus RJ, 1993, GUIDELINES USE IRON; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of Chief Government Statistician (OCGS) and ICF International, 2013, TANZ HIV AIDS MAL IN; The RTS, 2011, NEW ENGL J MED, V365, P1863, DOI DOI 10.1056/NEJM0A1102287; Vandoolaeghe P, 2016, EXPERT REV VACCINES, V15, P1481, DOI 10.1080/14760584.2016.1236689; WHO, 2006, WHO TECH REP SER, V936, P1; WHO, MAL CHILDR 5; WHO/NHD, 2001, WHONHD013; World Health Organization, MAL FACT SHEET; Yakasai AM, 2015, J TROP MED, DOI 10.1155/2015/189232; Zhou G, 2011, PLOS ONE, V6, P20318, DOI DOI 10.1371/J0URNAL.P0NE.0020318	57	2	2	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 27	2017	16								433	10.1186/s12936-017-2078-3				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL4HJ	WOS:000414189500002	29078773	DOAJ Gold, Green Published			2019-03-26
J	Heylen, D; Fonville, M; van Leeuwen, AD; Stroo, A; Duisterwinkel, M; van Wieren, S; Diuk-Wasser, M; de Bruin, A; Sprong, H				Heylen, Dieter; Fonville, Manoj; van Leeuwen, Arieke Docters; Stroo, Arjan; Duisterwinkel, Martin; van Wieren, Sip; Diuk-Wasser, Maria; de Bruin, Arnout; Sprong, Hein			Pathogen communities of songbird-derived ticks in Europe's low countries	PARASITES & VECTORS			English	Article						Co-infection; Bird; Ixodes ricinus; Borrelia burgdorferi (s.l.); Borrelia miyamotoi; Rickettsiales	CANDIDATUS NEOEHRLICHIA MIKURENSIS; BORRELIA-BURGDORFERI S.L.; IXODES-RICINUS TICKS; LYME BORRELIOSIS; ANAPLASMA-PHAGOCYTOPHILUM; TRANSMISSION DYNAMICS; BORNE PATHOGENS; CLINICAL-MANIFESTATIONS; RICKETTSIA-HELVETICA; MIGRATING BIRDS	Background: Birds play a major role in the maintenance of enzootic cycles of pathogens transmitted by ticks. Due to their mobility, they affect the spatial distribution and abundance of both ticks and pathogens. In the present study, we aim to identify members of a pathogen community [Borrelia burgdorferi (s.l.), B. miyamotoi, 'Ca. Neoehrlichia mikurensis', Anaplasma phagocytophilum and Rickettsia helvetica] in songbird-derived ticks from 11 locations in the Netherlands and Belgium (2012-2014). Results: Overall, 375 infested songbird individuals were captured, belonging to 35 species. Thrushes (Turdus iliacus, T. merula and T. philomelos) were trapped most often and had the highest mean infestation intensity for both Ixodes ricinus and I. frontalis. Of the 671 bird-derived ticks, 51% contained DNA of at least one pathogenic agent and 13% showed co-infections with two or more pathogens. Borrelia burgdorferi (s.l.) DNA was found in 34% of the ticks of which majority belong to so-called avian Borrelia species (distribution in Borrelia-infected ticks: 47% B. garinii, 34% B. valaisiana, 3% B. turdi), but also the mammal-associated B. afzelii (16%) was detected. The occurrence of B. miyamotoi was low (1%). Prevalence of R. helvetica in ticks was high (22%), while A. phagocytophilum and 'Ca. N. mikurensis' prevalences were 5% and 4%, respectively. The occurrence of B. burgdorferi (s.l.) was positively correlated with the occurrence of 'Ca. N. mikurensis', reflecting variation in susceptibility among birds and/or suggesting transmission facilitation due to interactions between pathogens. Conclusions: Our findings highlight the contribution of European songbirds to co-infections in tick individuals and consequently to the exposure of humans to multiple pathogens during a tick bite. Although poorly studied, exposure to and possibly also infection with multiple tick-borne pathogens in humans seems to be the rule rather than the exception.	[Heylen, Dieter] Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium; [Fonville, Manoj; van Leeuwen, Arieke Docters; de Bruin, Arnout; Sprong, Hein] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Stroo, Arjan] Minist Econ Affairs, Netherlands Food & Consumer Prod Safety Author, Ctr Monitoring Vectors, Wageningen, Netherlands; [Duisterwinkel, Martin] Independent Agr Entrepreneur, Groningen, Netherlands; [van Wieren, Sip] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Diuk-Wasser, Maria] Columbia Univ, EcoEpidemiol Lab, New York, NY USA	Heylen, D (reprint author), Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium.	dieter.heylen@uantwerpen.be			Dutch Ministry of Health, Welfare and Sport (VWS); Fund for Scientific Research - Flanders Belgium (FWO) [G0.049.10]; University of Antwerp (KP BOF UA)	This study was financially supported by the Dutch Ministry of Health, Welfare and Sport (VWS), the Fund for Scientific Research - Flanders Belgium (FWO) (grant G0.049.10) and the University of Antwerp (KP BOF UA 2015). This work was done under the frame of EurNegVec Cost Action TD1303. Dieter Heylen is a postdoctoral fellow at the Fund for Scientific Research - Flanders Belgium (FWO). The funders had no role in study design, data collection, interpretation and analysis, decision to publish or preparation of the manuscript.	Acari Manila G., 1998, IXODIDA; Andersson M, 2014, APPL ENVIRON MICROB, V80, P1645, DOI 10.1128/AEM.03469-13; Arthur D.R., 1963, BRIT TICKS; Beati L, 1999, S AFR J SCI, V95, P448; Berthova L, 2016, EXP APPL ACAROL, V68, P299, DOI 10.1007/s10493-015-9975-3; Bjoersdorff A, 2001, EMERG INFECT DIS, V7, P877; Burri C, 2014, TICKS TICK-BORNE DIS, V5, P245, DOI 10.1016/j.ttbdis.2013.11.007; Capligina V, 2014, TICKS TICK-BORNE DIS, V5, P75, DOI 10.1016/j.ttbdis.2013.08.007; Coipan EC, 2016, INFECT GENET EVOL, V42, P66, DOI 10.1016/j.meegid.2016.04.019; Coipan EC, INFECT GENET EVOL; Coipan EC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00036; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; de Bruin A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0764-y; Dubska L, 2011, APPL ENVIRON MICROB, V77, P1115, DOI 10.1128/AEM.02278-10; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Duncan AB, 2015, J ANIM ECOL, V84, P498, DOI 10.1111/1365-2656.12302; Dunn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115494; Elfving K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008572; Franke J, 2010, TICKS TICK-BORNE DIS, V1, P109, DOI 10.1016/j.ttbdis.2010.03.001; Geller J, 2013, VECTOR-BORNE ZOONOT, V13, P443, DOI 10.1089/vbz.2012.1054; Ginsberg HS, 2008, EXP APPL ACAROL, V46, P29, DOI 10.1007/s10493-008-9175-5; Graham RI, 2010, MED VET ENTOMOL, V24, P340, DOI 10.1111/j.1365-2915.2010.00886.x; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Hamer SA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-231; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Heylen D., 2016, ECOLOGICAL INTERACTI, V4; Heylen D, 2017, SCI REP, V7; Heylen D, 2017, ENVIRON MICROBIOL, V19, P1857, DOI 10.1111/1462-2920.13685; Heylen D, 2016, ENVIRON MICROBIOL, V18, P988, DOI 10.1111/1462-2920.13164; Heylen D, 2014, TICKS TICK-BORNE DIS, V5, P693, DOI 10.1016/j.ttbdis.2014.05.006; Heylen D, 2014, ENVIRON MICROBIOL, V16, P2859, DOI 10.1111/1462-2920.12304; Heylen D, 2013, ENVIRON MICROBIOL, V15, P663, DOI 10.1111/1462-2920.12059; Hildebrandt A, 2010, TICKS TICK-BORNE DIS, V1, P105, DOI 10.1016/j.ttbdis.2009.12.003; Hillyard PD, 1996, TICKS N W EUROPE; Hofmeester TR, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/043001; Holden K, 2005, INFECT IMMUN, V73, P3440, DOI 10.1128/IAI.73.6.3440-3444.2005; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-128; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; HUDDE H, 1988, Vogelwarte, V34, P201; Humair PF, 2000, MICROBES INFECT, V2, P915, DOI 10.1016/S1286-4579(00)00393-2; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Humair PF, 1998, ZBL BAKT-INT J MED M, V287, P521, DOI 10.1016/S0934-8840(98)80194-1; Jahfari S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-365; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Kocan KA, 2003, VET PARASITOL, V112, P295, DOI 10.1016/S0304-4017(03)00018-9; Kurtenbach K, 2002, INFECT IMMUN, V70, P5893, DOI 10.1128/IAI.70.10.5893-5895.2002; Lipsker D, 2009, LYME BORRELIOSIS BIO; Lommano E, 2014, TICKS TICK-BORNE DIS, V5, P871, DOI 10.1016/j.ttbdis.2014.07.001; Lundqvist L, 1998, MED VET ENTOMOL, V12, P215, DOI 10.1046/j.1365-2915.1998.00101.x; Marsot M, 2012, INT J PARASITOL, V42, P781, DOI 10.1016/j.ijpara.2012.05.010; Maurer FP, 2013, J CLIN MICROBIOL, V51, P169, DOI 10.1128/JCM.01955-12; Molenberghs G., 2005, MODELS DISCRETE LONG; Moro MH, 2002, J INFECT DIS, V186, P428, DOI 10.1086/341452; Nilsson K, 1999, LANCET, V354, P1169, DOI 10.1016/S0140-6736(99)04093-3; Nilsson K, 2010, EMERG INFECT DIS, V16, P490, DOI 10.3201/eid1603.090184; Palomar AM, 2015, MED VET ENTOMOL, V29, P349, DOI 10.1111/mve.12124; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Richter D, 2012, VECTOR-BORNE ZOONOT, V12, P21, DOI 10.1089/vbz.2011.0668; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Sandelin LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133250; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Snow DW, 1998, BIRDS W PALEARCTIC C, V2; Spitalska E, 2011, VECTOR-BORNE ZOONOT, V11, P1235, DOI 10.1089/vbz.2010.0210; Sprong H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-41; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Susi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6975; Szekeres S, 2015, TICKS TICK-BORNE DIS, V6, P111, DOI 10.1016/j.ttbdis.2014.10.004; Taragel'ova V, 2008, APPL ENVIRON MICROB, V74, P1289, DOI 10.1128/AEM.01060-07; Thomas V, 2001, INFECT IMMUN, V69, P3359, DOI 10.1128/IAI.69.5.3359-3371.2001; ULMANEN I, 1977, OIKOS, V28, P20, DOI 10.2307/3543318; van Duijvendijk G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1389-5; VERBEKE G, 2001, LINEAR MIXED MODELS; Voordouw MJ, 2015, PARASITOLOGY, V142, P290, DOI 10.1017/S0031182014001486; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416; Wallmenius K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-318; Zemtsova G, 2010, EXP APPL ACAROL, V52, P383, DOI 10.1007/s10493-010-9375-7	78	2	3	5	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 18	2017	10								497	10.1186/s13071-017-2423-y				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FK4KG	WOS:000413461900003	29047399	DOAJ Gold, Green Published			2019-03-26
J	De Koninck, AS; Cnops, L; Hofmans, M; Jacobs, J; Van den Bossche, D; Philippe, J				De Koninck, Anne-Sophie; Cnops, Lieselotte; Hofmans, Mattias; Jacobs, Jan; Van den Bossche, Dorien; Philippe, Jan			Diagnostic performance of the loop-mediated isothermal amplification (LAMP) based illumigene (R) malaria assay in a non-endemic region	MALARIA JOURNAL			English	Article						Illumigene malaria assay; LAMP assay; Plasmodium; Loop-mediated isothermal amplification; Malaria	REAL-TIME PCR; IMPORTED MALARIA; MOLECULAR DIAGNOSIS; TESTS; INFECTIONS; TRAVEL; TOOL	Background: Light microscopy and antigen-based rapid diagnostic tests are the primary diagnostic tools for detecting malaria, although being labour-intensive and frequently challenged by lack of personnel's experience and low levels of parasite density. The latter being especially important in non-endemic settings. Novel molecular techniques aim to overcome this drawback. The objective of this study was to assess the diagnostic performance of the illumigene malaria assay (R) (Meridian Bioscience) compared to microscopy, RDT and real-time PCR. This loop-mediated isothermal amplification (LAMP) assay is a qualitative in vitro diagnostic test for the direct detection of Plasmodium spp. DNA in human venous whole blood samples. Methods: The illumigene assay was assessed on a retrospective panel of stored blood samples (n = 103) from returned travellers and external quality control samples (n = 12). Additionally the assay was prospectively assessed on 30 fresh routine samples with a request for malaria diagnosis. The illumigene assay was compared to microscopy, RDT and Plasmodium species specific real-time PCR. Results: In the retrospective evaluation, the illumigene assay showed 100% agreement with the real-time PCR, RDT and microscopy yielding a sensitivity and specificity of 100% (95% CI 95.1-100% and 89.7-100%, respectively). Seven samples from patients recently treated for Plasmodium falciparum infection that were RDT positive and microscopy negative yielded positive test results. The performance of the illumigene assay equals that of microscopy combined with RDT in the prospective panel with three false negative RDT results and one false negative microscopy result. Excellent concordance with PCR was observed. The limit of detection of the assay approached 0.5 parasites/mu L for both P. falciparum and Plasmodium vivax. Conclusion: In non-endemic regions where the diagnostic process for malaria infections is questioned by lack of experience and low levels of parasite densities, the illumigene assay can be of value. Due to its high sensitivity, the LAMP assay may be considered as primary diagnostic test. The results of this study indicate that negative screen results do not need further confirmation. However, before implementation, this approach needs to be confirmed in larger, prospective studies. A shortcoming of this assay is that no species identification nor determination of parasite density are possible.	[De Koninck, Anne-Sophie; Hofmans, Mattias; Philippe, Jan] Ghent Univ Hosp, Dept Lab Med, De Pintelaan 185, B-9000 Ghent, Belgium; [Cnops, Lieselotte; Jacobs, Jan; Van den Bossche, Dorien] Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium	Philippe, J (reprint author), Ghent Univ Hosp, Dept Lab Med, De Pintelaan 185, B-9000 Ghent, Belgium.	jan.philippe@uzgent.be			Agency for Innovation by Science and Technology (VLAIO) from the Flemish Government	We would like to thank Meridian Bioscience for providing study instrumentation and corresponding disposables for this evaluation. Research funding: LC holds an innovation mandate from the Agency for Innovation by Science and Technology (VLAIO) from the Flemish Government. Honorarium: None declared.	Abanyie FA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-340; Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175; [Anonymous], ILL MAL PACK INS; Askling HH, 2012, MALARIA J, V11, P328; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Das DK, 2015, J MICROSC-OXFORD, V260, P1, DOI 10.1111/jmi.12270; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-262; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/ERM.12.144, 10.1586/erm.12.144]; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Huang ZJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-269; Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Oriero EC, 2015, EXPERT REV MOL DIAGN, V15, P1419, DOI 10.1586/14737159.2015.1090878; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Ponaka C., 2015, ASS MOL PATHOLOGY AM; Tatem AJ, 2017, LANCET INFECT DIS, V17, P98, DOI 10.1016/S1473-3099(16)30326-7; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, POL BRIEF MAL DIAGN; World Health Organization, WORLD MAL REP 2016	30	5	5	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 17	2017	16								418	10.1186/s12936-017-2065-8				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FK3CZ	WOS:000413363700002	29041927	DOAJ Gold, Green Published			2019-03-26
J	Beaufay, C; Herent, MF; Quetin-Leclercq, J; Bero, J				Beaufay, Claire; Herent, Marie-France; Quetin-Leclercq, Joelle; Bero, Joanne			In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts	MALARIA JOURNAL			English	Article						Keetia leucantha; Triterpene esters; Anti-malarial; Plasmodium; Oleanolic; Ursolic; Rubiaceae	BETULINIC ACID; ANTIPLASMODIAL ACTIVITY; PLASMODIUM-FALCIPARUM; MEDICINAL-PLANTS; OLEANOLIC ACID; PHARMACOLOGICAL-ACTIVITIES; PENTACYCLIC TRITERPENES; TRADITIONAL MEDICINE; DRUG DISCOVERY; VITRO	Background: Considering the need for new anti-malarial drugs, further investigations on Keetia leucantha (Rubiaceae), an in vitro antiplasmodial plant traditionally used to treat malaria, were carried out. This paper aimed to assess the in vivo anti-malarial efficacy of K. leucantha triterpenic esters previously identified as the most in vitro active components against Plasmodium falciparum and their potential toxicity as well as those of anti-malarial extracts. Results: These eight triterpenic esters and the major antiplasmodial triterpenic acids, ursolic and oleanolic acids, were quantified in the twigs dichloromethane extract by validated HPLC-UV methods. They account for about 19% of this extract (16.9% for acids and 1.8% for esters). These compounds were also identified in trace in the twigs decoction by HPLC-HRMS. Results also showed that extracts and esters did not produce any haemolysis, and were devoid of any acute toxicity at a total cumulative dose of 800 and 150 mg/kg respectively. Moreover, esters given intraperitoneally at 50 mg/kg/day to Plasmodium berghei-infected mice showed a very significant (p < 0.01) parasitaemia inhibition (27.8 +/- 5.4%) on day 4 post-infection compared to vehicle-treated mice. Conclusions: These results bring out new information on the safety of K. leucantha use and on the identification of anti-malarial compounds from its dichloromethane extract. Its activity can be explained by the presence of triterpenic acids and esters which in vivo activity and safety were demonstrated for the first time.	[Beaufay, Claire; Herent, Marie-France; Quetin-Leclercq, Joelle; Bero, Joanne] Catholic Univ Louvain, Pharmacognosy Res Grp, Louvain Drug Res Inst, Ave E Mounier 72,B1-72-03, B-1200 Brussels, Belgium	Beaufay, C (reprint author), Catholic Univ Louvain, Pharmacognosy Res Grp, Louvain Drug Res Inst, Ave E Mounier 72,B1-72-03, B-1200 Brussels, Belgium.	Claire.beaufay@uclouvain.be		Leclercq, Joelle/0000-0002-2278-6206	Belgian National Fund for Scientific Research (FNRS) [FRFC 2.4555.08, PDR T.0190.13]; Faculty of Pharmacy and Biomedical Sciences of UCL	This work was supported by the Belgian National Fund for Scientific Research (FNRS) (FRFC 2.4555.08 and PDR T.0190.13) and the Faculty of Pharmacy and Biomedical Sciences of UCL.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bero J, 2013, PHYTOMEDICINE, V20, P270, DOI 10.1016/j.phymed.2012.10.010; Bero J, 2013, J ETHNOPHARMACOL, V149, P176, DOI 10.1016/j.jep.2013.06.018; Bero J, 2011, J ETHNOPHARMACOL, V137, P998, DOI 10.1016/j.jep.2011.07.022; Bero J, 2009, J ETHNOPHARMACOL, V122, P439, DOI 10.1016/j.jep.2009.02.004; Broniatowski M, 2014, BBA-BIOMEMBRANES, V1838, P2530, DOI 10.1016/j.bbamem.2014.05.027; Broniatowski M, 2012, J COLLOID INTERF SCI, V381, P116, DOI 10.1016/j.jcis.2012.05.020; Cao F, 2012, MOL PHARMACEUT, V9, P2127, DOI 10.1021/mp200447r; Chinaeke EE, 2015, DRUG DELIV, V22, P652, DOI 10.3109/10717544.2014.881633; Cimanga RK, 2006, PHARM BIOL, V44, P677, DOI 10.1080/13880200601009123; da Silva GNS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-89; de Sa MS, 2009, PARASITOL RES, V105, P275, DOI 10.1007/s00436-009-1394-0; Deharo E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S5; Drag-Zalesinska M, 2009, BIOORG MED CHEM LETT, V19, P4814, DOI 10.1016/j.bmcl.2009.06.046; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Fajardo-Sanchez E, 2017, J BIOMOL STRUCT DYN, V35, P2688, DOI 10.1080/07391102.2016.1229219; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Ginsburg H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S1; Gnoatto SCB, 2008, BIOORGAN MED CHEM, V16, P771, DOI 10.1016/j.bmc.2007.10.031; Habila JD, 2011, AFR J PHARM PHARMACO, V5, P2667, DOI 10.5897/AJPP11.589; Innocente AM, 2012, MOLECULES, V17, P12003, DOI 10.3390/molecules171012003; Ioset J.-R., 2009, DRUG SCREENING KINET; Isah MB, 2016, PARASITOLOGY, V143, P1219, DOI 10.1017/S0031182016000718; Koga K, 2013, DRUG DES DEV THER, V7, P1235, DOI 10.2147/DDDT.S51638; Mavondo GA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1278-6; Moneriz C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-103; Muganga R, 2014, PLANTA MED, V80, P482, DOI 10.1055/s-0034-1368322; Mutai C, 2008, AFR J TRADIT COMPLEM, V5, P46; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Vo NNQ, 2017, J NAT MED-TOKYO, V71, P50, DOI 10.1007/s11418-016-1026-9; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038//nrd1824; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Sairafianpour M, 2003, PLANTA MED, V69, P846, DOI 10.1055/s-2003-43212; Schmidt TJ, 2012, CURR MED CHEM, V19, P2128; Simelane MBC, 2013, MOLECULES, V18, P12313, DOI 10.3390/molecules181012313; Steele JCP, 1999, PHYTOTHER RES, V13, P115, DOI 10.1002/(SICI)1099-1573(199903)13:2<115::AID-PTR404>3.0.CO;2-1; Sultana Nighat, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P3; Sun WZ, 2011, CHEM BIOL DRUG DES, V77, P206, DOI 10.1111/j.1747-0285.2010.01077.x; Suneela D, 2012, BIOORG MED CHEM LETT, V22, P7582, DOI 10.1016/j.bmcl.2012.10.017; Tagboto S, 2001, ADV PARASIT, V50, P199, DOI 10.1016/S0065-308X(01)50032-9; Thakkar M, 2016, DRUG DELIV TRANSL RE, V6, P414, DOI 10.1007/s13346-016-0290-2; WHO, 2015, WORLD MAL REP 2015; Wozniak L, 2015, MOLECULES, V20, P20614, DOI 10.3390/molecules201119721; Yu ZJ, 2016, MOL PHARMACEUT, V13, P1699, DOI 10.1021/acs.molpharmaceut.6b00129; Zhai X, 2016, LANCET, V387, P1722, DOI 10.1016/S0140-6736(16)30261-6; Zhang B, 2012, J AGR FOOD CHEM, V60, P10278, DOI 10.1021/jf303160y; Ziegler HL, 2004, BIOORGAN MED CHEM, V12, P119, DOI 10.1016/j.bmc.2003.10.010	50	3	3	1	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 10	2017	16								406	10.1186/s12936-017-2054-y				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FJ3VN	WOS:000412660600003	29017554	DOAJ Gold, Green Published			2019-03-26
J	Ramanantsoa, A; Wilson-Barthes, M; Rahenintsoa, R; Hoibak, S; Ranaivoharimina, H; Rahelimalala, MD; Rakotomanga, A; Finlay, A; Ribera, JM; Grietens, KP				Ramanantsoa, Ambinina; Wilson-Barthes, Marta; Rahenintsoa, Rindra; Hoibak, Sarah; Ranaivoharimina, Harilala; Rahelimalala, Martha Delphine; Rakotomanga, Avotiana; Finlay, Alyssa; Ribera, Joan Muela; Grietens, Koen Peeters			Can the collection of expired long-lasting insecticidal nets reduce their coverage and use? Sociocultural aspects related to LLIN life cycle management and use in four districts in Madagascar	MALARIA JOURNAL			English	Article						Malaria; Recycling; Disposal; Net collection campaign; Insecticide treated nets (ITNs); Long lasting insecticide treated nets (LLINs)	TREATED BED NETS; MALARIA TRANSMISSION; WESTERN KENYA; BEDNETS; IMPACT	Background: There is growing awareness of the likely impact increased numbers of LLINs will have on the environment, if not disposed of or recycled appropriately. As part of a World Health Organization (WHO) and United Nations Environment Programme (UNEP) pilot study to assess environmentally-sound and cost-effective LLIN recycling strategies, the USAID-Deliver Project collected 22,559 used bed nets in Madagascar. A social science study was conducted to provide data on socio-cultural factors related to collection and replacement of LLINs, including impact on primary and other net uses. Methods: Ethnographic exploratory research was carried out following the pilot USAID-Deliver net collection and recycling campaign in Betioky, Tsihombe, Fenerive Est and Ambanja districts of Madagascar, triangulating participant observation, interviewing and group discussions. Sampling was theoretical and data analysis was a continuous and iterative process concurrent to data collection. Final analysis was conducted using NVivo10. Results: The following themes emerged as contributing to the success of collecting expired LLINs in the community for recycling purposes: (i) net adequacy and preference: characteristic differences between collected and newly distributed nets lead to communities' reticence to relinquish old nets before confirming new nets were appropriate for intended use. Where newly distributed nets failed to meet local requirements, this was expected to increase alternative uses and decrease household turn over. (ii) Net collection strategies: the net collection campaign brought net use out of the private sphere and into the public arena. Net owners reported feeling ashamed when presenting damaged nets in public for collection, leading to reduced net relinquishment. (iii) Net lifecycle: communities perceived nets as being individually owned and economic value was attributed both to good-condition nets for sleeping and to worn nets for alternative/secondary purposes. Collecting nets at the stage of waste rather than at their prescribed end of life was locally acceptable. Conclusion: The collection of LLINs for recycling/disposal can lead to lower coverage under certain conditions. Collecting used LLINs may be appropriate under the following conditions: (i) nets are collected at the stage of waste; (ii) new nets are in line with community preferences; and (iii) collection strategies have been agreed upon within the community prior to replacement activities. Any collection/recycling of old LLINs should be based on in-depth understanding of the local context and include participatory processes to prevent reduced coverage.	[Ramanantsoa, Ambinina; Rahenintsoa, Rindra] Focus Dev Agcy, Antananarivo, Madagascar; [Ramanantsoa, Ambinina; Rahenintsoa, Rindra] Univ Antananarivo, Dept Sociol, Antananarivo, Madagascar; [Wilson-Barthes, Marta] Emmanuel Int, Zomba, Malawi; [Hoibak, Sarah] Global Fund, Geneva, Switzerland; [Ranaivoharimina, Harilala] Minist Hlth, Antananarivo, Madagascar; [Rahelimalala, Martha Delphine] Minist Environm, Antananarivo, Madagascar; [Rakotomanga, Avotiana] USAID Deliver Project, Antananarivo, Madagascar; [Finlay, Alyssa] CDC, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Ribera, Joan Muela; Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium	Grietens, KP (reprint author), Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.; Grietens, KP (reprint author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.; Grietens, KP (reprint author), Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium.	kpeeters@itg.be			UNEP; WHO Strategic Approach to International Chemicals Management (SAICM) Quick Start Programme Trust Fund project	This research is part of a UNEP and WHO Strategic Approach to International Chemicals Management (SAICM) Quick Start Programme Trust Fund project being implemented in Madagascar.	Afolabi BM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-30; Albrecht T. C., 1993, SUCCESSFUL FOCUS GRO, P51, DOI DOI 10.4135/9781483349008; *AM ANTHR ASS, 1998, COD ETH AM ANTHR ASS; [Anonymous], 2011, ALLIANCE MALARIA PRE; [Anonymous], 2016, WHOPES 13 WORK GROUP; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gobena T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-914; Green J, 2004, QUALITATIVE METHODS; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Hakizimana E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-344; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Lindlof T. R., 2002, QUALITATIVE COMMUNIC; Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199; Milliner J., 2010, NET MAPPING PROJECT; Minakawa N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-165; Nelson M, 2011, LLIN RECYCLING PILOT, P3; Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P100, DOI 10.4269/ajtmh.2003.68.100; The Global Fund to Fight AIDS Tuberculosis and Malaria, RES REP 2016; Vanden EL, 2010, MALARIA J, V9, P133; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2016, WORLD MAL REP 2016; WHO, 2008, GLOB MAL ACT PLAN; WHO, 2015, WORLD MAL REP 2015; WHO, 2007, INS TREAT MOSQ NETS; World Health Organisation. WHO Global Malaria Programme, 2014, WHO GLOB MAL PROGR; World Health Organization, 2008, SALT VEH FORT REP WH, P1	33	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 10	2017	16								404	10.1186/s12936-017-2053-z				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FJ3VN	WOS:000412660600001	29017531	DOAJ Gold, Green Published			2019-03-26
J	Tihon, E; Imamura, H; Dujardin, JC; Van Den Abbeele, J				Tihon, Eliane; Imamura, Hideo; Dujardin, Jean-Claude; Van Den Abbeele, Jan			Evidence for viable and stable triploid Trypanosoma congolense parasites	PARASITES & VECTORS			English	Article						Trypanosoma congolense; Triploidy; Whole genome sequencing	GENETIC EXCHANGE; DRUG-RESISTANCE; TSETSE-FLY; LEISHMANIA; BRUCEI; CHROMOSOME; PLOIDY; MECHANISMS	Background: Recent whole genome sequencing (WGS) analysis identified a viable triploid strain of Trypanosoma congolense. This triploid strain BANANCL2 was a clone of the field isolate BANAN/83/CRTRA/64 that was collected from cattle in Burkina Faso in 1983. Results: We demonstrated the viability and stability of triploidy throughout the complete life-cycle of the parasite by infecting tsetse flies with the triploid clone BANANCL2. Proboscis-positive tsetse flies efficiently transmitted the parasites to mice resulting in systemic infections. WGS of the parasites was performed at all life-cycle stages, and a method based on a block alternative allele frequency spectrum was developed to efficiently detect the ploidy profiles of samples with low read depth. This approach confirmed the triploid profile of parasites throughout their life-cycle in the tsetse fly and the mammalian host, demonstrating that triploidy is present at all stages and is stable over time. Conclusion: The presence of viable field-isolated triploid parasites indicates another possible layer of genetic diversity in natural T. congolense populations. The comparison between triploid and diploid parasites provides a unique model system to study the impact of chromosome copy number variations in African trypanosomes. In addition, the consequences of triploidy can be further investigated using this stable triploid model.	[Tihon, Eliane; Imamura, Hideo; Dujardin, Jean-Claude; Van Den Abbeele, Jan] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium	Van Den Abbeele, J (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	jvdabbeele@itg.be		Van Den Abbeele, Jan/0000-0002-4533-4480; Imamura, Hideo/0000-0002-3282-1319	EU-GPARD [TRYRAC/DCI-FOOD/2011/279-754]; Department of Economy, Science and Innovation in Flanders, ITM-SOFIB GemiNI	This work was financed by the EU-GPARD, Grant reference number: TRYRAC/DCI-FOOD/2011/279-754, and the Department of Economy, Science and Innovation in Flanders, ITM-SOFIB GemiNI.	Bennett R. J., 2014, COLD SPRING HARB PER, V4; BORST P, 1982, MOL BIOCHEM PARASIT, V6, P13, DOI 10.1016/0166-6851(82)90049-4; Caljon G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005744; CLAUSEN PH, 1992, ACTA TROP, V51, P229, DOI 10.1016/0001-706X(92)90041-U; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Elsen P., 1993, REV ZOOL AFRICAINE, V107, P439; Gerstein AC, 2015, MBIO, V6, DOI 10.1128/mBio.01340-15; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; GIBSON WC, 1985, MOL BIOCHEM PARASIT, V16, P231, DOI 10.1016/0166-6851(85)90066-0; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Hope M, 1999, MOL BIOCHEM PARASIT, V104, P1, DOI 10.1016/S0166-6851(99)00103-6; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Lima FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063738; MacLeod A, 2007, SYSTEM GENETIC EXCHA, P2007; Martinez-Calvillo S, 2005, INT J PARASITOL, V35, P419, DOI 10.1016/j.ijpara.2004.12.014; Masumu J, 2009, RES VET SCI, V87, P265, DOI 10.1016/j.rvsc.2009.03.003; Peacock L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-78; Peacock L, 2014, CURR BIOL, V24, P181, DOI 10.1016/j.cub.2013.11.044; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; PINDER M, 1984, ACTA TROP, V41, P247; POTAPOVA T, 2017, BIOL BASEL, V6; Rogers MB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004092; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Souza RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023042; Tihon E, 2017, MOL ECOL, V26, P6524, DOI 10.1111/mec.14271; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115	29	1	1	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 10	2017	10								468	10.1186/s13071-017-2406-z				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FJ4GE	WOS:000412693600011	29017575	DOAJ Gold, Green Published			2019-03-26
J	Ntsambi-Eba, G; Kalubye, AB; Okito, JPK				Ntsambi-Eba, G.; Kalubye, Beltchika A.; Okito, Kalala J. P.			Need for surgical treatment of epilepsy and excision of tumors and posttraumatic epileptogenic lesions in Kinshasa, RDC	MEDECINE ET SANTE TROPICALES			French	Article						epilepsy; presurgical evaluation; developing countries; surgical treatment; DRC	SUB-SAHARAN AFRICA; DEVELOPING-COUNTRIES; ANTIEPILEPTIC DRUGS; SURGERY; EPIDEMIOLOGY; PREVALENCE; SELECTION; SEIZURES; OUTCOMES; WORLD	Surgery is a treatment to consider in epilepsy when the condition is refractory or epileptic events are related to a clearly identified brain abnormality. The tropical climate of the DRC explains the high risk of epilepsy and the potentially large number of refractory cases. The number of patients with epilepsy in Kinshasa is estimated to be at least 120 000, and almost one third may be refractory. Hence, the need to integrate the use of surgery in the treatment of this disease. Most neurosurgical techniques used for treating epilepsy are practiced with a neurosurgical microscope and neuronavigation. In most developing countries, neither the material conditions for optimum realization of these surgical techniques nor the equipment for epilepsy investigation are close to fully available. Nonetheless, the selection of a large number of patients for surgery often does not require the use of all these explorations. The current availability in Kinshasa of the equipment for the basic investigation of epilepsy, such as EEG and MRI instruments, and the experience of the local neurological/neurosurgical team together make it possible to diagnose this pathology and treat it surgically when necessary. The creation of a multidisciplinary team for epilepsy will enable the selection of candidates who can most effectively benefit from surgical treatment. This surgery should focus initially on well circumscribed lesions that do not require sophisticated methods of investigation and can be removed relatively easily, with a high probability of seizure suppression.	[Ntsambi-Eba, G.] Univ Kinshasa, Clin Univ Kinshasa, Serv Neurochirurg, BP 133, Kinshasa, DEM REP CONGO; [Kalubye, Beltchika A.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Okito, Kalala J. P.] Univ Gant, Ghent, Belgium	Ntsambi-Eba, G (reprint author), Univ Kinshasa, Clin Univ Kinshasa, Serv Neurochirurg, BP 133, Kinshasa, DEM REP CONGO.	nebaglen@gmail.com					Almu S, 2006, SEIZURE-EUR J EPILEP, V15, P211, DOI 10.1016/j.seizure.2006.01.004; Asadi-Pooya AA, 2012, INJURY VIOLENCE, V4, P16; Asadi-Pooya AA, 2008, EPILEPSIA, V49, P381, DOI 10.1111/j.1528-1167.2007.01383.x; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Bano S, 2011, J PEDIATR NEUROSCI, V6, P19, DOI 10.4103/1817-1745.84401; Berg AT, 2003, EPILEPSIA, V44, P1425, DOI 10.1046/j.1528-1157.2003.24203.x; Birbeck G, 2007, LANCET NEUROL, V6, P39, DOI 10.1016/S1474-4422(06)70629-9; Blumcke I, 2014, ACTA NEUROPATHOL, V128, P1, DOI 10.1007/s00401-014-1301-3; Boling W, 2009, EPILEPSIA, V50, P1256, DOI 10.1111/j.1528-1167.2008.01984.x; Chang F, 2011, ANN INDIAN ACAD NEUR, V14, P225, DOI 10.4103/0972-2327.85918; Cherian PJ, 2002, NEUROL INDIA, V50, P11; Engrad N, 2009, REANIMATION, V18, P21; Gallo Dio A, 2003, ACTA TROP, V87, P149; Gavin CA, 2002, MJA, V176, P410; Guenot M, 2004, REV NEUROL-FRANCE, V160, pS185; Hauptman JS, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03619.x; Kwan P, 2009, EPILEPSIA, V50, P57, DOI 10.1111/j.1528-1167.2009.02237.x; Mansouri A, 2012, EPILEPSY RES TREAT; MATONDA M N, 2011, ACTA PSYCHIAT BELG, V113, P26; Mirsattari SM, 2011, EPILEPSY RES, V94, P39, DOI 10.1016/j.eplepsyres.2011.01.001; Moulinier MB, 2001, ANN FR ANESTH, V20, P97; Nei M, 2006, EPILEPSIA, V47, P115, DOI 10.1111/j.1528-1167.2006.00377.x; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngoungou E.B., 2006, EPILEPSIES, V18, P25; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Novy J, 2010, Rev Med Suisse, V6, P918; Ntsambi-Eba G, 2013, NEUROSURGERY, V72, P890, DOI 10.1227/NEU.0b013e31828ba750; Nuhu FT, 2012, S AFR J CHILD HEALTH, V6, P132, DOI 10.7196/SAJCH.512; Paul Abigail, 2012, J Glob Health, V2, P020405, DOI 10.7189/jogh.02.020405; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Ronsenfeld JV, 2002, JR COLL EDINB, V47, P653; Sanyal SK, 2007, NEUROLOGY ASIA S2, V12, P23; Scott RA, 2001, B ORG MONDE SANTE, V5, P80; Sylaja PN, 2003, EPILEPSIA, V44, P48, DOI 10.1046/j.1528-1157.44.s.1.11.x; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Unnwongse K, 2010, CURR NEUROL NEUROSCI, V10, P299, DOI 10.1007/s11910-010-0114-6; Velez-Ruiz NJ, 2012, SEMIN NEUROL, V32, P361, DOI 10.1055/s-0032-1331809; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; You G, 2012, NEURO-ONCOLOGY, V14, P230, DOI 10.1093/neuonc/nor205	39	0	0	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	OCT-DEC	2017	27	4					415	420		10.1684/mst.2017.0742				6	Tropical Medicine	Tropical Medicine	FW3UM	WOS:000425236300017	29313510				2019-03-26
J	Fitzpatrick, C; Asiedu, K; Sands, A; Pena, TG; Marks, M; Mitja, O; Meheus, F; Van der Stuyft, P				Fitzpatrick, Christopher; Asiedu, Kingsley; Sands, Anita; Pena, Tita Gonzalez; Marks, Michael; Mitja, Oriol; Meheus, Filip; Van der Stuyft, Patrick			The cost and cost-effectiveness of rapid testing strategies for yaws diagnosis and surveillance	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SUB-SAHARAN AFRICA; OF-CARE TEST; SYPHILIS	Background Yaws is a non-venereal treponemal infection caused by Treponema pallidum subspecies pertenue. The disease is targeted by WHO for eradication by 2020. Rapid diagnostic tests (RDTs) are envisaged for confirmation of clinical cases during treatment campaigns and for certification of the interruption of transmission. Yaws testing requires both treponemal (trep) and non-treponemal (non-trep) assays for diagnosis of current infection. We evaluate a sequential testing strategy (using a treponemal RDT before a trep/non-trep RDT) in terms of cost and cost-effectiveness, relative to a single-assay combined testing strategy (using the trep/non-trep RDT alone), for two use cases: individual diagnosis and community surveillance. Methods We use cohort decision analysis to examine the diagnostic and cost outcomes. We estimate cost and cost-effectiveness of the alternative testing strategies at different levels of prevalence of past/current infection and current infection under each use case. We take the perspective of the global yaws eradication programme. We calculate the total number of correct diagnoses for each strategy over a range of plausible prevalences. We employ probabilistic sensitivity analysis (PSA) to account for uncertainty and report 95% intervals. Results At current prices of the treponemal and trep/non-trep RDTs, the sequential strategy is cost-saving for individual diagnosis at prevalence of past/current infection less than 85% (81-90); it is cost-saving for surveillance at less than 100%. The threshold price of the trep/non-trep RDT (below which the sequential strategy would no longer be cost-saving) is US$1.08 (1.02-1.14) for individual diagnosis at high prevalence of past/current infection (51%) and US$ 0.54 (0.52-0.56) for community surveillance at low prevalence (15%). Discussion We find that the sequential strategy is cost-saving for both diagnosis and surveillance in most relevant settings. In the absence of evidence assessing relative performance (sensitivity and specificity), cost-effectiveness is uncertain. However, the conditions under which the combined test only strategy might be more cost-effective than the sequential strategy are limited. A cheaper trep/non-trep RDT is needed, costing no more than US$0.5-1.00, depending on the use case. Our results will help enhance the cost-effectiveness of yaws programmes in the 13 countries known to be currently endemic. It will also inform efforts in the much larger group of 71 countries with a history of yaws, many of which will have to undertake surveillance to confirm the interruption of transmission.	[Fitzpatrick, Christopher; Asiedu, Kingsley; Sands, Anita; Pena, Tita Gonzalez] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Pena, Tita Gonzalez] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC USA; [Marks, Michael] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England; [Mitja, Oriol] Univ Barcelona, Barcelona Inst Global Hlth, Hosp Clin, Barcelona, Spain; [Meheus, Filip] Inst Trop Med, Unit Epidemiol & Control Neglected Trop Dis, Antwerp, Belgium; [Meheus, Filip] Int Agcy Res Canc, Prevent & Implementat Grp, Lyon, France; [Van der Stuyft, Patrick] Inst Trop Med, Unit Gen Epidemiol & Dis Control, Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, Ghent, Belgium	Fitzpatrick, C (reprint author), WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland.	fitzpatrickc@who.int	Mitja, Oriol/W-4181-2018	Mitja, Oriol/0000-0003-3266-8868; Marks, Michael/0000-0002-7585-4743; Sands, Anita/0000-0002-8424-754X	Wellcome Trust Clinical Research Fellowship [102807]	MM is supported by a Wellcome Trust Clinical Research Fellowship 102807. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P189; Asiedu K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003016; Ayove T, 2014, LANCET GLOB HEALTH, V2, pE415, DOI 10.1016/S2214-109X(14)70231-1; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Fitzpatrick C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003165; Giacani L, 2014, CLIN MICROBIOL REV, V27, P89, DOI 10.1128/CMR.00070-13; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Marks M, 2016, CLIN INFECT DIS, V63, P627, DOI 10.1093/cid/ciw348; Marks M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003988; Marks M, 2015, AM J TROP MED HYG, V92, P129, DOI 10.4269/ajtmh.14-0438; Mitja O, 2016, NEW ENGL J MED, V375, P1094, DOI 10.1056/NEJMc1503442; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P997, DOI 10.1097/OLQ.0b013e3182260987; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P448, DOI 10.1097/OLQ.0b013e3182036a0f; R Core Team, 2012, R LANG ENV STAT COMP; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Terris-Prestholt Fern, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS73, DOI 10.1016/j.ijgo.2015.04.007; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824	17	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0005985	10.1371/journal.pntd.0005985				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400045	29073145	DOAJ Gold, Green Published, Green Accepted			2019-03-26
J	N'Djetchi, MK; Ilboudo, H; Koffi, M; Kabore, J; Kabore, JW; Kaba, D; Courtin, F; Coulibaly, B; Fauret, P; Kouakou, LA; Ravel, S; Deborggraeve, S; Solano, P; De Meeus, T; Bucheton, B; Jamonneau, V				N'Djetchi, Martial Kassi; Ilboudo, Hamidou; Koffi, Mathurin; Kabore, Jacques; Kabore, Justin Windingoudi; Kaba, Dramane; Courtin, Fabrice; Coulibaly, Bamoro; Fauret, Pierre; Kouakou, Lingue; Ravel, Sophie; Deborggraeve, Stijn; Solano, Philippe; De Meeus, Thierry; Bucheton, Bruno; Jamonneau, Vincent			The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Cote d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SLEEPING SICKNESS FOCUS; APARASITEMIC SEROLOGICAL SUSPECTS; GLOSSINA-PALPALIS-PALPALIS; POLYMERASE-CHAIN-REACTION; TSETSE-FLIES; IVORY-COAST; EQUATORIAL-GUINEA; DNA AMPLIFICATION; BURKINA-FASO; ELIMINATION	"Background Important control efforts have led to a significant reduction of the prevalence of human African trypanosomiasis (HAT) in Cote d'Ivoire, but the disease is still present in several foci. The existence of an animal reservoir of Trypanosoma brucei gambiense may explain disease persistence in these foci where animal breeding is an important source of income but where the prevalence of animal African trypanosomiasis (AAT) is unknown. The aim of this study was to identify the trypanosome species circulating in domestic animals in both Bonon and Sinfra HAT endemic foci. Methodology/Principal findings 552 domestic animals (goats, pigs, cattle and sheep) were included. Blood samples were tested for trypanosomes by microscopic observation, species-specific PCR for T. brucei sl, T. congolense, T. vivax and subspecies-specific PCR for T. b. gambiense and T. b. gambiense immune trypanolysis (TL). Infection rates varied significantly between animal species and were by far the highest in pigs (30%). T. brucei s. l was the most prevalent trypanosome species (13.7%) followed by T. congolense. No T. b. gambiense was identified by PCR while high TL positivity rates were observed using T. b. gambiense specific variants (up to 27.6% for pigs in the Bonon focus). Conclusion This study shows that domestic animals are highly infected by trypanosomes in the studied foci. This was particularly true for pigs, possibly due to a higher exposure of these animals to tsetse flies. Whereas T. brucei s.l. was the most prevalent species, discordant results were obtained between PCR and TL regarding T. b. gambiense identification. It is therefore crucial to develop better tools to study the epidemiological role of potential animal reservoir for T. b. gambiense. Our study illustrates the importance of ""one health"" approaches to reach HAT elimination and contribute to AAT control in the studied foci."	[N'Djetchi, Martial Kassi; Koffi, Mathurin] Univ Jean Lorougnon Guede, Unite Format & Rech Environm, Lab Interact Hote Microorganisme Environm & Evolu, Daloa, Cote Ivoire; [Ilboudo, Hamidou; Kabore, Jacques; Kabore, Justin Windingoudi] Ctr Int Rech Dev Elevage Zone Subhumide, Unite Rech Bases Biol Lutte Integree, Bobo Dioulasso, Burkina Faso; [Kabore, Jacques] Univ Nazi Boni, Unite Format & Rech Sci & Tech, Bobo Dioulasso, Burkina Faso; [Kaba, Dramane; Courtin, Fabrice; Coulibaly, Bamoro; Fauret, Pierre; Jamonneau, Vincent] Inst Pierre Richet, Unite Rech Trypanosomoses, Bouake, Cote Ivoire; [Courtin, Fabrice; Fauret, Pierre; Ravel, Sophie; Solano, Philippe; De Meeus, Thierry; Bucheton, Bruno; Jamonneau, Vincent] IRD, INTERTRYP, Unite Mixte Rech IRD CIRAD 177, Montpellier, France; [Kouakou, Lingue] Minist Sante & Hyg Publ, Programme Natl Eliminat Trypanosomose Humaine Afr, Abidjan, Cote Ivoire; [Deborggraeve, Stijn] Inst Trop Med, Biomed Sci Dept, Antwerp, Belgium	Jamonneau, V (reprint author), Inst Pierre Richet, Unite Rech Trypanosomoses, Bouake, Cote Ivoire.; Jamonneau, V (reprint author), IRD, INTERTRYP, Unite Mixte Rech IRD CIRAD 177, Montpellier, France.	Vincent.jamonneau@ird.fr	; Jamonneau, Vincent/K-1124-2016	solano, philippe/0000-0002-4351-3506; KABORE, Windingoudi Justin/0000-0002-1865-813X; Jamonneau, Vincent/0000-0001-8427-0769; Deborggraeve, Stijn/0000-0003-1501-5355	"Programme d'Appui a l'Enseignement superieur/Union Economique et Monetaire Ouest Africaine; Word Health Organization (WHO) - Institut de Recherche pour le Developpement (IRD) collaborative project; ""Jeunes Equipes AIRD"" JEAI program (ERHATryp project)"	"This study was funded by Programme d'Appui a l'Enseignement superieur/Union Economique et Monetaire Ouest Africaine (http://www.uemoa.int/) to MK. This study also received support from a Word Health Organization (WHO) - Institut de Recherche pour le Developpement (IRD) collaborative project to VJ. MK, DK, HI, and JK are supported by the ""Jeunes Equipes AIRD"" JEAI program (ERHATryp project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	[Anonymous], 1985, CAHIERS ORSTOMSERIE; [Anonymous], 2003, LUTTE MALADIE SOMMEI; [Anonymous], 2015, MONITORING PROGR ELI, DOI DOI 10.1371/J0URNAL.PNTD.0003785; Balyeidhusa ASP, 2012, VET PARASITOL, V187, P157, DOI 10.1016/j.vetpar.2011.12.005; Bengaly Z, 2002, VET PARASITOL, V108, P1, DOI 10.1016/S0304-4017(02)00164-4; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; Biteau N, 2000, MOL BIOCHEM PARASIT, V105, P185, DOI 10.1016/S0166-6851(99)00171-1; BROMIDGE T, 1993, ACTA TROP, V53, P107, DOI 10.1016/0001-706X(93)90023-5; Caljon G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005744; Capewell P., 2016, ELIFE, V5; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233; Cordon-Obras C, 2009, TROP MED INT HEALTH, V14, P535, DOI 10.1111/j.1365-3156.2009.02271.x; Cordon-Obras C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00765; Cordon-Obras C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000704; Courtin Fabrice, 2005, Int J Health Geogr, V4, P27, DOI 10.1186/1476-072X-4-27; Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/erm.12.72, 10.1586/ERM.12.72]; Deborggraeve S, 2010, LANCET INFECT DIS, V10, P433, DOI 10.1016/S1473-3099(10)70077-3; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dje NN, 2003, B SOC PATHOL EXOT, V95, P359; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Funk S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002855; GOUTEUX JP, 1985, ANN PARASIT HUM COMP, V60, P329, DOI 10.1051/parasite/1985603329; Hoare C.A., 1972, ZOOLOGICAL MONOGRAPH, P749; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Kaba D, 2006, TROP MED INT HEALTH, V11, P136, DOI 10.1111/j.1365-3156.2005.01549.x; Kabore J, 2013, INFECT GENET EVOL, V20, P171, DOI 10.1016/j.meegid.2013.08.006; Kabore J, 2011, INFECT GENET EVOL, V11, P1250, DOI 10.1016/j.meegid.2011.04.014; Kagbadouno M, 2009, PARASITE, V16, P29, DOI 10.1051/parasite/2009161029; Kagbadouno MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001949; Kambire R, 2012, PARASITE, V19, P389, DOI 10.1051/parasite/2012194389; Kiendrebeogo D, 2012, PARASITE, V19, P397, DOI 10.1051/parasite/2012194397; Koffi M, 2006, ACTA TROP, V98, P183, DOI 10.1016/j.actatropica.2006.04.001; Koffi M., 2014, Journal of Applied Biosciences, V83, P7570; Koffi M, 2009, P NATL ACAD SCI USA, V106, P209, DOI 10.1073/pnas.0811080106; Koffi M, 2007, INFECT GENET EVOL, V7, P675, DOI 10.1016/j.meegid.2007.07.001; Koffi M, 2016, PARASITE, V23, DOI 10.1051/parasite/2016059; LAVEISSIERE C, 1985, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V23, P297; Laveissiere C, 2003, LUTTE MALADIE SOMMEI; Lehane M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004437; MacLeod A, 2005, NUCLEIC ACIDS RES, V33, P6688, DOI 10.1093/nar/gki980; MAJIWA PAO, 1994, PARASITOLOGY, V108, P313, DOI 10.1017/S0031182000076150; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; MEHLITZ D, 1985, TROP MED PARASITOL, V36, P18; Molyneux D H, 1973, Ann Soc Belg Med Trop, V53, P605; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Nimpaye H, 2011, PARASITE, V18, P171, DOI 10.1051/parasite/2011182171; Njiokou F, 2006, INFECT GENET EVOL, V6, P147, DOI 10.1016/j.meegid.2005.04.003; Njiokou F, 2010, PARASITE, V17, P61, DOI 10.1051/parasite/2010171061; Njitchouang GR, 2011, MED VET ENTOMOL, V25, P289, DOI 10.1111/j.1365-2915.2010.00936.x; NOIREAU F, 1989, TROP MED PARASITOL, V40, P9; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Ravel S, 2007, INFECT GENET EVOL, V7, P116, DOI 10.1016/j.meegid.2006.07.002; Ravel S, 2015, FOLIA PARASIT, V62, DOI 10.14411/fp.2015.044; Rayaisse JB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001332; RUIZ JP, 2015, PARASIT VECTORS, V8; Sane B, 2000, TROP MED INT HEALTH, V5, P73, DOI 10.1046/j.1365-3156.2000.00488.x; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Simarro PP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003785; Simo G, 2008, INFECT GENET EVOL, V8, P34, DOI 10.1016/j.meegid.2007.09.005; Simo G, 2006, VET PARASITOL, V139, P57, DOI 10.1016/j.vetpar.2006.02.026; Simo G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1254-y; Simukoko H, 2007, VET PARASITOL, V147, P231, DOI 10.1016/j.vetpar.2007.04.005; Takezaki N, 1996, GENETICS, V144, P389; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trindade S, 2016, CELL HOST MICROBE, V19, P837, DOI 10.1016/j.chom.2016.05.002; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; WHO, 2016, LOW CAS REC WORLD PR	71	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0005993	10.1371/journal.pntd.0005993				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400051	29045405	DOAJ Gold, Green Published			2019-03-26
J	Vergote, V; Laenen, L; Vanmechelen, B; Van Ranst, M; Verbeken, E; Hooper, JW; Maes, P				Vergote, Valentijn; Laenen, Lies; Vanmechelen, Bert; Van Ranst, Marc; Verbeken, Erik; Hooper, Jay W.; Maes, Piet			A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PULMONARY SYNDROME; HEMORRHAGIC-FEVER; DENSITY-LIPOPROTEINS; NUCLEOCAPSID PROTEIN; VIRUS-INFECTION; GOLDEN-HAMSTER; ACTIVATION; MODULATION; RESPONSES; CELLS	Background Hantavirus, the hemorrhagic causative agent of two clinical diseases, is found worldwide with variation in severity, incidence and mortality. The most lethal hantaviruses are found on the American continent where the most prevalent viruses like Andes virus and Sin Nombre virus are known to cause hantavirus pulmonary syndrome. New World hantavirus infection of immunocompetent hamsters results in an asymptomatic infection except for Andes virus and Maporal virus; the only hantaviruses causing a lethal disease in immunocompetent Syrian hamsters mimicking hantavirus pulmonary syndrome in humans. Methodology/Principal findings Hamsters, immunosuppressed with dexamethasone and cyclophosphamide, were infected intramuscularly with different New World hantavirus strains (Bayou virus, Black Creek Canal virus, Cano Delgadito virus, Choclo virus, Laguna Negra virus, and Maporal virus). In the present study, we show that immunosuppression of hamsters followed by infection with a New World hantavirus results in an acute disease that precisely mimics both hantavirus disease in humans and Andes virus infection of hamsters. Conclusions/Significance Infected hamsters showed specific clinical signs of disease and moreover, histological analysis of lung tissue showed signs of pulmonary edema and inflammation within alveolar septa. In this study, we were able to infect immunosuppressed hamsters with different New World hantaviruses reaching a lethal outcome with signs of disease mimicking human disease. Author summary Hemorrhagic fever viruses have become of much greater importance in recent years. The more prominent presence of these viruses in a day-to-day setting and their impact on global health has had a positive impact on studying these viruses. Resolving their disease mechanisms and ways to intervene in their replication and associated health burden will stay a challenge for the upcoming decades. This challenge also counts for hantavirus, an emerging zoonosis. No vaccine or antiviral treatment is WHO prequalifled or has shown to elicit a good protective or therapeutic antiviral response in humans. One of the main reasons is the lack of good animal disease models and the research focusing on this topic. Without a representative model, it is difficult to investigate new potential drugs. Within this setting we focused on establishing a disease model for the most prominent New World hantaviruses.	[Vergote, Valentijn; Laenen, Lies; Vanmechelen, Bert; Van Ranst, Marc; Maes, Piet] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Lab Clin Virol, Zoonot Infect Dis Unit, Leuven, Belgium; [Verbeken, Erik] KU Leuven Univ Leuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium; [Hooper, Jay W.] US Army, Med Res Inst Infect Dis, Dept Mol Virol, Virol Div, Ft Detrick, MD 21702 USA	Maes, P (reprint author), KU Leuven Univ Leuven, Dept Microbiol & Immunol, Lab Clin Virol, Zoonot Infect Dis Unit, Leuven, Belgium.	piet.maes@kuleuven.be	Vergote, Valentijn/F-5831-2018; Laenen, Lies/F-7864-2018; Ucar, Abdullah/P-8329-2017; Van Ranst, Marc/P-7522-2017; Maes, Piet/P-7782-2017; Vanmechelen, Bert/E-7680-2018	Vergote, Valentijn/0000-0002-4436-3212; Laenen, Lies/0000-0001-9118-8608; Van Ranst, Marc/0000-0002-1674-4157; Maes, Piet/0000-0002-4571-5232; Vanmechelen, Bert/0000-0002-8350-4356	KU LEUVEN grant [CREA/11/027]; Military Infectious Disease Research Program; Program Area T	This project was funded in part by KU LEUVEN grant CREA/11/027 awarded to PM (www.kuleuven.be/english/research). JWH is partially funded by Military Infectious Disease Research Program, Program Area T (midrib.amedd.army.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avsic-Zupanc T, 2015, CLIN MICROBIOL INFEC; Brocato RL, 2014, J VIROL, V88, P811, DOI 10.1128/JVI.02906-13; Buys Kristin K., 2011, Antiviral Chemistry & Chemotherapy, V21, P193, DOI 10.3851/IMP1729; Chiang CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164768; Chyu KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092095; Cimica V, 2014, MBIO, V5, DOI 10.1128/mBio.01088-13; Clement J, 2012, EUR J CLIN MICROBIOL, V31, P1, DOI 10.1007/s10096-011-1456-y; CUTHBERT JA, 1984, P NATL ACAD SCI-BIOL, V81, P4539, DOI 10.1073/pnas.81.14.4539; CUTHBERT JA, 1986, J BIOL CHEM, V261, P3620; De Palma AM, 2009, J PATHOL, V217, P633, DOI 10.1002/path.2501; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Dutta D, 2012, CELL LOGIST, V2, P203, DOI DOI 10.4161/CL.23967; Eyzaguirre EJ, 2008, AM J TROP MED HYG, V78, P669, DOI 10.4269/ajtmh.2008.78.669; Gack MU, 2014, J VIROL, V88, P5213, DOI 10.1128/JVI.03370-13; Golden JW, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/793257; Gorbunova EE, 2016, MBIO, V7, DOI 10.1128/mBio.01747-16; Gowen BB, 2017, J MICROBIOL, V55, P183, DOI 10.1007/s12275-017-7029-8; Hammerbeck CD, 2011, J VIROL, V85, P9929, DOI 10.1128/JVI.05356-11; Hardcastle K, 2016, VET PATHOL, V53, P182, DOI 10.1177/0300985815570071; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Kang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006149; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Laenen L, 2016, MOL ECOL, V25, P5994, DOI 10.1111/mec.13887; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LEVY H, 1994, AM J RESP CRIT CARE, V149, P1710, DOI 10.1164/ajrccm.149.6.8004332; Maes P, 2004, VIRAL IMMUNOL, V17, P315, DOI 10.1089/0882824041310540; Milazzo ML, 2002, J INFECT DIS, V186, P1390, DOI 10.1086/344735; MORZUNOV SP, 1995, J VIROL, V69, P1980; NIKLASSON B, 1991, AM J TROP MED HYG, V45, P660, DOI 10.4269/ajtmh.1991.45.660; Ogg M, 2013, VIRUSES-BASEL, V5, P2704, DOI 10.3390/v5112704; Pan W, 2015, VIRAL IMMUNOL, V28, P448, DOI 10.1089/vim.2015.0004; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Prescott J, 2013, IMMUNOLOGY, V140, P168, DOI 10.1111/imm.12116; Rang A, 2010, CRIT REV IMMUNOL, V30, P515, DOI 10.1615/CritRevImmunol.v30.i6.20; RAVKOV EV, 1995, VIROLOGY, V210, P482, DOI 10.1006/viro.1995.1366; Safronetz D, 2013, ANTIMICROB AGENTS CH, V57, P4673, DOI 10.1128/AAC.00886-13; Simpson SQ, 2010, INFECT DIS CLIN N AM, V24, P159, DOI 10.1016/j.idc.2009.10.011; Song JW, 2007, EMERG INFECT DIS, V13, P980, DOI 10.3201/eid1307.070031; Weiss S, 2012, EMERG INFECT DIS, V18, P159, DOI 10.3201/eid1801.111026; Witkowski PT, 2016, VIROLOGY, V493, P189, DOI 10.1016/j.virol.2016.03.018; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0006042	10.1371/journal.pntd.0006042				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400078	29077702	DOAJ Gold, Green Published			2019-03-26
J	Hinckel, BCB; Marlais, T; Airs, S; Imamura, H; Dujardin, JC; Falconar, AK; Bhattacharyya, T; Andersson, B; Mertens, P; Miles, MA				Hinckel, B. C. Bremer; Marlais, T.; Airs, S.; Imamura, H.; Dujardin, J. C.; Falconar, A. K.; Bhattacharyya, T.; Andersson, B.; Mertens, P.; Miles, M. A.			Visceral leishmaniasis: a combined wet-lab and in silico approach to the discovery of biomarkers of disease progression and post-chemotherapy relapse	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hinckel, B. C. Bremer] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Hinckel, B. C. Bremer; Mertens, P.] Coris BioConcept, Gembloux, Belgium; [Marlais, T.; Airs, S.; Miles, M. A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Imamura, H.; Dujardin, J. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Falconar, A. K.] Univ Norte, Dept Med, Barranquilla, Colombia; [Andersson, B.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S1.4	3	3		10.1111/tmi.12985				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900005		Bronze			2019-03-26
J	Kuhne, V; Diro, E; El-Safi, S; Buscher, P				Kuhne, V.; Diro, E.; El-Safi, S.; Buscher, P.			Finding Mimo: Developing an alternative rapid test for the serodiagnosis of visceral leishmaniasis in Eastern African populations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kuhne, V.; Buscher, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Diro, E.] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [El-Safi, S.] Univ Khartoum, Fac Med, Khartoum, Sudan					European Union's H2020 Programme under the MSCA GA [642609]	This research is funded by the European Union's H2020 Programme under the MSCA GA no. 642609.		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S1.3	3	3		10.1111/tmi.12984				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900004		Bronze			2019-03-26
J	Serra-Casas, E; Manrique, P; Ding, XC; Carrasco, G; Alava, F; Gave, A; Contreras, JJ; Rosas-Aguirre, A; Gonzalez, IJ; Gamboa, D; Rosanas-Urgell, A				Serra-Casas, E.; Manrique, P.; Ding, X. C.; Carrasco, G.; Alava, F.; Gave, A.; Contreras, J. J.; Rosas-Aguirre, A.; Gonzalez, I. J.; Gamboa, D.; Rosanas-Urgell, A.			Loop-mediated isothermal amplification for asymptomatic malaria diagnosis in the Peruvian Amazon: technical performance and pilot implementation in challenging field settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Serra-Casas, E.; Rosanas-Urgell, A.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Manrique, P.; Carrasco, G.; Alava, F.; Gave, A.; Contreras, J. J.; Gamboa, D.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lima, Peru; [Ding, X. C.; Gonzalez, I. J.] FIND, Geneva, Switzerland; [Rosas-Aguirre, A.; Gamboa, D.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, D.] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares & Mol, Fac Ciencias & Filosofia, Lima, Peru								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S2.2	4	4						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900007					2019-03-26
J	Tadesse, M; Abebe, G; de Rijk, P; Meehan, C; de Jong, BC; Rigouts, L				Tadesse, M.; Abebe, G.; de Rijk, P.; Meehan, C.; de Jong, B. C.; Rigouts, L.			Revealing the genetic diversity of mycobacterium tuberculosis strains causing tuberculous lymphadenitis in southwest Ethiopia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tadesse, M.; Abebe, G.] Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Tadesse, M.; Rigouts, L.] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [de Rijk, P.; Meehan, C.; de Jong, B. C.; Rigouts, L.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S3.4	7	7						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900013					2019-03-26
J	Eddyani, M; Vandelannoote, K; Meehan, C; Affolabi, D; Aguiar, J; Marion, E; Sopoh, G; Portaels, F; de Jong, BC; Stinear, T				Eddyani, M.; Vandelannoote, K.; Meehan, C.; Affolabi, D.; Aguiar, J.; Marion, E.; Sopoh, G.; Portaels, F.; de Jong, B. C.; Stinear, T.			Micro-epidemiological approach to understanding transmission dynamics of Mycobacterium ulcerans in the Oueme river valley in southern Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Eddyani, M.; Vandelannoote, K.; Meehan, C.; Portaels, F.; de Jong, B. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Affolabi, D.] Lab Reference Mycobacteries, Cotonou, Benin; [Aguiar, J.] Ctr Depistage & Traitement Ulcere Buruli Gbemotin, Zagnanado, Benin; [Marion, E.] Univ Angers, Angers, France; [Sopoh, G.] Ctr Depistage & Traitement Ulcere Buruli, Allada, Benin; [Stinear, T.] Univ Melbourne, Melbourne, Vic, Australia								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S4.1	8	8						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900015					2019-03-26
J	Cuypers, L; Libin, P; Abecasis, A; Vandamme, AM; Theys, K				Cuypers, L.; Libin, P.; Abecasis, A.; Vandamme, A. -M.; Theys, K.			Zika virus genetic diversity and selective pressure: importance for diagnostics, vaccines and therapeutics	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cuypers, L.; Libin, P.; Vandamme, A. -M.; Theys, K.] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Libin, P.] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium; [Abecasis, A.; Vandamme, A. -M.] Univ Nova Lisboa, Inst Hyg & Trop Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal			Abecasis, Ana/B-6295-2009; Vandamme, Anne-Mieke/I-4127-2012	Abecasis, Ana/0000-0002-3903-5265; Vandamme, Anne-Mieke/0000-0002-6594-2766				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S4.3	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900017					2019-03-26
J	Domagalska, MA; Imamura, H; Sanders, M; Rijal, S; Berriman, M; Cotton, J; Dujardin, JC				Domagalska, M. A.; Imamura, H.; Sanders, M.; Rijal, S.; Berriman, M.; Cotton, J.; Dujardin, J. -C.			Direct sequencing of Leishmania genome in clinical samples	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Domagalska, M. A.; Imamura, H.; Dujardin, J. -C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sanders, M.; Berriman, M.; Cotton, J.] Wellcome Trust Sanger Inst, Hinxton, England; [Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Dujardin, J. -C.] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S4.4	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900018					2019-03-26
J	Dallmeier, K; Mishra, N; Marques, RE; Ae-Choi, J; Kum, DB; Felipe, LS; Julander, JG; Neyts, J				Dallmeier, K.; Mishra, N.; Marques, R. E.; Ae-Choi, J.; Kum, D. B.; Felipe, L. Sanchez; Julander, J. G.; Neyts, J.			Efficient immunization and full protection from lethal challenge by PLLAV-YF17D, a novel thermostable and readily scalable plasmid-launched life-attenuated yellow fever vaccine candidate produced in E. coli	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dallmeier, K.; Mishra, N.; Marques, R. E.; Kum, D. B.; Felipe, L. Sanchez; Neyts, J.] KU Leuven Univ Leuven, Rega Inst, Leuven, Belgium; [Marques, R. E.] Lab Nacl Biociencias, Campinas, SP, Brazil; [Ae-Choi, J.; Julander, J. G.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S5.1	10	10						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900019					2019-03-26
J	Schmid, MA; Mishra, N; Neyts, J; Dallmeier, K				Schmid, M. A.; Mishra, N.; Neyts, J.; Dallmeier, K.			Dendritic cells, macophages, and fibroblasts are the initial targets for replication of the live-attenuated yellow fever vaccine in the dermis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Schmid, M. A.; Mishra, N.; Neyts, J.; Dallmeier, K.] KU Leuven Univ Leuven, Rega Inst Med Res, Dept Immunol & Microbiol, Virol & Chemotherapy, Leuven, Belgium			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S5.2	10	10						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900020					2019-03-26
J	Abdelnabi, R; Jochmans, D; Verbeken, E; Delang, L; Neyts, J				Abdelnabi, R.; Jochmans, D.; Verbeken, E.; Delang, L.; Neyts, J.			Antiviral treatment efficiently inhibits Chikungunya virus replication in the joints of mice during the acute but not during the chronic phase of infection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Abdelnabi, R.; Jochmans, D.; Delang, L.; Neyts, J.] Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Leuven, Belgium; [Verbeken, E.] Univ Leuven, Leuven, Belgium; [Verbeken, E.] Leuven Univ Hosp, Dept Pathol, Leuven, Belgium			Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017	Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514			Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S6.4	13	13						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900027					2019-03-26
J	Delang, L; Yen, P; Vazeille, M; Neyts, J; Failloux, A				Delang, L.; Yen, P.; Vazeille, M.; Neyts, J.; Failloux, A.			Antiviral drug-resistant Chikungunya viruses can be transmitted by their mosquito vectors	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Delang, L.; Neyts, J.] Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Yen, P.; Vazeille, M.; Failloux, A.] Inst Pasteur, Dept Virol, URE Arboviruses & Insect Vectors, Paris, France			Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017	Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514				0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S2.1	15	16						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900033					2019-03-26
J	Jansen, F; Berkvens, N; Deblauwe, I; Van Loo, T; Casteels, H; Witters, J; Van Damme, V; Berkvens, D				Jansen, F.; Berkvens, N.; Deblauwe, I.; Van Loo, T.; Casteels, H.; Witters, J.; Van Damme, V.; Berkvens, D.			HarmVect: A simulation based tool for pathway risk maps of invasive arthropods in Belgium - Case study: Aedes albopictus	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jansen, F.; Deblauwe, I.; Van Loo, T.; Berkvens, D.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Berkvens, N.; Casteels, H.; Witters, J.; Van Damme, V.] Inst Agr & Fisheries Res, Crop Protect Unit, Merelbeke, Belgium; [Berkvens, D.] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S2.2	16	16						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900034					2019-03-26
J	Dao, T; Nguyen, T; Dermauw, V; Gabriel, S; Dorny, P				Dao, T.; Nguyen, T.; Dermauw, V.; Gabriel, S.; Dorny, P.			Opisthorchis viverrini and a novel sister species in ducks share the same intermediate snail and fish hosts in Central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dao, T.; Nguyen, T.] Natl Inst Vet Res, Dept Parasitol, Hanoi, Vietnam; [Dao, T.; Dermauw, V.; Dorny, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dao, T.; Gabriel, S.; Dorny, P.] Univ Ghent, Vet Med, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S3.1	17	18						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900038					2019-03-26
J	Deblauwe, I; Demeulemeester, J; Sohier, C; Van Loo, T; De Witte, J; Madder, M; Coosemans, M				Deblauwe, I.; Demeulemeester, J.; Sohier, C.; Van Loo, T.; De Witte, J.; Madder, M.; Coosemans, M.			Invasive mosquito species surveillance in Belgium: towards a structural plan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Deblauwe, I.; Demeulemeester, J.; Van Loo, T.; De Witte, J.; Coosemans, M.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sohier, C.] CODA CERVA, Brussels, Belgium; [Madder, M.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa; [Madder, M.] Clinglobal, Oosterhout, Netherlands								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S2.4	17	17						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900036					2019-03-26
J	Meurs, L; Mbow, M; Vereecken, K; Van den Broeck, F; Mpabanzi, L; Boon, N; Huyse, T; Polman, K				Meurs, L.; Mbow, M.; Vereecken, K.; Van den Broeck, F.; Mpabanzi, L.; Boon, N.; Huyse, T.; Polman, K.			Dynamics of S. haematobium and s. mansoni infection and morbidity: an eight-year follow-up study in a rural community in the north of Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meurs, L.; Vereecken, K.; Van den Broeck, F.; Mpabanzi, L.; Boon, N.; Huyse, T.; Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Mbow, M.] Aristide le Dantec Univ Hosp, Lab Bacteriol & Virol, Dept Immunol, Dakar, Senegal; [Boon, N.; Huyse, T.] Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Huyse, T.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S3.3	18	19						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900040					2019-03-26
J	Cnops, L; Nakayama, EE; Caron, E; Eggermont, K; Van Esbroeck, M; Bottieau, E; Jacobs, J; Shioda, T; Huits, R				Cnops, L.; Nakayama, E. E.; Caron, E.; Eggermont, K.; Van Esbroeck, M.; Bottieau, E.; Jacobs, J.; Shioda, T.; Huits, R.			Detection of zika virus NS1 antigen in semen by a prototype rapid test	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cnops, L.; Caron, E.; Eggermont, K.; Van Esbroeck, M.; Bottieau, E.; Jacobs, J.; Huits, R.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Nakayama, E. E.; Shioda, T.] Osaka Univ, Microbial Dis Res Inst, MOCID, Osaka, Japan								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S1.3	27	27						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900062					2019-03-26
J	Huits, R; De Kort, J; Van den Berg, R; Chong, L; Eggermont, K; Arien, K; Cnops, L; Jacobs, J; Van Esbroeck, M; Bottieau, E				Huits, R.; De Kort, J.; Van den Berg, R.; Chong, L.; Eggermont, K.; Arien, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.			Clinical features of Chikungunya infection and chronic polyarthralgia after the 2014-2015 outbreak on Aruba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huits, R.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [De Kort, J.] Horacio Oduber Hosp, Oranjestad, Aruba; [Van den Berg, R.; Chong, L.] Landslab Aruba, Oranjestad, Aruba; [Arien, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Jacobs, J.] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S1.2	27	27						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900061					2019-03-26
J	Caluwaerts, S; Axelle, R; Daphne, L; Annick, A				Caluwaerts, S.; Axelle, R.; Daphne, L.; Annick, A.		Ebola Invest Platform	Inclusion of pregnant women in Ebola clinical trials	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Caluwaerts, S.; Axelle, R.; Daphne, L.; Annick, A.] Medecins Sans Frontieres, Dept Med, Brussels, Belgium; [Caluwaerts, S.] Inst Trop Med, Antwerp, Belgium; [Ebola Invest Platform] Medecins Sans Frontieres, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S2.2	29	30						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900067					2019-03-26
J	Huits, R; Van den Bossche, D; Feyen, A; Potters, I; Lotgering, E; Eggermont, K; Cnops, L; Jacobs, J; Van Esbroeck, M; Bottieau, E				Huits, R.; Van den Bossche, D.; Feyen, A.; Potters, I.; Lotgering, E.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.			Incidence of travel-associated zika virus infection in 2016: preliminary results of a prospective cohort study in Belgian travellers to the Americas	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huits, R.; Van den Bossche, D.; Feyen, A.; Potters, I.; Lotgering, E.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, J.] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S1.6	29	29						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900065					2019-03-26
J	Verdonck, K; Mukendi, D; Barbe, B; Arien, K; Yansouni, CP; Lutumba, P; Boelaert, M; Chappuis, F; Muyembe, JJ; Bottieau, E				Verdonck, K.; Mukendi, D.; Barbe, B.; Arien, K.; Yansouni, C. P.; Lutumba, P.; Boelaert, M.; Chappuis, F.; Muyembe, J. J.; Bottieau, E.			Human T-Lymphotropic virus 1 and 2 infections among patients with neurological disorders in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verdonck, K.; Barbe, B.; Arien, K.; Boelaert, M.; Bottieau, E.] Inst Trop Med, Antwerp, Belgium; [Mukendi, D.; Lutumba, P.; Muyembe, J. J.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mukendi, D.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Yansouni, C. P.] McGill Univ, Ctr Hlth, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S2.3	30	30						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900068					2019-03-26
J	Schwartz, IS; Kenyon, CR; Claasens, S; Spengane, Z; Lehloenya, R; Prozesky, HW; Colebunders, R; Dlamini, S				Schwartz, I. S.; Kenyon, C. R.; Claasens, S.; Spengane, Z.; Lehloenya, R.; Prozesky, H. W.; Colebunders, R.; Dlamini, S.			AIDS-related systemic mycoses endemic to Western Cape, South Africa and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Schwartz, I. S.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium; [Schwartz, I. S.] Univ Manitoba, Dept Med Microbiol, Max Rady Coll Med, Winnipeg, MB, Canada; [Kenyon, C. R.; Spengane, Z.; Lehloenya, R.; Dlamini, S.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Kenyon, C. R.] Inst Trop Med, Sexually Transmitted Infect Unit, Antwerp, Belgium; [Claasens, S.; Prozesky, H. W.] Stellenbosch Univ, Dept Med, Cape Town, South Africa							Schwartz IS, 2015, CLIN INFECT DIS, V61, P1004, DOI 10.1093/cid/civ439	1	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S2.6	31	31						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900071					2019-03-26
J	Annette, E; Veronica, SC; Christopher, D; Angel, R; Jean-Pierre, VG; Anna, R; Niko, S; Dioni, G; Umberto, D; Alejandro, L				Annette, E.; Veronica, S. -C.; Christopher, D.; Angel, R.; Jean-Pierre, V. G.; Anna, R.; Niko, S.; Dioni, G.; Umberto, D.; Alejandro, L.			P. vivax recurrences after radical treatment in the Peruvian Amazon: a 2-year cohort study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Annette, E.; Anna, R.] Inst Trop Med, Antwerp, Belgium; [Veronica, S. -C.; Christopher, D.; Angel, R.; Dioni, G.; Alejandro, L.] Univ Peruana Cayetano Heredia, Lima, Peru; [Christopher, D.; Jean-Pierre, V. G.] Univ Antwerp, Antwerp, Belgium; [Angel, R.; Niko, S.] Catholic Univ Louvain, Louvain, Belgium; Minist Salud, Direcc Reg Salud Loreto, Lima, Peru; [Umberto, D.] MRC Unit, Fajara, Gambia								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S3.2	32	32						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900073					2019-03-26
J	Thanh, PV; Hong, NV; Xa, NX; Van, NV; Cleves, MA; Duong, TT; Xuan, HL; Anna, RU; Umberto, D; Niko, S; Annette, E				Thanh, P. V.; Hong, N. V.; Xa, N. X.; Van, N. V.; Cleves, M. A.; Duong, T. T.; Xuan, H. Le; Anna, R. -U.; Umberto, D.; Niko, S.; Annette, E.			Vivax malaria morbidity after radical treatment: a 2-year cohort study in central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thanh, P. V.; Xa, N. X.; Duong, T. T.; Xuan, H. Le] NIMPE, Dept Epidemiol, Hanoi, Vietnam; [Hong, N. V.] NIMPE, Dept Clin Res, Hanoi, Vietnam; [Van, N. V.] Prov Malaria Stn Quang Nam, Tam Ky, Vietnam; [Cleves, M. A.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Little Rock, AR 72205 USA; [Anna, R. -U.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Umberto, D.] MRC Unit, Fajara, Gambia; [Niko, S.] Catholic Univ Louvain, Brussels, Belgium; [Annette, E.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S3.1	32	32						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900072					2019-03-26
J	Issa, G; Palpouguini, L; Post, A; Barbara, B; Tinto, H; Jacobs, J				Issa, G.; Palpouguini, L.; Post, A.; Barbara, B.; Tinto, H.; Jacobs, J.			Asymptomatic bacteriuria in pregnant women as a proxy for antibiotic resistance surveillance in the community: preliminary results from a study in Nanoro, rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Issa, G.; Palpouguini, L.; Tinto, H.] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Issa, G.; Jacobs, J.] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Post, A.; Barbara, B.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S4.1	33	34						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900077					2019-03-26
J	Vlieghe, E				Vlieghe, E.			Antibiotics under pressure	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Vlieghe, E.] Univ Antwerp, Fac Med & Life Sci, Antwerp, Belgium; [Vlieghe, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S4.3	34	34						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900079					2019-03-26
J	Leopold, B; Samuel, N; Aimable, D; Joannes, C				Leopold, B.; Samuel, N.; Aimable, D.; Joannes, C.			New diagnostic tests for tuberculosis: Performance of LAM and Xpert MTB/RIF in urine of hospitalized patients on intensive phase of TB treatment, and its association with TB dissemination and HIV status. Preliminary results from an observational cohort study in Kigali, Rwanda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Leopold, B.; Samuel, N.; Aimable, D.] Ctr Hosp Univ Kigali, Dept Internal Med, Kigali, Rwanda; [Joannes, C.] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S5.2	35	35						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900081					2019-03-26
J	Ng, KS; Meehan, CJ; Torrea, G; Goeminne, L; Diels, M; Rigouts, L; de Jong, B; Andre, E				Ng, K. S.; Meehan, C. J.; Torrea, G.; Goeminne, L.; Diels, M.; Rigouts, L.; de Jong, B.; Andre, E.			Association between rpoB mutations and probe profiles, and potential application of WHO-endorsed rapid diagnostic tests for rifampicin resistant-TB control	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ng, K. S.; Meehan, C. J.; Torrea, G.; Diels, M.; Rigouts, L.; de Jong, B.] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Goeminne, L.; Andre, E.] Catholic Univ Louvain, Inst Rech Expt & Clin, Brussels, Belgium; [Andre, E.] Clin Univ St Luc, Microbiol Unit, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S5.3	35	36						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900082					2019-03-26
J	Cnops, L; Maniewski, U; Soentjens, P; Huyse, T; Bottieau, E; Clerinx, J; Van Esbroeck, M				Cnops, L.; Maniewski, U.; Soentjens, P.; Huyse, T.; Bottieau, E.; Clerinx, J.; Van Esbroeck, M.			Early diagnosis of acute schistosomiasis by schistosome DNA detection in serum in a cluster cohort of 34 travelers exposed in South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cnops, L.; Maniewski, U.; Soentjens, P.; Bottieau, E.; Clerinx, J.; Van Esbroeck, M.] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [Huyse, T.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S6.1	37	37						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900085					2019-03-26
J	Makhado, NA; Colebunders, R; Nchabeleng, M; de Jong, BC				Makhado, N. A.; Colebunders, R.; Nchabeleng, M.; de Jong, B. C.			Identification of non-tuberculous mycobacteria isolated from clinical specimens at Dr George Mukhari Tertiary Laboratory, South Africa, using the genotype mycobacterium CM/AS assay and 16S RRNA gene sequencing	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							DIAGNOSIS		[Makhado, N. A.; Nchabeleng, M.] Dr George Mukhari Tertiary Lab, Dept Med Microbiol, Natl Hlth Lab Serv, Pretoria, South Africa; [Makhado, N. A.; Nchabeleng, M.] Sefako Makgatho Hlth Sci Univ, Dept Microbiol Pathol, Pretoria, South Africa; [Makhado, N. A.; Colebunders, R.; de Jong, B. C.] Univ Antwerp, Dept Med & Hlth Sci, Antwerp, Belgium; [Makhado, N. A.; de Jong, B. C.] Inst Trop Med, Dept Mycobacteriol, Antwerp, Belgium							Couto I, 2010, CLIN MICROBIOL INFEC, V16, P1161, DOI 10.1111/j.1469-0691.2009.03076.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Sookan L, 2014, SAMJ S AFR MED J, V104, P766, DOI [10.7196/SAMJ.8017, 10.7196/samj.8017]; van Ingen J, 2013, SEMIN RESP CRIT CARE, V34, P103, DOI 10.1055/s-0033-1333569	4	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S5.5	37	37						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900084					2019-03-26
J	Florian, B; Justin, KC; Joel, AY; Jean, TC; von Lutz, M; Katja, P; Marleen, B; Eliezer, KN; Jurg, U; Soren, LB				Florian, B.; Justin, K. C.; Joel, A. Y.; Jean, T. C.; von Lutz, M.; Katja, P.; Marleen, B.; Eliezer, K. N.; Jurg, U.; Soren, L. B.			Polymerase chain reaction for the diagnosis of Clostridium difficile infection in patients with persistent digestive disorders and asymptomatic controls in Cote d'Ivoire	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Florian, B.; von Lutz, M.; Soren, L. B.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Justin, K. C.] Hop Methodiste Dabou, Dabou, Cote Ivoire; [Joel, A. Y.; Jean, T. C.; Eliezer, K. N.] Univ Felix Houphouet Boigny, UFR Biosci, Abidjan, Cote Ivoire; [Joel, A. Y.; Jean, T. C.; Eliezer, K. N.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Jean, T. C.; Jurg, U.; Soren, L. B.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Jean, T. C.; Jurg, U.; Soren, L. B.] Univ Basel, Basel, Switzerland; [Katja, P.; Marleen, B.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S7.1	40	40						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900090					2019-03-26
J	Mbuyi, KL; Barbara, B; Joule, M; Clementine, R; Gaelle, N; Katja, P; Pascal, L; Marie-France, P; Octavie, L; Jan, J				Mbuyi, K. Lisette; Barbara, B.; Joule, M.; Clementine, R.; Gaelle, N.; Katja, P.; Pascal, L.; Marie-France, P.; Octavie, L.; Jan, J.			No association between Salmonella intestinal carriage and Schistosoma mansoni infection in healthy individuals, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mbuyi, K. Lisette; Marie-France, P.; Octavie, L.] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Mbuyi, K. Lisette; Gaelle, N.; Marie-France, P.; Octavie, L.] Univ Hosp Kinshasa, Microbiol Serv, Kinshasa, DEM REP CONGO; [Barbara, B.; Jan, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Joule, M.; Clementine, R.; Katja, P.; Pascal, L.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Joule, M.; Pascal, L.] Natl Inst Biomed Res, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Joule, M.] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium; [Pascal, L.] Univ Hosp Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Jan, J.] Katholieke Univ Leuven, Microbiol & Immunol, Leuven, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S7.2	40	40						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900091					2019-03-26
J	Koirala, KD; Verdonck, K; Barbe, B; Khanal, B; Bhattarai, NR; Pradhan, B; Bhatta, NK; Karki, P; Rijal, S; Boelaert, M; Chappuis, F; Jacobs, J				Koirala, K. D.; Verdonck, K.; Barbe, B.; Khanal, B.; Bhattarai, N. R.; Pradhan, B.; Bhatta, N. K.; Karki, P.; Rijal, S.; Boelaert, M.; Chappuis, F.; Jacobs, J.			Use of antibiotics prior to blood culture sampling in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Koirala, K. D.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Koirala, K. D.; Verdonck, K.; Boelaert, M.] Inst Trop Med, Unit Epidemiol & Control Trop Dis, Antwerp, Belgium; [Koirala, K. D.; Chappuis, F.] Univ Geneva, Geneva, Switzerland; [Barbe, B.; Jacobs, J.] Inst Trop Med, Unit Trop Lab Med, Antwerp, Belgium; [Khanal, B.; Bhattarai, N. R.] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Pradhan, B.; Karki, P.; Rijal, S.] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Bhatta, N. K.] BP Koirala Inst Hlth Sci, Dept Paediat & Adolescent Med, Dharan, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S7.3	41	41						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900092					2019-03-26
J	Phe, T; Lim, K; Leng, L; Verdonck, K; Barbe, B; Jacobs, J; Parola, P; Rijal, S; Boelaert, M; Chappuis, F				Phe, T.; Lim, K.; Leng, L.; Verdonck, K.; Barbe, B.; Jacobs, J.; Parola, P.; Rijal, S.; Boelaert, M.; Chappuis, F.			Prevalence of neglected infectious diseases in patients with persistent fever in Sihanouk Hospital Center of HOPE, Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Phe, T.; Lim, K.; Leng, L.] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Verdonck, K.; Barbe, B.; Jacobs, J.; Boelaert, M.] Inst Trop Med, Antwerp, Belgium; [Parola, P.] Univ Hosp Inst Mediterranee Infect, Marseille, France; [Rijal, S.] BP Koirala Inst Trop Med, Dharan, Nepal; [Chappuis, F.] Geneva Univ Hosp, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S8.3	42	43						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900096					2019-03-26
J	Lenaerts, E; Mukendi, D; Mandro, M; Dolo, H; Wonya'Rossi, DU; Ngave, F; Colebunders, R; Suykerbuyk, P				Lenaerts, E.; Mukendi, D.; Mandro, M.; Dolo, H.; Wonya'Rossi, D. Ucima; Ngave, F.; Colebunders, R.; Suykerbuyk, P.			Epidemiology of onchocerciasis and epilepsy in Ituri Province in the Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lenaerts, E.; Mandro, M.; Dolo, H.; Colebunders, R.; Suykerbuyk, P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Mukendi, D.] Univ Kinshasa CNPP UNIKIN, Ctr Neuro Psycho Pathol, Kinshasa, DEM REP CONGO; [Mandro, M.] Minist Hlth, Prov Hlth Div Ituri, Bunia, DEM REP CONGO; [Dolo, H.] Fac Med & Odonto Stomatol, Int Ctr Excellence Res, Bamako, Mali; [Wonya'Rossi, D. Ucima] Minist Hlth, Neglected Trop Dis Control Program, Bunia, DEM REP CONGO; [Wonya'Rossi, D. Ucima; Ngave, F.] Hop Gen Reference Rethy, Ctr Rech Malad Trop, Rethy, DEM REP CONGO								0	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S8.4	43	43						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900097					2019-03-26
J	Martinez, DY; Verdonck, K; Adaui, V; Jara, M; Alba, M; Arevalo, J; Polman, K; Llanos-Cuentas, A; Dujardin, JC; Boelaert, M				Martinez, D. Y.; Verdonck, K.; Adaui, V.; Jara, M.; Alba, M.; Arevalo, J.; Polman, K.; Llanos-Cuentas, A.; Dujardin, J. C.; Boelaert, M.			Intestinal helminthiasis as a determinant of response to pentavalent antimony treatment in Peruvian patients with cutaneous leishmaniasis: a case-control study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Martinez, D. Y.; Llanos-Cuentas, A.] HCH, Dept Enfermedades Infecciosas Dermatol & Trop, Lima, Peru; [Martinez, D. Y.; Adaui, V.; Jara, M.; Alba, M.; Arevalo, J.; Llanos-Cuentas, A.] UPCH, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Martinez, D. Y.] UPCH, Fac Med Alberto Hurtado, Lima, Peru; [Verdonck, K.; Polman, K.; Dujardin, J. C.; Boelaert, M.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S8.5	43	44						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900098					2019-03-26
J	Vogt, F; Mekonnen, T; Fikre, H; Takele, Y; Adem, E; Mohammed, R; Ritmeijer, K; Adriaensen, W; Diro, E; Van Griensven, J				Vogt, F.; Mekonnen, T.; Fikre, H.; Takele, Y.; Adem, E.; Mohammed, R.; Ritmeijer, K.; Adriaensen, W.; Diro, E.; Van Griensven, J.			Accuracy of antigen detection in urine using Katex for non-invasive visceral leishmaniasis diagnosis and treatment monitoring in HIV-coinfected patients	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vogt, F.; Adriaensen, W.; Van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Mekonnen, T.; Fikre, H.; Takele, Y.; Adem, E.; Mohammed, R.; Diro, E.] Univ Gondar, Leishmania Res & Training Ctr, Gondar, Ethiopia; [Ritmeijer, K.] Doctors Borders, Operat Ctr Amsterdam, Amsterdam, Netherlands								0	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S9.1	44	45						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900100					2019-03-26
J	van Griensven, J; Van Henten, S; Mengesha, B; Endris, M; Van Den Bossche, D; Cnops, L; Adriaensen, W; Gedamu, Y; Vogt, F; Diro, E				van Griensven, J.; Van Henten, S.; Mengesha, B.; Endris, M.; Van Den Bossche, D.; Cnops, L.; Adriaensen, W.; Gedamu, Y.; Vogt, F.; Diro, E.			Prevalence and risk factors of asymptomatic Leishmania infection in HIV-infected individuals in North West Ethiopia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van Griensven, J.; Van Henten, S.; Van Den Bossche, D.; Cnops, L.; Adriaensen, W.; Vogt, F.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Mengesha, B.; Endris, M.; Gedamu, Y.; Diro, E.] Univ Gondar Hosp, Gondar, Ethiopia; Metema Hosp, Gondar, Ethiopia								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S9.5	46	46						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900104					2019-03-26
J	van Griensven, J; Simegn, T; Endris, M; Diro, E				van Griensven, J.; Simegn, T.; Endris, M.; Diro, E.			Visceral leishmaniasis and HIV co-infection in northwest Ethiopia: uptake of antiretroviral treatment and burden of disease amongst patients enrolled in HIV care	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Simegn, T.] Metema Hosp, Gondar, Ethiopia; [Endris, M.; Diro, E.] Univ Gondar Hosp, Gondar, Ethiopia								0	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S9.6	46	47						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900105					2019-03-26
J	Cools, P; Vlaminck, J; Albonico, M; Ame, S; Ayana, M; Keiser, J; Mekonnen, Z; Montresor, A; Sayasone, S; Verweij, J; Vercruysse, J; Levecke, B				Cools, P.; Vlaminck, J.; Albonico, M.; Ame, S.; Ayana, M.; Keiser, J.; Mekonnen, Z.; Montresor, A.; Sayasone, S.; Verweij, J.; Vercruysse, J.; Levecke, B.			Comparison of single Kato-Katz, duplicate Kato-Katz, mini-FLOTAC and FECPAK(G2) for the assessment of anthelminthic efficacy of single dose albendazole	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cools, P.; Vlaminck, J.; Vercruysse, J.; Levecke, B.] Dept Virol, Parasitol Lab, Parasitol, Immunol, Merelbeke, Belgium; [Albonico, M.; Montresor, A.] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Ame, S.] Publ Hlth Lab Ivo de Carneri, Chake Chake, Tanzania; [Ayana, M.; Mekonnen, Z.] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Keiser, J.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Sayasone, S.] Minist Hlth, Natl Inst Publ Hlth, Viangchan, Laos; [Verweij, J.] St Elizabeth Hosp, Tilburg, Netherlands								0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S10.1	47	47						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900106					2019-03-26
J	Mpanya, A; Claeys, Y; Fukinsia, A; Snijders, R; Makabuza, J; Boelaert, M; Lutumba, P; Lumbala, C; Hasker, E				Mpanya, A.; Claeys, Y.; Fukinsia, A.; Snijders, R.; Makabuza, J.; Boelaert, M.; Lutumba, P.; Lumbala, C.; Hasker, E.			Innovative methods of case finding to achieve elimination of human African trypanosomiasis in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mpanya, A.; Fukinsia, A.; Makabuza, J.; Lumbala, C.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Claeys, Y.; Snijders, R.; Boelaert, M.; Hasker, E.] Inst Med Trop Anvers, Antwerp, Belgium; [Lutumba, P.] Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S1.1	49	49						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900111					2019-03-26
J	Willem, L; Verelst, F; Kuylen, E; Abboud, LA; Bicke, J; Hens, N; Broeckhove, J; Beutels, P				Willem, L.; Verelst, F.; Kuylen, E.; Abboud, L. A.; Bicke, J.; Hens, N.; Broeckhove, J.; Beutels, P.			Catching the risk of measles outbreaks in a clustered society	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Willem, L.; Verelst, F.; Abboud, L. A.; Bicke, J.; Hens, N.; Beutels, P.] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, Antwerp, Belgium; [Kuylen, E.; Broeckhove, J.] Univ Antwerp, Dept Math & Comp Sci, Modeling Syst & Internet Commun, Antwerp, Belgium; [Hens, N.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Beutels, P.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia			Beutels, Philippe/A-1919-2010	Beutels, Philippe/0000-0001-5034-3595				0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S2.3	52	52						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900118					2019-03-26
J	Laudisoit, A; Verheyen, E; Baelo, P; Akonda, I; Nebesse, C; Ngoy, S; Gembu, G; Tepage, F; Muyembe, JJ; Alworonga, O; Mande, D; Angotolwa, Z; Leirs, H; Ngbonda, D; Colebunders, R				Laudisoit, A.; Verheyen, E.; Baelo, P.; Akonda, I.; Nebesse, C.; Ngoy, S.; Gembu, G.; Tepage, F.; Muyembe, J. J.; Alworonga, O.; Mande, D.; Angotolwa, Z.; Leirs, H.; Ngbonda, D.; Colebunders, R.			A One Health team to improve Monkeypox virus outbreak response: an example from the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laudisoit, A.; Verheyen, E.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Laudisoit, A.; Verheyen, E.; Leirs, H.] Univ Antwerp, Evolutionary Biol Grp, Antwerp, Belgium; [Laudisoit, A.] Univ Liverpool, Inst Integrat Biol, Sch Biol Sci, Liverpool, Merseyside, England; [Verheyen, E.] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Baelo, P.; Nebesse, C.; Ngoy, S.; Gembu, G.] Univ Kisangani, Biodivers Monitoring Ctr, Fac Sci, Kisangani, DEM REP CONGO; [Baelo, P.; Nebesse, C.; Ngoy, S.; Gembu, G.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Akonda, I.; Tepage, F.] Minist Hlth, Bas Uele Prov Hlth Div, Kisangani, DEM REP CONGO; [Muyembe, J. J.] Inst Natl Rech Biomed Kinshasa, Kinshasa, DEM REP CONGO; [Alworonga, O.; Mande, D.; Angotolwa, Z.; Ngbonda, D.] Univ Kisangani, Fac Med, Kisangani, DEM REP CONGO								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S2.5	53	53						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900120					2019-03-26
J	Claeys, Y; Makabuza, J; Mpanya, A; Boelaert, M; Lutumba, P; Lebuki, J; Hasker, E; Lumbala, C				Claeys, Y.; Makabuza, J.; Mpanya, A.; Boelaert, M.; Lutumba, P.; Lebuki, J.; Hasker, E.; Lumbala, C.			Digitalization and planning of active HAT screening in the Democratic Republic of Congo to reach elimination	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Claeys, Y.; Boelaert, M.; Hasker, E.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium; [Makabuza, J.; Mpanya, A.; Lutumba, P.; Lebuki, J.; Lumbala, C.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; Kinshasa Univ, Dept Trop Med, Kinshasa, DEM REP CONGO								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S3.2	54	54						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900123					2019-03-26
J	Vanlerberghe, V; Toledo, ME; Ocampo, C; Manrique-Saide, P; Honorio, N; Vazquez-Prokopec, G; Mirabal, M; Alexander, N; Frutuoso, RL; Stuyft, PVD				Vanlerberghe, V.; Toledo, M. E.; Ocampo, C.; Manrique-Saide, P.; Honorio, N.; Vazquez-Prokopec, G.; Mirabal, M.; Alexander, N.; Frutuoso, R. L.; Stuyft, P. V. der			Considering the spatial heterogeneity of Dengue transmission for designing an Aedes control strategy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vanlerberghe, V.; Stuyft, P. V. der] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Toledo, M. E.] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Ocampo, C.; Alexander, N.] Int Training & Med Res Ctr, Cali, Colombia; [Manrique-Saide, P.] Univ Yucatan, Dept Entomol, Merida, Mexico; [Honorio, N.] Fiocruz MS, Rio De Janeiro, Brazil; [Vazquez-Prokopec, G.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Mirabal, M.] Finlay Vaccine Inst, Clin Res & Impact Evaluat Div, Havana, Cuba; [Frutuoso, R. L.] Minist Hlth, Natl Program Prevent & Control Malaria & Dis Tran, Brasilia, DF, Brazil; [Stuyft, P. V. der] Univ Ghent, Dept Publ Hlth, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S3.1	54	54						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900122					2019-03-26
J	Hasker, E; Baco, A; Younoussa, A; Mzembaba, A; Salim, Z; Amidy, M; Grillone, S; Demeulenaere, T; Ortuno-Gutierrez, N; Groenen, G; Suffys, P; de Jong, B				Hasker, E.; Baco, A.; Younoussa, A.; Mzembaba, A.; Salim, Z.; Amidy, M.; Grillone, S.; Demeulenaere, T.; Ortuno-Gutierrez, N.; Groenen, G.; Suffys, P.; de Jong, B.			Mapping of leprosy cases as a tool for rationalizing contact screening	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hasker, E.; de Jong, B.] Inst Trop Med, Antwerp, Belgium; [Baco, A.; Younoussa, A.; Mzembaba, A.; Salim, Z.; Amidy, M.; Grillone, S.] Leprosy & TB Control Program, Brussels, Belgium; [Demeulenaere, T.; Ortuno-Gutierrez, N.] Damien Fdn, Brussels, Belgium; [Groenen, G.] BELTA TBnet, Brussels, Belgium; [Suffys, P.] Fiocruz MS, Rio De Janeiro, Brazil								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S3.4	55	55						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900125					2019-03-26
J	Bannister-Tyrrell, M; Xa, NX; Van, NV; Dung, VA; Hieu, TM; Hong, NV; Kattenberg, JH; Rovira-Vallbona, E; Duong, TT; Urgell, AR; Grietens, KP; Erhart, A				Bannister-Tyrrell, M.; Xa, N. X.; Van, N. V.; Dung, V. A.; Hieu, T. M.; Hong, N. V.; Kattenberg, J. H.; Rovira-Vallbona, E.; Duong, T. T.; Urgell, A. R.; Grietens, K. P.; Erhart, A.			Micro-epidemiology of malaria exposure in central Vietnam: a mixed-methods case study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bannister-Tyrrell, M.; Grietens, K. P.; Erhart, A.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Xa, N. X.; Dung, V. A.; Hieu, T. M.; Hong, N. V.; Duong, T. T.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Van, N. V.] Quang Nam Prov Hlth Serv, Tam Ky, Vietnam; [Kattenberg, J. H.; Rovira-Vallbona, E.; Urgell, A. R.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Erhart, A.] MRC, Fajara, Gambia								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S4.1	56	56						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900127					2019-03-26
J	Sommerland, N; Wouters, E; Masquillier, C; Rau, A; Engelbrecht, M; Kigozi, G; Uebel, K				Sommerland, N.; Wouters, E.; Masquillier, C.; Rau, A.; Engelbrecht, M.; Kigozi, G.; Uebel, K.			Stigma among healthcare workers as a barrier to the use of TB services at occupational health units in South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sommerland, N.; Wouters, E.; Masquillier, C.] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Rau, A.; Engelbrecht, M.; Kigozi, G.; Uebel, K.] Univ Free State, Dept Hlth Syst Res & Dev, Bloemfontein, South Africa			Wouters, Edwin/G-9073-2012	Wouters, Edwin/0000-0003-2268-3829				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S4.2	56	57						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900128					2019-03-26
J	Mukumbang, FC; Van Belle, S; Marchal, B; Van Wyk, B				Mukumbang, F. C.; Van Belle, S.; Marchal, B.; Van Wyk, B.			Why would antiretroviral treatment adherence clubs work in the Western Cape Province, South Africa?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mukumbang, F. C.; Marchal, B.; Van Wyk, B.] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa; [Mukumbang, F. C.; Van Belle, S.; Marchal, B.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S4.3	57	57						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900129					2019-03-26
J	Mmbando, BP; Mnacho, M; Makunde, M; Kakorozya, A; Matuja, W; Greter, H; Suykerbuyk, P; Colebunders, R				Mmbando, B. P.; Mnacho, M.; Makunde, M.; Kakorozya, A.; Matuja, W.; Greter, H.; Suykerbuyk, P.; Colebunders, R.			High prevalence of epilepsy and onchocerciasis after 20 years of ivermectin use in four villages of the Mahenge area in Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mmbando, B. P.; Makunde, M.] Natl Inst Med Res, Tanga Res Ctr, Tanga, Tanzania; [Mnacho, M.; Matuja, W.] Muhimbili Univ Hlth Sci, Dar Es Salaam, Tanzania; [Kakorozya, A.] Enhance Tanzania Fdn, Dar Es Salaam, Tanzania; [Greter, H.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S6.4	61	61						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900139					2019-03-26
J	van den Bergh, R; Panunzi, I; Benedetti, G; Mandi, H; Beijnsberger, J; Bachy, C; Pineda, S; Lambert, V; Zachariah, R; Van Herp, M				van den Bergh, R.; Panunzi, I.; Benedetti, G.; Mandi, H.; Beijnsberger, J.; Bachy, C.; Pineda, S.; Lambert, V.; Zachariah, R.; Van Herp, M.			"Hit early, hit hard: feasibility and effectiveness of the focused ""Coup de Poing"" measles outbreak response in the democratic Republic of Congo"	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van den Bergh, R.; Panunzi, I.; Benedetti, G.; Bachy, C.; Pineda, S.; Zachariah, R.; Van Herp, M.] Med Sans Frontieres, Operat Ctr Brussels, Med Dept, Brussels, Belgium; [Mandi, H.; Beijnsberger, J.] Med Sans Frontieres Democrat Republ Congo, Operat Ctr Brussels, Kinshasa, DEM REP CONGO; [Lambert, V.] Med Sans Frontieres, Operat Ctr Brussels, Operat Dept, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S7.4	63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900144					2019-03-26
J	Vorsters, A; Pattyn, J; Van Keer, S; Biesmans, S; Van Damme, P				Vorsters, A.; Pattyn, J.; Van Keer, S.; Biesmans, S.; Van Damme, P.			The use of first void urine to monitor HPV vaccination impact, results from Bhutan and Rwanda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vorsters, A.; Pattyn, J.; Van Keer, S.; Biesmans, S.; Van Damme, P.] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium							Franceschi S, 2016, INT J CANCER, V139, P518, DOI 10.1002/ijc.30092	1	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S7.3	63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900143					2019-03-26
J	Coulborn, RM; Nackers, F; Panunzi, I; Bachy, C; Porten, K; Vochten, H; Van Herp, M; Bibala-Faray, E; Cohuet, S				Coulborn, R. M.; Nackers, F.; Panunzi, I.; Bachy, C.; Porten, K.; Vochten, H.; Van Herp, M.; Bibala-Faray, E.; Cohuet, S.			Field challenges to measles elimination in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Coulborn, R. M.; Nackers, F.; Porten, K.; Cohuet, S.] Epicentre, Paris, France; [Panunzi, I.; Bachy, C.; Van Herp, M.] Med Sans Frontieres, Brussels, Belgium; [Vochten, H.] Med Sans Frontieres, Kinshasa, DEM REP CONGO; [Bibala-Faray, E.] Minist Publ Hlth, Maniema, DEM REP CONGO								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S8.2	64	65						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900147					2019-03-26
J	Verelst, F; Willem, L; Kessels, R; Beutels, P				Verelst, F.; Willem, L.; Kessels, R.; Beutels, P.			Extracting the incentives: vaccination behavior as a multicriteria decision	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verelst, F.; Willem, L.; Beutels, P.] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis CHERMID, Antwerp, Belgium; [Kessels, R.] Univ Antwerp, Fac Appl Econ, Antwerp, Belgium; [Beutels, P.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia			Beutels, Philippe/A-1919-2010; Kessels, Roselinde/N-8479-2016	Beutels, Philippe/0000-0001-5034-3595; Kessels, Roselinde/0000-0002-4534-0047				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S8.1	64	64						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900146					2019-03-26
J	De Kesel, T; Rudelsheim, P				De Kesel, T.; Rudelsheim, P.			WHO GAP III roadmap to compliance for poliovirus-essessential facilities	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Kesel, T.] Febris Biorisk Consult BVBA, Aalter, Belgium; [Rudelsheim, P.] Perseus BVBA, St Martens Latem, Belgium							WHO GAP III, 2015, WHO GLOB ACT PLAN MI	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S8.3	65	65						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900148					2019-03-26
J	Sunyoto, T; Atia, AM; Khalid, G; Alcoba, G; den Boer, M; Boelaert, M				Sunyoto, T.; Atia, A. M.; Khalid, G.; Alcoba, G.; den Boer, M.; Boelaert, M.			Suffering in silence: a qualitative study on reasons of delay in seeking care for visceral leishmaniasis in southern Gedaref, Sudan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland; [Atia, A. M.; den Boer, M.] KalaCORE WHO, Khartoum, Sudan; [Khalid, G.] Univ Gedaref, Fac Med, Al Qadarif, Sudan; [Alcoba, G.] Med Sans Frontieres, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S9.4	67	68						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900154					2019-03-26
J	Atia, AM; Den Boer, M; Elhag, MS; Ahmed, R; Alcoba, G; Chappuis, F; van Griensven, J; Rony, Z				Atia, A. M.; Den Boer, M.; Elhag, M. Siddig; Ahmed, R.; Alcoba, G.; Chappuis, F.; van Griensven, J.; Rony, Z.			What are the true outcomes of patients declared lost to follow up in a visceral Leishmaniasis program in Sudan?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Atia, A. M.] KalaCORE, Khartoum, Sudan; [Den Boer, M.] Med Sans Frontieres UK, London, England; [Elhag, M. Siddig] Fed Minist Hlth, Khartoum, Sudan; [Ahmed, R.] Minist Hlth, Gedaref, Gedaref State, Sudan; [Alcoba, G.; Chappuis, F.] Med Sans Frontieres Switzerland, Operat Ctr, Geneva, Switzerland; [Chappuis, F.] Geneva Univ Hosp, Geneva, Switzerland; [van Griensven, J.] Inst Trop Med, Antwerp, Belgium; [Rony, Z.] Med Sans Frontieres Brussels, Operat Ctr, Luxembourg, Luxembourg								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S9.5	68	68						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900155					2019-03-26
J	Le Rutte, EA; Chapman, LAC; Coffeng, LE; Jervis, S; Hasker, EC; Dwivedi, S; Karthick, MP; Mahapatra, T; Chaudhury, I; Boelaert, MC; Medley, GF; Srikantiah, S; Hollingsworth, TD; de Vlas, SJ				Le Rutte, E. A.; Chapman, L. A. C.; Coffeng, L. E.; Jervis, S.; Hasker, E. C.; Dwivedi, S.; Karthick, M. P.; Mahapatra, T.; Chaudhury, I.; Boelaert, M. C.; Medley, G. F.; Srikantiah, S.; Hollingsworth, T. Deirdre; de Vlas, S. J.			Elimination of visceral leishmaniasis on the Indian subcontinent: a comparison of multiple transmission models	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Le Rutte, E. A.; Coffeng, L. E.; de Vlas, S. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Chapman, L. A. C.; Jervis, S.; Hollingsworth, T. Deirdre] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Hasker, E. C.; Boelaert, M. C.] Inst Trop Med, Antwerp, Belgium; [Dwivedi, S.; Karthick, M. P.; Mahapatra, T.; Chaudhury, I.; Srikantiah, S.] CARE India Solut Sustainable Dev, Patna, Bihar, India; [Medley, G. F.] London Sch Hyg & Trop Med, Keppel St, London, England			Hollingsworth, Deirdre/D-2421-2009; Medley, Graham/B-7289-2008	Hollingsworth, Deirdre/0000-0001-5962-4238; Medley, Graham/0000-0002-0030-7278				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S10.2	68	69						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900157					2019-03-26
J	Malviya, P; Hasker, E; Boelaert, M; Sundar, S				Malviya, P.; Hasker, E.; Boelaert, M.; Sundar, S.			Health seeking behavior of patients in Muzaffarpur-TMRC HDSS may hinder Kala-azar elimination in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Malviya, P.] Banaras Hindu Univ, Varanasi, Uttar Pradesh, India; [Hasker, E.; Boelaert, M.] ITM, Antwerp, Belgium; [Sundar, S.] BHU, IMS, Varanasi, Uttar Pradesh, India								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S10.4	69	70						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900159					2019-03-26
J	Lurton, G; Antony, M; Legrand, A; de Borman, N				Lurton, G.; Antony, M.; Legrand, A.; de Borman, N.			Defining a supervision strategy using artificial intelligence (AI). The case of data supervision for the results based financing intervention in Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lurton, G.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Antony, M.] European Agcy Dev & Hlth, Brussels, Belgium; [Legrand, A.; de Borman, N.] BlueSquare, Brussels, Belgium								0	0	0	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.2	70	70						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900161					2019-03-26
J	Verbeke, F; Karara, G; Van Bastelaere, S				Verbeke, F.; Karara, G.; Van Bastelaere, S.			Primitive metrics for predicting clinical documentation performance in Burundian public hospitals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verbeke, F.; Karara, G.] Vrije Univ Brussel, Dept Biostat & Med Informat, Brussels, Belgium; [Van Bastelaere, S.] Belgian Dev Agcy, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.3	70	71						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900162					2019-03-26
J	Verbeke, F; Van Laere, S; Nyssen, M				Verbeke, F.; Van Laere, S.; Nyssen, M.			An open source API for real time drug prescription monitoring at the point of care in low resource settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verbeke, F.; Van Laere, S.; Nyssen, M.] Vrije Univ Brussel, Dept Biostat & Med Informat, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.1	70	70						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900160					2019-03-26
J	Legrand, A; Nembetwa, N				Legrand, A.; Nembetwa, N.			Digitizing routine health facility assessment in low-resource settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Legrand, A.; Nembetwa, N.] Bluesquare, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.5	71	72						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900164					2019-03-26
J	Meyanti, F; Verdonck, K; Polman, K; Mahendradhata, Y				Meyanti, F.; Verdonck, K.; Polman, K.; Mahendradhata, Y.			Reasons for not attending a health care centre for soil-transmitted helminth infections in a rural village in Indonesia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meyanti, F.; Mahendradhata, Y.] Univ Gadjah Mada, Fac Med, Ctr Trop Med, Yogyakarta, Indonesia; [Verdonck, K.; Polman, K.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S2.3	72	73						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900167					2019-03-26
J	Dossou, JP; Marchal, B				Dossou, J. P.; Marchal, B.			State to the test of trust: implementation of a public fee exemption policy in non-state facilities in Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dossou, J. P.; Marchal, B.] Res Ctr Human Reprod & Demog, Dept Publ Hlth, Cotonou, Benin; [Dossou, J. P.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S3.4	75	75						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900173					2019-03-26
J	Landu, DJM; Liegeois, S; Kuwekita, JM; Mbinze, J; Nsiona, JM; Hubert, P; Michel, B; Reginster, JY; Frederich, M; Djang'Eing'A, RM				Landu, D. J. Mavungu; Liegeois, S.; Kuwekita, J. Manzambi; Mbinze, J.; Nsiona, J. Mavungu; Hubert, P.; Michel, B.; Reginster, J-Y.; Frederich, M.; Djang'Eing'A, R. Marini			The quality of Artemether-Lumefantrine combination and characteristics of pharmacies in the Periurban areas of Kinshasa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Landu, D. J. Mavungu; Liegeois, S.; Hubert, P.; Frederich, M.; Djang'Eing'A, R. Marini] Univ Liege, Dept Pharm, Liege, Belgium; [Landu, D. J. Mavungu; Michel, B.] Ecole Reg Postuniv Amenagement & Gest Integres Fo, Kinshasa, DEM REP CONGO; [Liegeois, S.; Kuwekita, J. Manzambi; Reginster, J-Y.] Univ Liege, Dept Sci Sante Publ, Liege, Belgium; [Kuwekita, J. Manzambi] Inst Super Tech Med Kinshasa, Sect Sante Communautaire, Kinshasa, DEM REP CONGO; [Mbinze, J.] Univ Kinshasa, Dept Galen & Anal Medicaments, Kinshasa, DEM REP CONGO; [Nsiona, J. Mavungu] Div Prov Sante, Kinshasa, DEM REP CONGO; [Michel, B.] Univ Liege, Fac Univ Sci Agron Gembloux, Gembloux, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.1	76	76						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900175					2019-03-26
J	Ravinetto, R; Lotay, PS; De Santi, O				Ravinetto, R.; Lotay, P. Singh; De Santi, O.			How the quality strategy can tackle the challenges of procuring medicines in weak regulatory environments: the experience of a sub-Saharan African procurement centre	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.; Lotay, P. Singh; De Santi, O.] Inst Trop Med, Antwerp, Belgium; [Ravinetto, R.; Lotay, P. Singh; De Santi, O.] Cent Humanitaire Med Pharmaceut, Nairobi, Kenya								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.3	76	77						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900177					2019-03-26
J	Van Assche, K; Giralt, AN; Caudron, JM; Ravinetto, R				Van Assche, K.; Giralt, A. Nebot; Caudron, J. M.; Ravinetto, R.			The impact of local private distributors on quality of medicines available in non African low- and middle-income countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Giralt, A. Nebot; Ravinetto, R.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Caudron, J. M.] QUAMED, Castres, France								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.2	76	76						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900176					2019-03-26
J	Carasso, KB; Naylor, M; Ngwaru, T; Caffrey, M; Witter, S				Carasso, K. B.; Naylor, M.; Ngwaru, T.; Caffrey, M.; Witter, S.			A health system perspective to improving pharmaceutical supply: lessons from Zimbabwe	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Carasso, K. B.] Hera, Reet, Belgium; [Naylor, M.] Oxford Policy Management, Oxford, England; [Ngwaru, T.] Oxford Policy Management, Pretoria, South Africa; [Caffrey, M.] Univ Liverpool Liverpool Sch Trop Med, CMNH, Liverpool, Merseyside, England; [Witter, S.] Queen Margaret Univ, IGHD, Edinburgh, Midlothian, Scotland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.4	77	77						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900178					2019-03-26
J	Agudelo, EL; Salva, AR; Jo, AS; Pinera, AD; Cantillo, GM; Acosta, SB; Van der Stuyft, P				Agudelo, E. Londono; Salva, A. Rodriguez; Jo, A. Seuc; Pinera, A. Diaz; Cantillo, G. Maldonado; Acosta, S. Balcindes; Van der Stuyft, P.			Assessment of diabetes care in the municipalities of Cardenas and Santiago (Cuba)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Agudelo, E. Londono] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Salva, A. Rodriguez; Jo, A. Seuc; Pinera, A. Diaz; Cantillo, G. Maldonado; Acosta, S. Balcindes] Inst Nacl Higiene Epidemiol & Microbiol, Dept Salud Publ, Havana, Cuba; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Van der Stuyft, P.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S5.2	78	78						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900180					2019-03-26
J	Adepoju, IOO; Douwes, R; Abugnaba-Abanga, R; van der Heiden, M; Apentibadek, N; Zweekhorst, M; Bardaji, A; van Roosmalen, J; De Brouwere, V				Adepoju, I. O. O.; Douwes, R.; Abugnaba-Abanga, R.; van der Heiden, M.; Apentibadek, N.; Zweekhorst, M.; Bardaji, A.; van Roosmalen, J.; De Brouwere, V.			mHealth for improving quality of antenatal care in northern Ghana: the Bliss4Midwives project	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adepoju, I. O. O.; Zweekhorst, M.; van Roosmalen, J.] Vrije Univ, Athena Inst, Amsterdam, Netherlands; [Adepoju, I. O. O.; De Brouwere, V.] Inst Trop Med, Dept Publ Hlth, Maternal & Reprod Hlth Unit, Antwerp, Belgium; [Adepoju, I. O. O.; Bardaji, A.] Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Douwes, R.] Simavi, Amsterdam, Netherlands; [Abugnaba-Abanga, R.] Presbyterian Hlth Serv North, Bolgatanga, Ghana; [van der Heiden, M.] TNO Org Appl Sci Res, Delft, Netherlands; [Apentibadek, N.] Assoc Church Dev Projects ACDEP, Tamale, Ghana; [van Roosmalen, J.] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S7.2	81	81						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900187					2019-03-26
J	Philippe, V; Laurent, A; Nathalie, C; Mit, P				Philippe, V.; Laurent, A.; Nathalie, C.; Mit, P.			Financial access barriers for HIV patients in Kinshasa, DRC and possible mitigation by patient associations' managed vouchers	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Philippe, V.] ALTER, Montpellier, France; [Laurent, A.] ECOSAN, Montpellier, France; [Nathalie, C.; Mit, P.] Med Sans Frontieres, Dept Anal, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S8.4	83	84						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900194					2019-03-26
J	Renmans, D; Holvoet, N; Criel, B				Renmans, D.; Holvoet, N.; Criel, B.			It takes two to own - the policy process behind the implementation of PBF in Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Renmans, D.; Holvoet, N.] Univ Antwerp, Inst Dev Policy & Management, Antwerp, Belgium; [Renmans, D.; Criel, B.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S8.2	83	83						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900192					2019-03-26
J	Eerens, P				Eerens, P.			Translation of multiple health systems flows in the language of complex networks	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Eerens, P.] Living Hlth Syst, Brussels, Belgium							Pfadenhauer LM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0552-5; Rajaram R, 2012, COMPLEXITY, V18, P8, DOI 10.1002/cplx.21412; Ramalingam B., 2008, DEVELOPMENT, V16, P89	3	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S9.3	85	85						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900197					2019-03-26
J	Steurs, L; Delputte, S; Orbie, J				Steurs, L.; Delputte, S.; Orbie, J.			The love-hate relationship between European donors and the global health initiatives	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Steurs, L.; Delputte, S.; Orbie, J.] Univ Ghent, Dept Polit Sci, Ctr EU Studies, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S1.1	85	85						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900198					2019-03-26
J	Steurs, L; Delputte, S; Orbie, J				Steurs, L.; Delputte, S.; Orbie, J.			European donors and health system strengthening: a distinct approach?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Steurs, L.; Delputte, S.; Orbie, J.] Univ Ghent, Dept Polit Sci, Ctr EU Studies, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S1.3	86	86						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900200					2019-03-26
J	De Buck, E; Van Remoortel, H; Veegaete, AV; Singhal, M; Vandekerckhove, P; Agarwal, SP				De Buck, E.; Van Remoortel, H.; Veegaete, A. Vande; Singhal, M.; Vandekerckhove, P.; Agarwal, S. P.			Evidence-based guidelines and training materials for first aid by laypeople: the example of India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Buck, E.; Van Remoortel, H.; Veegaete, A. Vande] Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium; [De Buck, E.; Vandekerckhove, P.] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Singhal, M.] All India Inst Med Sci, Dept Trauma Surg, New Delhi, India; [Vandekerckhove, P.] Belgian Red Cross, Mechelen, Belgium; [Vandekerckhove, P.] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Agarwal, S. P.] Indian Red Cross Soc, New Delhi, India								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S2.4	87	88						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900204					2019-03-26
J	Kennis, J; Van den Broucke, S; Clerinx, J; Huits, R; Zolfo, M; Bottieau, E				Kennis, J.; Van den Broucke, S.; Clerinx, J.; Huits, R.; Zolfo, M.; Bottieau, E.			WikiTropica: a concept for a knowledge management platform in the field of tropical medicine and travel health	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kennis, J.; Van den Broucke, S.; Clerinx, J.; Huits, R.; Zolfo, M.; Bottieau, E.] Inst Trop Med, Clin Sci Dept, Antwerp, Belgium			Kennis, Jan/D-4064-2018; Zolfo, Maria/B-9787-2015	Kennis, Jan/0000-0002-6431-1372; Zolfo, Maria/0000-0001-9756-9380				0	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S2.3	87	87						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900203					2019-03-26
J	Jiang, L; Qui, QHN; Simpson, G; Quesada, F; Artama, WT; Joseph, J; Thys, S				Jiang, L.; Qui, Q. H. Nguyen; Simpson, G.; Quesada, F.; Artama, W. T.; Joseph, J.; Thys, S.			Mapping One health curriculum for better disease prevention and control: what and why	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jiang, L.] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Qui, Q. H. Nguyen] Natl Inst Anim Sci, Dept Anim Physiol Biochem & Behav, Hanoi, Vietnam; [Simpson, G.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa; [Quesada, F.] Wild Spirit, Hoedspruit, South Africa; [Artama, W. T.] Univ Gadjah Mada, Hlth Resource Ctr 1, Yogyakarta, Indonesia; [Joseph, J.] Publ Hlth Fdn India, New Delhi, India; [Thys, S.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S2.5	88	88						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900205					2019-03-26
J	Sunyoto, T; Potet, J; Torrellee, E; Boelaert, M				Sunyoto, T.; Potet, J.; Torrellee, E.; Boelaert, M.			Miltefosine: a case study of a product development partnership and why a life-saving drug is not available to patients who need it most	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.; Potet, J.; Torrellee, E.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S3.2	89	89						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900207					2019-03-26
J	Arsenijevic, J; Contenta, A; Moissaing, S; Ponthie, A; Malvisi, L; Zamatto, F; Severy, N; Manzi, M; de Vingne, B; Zachariah, R				Arsenijevic, J.; Contenta, A.; Moissaing, S.; Ponthie, A.; Malvisi, L.; Zamatto, F.; Severy, N.; Manzi, M.; de Vingne, B.; Zachariah, R.			A crisis of protection and humane treatment: violence, physical trauma and deaths among migrants/refugees travelling along the Western Balkan corridor to Northern Europe	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Arsenijevic, J.; Contenta, A.; Moissaing, S.] Med Sans Frontieres, Lekari Bez Granica Strahinica Ban, Belgrade, Serbia; [Ponthie, A.] Med Sans Frontieres, Anal & Advocacy Unit, MSF Brussels Operat Ctr, Brussels, Belgium; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Operat Dept, Brussels Operat Ctr, Rome, Italy; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Med Dept, Brussels Operat Ctr, Rome, Italy; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Operat Dept, Brussels Operat Ctr, Brussels, Belgium; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Med Dept, Brussels Operat Ctr, Brussels, Belgium; [Manzi, M.; Zachariah, R.] Med Sans Frontieres, Operat Res Unit LuxOR, MSF Brussels Operat Ctr, Luxembourg, Luxembourg								0	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7S2.1	92	92						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900215					2019-03-26
J	Lafaut, D				Lafaut, D.			Needs versus rights: moral understandings of healthcare workers and undocumented migrants in Belgium regarding access to healthcare	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lafaut, D.] VUB, Dept Philosophy & Eth, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7S2.3	93	93						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900217					2019-03-26
J	Kotsioni, I; Kastrissianaki, A; Haziri, I; Papachristou, A; Kokkiniotis, M; Zerva, E; Vallianou, A; Zamatto, F; Van den Bergh, R; Gionakis, N; Sarantou, E				Kotsioni, I.; Kastrissianaki, A.; Haziri, I.; Papachristou, A.; Kokkiniotis, M.; Zerva, E.; Vallianou, A.; Zamatto, F.; Van den Bergh, R.; Gionakis, N.; Sarantou, E.			Comprehensive care for migrants and refugees who have suffered torture and other forms of ill-treatment - the MSF experience in Athens	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kotsioni, I.; Kastrissianaki, A.; Haziri, I.; Papachristou, A.; Kokkiniotis, M.; Zerva, E.; Vallianou, A.; Zamatto, F.; Van den Bergh, R.] Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium; [Gionakis, N.] Day Ctr BABEL, Athens, Greece; [Sarantou, E.] Greek Council Refugees, Athens, Greece								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7S2.5	94	94						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900219					2019-03-26
J	Natama, HM; Rovira-Vallbona, E; Sorgho, H; Some, MA; Coulibaly-Traore, M; Schallig, HDFH; D'Alessandro, U; Kestens, L; Tinto, H; Rosanas-Urgell, A				Natama, H. M.; Rovira-Vallbona, E.; Sorgho, H.; Some, M. A.; Coulibaly-Traore, M.; Schallig, H. D. F. H.; D'Alessandro, U.; Kestens, L.; Tinto, H.; Rosanas-Urgell, A.			Malaria in pregnancy preventive treatments may provide additional protection against febrile illnesses during the first year of life	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Natama, H. M.; Sorgho, H.; Some, M. A.; Coulibaly-Traore, M.; Tinto, H.] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Natama, H. M.; Rovira-Vallbona, E.; Kestens, L.; Rosanas-Urgell, A.] Inst Trop Med, Antwerp, Belgium; [Natama, H. M.; Kestens, L.] Univ Antwerp, Antwerp, Belgium; [Schallig, H. D. F. H.] Acad Med Ctr, Amsterdam, Netherlands; [D'Alessandro, U.] MRC Unit, Banjul, Gambia; [Tinto, H.] Ctr Muraz, Bobo Dioulasso, Burkina Faso							Scott S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-340	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.1	94	95						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900220					2019-03-26
J	Rouamba, T; Kpoda, H; Valea, I; Mens, PF; Gomes, M; Tinto, H; Kirakoya-Samadoulougou, F				Rouamba, T.; Kpoda, H.; Valea, I.; Mens, P. F.; Gomes, M.; Tinto, H.; Kirakoya-Samadoulougou, F.			Safety of antimalarial drug use during early pregnancy in Bobo Dioulasso: Examining low birth weight and congenital malformations as potential adverse outcomes	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rouamba, T.; Valea, I.; Tinto, H.] IRSS CRUN, Nanoro, Burkina Faso; [Rouamba, T.; Kirakoya-Samadoulougou, F.] Univ Libre Bruxelles, Ctr Rech Epidemiol Biostat & Rech Clin, Brussels, Belgium; [Kpoda, H.; Valea, I.; Tinto, H.] Ctr Muraz, Dept Clin Res, Bobo Dioulasso, Burkina Faso; [Mens, P. F.] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Gomes, M.] World Hlth Org WHO TDR, Geneva, Switzerland								0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.2	95	95						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900221					2019-03-26
J	Bahizire, E; Tugirimana, PL; Dramaix, M; Zozo, D; Bahati, M; Mwale, A; Meuris, S; Donnen, P				Bahizire, E.; Tugirimana, P. L.; Dramaix, M.; Zozo, D.; Bahati, M.; Mwale, A.; Meuris, S.; Donnen, P.			Malaria is more prevalent than iron deficiency among anemic pregnant women at the first antenatal visit in rural South-Kivu	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bahizire, E.; Zozo, D.] Ctr Rech Sci Nat Lwiro, Bukavu, DEM REP CONGO; [Bahizire, E.; Dramaix, M.; Donnen, P.] Univ Libre Bruxelles, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium; [Bahizire, E.; Mwale, A.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Tugirimana, P. L.] Natl Univ Rwanda, Dept Biol Clin, Kigali, Rwanda; [Tugirimana, P. L.] Univ Goma, Fac Med, Goma, DEM REP CONGO; [Bahati, M.] Div Prov Sante Sud Kivu, Bukavu, DEM REP CONGO; [Meuris, S.] Univ Libre Bruxelles, Lab Expt Hormonol, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.5	96	96						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900224					2019-03-26
J	Ruizendaal, E; Schallig, HDFH; Traore, M; Lompo, P; Magloire, NH; Traore, O; Valea, I; Pagnoni, F; Dierickx, S; Scott, S; Bradley, J; d'Alessandro, U; Tinto, H; Mens, PF				Ruizendaal, E.; Schallig, H. D. F. H.; Traore, M.; Lompo, P.; Magloire, N. H.; Traore, O.; Valea, I.; Pagnoni, F.; Dierickx, S.; Scott, S.; Bradley, J.; d'Alessandro, U.; Tinto, H.; Mens, P. F.			Malaria screening during pregnancy with RDTs performed by community health workers in Nanoro, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ruizendaal, E.; Schallig, H. D. F. H.; Mens, P. F.] Acad Med Ctr, Parasitol Unit, Dept Med Microbiol, Amsterdam, Netherlands; [Traore, M.; Lompo, P.; Magloire, N. H.; Traore, O.; Valea, I.; Tinto, H.] IRSS URCN, Nanoro, Burkina Faso; [Pagnoni, F.] WHO TDR, Geneva, Switzerland; [Dierickx, S.] Inst Trop Med, Antwerp, Belgium; [Scott, S.; d'Alessandro, U.] MRC, Banjul, Senegal; [Bradley, J.] London Sch Trop Med & Hyg, London, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.4	96	96						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900223					2019-03-26
J	Compaore, A; Gies, S; Brabin, BJ; Tinto, H; Brabin, L				Compaore, A.; Gies, S.; Brabin, B. J.; Tinto, H.; Brabin, L.			A qualitative study of the acceptability of weekly iron supplementation prior to the first pregnancy in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Compaore, A.; Tinto, H.] Inst Res Hlth Sci IRSS URCN, Clin Res Unit, Nanoro, Burkina Faso; [Gies, S.] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gies, S.] Med Mission Inst, Wurzburg, Germany; [Brabin, B. J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Brabin, B. J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Brabin, B. J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Amsterdam, Netherlands; [Brabin, L.] Univ Manchester, Fac Biol Med & Hlth, Inst Canc Sci, Manchester, Lancs, England								0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S2.4	98	98						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900228					2019-03-26
J	Gies, S; Diallo, S; Tinto, H; Brabin, L; Roberts, S; D'Alessandro, U; Brabin, J				Gies, S.; Diallo, S.; Tinto, H.; Brabin, L.; Roberts, S.; D'Alessandro, U.; Brabin, J.			Malaria risk in young children after periconceptional iron supplementation of mothers in rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gies, S.] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gies, S.] Med Mission Inst, Wurzburg, Germany; [Diallo, S.; Tinto, H.] Inst Res Hlth Sci IRSS URCN, Clin Res Unit, Nanoro, Burkina Faso; [Brabin, L.] Univ Manchester, Fac Biol Med & Hlth, Inst Canc Sci, Manchester, Lancs, England; [Roberts, S.] Univ Manchester, Ctr Biostat, Fac Biol Med & Hlth, Manchester, Lancs, England; [D'Alessandro, U.] Med Res Council Unit MRC, Banjul, Gambia; [D'Alessandro, U.] London Sch Hyg & Trop Med, London, England; [Brabin, J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Brabin, J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Brabin, J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Amsterdam, Netherlands								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S2.5	98	98						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900229					2019-03-26
J	Bosmans, M; Gyselinck, K; Van Bastelaere, S; Bossyns, P				Bosmans, M.; Gyselinck, K.; Van Bastelaere, S.; Bossyns, P.			Critical reflections on SRHR policies and law	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bosmans, M.; Gyselinck, K.; Van Bastelaere, S.; Bossyns, P.] BTC Belgian Dev Agcy, Hlth Unit, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.1	99	99						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900231					2019-03-26
J	Mayhew, S; Van Belle, S				Mayhew, S.; Van Belle, S.			Evaluating DANIDA's global SRHR policy: Tracing accountability pathways at the global policy level	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mayhew, S.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Van Belle, S.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.2	99	100						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900232					2019-03-26
J	Degomme, O; Michielsen, K; Van Braeckel, D				Degomme, O.; Michielsen, K.; Van Braeckel, D.			Academic network for sexual and reproductive health and rights policy (ANSER)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Degomme, O.; Michielsen, K.; Van Braeckel, D.] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.4	100	101						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900234					2019-03-26
J	Van de Voorde, W; Blondeel, K				Van de Voorde, W.; Blondeel, K.		Working Grp Sexual Reprod Hlth; Belgian Platform Int Hlth	Body & Rights - E-learning on sexual and reproductive health and rights for stakeholders of development cooperation	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van de Voorde, W.] Flemish Expertise Ctr Sexual Hlth, Sensoa, Antwerp, Belgium; [Blondeel, K.] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium							[Anonymous], 2013, DEV COOP; FAO, 2011, E LEARN METH GUID DE; Fee K, 2009, DELIVERING E LEARNIN	3	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.3	100	100						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900233					2019-03-26
J	Dossou, JP; Kanhonou, L; Bello, K; Goufodji, S				Dossou, J. P.; Kanhonou, L.; Bello, K.; Goufodji, S.			Addressing unsafe abortion in Benin: why is the current policy inappropriate?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dossou, J. P.; Kanhonou, L.; Bello, K.; Goufodji, S.] Res Ctr Human Reprod & Demog, Dept Publ Hlth, Cotonou, Benin; [Dossou, J. P.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.5	101	101						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900235					2019-03-26
J	Zewolde, S; Florquin, S; Bos, M; Dubourg, D; Richard, F; O'Neill, S				Zewolde, S.; Florquin, S.; Bos, M.; Dubourg, D.; Richard, F.; O'Neill, S.			"Never trust an open door"" - Controversies of sexual pleasure, pain and female genital mutilation among African migrants in Belgium, the Netherlands and the UK	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Zewolde, S.] UCL IOE, London, England; [Zewolde, S.] FORWARD, London, England; [Florquin, S.; Richard, F.] GAMS Belgique, Brussels, Belgium; [Florquin, S.] HIMILO Fdn, Amsterdam, Netherlands; [Dubourg, D.] Observ Wallon Sante, Antwerp, Belgium; [O'Neill, S.] ITM, Dept Publ Hlth, Antwerp, Belgium								0	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S4.4	102	103						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900239					2019-03-26	
J	Van Malderen, C; Amouzou, A; Masquelier, B; Van Oyen, H; Speybroeck, N				Van Malderen, C.; Amouzou, A.; Masquelier, B.; Van Oyen, H.; Speybroeck, N.			Country-specific pathways from socioeconomic determinants to under-five mortality in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Malderen, C.; Speybroeck, N.] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Amouzou, A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Masquelier, B.] Catholic Univ Louvain, Ctr Rech Demog, Louvain La Neuve, Belgium; [Van Oyen, H.] Sci Inst Publ Hlth, Publ Hlth & Surveillance, Brussels, Belgium; [Van Oyen, H.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S6.3	106	106						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900247					2019-03-26	
J	Hinckel, BCB				Hinckel, B. C. Bremer			Reality versus idealism: was Rutherford right?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hinckel, B. C. Bremer] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Hinckel, B. C. Bremer] Coris BioConcept, Gembloux, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S3.2	111	112						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900260					2019-03-26	
J	Sunyoto, T; Potet, J; Picado, A; Boelaert, M				Sunyoto, T.; Potet, J.; Picado, A.; Boelaert, M.			Access to leishmaniasis care - bridging research and humanitarian needs: a Euroleish experience	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.; Potet, J.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland; [Picado, A.] ISGlobal, Barcelona, Spain								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S3.1	111	111						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900259					2019-03-26	
J	Hefnawy, A; Cantizani, J; Pena, I; Dujardin, JC; de Muylder, G; Martin, J				Hefnawy, A.; Cantizani, J.; Pena, I.; Dujardin, J. C.; de Muylder, G.; Martin, J.			The challenges and motivations for doing a PhD in a neglected tropical disease	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hefnawy, A.; Dujardin, J. C.; de Muylder, G.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Cantizani, J.; Pena, I.; Martin, J.] GlaxoSmithKline, Dis Developing World, Tres Cantos, Spain								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S3.3	112	112						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900261					2019-03-26	
J	Bannister-Tyrrell, M				Bannister-Tyrrell, M.			Micro-epidemiology of malaria in three villages in a low-transmission setting in north-eastern Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bannister-Tyrrell, M.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S4.2	114	114						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900266					2019-03-26	
J	Sarkar, N				Sarkar, N.			The perceived social aetiologies and solutions of perinatal common mental disorders in rural Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sarkar, N.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S4.4	114	114						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900268					2019-03-26	
J	De Koninck, AS; Cnops, L; Hofmans, M; Jacobs, J; Van den Bossche, D; Philippe, J				De Koninck, A-S.; Cnops, L.; Hofmans, M.; Jacobs, J.; Van den Bossche, D.; Philippe, J.			Diagnostic performance of the Loop-Mediated Isothermal Amplification (LAMP) based illumigene (R) Malaria assay in a non-endemic region	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Koninck, A-S.; Hofmans, M.; Philippe, J.] Ghent Univ Hosp GUH, Dept Lab Med, Ghent, Belgium; [Cnops, L.; Jacobs, J.; Van den Bossche, D.] Inst Trop Med ITM Antwerp, Antwerp, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P3	116	116						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900271					2019-03-26	
J	Hefnawy, A; Cantizani, J; Pena, I; Dujardin, JC; de Muylder, G; Martin, J				Hefnawy, A.; Cantizani, J.; Pena, I.; Dujardin, J. C.; de Muylder, G.; Martin, J.			Evaluation of the leishbox compounds on nepalese clinical isolates of Leishmania donovani, an industrial/academic collaboration	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hefnawy, A.; Dujardin, J. C.; de Muylder, G.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Cantizani, J.; Pena, I.; Martin, J.] GlaxoSmithKline, Dis Developing World, Tres Cantos, Spain					European Union's H2020 Programme under the MSCA GA [642609]	This research is funded by the European Union's H2020 Programme under the MSCA GA no 642609.	Hefnawy A, 2017, TRENDS PARASITOL, V33, P162, DOI 10.1016/j.pt.2016.11.003; Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771	2	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P5	116	117						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900273					2019-03-26	
J	Lanko, K; Kaptein, S; Eggermont, K; Patel, A; Claes, C; Guo, W; Van Damme, P; Van den Bosch, L; Delang, L; Verfaillie, C; Neyts, J				Lanko, K.; Kaptein, S.; Eggermont, K.; Patel, A.; Claes, C.; Guo, W.; Van Damme, P.; Van den Bosch, L.; Delang, L.; Verfaillie, C.; Neyts, J.			Induced pluripotent stem cell-derived neuronal cultures as a model to study ZIKA virus infections and antivirals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lanko, K.; Kaptein, S.; Delang, L.; Neyts, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Eggermont, K.; Patel, A.; Claes, C.; Verfaillie, C.] Katholieke Univ Leuven, Stem Cell Inst, Leuven, Belgium; [Guo, W.; Van Damme, P.; Van den Bosch, L.] Katholieke Univ Leuven, Lab Neurobiol, Leuven, Belgium			Lanko, Kristina/D-9579-2018; Neyts, Johan/U-8267-2017; Delang, Leen/D-9548-2018	Lanko, Kristina/0000-0002-0749-0079; Neyts, Johan/0000-0002-0033-7514; Delang, Leen/0000-0002-8874-675X				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P8	117	118						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900276					2019-03-26	
J	Tricot, T; Helsen, N; Kaptein, S; Neyts, J; Verfaillie, C				Tricot, T.; Helsen, N.; Kaptein, S.; Neyts, J.; Verfaillie, C.			Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess efficacy of potential antivirals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tricot, T.; Helsen, N.; Verfaillie, C.] Katholieke Univ Leuven, Stem Cell Inst, Dept Dev & Regenerat, Leuven, Belgium; [Kaptein, S.; Neyts, J.] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Expt Chemotherapy, Leuven, Belgium			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P6	117	117						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900274					2019-03-26	
J	Vlaminck, J; Dana, D; Demeyer, L; Mekonnen, Z; Weil, GJ; Geldhof, P; Levecke, B				Vlaminck, J.; Dana, D.; Demeyer, L.; Mekonnen, Z.; Weil, G. J.; Geldhof, P.; Levecke, B.			An immunomics approach detects promising candidate antigens for Ascaris serodiagnosis in pigs and humans	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vlaminck, J.; Dana, D.; Demeyer, L.; Geldhof, P.; Levecke, B.] Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Dana, D.; Mekonnen, Z.] Jimma Univ, Lab Parasitol, Jimma, Ethiopia; [Weil, G. J.] Washington Univ, Dept Internal Med, Div Infect Dis, St Louis, MO USA								0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P9	118	118						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900277					2019-03-26	
J	Hoekstra, PT; Madinga, J; Lutumba, P; Corstjens, PLAM; van Dam, GJ; Polman, K; van Lieshout, L				Hoekstra, P. T.; Madinga, J.; Lutumba, P.; Corstjens, P. L. A. M.; van Dam, G. J.; Polman, K.; van Lieshout, L.			Diagnosis of schistosomiasis without a microscope: a community-based survey using PCR and CCA-CAA detection on banked stool and urine samples from Dr Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hoekstra, P. T.; van Dam, G. J.; van Lieshout, L.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Madinga, J.] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium; [Madinga, J.; Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Corstjens, P. L. A. M.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P17	121	121						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900285					2019-03-26	
J	Van den Bossche, D; Foque, N; Michiels, J; Arien, KK; Van Esbroeck, M				Van den Bossche, D.; Foque, N.; Michiels, J.; Arien, K. K.; Van Esbroeck, M.			Can a ZIKA IGM and IGG immunoblot replace the virus neutralisation test to confirm screening test results?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Bossche, D.; Foque, N.; Van Esbroeck, M.] Inst Trop Med, Dept Clin Sci, Natl Reference Ctr Arboviruses, Antwerp, Belgium; [Michiels, J.; Arien, K. K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P18	122	122						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900286					2019-03-26	
J	Braet, S; Vandelannoote, K; Meehan, C; Rigouts, L; Fontes, AB; Rosa, P; Suffys, P; De Jong, B				Braet, S.; Vandelannoote, K.; Meehan, C.; Rigouts, L.; Fontes, A. Brum; Rosa, P.; Suffys, P.; De Jong, B.			Analysis of the specificity of a Mycobacterium leprae diagnostic qPCR	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Braet, S.; Vandelannoote, K.; Meehan, C.; Rigouts, L.; De Jong, B.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Fontes, A. Brum; Suffys, P.] Oswaldo Cruz Inst, Rio De Janeiro, Brazil; [Rosa, P.] Inst Lauro de Souza Lima, Bauru, Brazil							Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09	1	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P20	123	123						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900288					2019-03-26	
J	Morales-Yanez, FJ; Sariego, I; De Wael, K; Polman, K; Muylermans, S; Trashin, S				Morales-Yanez, F. J.; Sariego, I.; De Wael, K.; Polman, K.; Muylermans, S.; Trashin, S.			Development of a nanobody-based amperometric immunocapturing assay for sensitive and specific detection of Toxocara canis excretory-secretory antigen	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Morales-Yanez, F. J.; Muylermans, S.] Vrije Univ Brussel, Lab Mol & Cellular Immunol CMIM, Brussels, Belgium; [Morales-Yanez, F. J.; Polman, K.] Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Sariego, I.] Inst Med Trop Pedro Kouri, Dept Parasitol, Havana, Cuba; [De Wael, K.; Trashin, S.] Univ Antwerp, Dept Chem, Antwerp, Belgium			De Wael, Karolien/U-5545-2018					0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P21	123	123						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900289					2019-03-26	
J	Rutanga, JP; Van Puyvelde, S; De Block, T; Jacobs, J; Muvunyi, CM; Deborggraeve, S				Rutanga, J. P.; Van Puyvelde, S.; De Block, T.; Jacobs, J.; Muvunyi, C. M.; Deborggraeve, S.			Optimization of the PAXgene Blood RNA system to store Salmonella cells for subsequent RNA analysis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rutanga, J. P.] Univ Rwanda, Coll Sci & Technol, Kigali, Rwanda; [Rutanga, J. P.; Van Puyvelde, S.; De Block, T.; Deborggraeve, S.] Inst Trop Med, Dept Biomed Sci, Unit Diagnost Bacteriol, Antwerp, Belgium; [Rutanga, J. P.; Jacobs, J.] Katholieke Univ Leuven, Microbiol & Immunol, Biomed Sci, Leuven, Belgium; [Jacobs, J.] Inst Trop Med, Dept Clin Sci, Unit Trop Lab Med, Antwerp, Belgium; [Muvunyi, C. M.] Univ Rwanda, Coll Med & Hlth Sci, Kigali, Rwanda								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P24	124	125						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900292					2019-03-26	
J	Sariego, I; Rojas, L; Cantillo, J; Falcon, R; Polman, K				Sariego, I.; Rojas, L.; Cantillo, J.; Falcon, R.; Polman, K.			Usefulness of TOXOCARA CANIS larval low molecular weight excretory-secretory products for diagnosis of human toxocariasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sariego, I.; Rojas, L.] Inst Trop Med Pedro Kouri, Dept Parasitol, Havana, Cuba; [Cantillo, J.] Inst Trop Med Pedro Kouri, Anim House, Havana, Cuba; [Falcon, R.] Inst Trop Med Pedro Kouri, Bacteriol Mycol Dept, Havana, Cuba; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P26	125	125						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900294					2019-03-26	
J	Nakiwala, JK; Walker, NF; Diedrich, CR; Meintjes, G; Wilkinson, RJ; Mayanja-Kizza, H; Colebunders, R; Kestens, L; Wilkinson, KA; Lowe, DM				Nakiwala, J. K.; Walker, N. F.; Diedrich, C. R.; Meintjes, G.; Wilkinson, R. J.; Mayanja-Kizza, H.; Colebunders, R.; Kestens, L.; Wilkinson, K. A.; Lowe, D. M.			Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Nakiwala, J. K.; Walker, N. F.; Diedrich, C. R.; Meintjes, G.; Wilkinson, R. J.; Wilkinson, K. A.; Lowe, D. M.] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Nakiwala, J. K.; Walker, N. F.; Diedrich, C. R.; Meintjes, G.; Wilkinson, R. J.; Wilkinson, K. A.; Lowe, D. M.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Nakiwala, J. K.; Colebunders, R.; Kestens, L.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Nakiwala, J. K.; Kestens, L.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Walker, N. F.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Diedrich, C. R.] Univ Pittsburgh, Childrens Hosp, UPMC, Pediat,Div Infect Dis, Pittsburgh, PA 15260 USA; [Meintjes, G.; Wilkinson, R. J.; Lowe, D. M.] Imperial Coll London, Dept Med, London, England; [Wilkinson, R. J.; Wilkinson, K. A.] Francis Crick Inst, London, England; [Mayanja-Kizza, H.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Lowe, D. M.] UCL, Inst Immun & Transplantat, Royal Free Campus, London, England								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P28	126	126						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900296					2019-03-26	
J	Adriaensen, W; Diro, E; Abdellati, S; Gedamu, Y; Mengesha, B; Adem, E; Vogt, F; van Henten, S; Kestens, L; Van Griensven, J				Adriaensen, W.; Diro, E.; Abdellati, S.; Gedamu, Y.; Mengesha, B.; Adem, E.; Vogt, F.; van Henten, S.; Kestens, L.; Van Griensven, J.			Low levels of soluble CD40 ligand in asymptomatic leishmania donovani co-infected HIV patients	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adriaensen, W.; Abdellati, S.; Vogt, F.; van Henten, S.; Van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Diro, E.; Gedamu, Y.; Mengesha, B.; Adem, E.] Univ Gondar, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Kestens, L.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P30	127	127						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900298					2019-03-26	
J	Cisse, M; Awandare, GA; Soulama, A; Tinto, H; Hayette, MP; Guiguemde, RT				Cisse, M.; Awandare, G. A.; Soulama, A.; Tinto, H.; Hayette, M. P.; Guiguemde, R. T.			Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine- pyrimethamine is associated with selection of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cisse, M.; Soulama, A.; Guiguemde, R. T.] Ctr MURAZ, Lab Parasitol & Entomol, Bobo Dioulasso, Burkina Faso; [Cisse, M.] Univ Polytech Bobo Dioulasso, Lab Parasitol & Mycol, Bobo Dioulasso, Burkina Faso; [Awandare, G. A.] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana; [Tinto, H.] Ctr MURAZ, Dept Clin Res, Bobo Dioulasso, Burkina Faso; [Hayette, M. P.] Univ Hosp Liege, Lab Clin Microbiol, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P36	130	130						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900304					2019-03-26	
J	Soulama, A; Cisse, M; Awandare, AG; Hayette, MP; Guiguemde, TR				Soulama, A.; Cisse, M.; Awandare, A. G.; Hayette, M-P.; Guiguemde, T. R.			High prevalence of Pfdhfr and Pfdhps genes mutations in pregnant women in Bobo-Dioulasso, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Soulama, A.; Cisse, M.; Guiguemde, T. R.] Ctr MURAZ, Bobo Dioulasso, Burkina Faso; [Cisse, M.; Guiguemde, T. R.] Univ Nazi Boni Bobo Dioulasso, Inst Super Sci Sante, Bobo Dioulasso, Burkina Faso; [Awandare, A. G.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Accra, Ghana; [Hayette, M-P.] Ctr Hosp Univ Liege, Lab Microbiol Clin, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P39	131	131						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900307					2019-03-26	
J	Baraka, V; Hansson, H; Mavoko, HM; Nabasumba, C; Francis, F; Lutumba, P; Alifrangis, M; Geertruyden, JPV				Baraka, V.; Hansson, H.; Mavoko, H. M.; Nabasumba, C.; Francis, F.; Lutumba, P.; Alifrangis, M.; Geertruyden, J-P. V.			Pharmacogenetic profile of P450 2B6, 2C8 and 3A4 genetic variants and the clinical association with malaria recurrent infections in DR Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baraka, V.; Francis, F.] Tanga Res Ctr, Natl Inst Med Res, POB 5004, Tanga, Tanzania; [Baraka, V.; Mavoko, H. M.; Nabasumba, C.; Geertruyden, J-P. V.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Hansson, H.; Alifrangis, M.] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Hansson, H.; Alifrangis, M.] Rigshosp, Natl Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Mavoko, H. M.; Lutumba, P.] Univ Kinshasa, Fac Med, Dept Med Trop, BP 747 Kin 11, Kinshasa, DEM REP CONGO; [Nabasumba, C.] Epictr Mbarara Res Base, POB 930, Mbarara, Uganda								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P44	133	133						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900312					2019-03-26	
J	Cuypers, WL; Dougan, G; Jacobs, J; Laukens, K; Deborggraeve, S; Van Puyvelde, S				Cuypers, W. L.; Dougan, G.; Jacobs, J.; Laukens, K.; Deborggraeve, S.; Van Puyvelde, S.			First genome of Salmonella concord, a highly resistant and virulent salmonella serotype in the Horn of Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							CHILDREN		[Cuypers, W. L.; Deborggraeve, S.; Van Puyvelde, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dougan, G.] Wellcome Trust Sanger Inst, Microbial Pathogenesis, Hinxton Cambridge, England; [Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Laukens, K.] Univ Antwerp, Dept Math & Comp Sci, Antwerp, Belgium				Cuypers, Wim/0000-0002-1895-3526			Fabre L, 2009, ANTIMICROB AGENTS CH, V53, P1808, DOI 10.1128/AAC.00451-08; Hendriksen RS, 2009, PEDIATR INFECT DIS J, V28, P814, DOI 10.1097/INF.0b013e3181a3aeac	2	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P50	135	136						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900318					2019-03-26	
J	Sun, L; Tijsma, A; Thibaut, HJ; Mirabelli, C; Delang, L; Neyts, J				Sun, L.; Tijsma, A.; Thibaut, H. J.; Mirabelli, C.; Delang, L.; Neyts, J.			The establishment of an Enterovirus 71 (EV71) infection model with robust lethal neuro-pathogenicity in adult mice	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sun, L.; Tijsma, A.; Thibaut, H. J.; Mirabelli, C.; Delang, L.; Neyts, J.] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium			Delang, Leen/D-9548-2018; Mirabelli, Carmen/D-9441-2018; Thibaut, Hendrik Jan/D-9505-2018; Neyts, Johan/U-8267-2017	Delang, Leen/0000-0002-8874-675X; Mirabelli, Carmen/0000-0002-4785-5482; Thibaut, Hendrik Jan/0000-0001-5785-8276; Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P55	138	138						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900323					2019-03-26	
J	Willen, L; Mertens, P; Volf, P				Willen, L.; Mertens, P.; Volf, P.			Preparation of colloidal gold immunochromatigraphic test to detect dog exposure to Phlebotomus Perniciosus in endemic settings of canine Leishmaniasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Willen, L.; Volf, P.] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Mertens, P.] Coris BioConcept, Crealys Pk, Gembloux, Belgium			Volf, Petr/C-4300-2012; Willen, Laura/B-2977-2018	Volf, Petr/0000-0003-1790-1123; Willen, Laura/0000-0002-8027-8621				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P66	142	142						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900334					2019-03-26	
J	Vinueza, C; De Zutter, L				Vinueza, C.; De Zutter, L.			Important foodborne bacteria and their antimicrobial resistances in Ecuadorian poultry	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vinueza, C.] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [De Zutter, L.] Univ Ghent, Fac Vet, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium							Vinueza C., 2016, PLOS ONE, V11, P1; Vinueza-Burgos C, 2017, ECUADORIAN BROILERS, P1	2	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P4	144	144						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900338					2019-03-26	
J	Johansen, MV; Braae, UC; Trevisan, C; Lekule, F; Magnussen, P; Ngowi, H				Johansen, M. V.; Braae, U. C.; Trevisan, C.; Lekule, F.; Magnussen, P.; Ngowi, H.			A one health approach to Taenia Solium control in subSaharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Johansen, M. V.; Magnussen, P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark; [Braae, U. C.] Ross Univ, One Hlth Ctr Zoonoses & Trop Vet Med, Sch Vet Med, Basseterre, St Kitts & Nevi; [Trevisan, C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Lekule, F.] Sokoine Univ Agr, Fac Agr, Morogoro, Tanzania; [Magnussen, P.] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Ngowi, H.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania				Magnussen, Pascal/0000-0001-7372-0250				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P6	145	145						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900340					2019-03-26	
J	Trevisan, C; Fevre, EM; Owinyi, M; Ngere, I; Johansen, MV				Trevisan, C.; Fevre, E. M.; Owinyi, M.; Ngere, I.; Johansen, M. V.			Minyoo Matata - The Vicious Worm - A Taenia Solium taeniosis/cysticercosis health education tool - in Swahili	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Trevisan, C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Fevre, E. M.; Owinyi, M.; Ngere, I.] Int Livestock Res Inst, Nairobi, Kenya; [Fevre, E. M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Owinyi, M.; Ngere, I.] Kenya Field Epidemiol & Lab Training Programme, Nairobi, Kenya; [Johansen, M. V.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P7	145	145						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900341					2019-03-26	
J	Chamlagain, D; Aryal, A; Pokhrel, KN; Poudel, KN; Kattel, B; Kakkar, M; Thys, S; Jiang, L; Agrawal, Y; Kattel, V				Chamlagain, D.; Aryal, A.; Pokhrel, K. N.; Poudel, K. N.; Kattel, B.; Kakkar, M.; Thys, S.; Jiang, L.; Agrawal, Y.; Kattel, V.			Gaps in the control of zoonoses In Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Chamlagain, D.] Minist Hlth, Dept Hlth Serv, Kathmandu, Nepal; [Aryal, A.] Cent Vet Hosp, Dept Livestock Dev, Kathmandu, Nepal; [Pokhrel, K. N.] UN, Populat Funds, Sunsari, Nepal; [Poudel, K. N.] Mid Western Reg Hosp, Dept Internal Med, Surkhet, Nepal; [Kattel, B.] Cent Collage Technol, Dept Food Engn, Dharan, Nepal; [Kakkar, M.] Publ Hlth Fdn India, Delhi, India; [Thys, S.; Jiang, L.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Agrawal, Y.; Kattel, V.] BPKIHS, Dept Internal Med, Dharan, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P10	146	147						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900344					2019-03-26	
J	Jansen, F; Dorny, P; Makay, C; van den Broeck, N; Berkvens, D; Gabrie, S				Jansen, F.; Dorny, P.; Makay, C.; van den Broeck, N.; Berkvens, D.; Gabrie, S.			Evaluation of post-mortem detection techniques for bovine cysticercosis in Belgium	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jansen, F.; Dorny, P.; Makay, C.; van den Broeck, N.; Berkvens, D.; Gabrie, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabrie, S.] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P20	150	151						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900354					2019-03-26	
J	Manzambi, E; Ilombe, G; Mampangulu, T; Madinga, J; Likwela, J; Lutumba, P; Van Geertruyden, JP; Seth, I; Muyembe, JJ; Wat'senga, TF				Manzambi, E.; Ilombe, G.; Mampangulu, T.; Madinga, J.; Likwela, J.; Lutumba, P.; Van Geertruyden, J. P.; Seth, I.; Muyembe, J. J.; Wat'senga, T. F.			Anopheles mosquitoes and transmission of malaria in the mountainous region of Rutshuru, in eastern Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Manzambi, E.; Ilombe, G.; Mampangulu, T.; Muyembe, J. J.; Wat'senga, T. F.] Inst Natl Rech Biomed, Dept Ecol Vectorielle & Environm, Kinshasa, DEM REP CONGO; [Madinga, J.] Univ Kinshasa, Dept Parasitol, Fac Med, Kinshasa, DEM REP CONGO; [Likwela, J.] Programme Natl Lutte Paludisme, Kinshasa, DEM REP CONGO; [Lutumba, P.] Inst Natl Rech Biomed, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Seth, I.] Ctr Dis Control & Prevent, Entomol Branch, Atlanta, GA USA; [Van Geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P31	155	155						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900365					2019-03-26	
J	Theodorakos, K; Broeckhove, J; Willem, L				Theodorakos, K.; Broeckhove, J.; Willem, L.			Examination of influencing factors and high-risk regions of dengue In Nicaragua, using spatiotemporal compartmental simulations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Theodorakos, K.; Broeckhove, J.] Univ Antwerp, Dept Math & Comp Sci, Modeling Syst & Internet Commun, Antwerp, Belgium; [Willem, L.] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P35	156	157						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900369					2019-03-26	
J	Falay, D; Peeters, M; Tanzito, J; Akaibe, D; Lunguya, O; Matheus, W; Bertrand, S; Van Geet, C; Ngbonda, D; Jacobs, J				Falay, D.; Peeters, M.; Tanzito, J.; Akaibe, D.; Lunguya, O.; Matheus, W.; Bertrand, S.; Van Geet, C.; Ngbonda, D.; Jacobs, J.			Rats as a potential reservoir of invasive non-Typhi Salmonella: a field study in Kisangani, Province of Tshopo, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Falay, D.; Ngbonda, D.] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Peeters, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Tanzito, J.; Akaibe, D.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Lunguya, O.] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Matheus, W.; Bertrand, S.] Belgian Natl Ctr Salmonella, Sci Inst Publ Hlth, Brussels, Belgium; [Van Geet, C.] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Med & Pediat, Leuven, Belgium; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P40	159	159						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900374					2019-03-26	
J	Sungirai, M; Moyo, DZ; De Clercq, P; Madder, M				Sungirai, M.; Moyo, D. Z.; De Clercq, P.; Madder, M.			Expansion in the distributional range of ixodid ticks parasitising cattle in Zimbabwe	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sungirai, M.] Midlands State Univ, Dept Livestock & Wildlife Management, Gweru, Zimbabwe; [Moyo, D. Z.] Midlands State Univ, Dept Biol Sci, Gweru, Zimbabwe; [De Clercq, P.] Univ Ghent, Dept Crop Protect, Ghent, Belgium; [Madder, M.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa			De Clercq, Patrick/B-5721-2015	De Clercq, Patrick/0000-0003-0664-1602				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P46	162	162						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900380					2019-03-26	
J	Ilombe, G; Metelo, E; Binene, G; Tona, G; Maniania, J; Nagahuedi, J; Muyembe, JJ; Masiangi, P; Van Greertruyden, JP; Wondji, C				Ilombe, G.; Metelo, E.; Binene, G.; Tona, G.; Maniania, J.; Nagahuedi, J.; Muyembe, J. J.; Masiangi, P.; Van Greertruyden, J. P.; Wondji, C.			Status of insecticide resistance of Anopheles populations and identification of resistance mechanisms in Kwilu Province in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ilombe, G.; Metelo, E.; Binene, G.; Muyembe, J. J.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Ilombe, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol Unit, Kinshasa, DEM REP CONGO; [Metelo, E.] Univ Bandundu, Fac Med, Bandundu, DEM REP CONGO; [Maniania, J.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Nagahuedi, J.] Univ Kinshasa, Fac Sci, Kinshasa, DEM REP CONGO; [Muyembe, J. J.; Masiangi, P.] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Van Greertruyden, J. P.] Antwerp Univ, Fac Med, Int Hlth Epidemiol & Social Med, Antwerp, Belgium; [Wondji, C.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P49	163	163						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900383					2019-03-26	
J	Hendy, A; Sluydts, V; Tushar, T; De Witte, J; Odonga, P; Lakwo, T; Dujardin, JC; Post, RJ; Kalinga, A; Echodu, R				Hendy, A.; Sluydts, V.; Tushar, T.; De Witte, J.; Odonga, P.; Lakwo, T.; Dujardin, J. C.; Post, R. J.; Kalinga, A.; Echodu, R.			Esperanza window traps for the collection of anthropophilic blackflies (Diptera: Simuliidae) in Uganda and Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hendy, A.; De Witte, J.; Dujardin, J. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, V.] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Antwerp, Belgium; [Tushar, T.; Post, R. J.] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Odonga, P.; Lakwo, T.] Minist Hlth, Vector Control Div, Kampala, Uganda; [Post, R. J.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Kalinga, A.] Natl Inst Med Res, Tukuyu Res Ctr, Tukuyu, Tanzania; [Echodu, R.] Gulu Univ, Fac Sci, Gulu, Uganda								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P51	164	164						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900385					2019-03-26	
J	Huyse, T; Boon, N; Smitz, N; De Sciscio, A; Kanage, B; Polman, K; Volckaert, F; Van den Broeck, F				Huyse, T.; Boon, N.; Smitz, N.; De Sciscio, A.; Kanage, B.; Polman, K.; Volckaert, F.; Van den Broeck, F.			Don't overlook the snail: the role of the intermediate snail host in the dynamic epidemiology of schistosomiasis in Northern Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huyse, T.; Boon, N.; Kanage, B.; Volckaert, F.] Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Huyse, T.; Smitz, N.; De Sciscio, A.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium; [Boon, N.; Polman, K.; Van den Broeck, F.] Inst Trop Med, Dept Biomed Sci, Unit Med Helminthol, Antwerp, Belgium								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P57	166	166						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900391					2019-03-26	
J	Adem, E; Auwera, GV; Doleckova, K; Adriaensen, W; Van den Bossche, D; Diro, E; van Griensven, J; Cnops, L				Adem, E.; Auwera, G. Vander; Doleckova, K.; Adriaensen, W.; Van den Bossche, D.; Diro, E.; van Griensven, J.; Cnops, L.			Optimization of the Dna extraction and real-time PCR for low parasitemia Leishmania Infections	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adem, E.; Diro, E.] Univ Gondar Hosp, Gondar, Ethiopia; [Auwera, G. Vander] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Doleckova, K.; Adriaensen, W.; Van den Bossche, D.; van Griensven, J.; Cnops, L.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P15	172	172						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900406					2019-03-26	
J	Buscher, P; Mertens, P; Gilleman, Q; Rooney, B; Roge, S				Buscher, P.; Mertens, P.; Gilleman, Q.; Rooney, B.; Roge, S.			rHAT Sero-Strip, a new rapid diagnostic test for gambiense sleeping sickness using recombinant antigens	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Buscher, P.; Roge, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Mertens, P.; Gilleman, Q.] Coris BioConcept, Gembloux, Belgium; [Rooney, B.] Univ Kent, Canterbury, Kent, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P14	172	172						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900405					2019-03-26	
J	Bennis, I; Verdonck, K; Riyad, M; El Khalfaoui, N; Fellah, H; Sahibi, H; Van der Auwera, G; Dujardin, JC; Boelaert, M				Bennis, I.; Verdonck, K.; Riyad, M.; El Khalfaoui, N.; Fellah, H.; Sahibi, H.; Van der Auwera, G.; Dujardin, J-C.; Boelaert, M.			Accuracy of a rapid test for the diagnosis of cutaneous leishmaniasis in patients with suggestive skin lesions in Morocco	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bennis, I.] Minist Hlth, Natl Sch Publ Hlth, Rabat, Morocco; [Bennis, I.; Verdonck, K.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Bennis, I.; Dujardin, J-C.] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Biomed Sci, Antwerp, Belgium; [Riyad, M.; El Khalfaoui, N.] Univ Hassan II Casablanca, Lab Parasitol, Casablanca, Morocco; [Riyad, M.; El Khalfaoui, N.] Univ Hassan II Casablanca, Fac Med & Pharm, Res Team Immunopathol Infect & Syst Dis, Casablanca, Morocco; [Fellah, H.] Natl Inst Hlth, Lab Leishmaniasis, Rabat, Morocco; [Sahibi, H.] Hassan II Agron & Vet Inst, Dept Parasitol, Rabat, Morocco; [Van der Auwera, G.; Dujardin, J-C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P17	173	173						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900408					2019-03-26	
J	Peeters, M; Chung, P; Lin, H; Mortelmans, K; Phe, C; San, C; Kuijpers, L; Teav, S; Phe, T; Jacobs, J				Peeters, M.; Chung, P.; Lin, H.; Mortelmans, K.; Phe, C.; San, C.; Kuijpers, L.; Teav, S.; Phe, T.; Jacobs, J.			Diagnostic performance of the InBiOS rapid diagnostic test for the detection of Burkholderia pseudomallei in blood culture broth: results of a phase II evaluation study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Peeters, M.; Kuijpers, L.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Chung, P.; Phe, C.; San, C.; Teav, S.; Phe, T.] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lin, H.; Mortelmans, K.] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P19	174	174						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900410					2019-03-26	
J	Cox, JA; Jacobs, J; Vlieghe, E				Cox, J. A.; Jacobs, J.; Vlieghe, E.			Antibiotic stewardship programs in hospitals in low-and middle income countries: current status, priorities and barriers	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cox, J. A.; Jacobs, J.] Inst Trop Med, Unit Clin Sci, Antwerp, Belgium; [Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P22	175	176						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900413					2019-03-26	
J	Fofana, HKM; Saye, R; Becker, SL; Landoure, A; Polman, K; Chappuis, F; Boelaert, M; Traore, MS; Utzinger, J; Sacko, M				Fofana, H. K. M.; Saye, R.; Becker, S. L.; Landoure, A.; Polman, K.; Chappuis, F.; Boelaert, M.; Traore, M. S.; Utzinger, J.; Sacko, M.			Diagnostic accuracy of point-of-care circulating cathodic antigen, formalin-ether concentration and Kato-Katz techniques for Schistosoma mansoni infection in Niono, Mali	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Fofana, H. K. M.; Saye, R.; Landoure, A.; Traore, M. S.; Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Saye, R.; Becker, S. L.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Saye, R.; Becker, S. L.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P20	175	175						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900411					2019-03-26	
J	Diallo, S; Gies, S; Ki, A; Pagbelguem, JG; Tinto, H; Ouedraogo, GA; Brabin, BJ				Diallo, S.; Gies, S.; Ki, A.; Pagbelguem, J. G.; Tinto, H.; Ouedraogo, G. A.; Brabin, B. J.			Cross-sectional analysis in young non-pregnant and pregnant women in Burkina Faso of associations between biomarkers of iron status and effect modification by inflammation and P. falciparum infection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Diallo, S.; Ki, A.; Pagbelguem, J. G.; Tinto, H.] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Gies, S.] Inst Trop Med, Antwerp, Belgium; [Gies, S.] Med Mission Inst, Wurzburg, Germany; [Brabin, B. J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Ouedraogo, G. A.] Univ Polytech Bobo Dioulasso, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P29	178	179						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900420					2019-03-26	
J	Michel, K; Laudisoit, A; Tepage, F; Mandro, M; Levick, B; Suykerbuyk, P; Nicaise, AD; Tagoto, A; Falay, D; Colebunders, R				Michel, K.; Laudisoit, A.; Tepage, F.; Mandro, M.; Levick, B.; Suykerbuyk, P.; Nicaise, A. Drazo; Tagoto, A.; Falay, D.; Colebunders, R.			Onchocerciasis associated epilepsy and blackflies in the Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Michel, K.] Univ Kisangani, Fac Sci, Biodivers Monitoring Ctr, Kisangani, DEM REP CONGO; [Michel, K.; Nicaise, A. Drazo] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Laudisoit, A.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Laudisoit, A.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Evolutionary Biol Grp, Antwerp, Belgium; [Tepage, F.] Minist Hlth, Natl Onchocerciasis Control Program PNLO, Kinshasa, DEM REP CONGO; [Mandro, M.] Minist Hlth, Ituri Prov Hlth Div, Kinshasa, DEM REP CONGO; [Levick, B.] Univ Liverpool, Inst Integrat Biol, Sch Biol Sci, Liverpool, Merseyside, England; [Tagoto, A.] Minist Hlth, Natl HIV Program, Kinshasa, DEM REP CONGO; [Falay, D.] Univ Kisangani, Dept Pediat, Fac Med, Kisangani, DEM REP CONGO								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P31	179	180						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900422					2019-03-26	
J	Sow, MS; Versporten, A; Goossens, H; Sylla, AO				Sow, M. S.; Versporten, A.; Goossens, H.; Sylla, A. O.			The Global Point Prevalence Survey of antimicrobial consumption and resistance (Global-PPS): first results of antimicrobial prescribing in a tertiary care hospital in Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sow, M. S.; Sylla, A. O.] CHU Conakry, Hop Natl Donka, Serv Malad Infect, Conakry, Guinea; [Versporten, A.; Goossens, H.] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P30	179	179						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900421					2019-03-26	
J	Bottieau, E; Mukendi, D; Barbe, B; Yansouni, CP; Dorny, P; Gabriel, S; Winkler, AS; Lutumba, P; Chappuis, F; Boelaert, M				Bottieau, E.; Mukendi, D.; Barbe, B.; Yansouni, C. P.; Dorny, P.; Gabriel, S.; Winkler, A. S.; Lutumba, P.; Chappuis, F.; Boelaert, M.			Frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Province of Kwilu, the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bottieau, E.; Barbe, B.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Mukendi, D.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mukendi, D.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Yansouni, C. P.] McGill Univ, Ctr Hlth, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Dorny, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabriel, S.] Univ Ghent, Dept Vet Publ Hlth, Ghent, Belgium; [Winkler, A. S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkler, A. S.] Univ Oslo, Ctr Global Hlth, Oslo, Norway; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P33	180	180						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900424					2019-03-26	
J	Clerinx, J; Maniewski, U; Cnops, L; Soentjens, P; Van Esbroeck, M; Bottieau, E				Clerinx, J.; Maniewski, U.; Cnops, L.; Soentjens, P.; Van Esbroeck, M.; Bottieau, E.			Treatment issues with acute schistosomiasis in a cluster cohort of 34 travelers infected in South Africa - an observational study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Clerinx, J.; Maniewski, U.; Cnops, L.; Soentjens, P.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P34	181	181						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900425					2019-03-26	
J	Rouamba, T; Nakanabo, DS; Tarnagda, Z; Derra, K; Kazienga, A; Valea, I; Pagnoni, F; Kirakoya-Samandoulougou, F; Tinto, H				Rouamba, T.; Nakanabo, D. S.; Tarnagda, Z.; Derra, K.; Kazienga, A.; Valea, I.; Pagnoni, F.; Kirakoya-Samandoulougou, F.; Tinto, H.			Incidence of adverse drug reactions resulting from the use of Amodiaquine-Artesunate in Nanoro, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rouamba, T.; Tarnagda, Z.; Derra, K.; Kazienga, A.; Valea, I.; Tinto, H.] IRSS CRUN, Nanoro, Burkina Faso; [Rouamba, T.; Kirakoya-Samandoulougou, F.] Univ Libre Bruxelles, Ctr Rech Epidemiol Biostat & Rech Clin, Ecole Sante Publ, Brussels, Belgium; [Nakanabo, D. S.; Valea, I.; Tinto, H.] Ctr Muraz, Dept Clin Res, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P38	182	182						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900429					2019-03-26	
J	Stassijns, J; Vlieghe, E; Caluwaerts, A; Zolfo, M; Jacobs, J				Stassijns, J.; Vlieghe, E.; Caluwaerts, A.; Zolfo, M.; Jacobs, J.			Antibiotic resistance: the need for interdisciplinary education tailored to low-resource settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Stassijns, J.; Zolfo, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Caluwaerts, A.] Med Sans Frontieres, Dept Med, Operat Ctr Brussels, Brussels, Belgium			Zolfo, Maria/B-9787-2015	Zolfo, Maria/0000-0001-9756-9380				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P37	182	182						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900428					2019-03-26	
J	Abongomera, C; Diro, E; Vogt, F; Tsoumanis, A; Mekonnen, Z; Admassu, H; Colebunders, R; Mohammed, R; Ritmeijer, K; van Griensven, J				Abongomera, C.; Diro, E.; Vogt, F.; Tsoumanis, A.; Mekonnen, Z.; Admassu, H.; Colebunders, R.; Mohammed, R.; Ritmeijer, K.; van Griensven, J.			The risk and predictors of visceral Leishmaniasis relapse in HIV co-infected patients in Ethiopia: a retrospective cohort study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Abongomera, C.; Mekonnen, Z.; Admassu, H.] Med Sans Frontieres, Abdurafi, Ethiopia; [Abongomera, C.; Vogt, F.; Tsoumanis, A.; van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Diro, E.; Mohammed, R.] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Ritmeijer, K.] Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P39	183	183						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900430					2019-03-26	
J	Lula, Y; Engo, A; Nsimba, G; Mbo, J; Mulongo, R; Bisuta, S; Bakaswa, G; Mesia, G; Tona, G; Van Geertruyden, JP				Lula, Y.; Engo, A.; Nsimba, G.; Mbo, J.; Mulongo, R.; Bisuta, S.; Bakaswa, G.; Mesia, G.; Tona, G.; Van Geertruyden, J. P.			Safety and tolerability of two regimens used to treat multi-drug resistant tuberculosis in Kinshasa: a prospective cohort	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lula, Y.; Engo, A.; Nsimba, G.; Mesia, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Lula, Y.; Van Geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Fac Med, Antwerp, Belgium; [Mbo, J.; Mulongo, R.] Management Sci Hlth, Kinshasa, DEM REP CONGO; [Bisuta, S.; Bakaswa, G.] Natl Programme TB Control, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P53	188	189						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900444					2019-03-26	
J	Laranjo-Gonzalez, M; Devleesschauwer, B; Trevisan, C; Allepuz, A; Sotiraki, S; Dorny, P; Gabriel, S; Dermauw, V				Laranjo-Gonzalez, M.; Devleesschauwer, B.; Trevisan, C.; Allepuz, A.; Sotiraki, S.; Dorny, P.; Gabriel, S.; Dermauw, V.			The epidemiology of Taenia Saginata and Taenia Solium in Western Europe: a systematic review	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laranjo-Gonzalez, M.; Allepuz, A.] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Devleesschauwer, B.] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Trevisan, C.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Allepuz, A.] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain; [Sotiraki, S.] HAO DEMETER, Vet Res Inst, Campus Thermi, Thessaloniki, Greece; [Dorny, P.; Dermauw, V.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dorny, P.] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Gabriel, S.] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium			Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892				0	1	1	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P55	189	190						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900446					2019-03-26	
J	Lula, Y; Nzolo, D; Ntamabyaliro, PM; Nanga, T; Mesia, G; Tona, G; Van geertruyden, JP				Lula, Y.; Nzolo, D.; Ntamabyaliro, P. M.; Nanga, T.; Mesia, G.; Tona, G.; Van geertruyden, J. P.			Safety and tolerability of artesunate and amodiaquine combination in the treatment of uncomplicated malaria in Kinshasa: a pilot cohort event monitoring study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lula, Y.; Mesia, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Lula, Y.; Van geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Fac Med, Antwerp, Belgium; [Nzolo, D.; Ntamabyaliro, P. M.; Nanga, T.] Management Sci Hlth, Kinshasa, DEM REP CONGO; [Nzolo, D.; Ntamabyaliro, P. M.; Nanga, T.] Natl Programme TB Control, Kinshasa, DEM REP CONGO			Nanga Mfwawunu, Tom/E-9308-2019; Van geertruyden, Jean-Pierre/K-6425-2014	Nanga Mfwawunu, Tom/0000-0002-8926-0006; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P54	189	189						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900445					2019-03-26	
J	Van Dijck, C; Vlieghe, E; Cox, JA				Van Dijck, C.; Vlieghe, E.; Cox, J. A.			Systematic literature review of antibiotic stewardship interventions in hospitalized patients in low- and middle-income countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Dijck, C.; Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Vlieghe, E.; Cox, J. A.] Inst Trop Med, Dept Clin Sci, Unit Trop Lab Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P57	190	190						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900448					2019-03-26	
J	Saye, R; Landoue, A; Doumbia, MN; Becker, SL; Polman, K; Boelaert, M; Chappuis, F; Utzinger, J; Sacko, M; Traore, MS				Saye, R.; Landoure, A.; Doumbia, M. N.; Becker, S. L.; Polman, K.; Boelaert, M.; Chappuis, F.; Utzinger, J.; Sacko, M.; Traore, M. S.			Digestive disorders in Mali: assessment of a neglected public health issue	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saye, R.; Landoure, A.; Doumbia, M. N.; Sacko, M.; Traore, M. S.] Inst Natl Rech Sante Publ, Bamako, Mali; [Saye, R.; Becker, S. L.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Saye, R.; Becker, S. L.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P64	193	193						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900455					2019-03-26	
J	Saye, R; Becker, SL; Fofana, HKM; Doumbia, MN; Polman, K; Boelaert, M; Chappuis, F; Traore, MS; Utzinger, J; Sacko, M				Saye, R.; Becker, S. L.; Fofana, H. K. M.; Doumbia, M. N.; Polman, K.; Boelaert, M.; Chappuis, F.; Traore, M. S.; Utzinger, J.; Sacko, M.			Infectious aetiology of persistent digestive disorders (>= 2 weeks) in Niono, Mali, and implications for treatment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saye, R.; Fofana, H. K. M.; Doumbia, M. N.; Traore, M. S.; Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Saye, R.; Becker, S. L.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Saye, R.; Becker, S. L.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P63	193	193						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900454					2019-03-26	
J	Falay, D; Peeters, M; Mapendo, B; Hasivirwe, E; Phoba, MF; Lunguya, O; Devlieger, H; Van Geet, C; Ngbonda, D; Jacobs, J				Falay, D.; Peeters, M.; Mapendo, B.; Hasivirwe, E.; Phoba, M. -F.; Lunguya, O.; Devlieger, H.; Van Geet, C.; Ngbonda, D.; Jacobs, J.			Multicenter surveillance of bloodstream infections in Kisangani, Oriental Province, Democratic Republic of the Congo: auality indicators from blood cultures	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Falay, D.; Mapendo, B.; Ngbonda, D.] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Peeters, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Hasivirwe, E.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Phoba, M. -F.; Lunguya, O.] Na"	ACTA TROPICA			English	Article							SOUTHEAST-ASIA; CYSTICERCOSIS; PREVALENCE; ZOONOSES; EPILEPSY; PEOPLE; HEALTH; FOCUS; PCR	Following confirmation that a remote village of approximately 300 inhabitants in northern Lao PDR was hyperendemic for the Neglected Tropical Disease Taenia solium, a pilot human-porcine therapeutic control intervention was implemented between October 2013 and November 2014. Mass drug administration with a three day albendazole 400 mg protocol was offered to all eligible humans in October 2013 and March 2014. At these times, and again in October 2014, eligible village pigs received the anti-cysticercosis TSOL18 vaccination and an oral dose of oxfendazole anthelmintic at 30 mg/kg, both repeated one month later. Community and individual human taeniasis prevalences were estimated via copro-antigen ELISA of volunteered human faecal samples prior to October 2013, and again in January 2015, in order to examine the short term impact of the intervention. (C) 2016 The Author(s). Published by Elsevier B.V.	[Okello, Anna L.; Newberry, Kim; Allen, John] CSIRO, Australian Anim Hlth Lab AAHL Reg Programme, Geelong, Vic, Australia; [Okello, Anna L.] Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Okello, Anna L.] Univ Edinburgh, Ctr Infect Dis, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Inthavong, Phouth; Keokamphet, Chattouphone] Minist Agr, Natl Anim Hlth Lab, Dept Livestock & Fisheries, Viangchan, Laos; [Ash, Amanda; Thompson, R. C. Andrew] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Khamlome, Boualam] Minist Hlth, Dept Hyg & Prevent, Vientiane Capital, Laos; [Gauci, Charles G.; Lightowlers, Marshall W.] Univ Melbourne, Fac Vet & Agr Sci, 250 Princes Highway, Werribee, Vic 3030, Australia; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium	Okello, AL (reprint author), CSIRO, Australian Anim Hlth Lab AAHL Reg Programme, Geelong, Vic, Australia.; Okello, AL (reprint author), Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.; Okello, AL (reprint author), Univ Edinburgh, Ctr Infect Dis, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	anna.okello1@gmail.com		Thomas, Lian/0000-0001-8447-1210	Australian Centre for International Agricultural Research (ACIAR) Animal Health Programm [AH2009/001-019]; Australian National Health and Medical Research Council [1003546, 1043327]	The SPSP human and animal health component wish to thank their project counterparts from the Centre for International Agriculture in the Tropics (CIAT) and the Lao PDR National Agricultural and Forestry Research Institute (NAFRI) for their assistance during the pig interventions. The team also wish to thank the Lao PDR national WHO office for their overall support, as well as the Lao PDR Department for Communicable Disease Control (DCDC) for their facilitation and assistance in the human MDA interventions. In particular, the project team would like to thank the staff from the provincial and district Ministry of Health offices for their care and support in building community rapport during the project lifetime, and finally the community themselves for their hospitality, cooperation and trust. This research was funded by the Australian Centre for International Agricultural Research (ACIAR) Animal Health Programme, grant number AH2009/001-019. Funding support is also acknowledged from the Australian National Health and Medical Research Council, grants 1003546 and 1043327 (MWL).	Allan JC, 2006, PARASITOL INT, V55, pS75, DOI 10.1016/j.parint.2005.11.010; Ash A., 2015, ACTA TROP; Bardosh K, 2014, SOC SCI MED, V120, P215, DOI 10.1016/j.socscimed.2014.09.030; Carabin H., 2014, CURR TROP MED REP, P1; Conlan J, 2008, PARASITOL INT, V57, P252, DOI 10.1016/j.parint.2008.04.002; Conlan JV, 2011, VET PARASITOL, V182, P22, DOI 10.1016/j.vetpar.2011.07.013; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2004, SE ASIAN J TROP MED, V35, P223; FAO, 2014, TOP 10 LIST FOOD BOR; Gabriel S, 2015, VET PARASITOL, V213, P38, DOI 10.1016/j.vetpar.2015.03.006; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Maurice J, 2014, LANCET, V384, P571, DOI 10.1016/S0140-6736(14)61353-2; Moreno L, 2012, FOOD CHEM TOXICOL, V50, P3819, DOI 10.1016/j.fct.2012.07.023; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Okello A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-134; Okello AL, 2015, AM J TROP MED HYG, V92, P1059, DOI 10.4269/ajtmh.14-0551; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; R Development Core Team, 2005, R LANG ENV STAT COMP; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Stevenson M., 2013, EPIR R PACKAGE ANAL, P9; Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235; Tran Duc Si, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P537; WHO, 2015, LANDSC AN MAN NEUR E; WHO, 2015, 4 INT M CONTR NEGL Z; WHO, 2006, MAN HLTH PROF PROGR; Willingham AL, 2010, ADV PARASIT, V72, P235, DOI 10.1016/S0065-308X(10)72009-1; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; World Health Organization, 2012, ACC WORK OV GLOB IMP	32	2	2	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		261	267		10.1016/j.actatropica.2016.11.010				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400030	27887694	Green Published, Other Gold			2019-03-26
J	Coulibaly, YI; Coulibaly, SY; Dolo, H; Konate, S; Diallo, AA; Doumbia, SS; Soumaoro, L; Coulibaly, ME; Dicko, I; Sangare, MB; Dembele, B; Sangare, M; Dembele, M; Toure, YT; Kelly-Hope, L; Polman, K; Kyelem, D; Traore, SF; Bockarie, M; Klion, AD; Nutman, TB				Coulibaly, Yaya I.; Coulibaly, Siaka Y.; Dolo, Housseini; Konate, Siaka; Diallo, Abdallah A.; Doumbia, Salif S.; Soumaoro, Lamine; Coulibaly, Michel E.; Dicko, Ilo; Sangare, Moussa B.; Dembele, Benoit; Sangare, Modibo; Dembele, Massitan; Toure, Yeya T.; Kelly-Hope, Louise; Polman, Katja; Kyelem, Dominique; Traore, Sekou F.; Bockarie, Moses; Klion, Amy D.; Nutman, Thomas B.			Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali	PARASITES & VECTORS			English	Article						Wuchereria bancrofti; Transmission assessment survey; Anopheles gambiae complex; Mass drug administration; Post-MDA surveillance	LYMPHATIC FILARIASIS TRANSMISSION; INFECTION; MOSQUITOS; PROGRAMS; SURVEILLANCE; ELIMINATION; IMPACT; TOOLS; RATES; FOCUS	Background: After seven annual rounds of mass drug administration (MDA) in six Malian villages highly endemic for Wuchereria bancrofti (overall prevalence rate of 42.7%), treatment was discontinued in 2008. Surveillance was performed over the ensuing 5 years to detect recrudescence. Methods: Circulating filarial antigen (CFA) was measured using immunochromatographic card tests (ICT) and Og4C3 ELISA in 6-7 year-olds. Antibody to the W. bancrofti infective larval stage (L3) antigen, Wb123, was tested in the same population in 2012. Microfilaraemia was assessed in ICT-positive subjects. Anopheles gambiae complex specimens were collected monthly using human landing catch (HLC) and pyrethrum spray catch (PSC). Anopheles gambiae complex infection with W. bancrofti was determined by dissection and reverse transcriptase polymerase chain reaction (RT-PCR) of mosquito pools. Results: Annual CFA prevalence rates using ICT in children increased over time from 0% (0/289) in 2009 to 2. 7% (8/301) in 2011, 3.9% (11/285) in 2012 and 4.5% (14/309) in 2013 (trend chi(2) = 11.85, df = 3, P = 0.0006). Wb123 antibody positivity rates in 2013 were similar to the CFA prevalence by ELISA (5/285). Although two W. bancrofti-infected Anopheles were observed by dissection among 12,951 mosquitoes collected by HLC, none had L3 larvae when tested by L3-specific RT-PCR. No positive pools were detected among the mosquitoes collected by pyrethrum spray catch. Whereas ICT in 6-7 year-olds was the major surveillance tool, ICT positivity was also assessed in older children and adults (8-65 years old). CFA prevalence decreased in this group from 4.9% (39/800) to 3.5% (28/795) and 2.8% (50/1,812) in 2009, 2011 and 2012, respectively (trend.2 = 7.361, df = 2, P = 0.0067). Some ICT-positive individuals were microfilaraemic in 2009 [2.6% (1/39)] and 2011 [8.3% (3/36)], but none were positive in 2012 or 2013. Conclusion: Although ICT rates in children increased over the 5-year surveillance period, the decrease in ICT prevalence in the older group suggests a reduction in transmission intensity. This was consistent with the failure to detect infective mosquitoes or microfilaraemia. The threshold of ICT positivity in children may need to be re-assessed and other adjunct surveillance tools considered.	[Coulibaly, Yaya I.; Coulibaly, Siaka Y.; Dolo, Housseini; Konate, Siaka; Diallo, Abdallah A.; Doumbia, Salif S.; Soumaoro, Lamine; Coulibaly, Michel E.; Dicko, Ilo; Sangare, Moussa B.; Dembele, Benoit; Sangare, Modibo; Traore, Sekou F.] Fac Med & Odontostomatol, Int Ctr Excellence Res, Filariasis Unit, Bamako, Mali; [Dembele, Massitan] Natl Lymphat Filariasis Eliminat Program, Bamako, Mali; [Toure, Yeya T.] Fac Med & Odontostomatol Bamako, Bamako, Mali; [Coulibaly, Yaya I.; Kelly-Hope, Louise] Univ Liverpool Liverpool Sch Trop Med, Filarial Program, Support Unit, Liverpool, Merseyside, England; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kyelem, Dominique] Task Force Global Hlth, Neglected Trop Dis Support Ctr, Decatur, GA USA; [Bockarie, Moses] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Klion, Amy D.; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA	Coulibaly, YI (reprint author), Fac Med & Odontostomatol, Int Ctr Excellence Res, Filariasis Unit, Bamako, Mali.; Coulibaly, YI (reprint author), Univ Liverpool Liverpool Sch Trop Med, Filarial Program, Support Unit, Liverpool, Merseyside, England.	yicoulibaly@icermali.org			WHO/UNDP/World Bank Special Program for Tropical Diseases grant [A00583]; Task Force for Global Health; Division of Intramural Research, NIAID, NIH	This study was funded by the WHO/UNDP/World Bank Special Program for Tropical Diseases grant (ID A00583) to SFT and the Task Force for Global Health. This study was funded in part by the Division of Intramural Research, NIAID, NIH. The funding bodies did not play any role in the study design, data collection, analysis and interpretation, nor the decision to write the manuscript.	Amuzu H, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-85; Bakajika DK, 2014, AM J TROP MED HYG, V91, P1142, DOI 10.4269/ajtmh.14-0358; BRENGUES J, 1968, B WORLD HEALTH ORGAN, V38, P595; Coulibaly Y I, 2006, Mali Med, V21, P12; Coulibaly YI, 2015, AM J TROP MED HYG, V93, P356, DOI 10.4269/ajtmh.14-0516; Coulibaly YI, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-247; Dembele M, 2012, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd.0001574, DOI 10.1371/JOURNAL.PNTD.0001574.]; DETINOVA T. S., 1964, BULL WORLD HEALTH ORGAN, V30, P23; Dorkenoo A M, 2015, Bull Soc Pathol Exot, V108, P181, DOI 10.1007/s13149-014-0408-z; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Goodman DS, 2003, FILARIA J, V2, P11, DOI DOI 10.1186/1475-2883-2-11; Govella N, 2010, AM J TROP MED HYG, V83, P596, DOI 10.4269/ajtmh.2010.09-0682; Harnett W, 1998, PARASITOLOGY, V117, pS59; Keiser PB, 2003, AM J TROP MED HYG, V69, P331, DOI 10.4269/ajtmh.2003.69.331; Kia EB, 2014, IRAN J PARASITOL, V9, P145; Kubofcik J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001930; Lamberton PHL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0511-9; Laney SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000602; Lovato R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002821; Ngom EHM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0711-0; Ramaiah KD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003319; Ramaiah KD, 2013, T ROY SOC TROP MED H, V107, P293, DOI 10.1093/trstmh/trt011; Richards FO, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001346; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Steel C, 2013, CLIN VACCINE IMMUNOL, V20, P1155, DOI 10.1128/CVI.00252-13; Talla C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114047; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; Wanji S, 2015, PLOS NEGLECT TROP D, V9, P1; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; WHO, 2011, LYMPH FIL MON ED ASS; WHO, 2014, WKLY EPIDEMIOL REC, V89, P409; World Health Organization, 2013, GLOB PROGR EL LYMPH	32	4	4	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 3	2016	9								628	10.1186/s13071-016-1911-9				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EI3DS	WOS:000392370500004	27912789	DOAJ Gold, Green Published			2019-03-26
J	Collantes, J; Solari, FB; Rigouts, L				Collantes, Jimena; Barletta Solari, Francesca; Rigouts, Leen			Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							GENOTYPE MTBDRPLUS ASSAY; REAL-TIME PCR; RPOB MUTATIONS; NONTUBERCULOUS MYCOBACTERIA; CLINICAL SPECIMENS; COMPLEX; INHA; KATG; ELECTROPHORESIS; IDENTIFICATION	Drug susceptibility testing using molecular techniques can enhance the identification of drug-resistant Mycobacterium tuberculosis. Two multiplex real-time polymerase chain reaction (qPCR) assays were developed to detect the most common resistance-associated mutations to isoniazid (katGS315T, inhA-15C -> T), and rifampicin (rpoBH526Y and rpoBS531L). To assess the species specificity of the qPCR, we selected 31 nontuberculous mycobacteria (NTM) reference strains belonging to 17 species from the public collection of mycobacterial cultures (BCCM/ITM). Additionally, we tested 17 isoniazid and/or rifampicin-resistant strains with other mutations in the target genes to assess mutation specificity. The limit of detection for all the targeted mutations was 20 bacilli/reaction. Multiplex 1 showed 90%, 95%, and 100% efficiency for wild type (WT), Mut katGS315T, and Mut rpoBS531L, respectively; whereas Multiplex 2 showed 97%, 94%, and 90% efficiency for WT, Mut inhA-15, and Mut rpoBH526Y, respectively. Three of 17 strains that presented other mutations in the target genes were identified as rifampicin resistant and only 3/31 NTM showed a similar melting temperature to rpoBL531 and/or katG11.315 mutants. Thus, our proposed cascade of specific tuberculosis detection followed by drug resistance testing showed sensitivities for katGS315T, rpoBS531L, rpoBH526Y, and inhA-15 detection of 100%, 100%, 100%, and 96%, respectively; and specificities of 98%, 95%, 100%, and 100, respectively.	[Collantes, Jimena; Barletta Solari, Francesca] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Collantes, Jimena; Barletta Solari, Francesca] Univ Peruana Cayetano Heredia, Lima, Peru; [Rigouts, Leen] Inst Trop Med, Antwerp, Belgium; [Rigouts, Leen] Univ Antwerp, Antwerp, Belgium; [Rigouts, Leen] Inst Trop Med, Microbiol, Antwerp, Belgium	Collantes, J (reprint author), Inst Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Ave Honorio Delgado 430, Lima, Peru.	jimena_collantes@hotmail.com			Belgian Directorate General for Development Cooperation (DGDC)	This study was funded by the Belgian Directorate General for Development Cooperation (DGDC) through an institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium, and the Institute de Medicina Tropical Alexander von Humboldt in Lima, Peru.	Ahmad S, 2012, INDIAN J MED RES, V135, P756; Ahmad S, 2009, RESP MED, V103, P1777, DOI 10.1016/j.rmed.2009.07.010; Asencios Luis, 2012, Rev Peru Med Exp Salud Publica, V29, P92; Barletta F, 2014, AM J TROP MED HYG, V91, P709, DOI 10.4269/ajtmh.13-0603; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2004, CLIN MICROBIOL INFEC, V10, P662, DOI 10.1111/j.1469-0691.2004.00917.x; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; de Freitas FAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104100; Grange JM, GUIDELINES SPECIATIO; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Isfahani BN, 2006, MEM I OSWALDO CRUZ, V101, P597, DOI 10.1590/S0074-02762006000600004; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Kaiser M, 2009, ENVIRON MICROBIOL, V75, P414; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Leung ETY, 2006, ANTIMICROB AGENTS CH, V50, P1075, DOI 10.1128/AAC.50.3.1075-1078.2006; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; Maschmann RD, 2013, J CLIN MICROBIOL, V51, P1606, DOI 10.1128/JCM.00364-13; Mayta H, 2003, J CLIN MICROBIOL, V41, P5774, DOI 10.1128/JCM.41.12.5774-5777.2003; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; Menzies D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000150; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Montenegro SH, 2003, CLIN INFECT DIS, V36, P16, DOI 10.1086/344900; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Munayco CV, 2008, REV SAUDE PUBL, V42, P146, DOI [10.1590/S0034-89102008000100020, 10.1590/s0034-89102008000100020]; Murphy KM, 2003, EXPERT REV MOL DIAGN, V3, P811, DOI 10.1586/14737159.3.6.811; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nikolayevsky V, 2004, J CLIN MICROBIOL, V42, P4498, DOI 10.1128/JCM.42.10.4498-4502.2004; Perez-Osorio AC, 2012, J CLIN MICROBIOL, V50, P326, DOI 10.1128/JCM.05570-11; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Scarpellini P., 2003, New Microbiologica, V26, P345; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Sheng J, 2008, J APPL MICROBIOL, V105, P904, DOI 10.1111/j.1365-2672.2008.03815.x; Shi RR, 2007, MICROBES INFECT, V9, P1538, DOI 10.1016/j.micinf.2007.08.009; Silva MSN, 2003, J CLIN MICROBIOL, V41, P4471, DOI 10.1128/JCM.41.9.4471-4474.2003; Somoskovi A, 2001, RESPIR RES, V2, P164, DOI 10.1186/rr54; Sougakoff W, 2004, CLIN MICROBIOL INFEC, V10, P289, DOI 10.1111/j.1198-743X.2004.889.x; Steingart KR, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009593.PUB3; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Thacker TC, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-100; Ugarte-Gil César, 2008, Acta méd. peruana, V25, P171; Valim ARM, 2000, J CLIN MICROBIOL, V38, P3119; Van Deun A, 2013, INT J TUBERC LUNG D; van Doorn HR, 2006, CLIN MICROBIOL INFEC, V12, P769, DOI 10.1111/j.1469-0691.2006.01495.x; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; World Health Organization, 2014, GLOB TUB REP 2014; World Health Organization, 2013, TOP 10 CAUS DEATH; Zhao P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099659	59	0	0	1	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2016	95	6					1257	1264		10.4269/ajtmh.16-0120				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VF	WOS:000400206900007	27928076	Bronze, Green Published			2019-03-26
J	Manabe, YC; Worodria, W; van Leth, F; Mayanja-Kizza, H; Traore, AN; Ferro, J; Pakker, N; Frank, M; Grobusch, MP; Colebunders, R; Cobelens, F				Manabe, Yukari C.; Worodria, William; van Leth, Frank; Mayanja-Kizza, Harriet; Traore, Afsatou Ndama; Ferro, Josef; Pakker, Nadine; Frank, Matthias; Grobusch, Martin P.; Colebunders, Robert; Cobelens, Frank			Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SUB-SAHARAN AFRICA; INITIATING ANTIRETROVIRAL THERAPY; HIGH-INCOME COUNTRIES; DIAGNOSTIC-ACCURACY; TREATMENT PROGRAMS; RURAL DISTRICT; SCALING-UP; HIV; ADULTS; OUTCOMES	Early mortality after initiation of antiretroviral therapy (ART) occurs in 9-39% of patients in sub-Saharan Africa. A significant proportion of deaths are attributable to tuberculosis (TB). Low baseline CD4 T-cell count and low body mass index (BMI) are strongly associated with early mortality. We hypothesized that initiation of ART concurrent with presumptive anti-TB chemotherapy in high-risk patients would reduce mortality within the first 6 months by treating unrecognized TB. From October 2011 to December 2012, ART-naive, smear-negative participants with a CD4 T-cell count < 50 cells/mu L and BMI < 18 kg/m(2) were randomly assigned to undergo either empiric four-drug anti-TB treatment followed 2 weeks later by efavirenz-based ART (N = 23) (ART + TB) or ART only (N = 20). This open-label, 1:1 randomized, controlled trial took place in Uganda, Mozambique, and Gabon and was stopped prematurely by the sponsor for slow recruitment. Overall, the 43 participants had a median CD4 of 22 (interquartile range [IQR]: 9-35) cells/mu L and a median BMI of 17.5 (IQR: 16.6-18.0) kg/m(2). The mortality was 14% (95% confidence interval [CI]: 5.3-27.9); two (10.0%) participants (ART-only group), and four (17.4%; ART + TB group). The associated hazard ratio (HR) for all-cause mortality was 1.6 (95% CI: 0.30-8.90). Despite limited enrollment, the study did not suggest that empiric TB treatment in severely immunosuppressed patients with low BMI decreased mortality and, had an HR in the opposite direction than expected. Notably, two participants in the ART + TB group died with autopsy-confirmed drug-induced hepatotoxicity. Improved TB diagnostics sensitive in immunosuppressed patients presenting late to care are urgently needed for more targeted interventions.	[Manabe, Yukari C.; Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, POB 22418,Mulago Hosp Complex, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [van Leth, Frank; Pakker, Nadine; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [van Leth, Frank; Pakker, Nadine; Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Traore, Afsatou Ndama; Frank, Matthias; Grobusch, Martin P.] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Traore, Afsatou Ndama] Univ Venda, Dept Microbiol, Thohoyandou, South Africa; [Ferro, Josef] Catholic Univ Mozambique, Beira, Mozambique; [Frank, Matthias; Grobusch, Martin P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Grobusch, Martin P.] Univ Amsterdam, Div Internal Med, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Colebunders, Robert] Inst Trop Med, Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Cobelens, Frank] KNCV TB Fdn, The Hague, Netherlands; [Manabe, Yukari C.] Johns Hopkins Univ, Med, Baltimore, MD USA; [Worodria, William] Mulago Hosp, Dept Med, Kampala, Uganda; [Ferro, Josef] Catholic Univ Mozambique, Dept Med, Beira, Mozambique; [Pakker, Nadine] Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands; [Colebunders, Robert] Prince Leopold Inst Trop Med, Clin Sci, Antwerp, Belgium	Manabe, YC (reprint author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, POB 22418,Mulago Hosp Complex, Kampala, Uganda.	ymanabe@jhmi.edu		Mayanja-Kizza, Harriet/0000-0002-9297-6208; van Leth, Frank/0000-0002-5490-8968	European Developing Countries Trials Program (EDCTP) [IP.2009.33011.007]; National Institutes of Health Fogarty International Center [D43TW009771]	This clinical trial was funded by European Developing Countries Trials Program (EDCTP) (grant no. IP.2009.33011.007). Funding was withdrawn when EDCTP decided against trial continuation. Additional support for Yukari C. Manabe and William Worodria was provided from the National Institutes of Health Fogarty International Center (D43TW009771).	Alland D, 2015, C RETR OPP INF OR; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; BASSETT ICS, 2009, INTENSIVE TB SCREENI; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Braitstein P, 2006, LANCET, V367, P817; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Grant A, 2016, EMPIRICAL TB TREATME; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022730; Hosseinipour MC, 2016, LANCET, V387, P1198, DOI 10.1016/S0140-6736(16)00546-8; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Katagira W, 2016, JAIDS-J ACQ IMM DEF, V72, P297, DOI 10.1097/QAI.0000000000000970; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P1354, DOI 10.5588/ijtld.12.0174; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2012, AIDS, V26, P2121, DOI 10.1097/QAD.0b013e3283565dd1; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Pac L, 2015, JAIDS-J ACQ IMM DEF, V68, pE69, DOI 10.1097/QAI.0000000000000527; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2014, THE GAP REP 2014; WHO, 2007, IMPR DIAGN TREATM SM; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization (WHO), 2011, RAP IMPL XPERT MTB R; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	38	2	2	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2016	95	6					1265	1271		10.4269/ajtmh.16-0239				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VF	WOS:000400206900008	27928077	Bronze, Green Published			2019-03-26
J	Lagatie, O; Merino, M; Debrah, LB; Debrah, AY; Stuyver, LJ				Lagatie, Ole; Merino, Michelle; Debrah, Linda Batsa; Debrah, Alexander Y.; Stuyver, Lieven J.			An isothermal DNA amplification method for detection of Onchocerca volvulus infection in skin biopsies	PARASITES & VECTORS			English	Article						Onchocerca volvulus; River blindness; Onchocerciasis; Skin biopsy; DNA; cox1; LAMP; Isothermal; Diagnostic	POLYMERASE-CHAIN-REACTION; RIVER-BLINDNESS; BLACK FLIES; WUCHERERIA-BANCROFTI; ELIMINATION PROGRAMS; IVERMECTIN TREATMENT; FILARIAL INFECTIONS; DIAGNOSTIC METHODS; EXTRACTION METHODS; LOA-LOA	Background: Diagnostic procedures for the diagnosis of infection with the nematode parasite Onchocerca volvulus are currently based on the microscopic detection of microfilariae in skin biopsies. Alternative approaches based on amplification of parasitic DNA in these skin biopsies are currently being explored. Mostly this is based on the detection of the O-150 repeat sequence using PCR based techniques. Methods: An isothermal, loop-mediated amplification method has been designed using the mitochondrial O. volvulus cox1 gene as a target. Results: Analysis of dilution series of synthetic DNA containing the targeted sequence show a non-linear dose-response curve, as is usually the case for isothermal amplification methods. Evaluation of cross-reactivity with the heterologous sequence from the closely related parasites Wuchereria bancrofti, Loa loa and Brugia malayi demonstrated strong specificity, as none of these sequences was amplified. The assay however amplified both O. volvulus and O. ochengi DNA, but with a different melting point that can be used to discriminate between the species. Evaluation of this assay in a set of skin snip biopsies collected in an endemic area in Ghana showed a high correlation with O-150 qPCR and also demonstrated a similar sensitivity. Compared to qPCR, LAMP had a sensitivity of 88.2% and a specificity of 99.2%. Conclusions: We have developed a sensitive and specific loop-mediated amplification method for detection of O. volvulus DNA in skin biopsies that is capable of providing results within 30 min.	[Lagatie, Ole; Merino, Michelle; Stuyver, Lieven J.] Janssen Diagnost, Janssen R&D, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Debrah, Linda Batsa] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Debrah, Alexander Y.] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Kumasi, Ghana	Lagatie, O (reprint author), Janssen Diagnost, Janssen R&D, Turnhoutseweg 30, B-2340 Beerse, Belgium.	olagatie@its.jnj.com					Alhassan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108927; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boatin BA, 2002, PARASITOLOGY, V125, P545, DOI 10.1017/S0031182002002494; Borup LH, 2003, CUTIS, V72, P297; Bottomley C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1605-3; BOUSSINESQ M, 1993, ANN SOC BELG MED TR, V73, P189; BWANGAMOI O, 1969, Bulletin of Epizootic Diseases of Africa, V17, P321; Chandrashekar R, 1996, TROP MED INT HEALTH, V1, P575; Creecy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130260; Debrah AY, 2015, CLIN INFECT DIS, V61, P517, DOI 10.1093/cid/civ363; Denery JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000834; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Drame PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14; Enk CD, 2006, CLIN DERMATOL, V24, P176, DOI 10.1016/j.clindermatol.2005.11.008; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Globisch D, 2013, P NATL ACAD SCI USA, V110, P4218, DOI 10.1073/pnas.1221969110; Golden A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1623-1; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Gopal H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001712; Guevara AG, 2003, AM J TROP MED HYG, V68, P222, DOI 10.4269/ajtmh.2003.68.222; KATHOLI CR, 1995, J INFECT DIS, V172, P1414, DOI 10.1093/infdis/172.5.1414; Lagatie O, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1582-6; LAVEBRATT C, 1994, T ROY SOC TROP MED H, V88, P303, DOI 10.1016/0035-9203(94)90090-6; Lefoulon E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004233; Lipner EM, 2006, J INFECT DIS, V194, P216, DOI 10.1086/505081; Liu ZY, 2016, MITOCHONDRIAL DNA A, V27, P2318, DOI 10.3109/19401736.2015.1022762; Lloyd MM, 2015, ACTA TROP, V146, P114, DOI 10.1016/j.actatropica.2015.03.019; Nagai S, 2012, MAR GENOM, V7, P51, DOI 10.1016/j.margen.2012.03.002; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Poole CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139286; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Quintana JF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0656-1; Rejili M, 2016, B ENTOMOL RES, V106, P695, DOI 10.1017/S000748531600050X; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Rodriguez-Perez MA, 2006, AM J TROP MED HYG, V74, P1026, DOI 10.4269/ajtmh.2006.74.1026; Rodriguez-Perez MA, 2013, PARASITOL RES, V112, P3925, DOI 10.1007/s00436-013-3583-0; Seyrig G, 2015, J MICROBIOL METH, V119, P223, DOI 10.1016/j.mimet.2015.11.004; Steel C, 2015, CLIN VACCINE IMMUNOL, V22, P896, DOI 10.1128/CVI.00227-15; Sun Y, 2014, J VIROL METHODS, V204, P49, DOI 10.1016/j.jviromet.2014.04.006; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; TAYLOR HR, 1989, AM J TROP MED HYG, V41, P467, DOI 10.4269/ajtmh.1989.41.467; Toe L, 1998, J INFECT DIS, V178, P282, DOI 10.1086/517454; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Tritten L, 2014, MOL BIOCHEM PARASIT, V198, P14, DOI 10.1016/j.molbiopara.2014.11.001; Tritten L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002971; Vlaminck J, 2015, TRENDS PARASITOL, V31, P571, DOI 10.1016/j.pt.2015.06.007; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; WHO, 2015, WKLY EPIDEMIOL REC, V90, P661; World Health Organization (WHO), 2010, WHOHTMNTD20101; Zhang XZ, 2014, BIOSENS BIOELECTRON, V61, P491, DOI 10.1016/j.bios.2014.05.039; Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428	54	6	6	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 1	2016	9								624	10.1186/s13071-016-1913-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EI3DQ	WOS:000392370300004	27906100	DOAJ Gold, Green Published			2019-03-26
J	Braae, UC; Devleesschauwer, B; Gabriel, S; Dorny, P; Speybroeck, N; Magnussen, P; Torgerson, P; Johansen, MV				Braae, Uffe Christian; Devleesschauwer, Brecht; Gabriel, Sarah; Dorny, Pierre; Speybroeck, Niko; Magnussen, Pascal; Torgerson, Paul; Johansen, Maria Vang			CystiSim - An Agent-Based Model for Taenia solium Transmission and Control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HEALTH-EDUCATION INTERVENTION; PORCINE CYSTICERCOSIS; MASS CHEMOTHERAPY; MBEYA REGION; RISK-FACTORS; FIELD TRIAL; PIGS; OXFENDAZOLE; PREVALENCE; INFECTION	Taenia solium taeniosis/cysticercosis was declared eradicable by the International Task Force for Disease Eradication in 1993, but remains a neglected zoonosis. To assist in the attempt to regionally eliminate this parasite, we developed cystiSim, an agent-based model for T. solium transmission and control. The model was developed in R and available as an R package (http://cran.r-project.org/package=cystiSim). cystiSim was adapted to an observed setting using field data from Tanzania, but adaptable to other settings if necessary. The model description adheres to the Overview, Design concepts, and Details (ODD) protocol and consists of two entities D pigs and humans. Pigs acquire cysticercosis through the environment or by direct contact with a tapeworm carrier's faeces. Humans acquire taeniosis from slaughtered pigs proportional to their infection intensity. The model allows for evaluation of three interventions measures or combinations hereof: treatment of humans, treatment of pigs, and pig vaccination, and allows for customary coverage and efficacy settings. cystiSim is the first agent-based transmission model for T. solium and suggests that control using a strategy consisting of an intervention only targeting the porcine host is possible, but that coverage and efficacy must be high if elimination is the ultimate goal. Good coverage of the intervention is important, but can be compensated for by including an additional intervention targeting the human host. cystiSim shows that the scenarios combining interventions in both hosts, mass drug administration to humans, and vaccination and treatment of pigs, have a high probability of success if coverage of 75% can be maintained over at least a four year period. In comparison with an existing mathematical model for T. solium transmission, cystiSim also includes parasite maturation, host immunity, and environmental contamination. Adding these biological parameters to the model resulted in new insights in the potential effect of intervention measures.	[Braae, Uffe Christian; Magnussen, Pascal; Johansen, Maria Vang] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet Dis Biol, Frederiksberg, Denmark; [Devleesschauwer, Brecht] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium; [Dorny, Pierre] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Magnussen, Pascal] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Copenhagen, Denmark; [Torgerson, Paul] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland	Braae, UC (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet Dis Biol, Frederiksberg, Denmark.	braae@sund.ku.dk	Devleesschauwer, Brecht/G-9895-2018; Braae, Uffe/J-4720-2017; Torgerson, Paul/M-4447-2013	Devleesschauwer, Brecht/0000-0002-2867-6892; Braae, Uffe/0000-0002-2743-4584; Torgerson, Paul/0000-0003-4277-9983; Magnussen, Pascal/0000-0001-7372-0250	CYSTINET: European Network on taeniosis/cysticercosis, COST ACTION [TD1302]	The work was carried out with support from CYSTINET (http://www.cystinet.org/): European Network on taeniosis/cysticercosis, COST ACTION TD1302. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AM, 2012, INT HEALTH, V4, P164, DOI 10.1016/j.inhe.2012.04.003; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Arriola CS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003247; Assana E, 2010, INT J PARASITOL, V40, P515, DOI 10.1016/j.ijpara.2010.01.006; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Braae U.C., 2015, ACTA TROP; Braae Uffe Christian, 2016, Parasite Epidemiol Control, V1, P245; Braae UC, 2015, VET PARASITOL, V214, P187, DOI 10.1016/j.vetpar.2015.08.009; Braae UC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0938-7; Braae UC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0574-7; CAMACHO SPD, 1991, AM J TROP MED HYG, V45, P522, DOI 10.4269/ajtmh.1991.45.522; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; Devleesschauwer B, 2016, CYSTISIM AGENT BASED; Flisser A, 1994, Prog Clin Parasitol, V4, P77; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gomez-Puerta LA, 2014, REV BRAS PARASITOL V, V23, P94, DOI 10.1590/S1984-29612014014; Gonzalez AE, 2005, AM J TROP MED HYG, V72, P837, DOI 10.4269/ajtmh.2005.72.837; Gonzalez AE, 1998, AM J TROP MED HYG, V59, P832, DOI 10.4269/ajtmh.1998.59.832; Gonzalez AE, 2001, AM J TROP MED HYG, V65, P15, DOI 10.4269/ajtmh.2001.65.15; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; ILSOE B, 1990, ACTA VET SCAND, V31, P153; Jayashi CM, 2012, VET PARASITOL, V188, P261, DOI 10.1016/j.vetpar.2012.03.055; Jiang W, 2012, J THEOR BIOL, V293, P15, DOI 10.1016/j.jtbi.2011.10.006; Johansen MV, 2016, PARASITOLOGY, P1; KEILBACH N M, 1989, Acta Leidensia, V57, P181; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Krentel A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002447; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; LAWSON JR, 1990, PARASITOLOGY, V100, P143, DOI 10.1017/S0031182000060224; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Molinari JL, 1997, VET PARASITOL, V69, P55, DOI 10.1016/S0304-4017(96)01102-8; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2010, PLOS NEGL TROP DIS, V4; Okello AL, 2016, ACTA TROP, V159, P185, DOI 10.1016/j.actatropica.2016.03.012; Pawlowski Zbigniew S., 2002, P1, DOI 10.1079/9780851996288.0001; Pondja A, 2012, PLOS NEGL TROP DIS, V6; Rajshekhar V, 2003, ACTA TROP, V87, P53, DOI 10.1016/S0001-706X(03)00055-X; Rose H, 2015, ECOL MODEL, V297, P232, DOI 10.1016/j.ecolmodel.2014.11.033; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; Sarti E, 1997, AM J TROP MED HYG, V56, P127, DOI 10.4269/ajtmh.1997.56.127; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; Sikasunge CS, 2008, VET PARASITOL, V158, P57, DOI 10.1016/j.vetpar.2008.08.014; URT, 2013, POP HOUS CENS 2012 P, P1; URT URoT, 2012, NAT SAMPL CENS AGR 2; Verastegui M, 2000, VET PARASITOL, V94, P33, DOI 10.1016/S0304-4017(00)00369-1; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2016	10	12							e0005184	10.1371/journal.pntd.0005184				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0IX	WOS:000392158100053	27984581	DOAJ Gold, Green Published			2019-03-26
J	De Muylder, G; Vanhollebeke, B; Caljon, G; Wolfe, AR; McKerrow, J; Dujardin, JC				De Muylder, Geraldine; Vanhollebeke, Benoit; Caljon, Guy; Wolfe, Alan R.; McKerrow, James; Dujardin, Jean-Claude			Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LARGE GENE LISTS; TUBERCULOSIS; DONOVANI; INHIBITOR; TARGETS; POTENT	Host-directed therapies (HDTs) constitute promising alternatives to traditional therapy that directly targets the pathogen but is often hampered by pathogen resistance. HDT could represent a new treatment strategy for leishmaniasis, a neglected tropical disease caused by the obligate intracellular parasite Leishmania. This protozoan develops exclusively within phagocytic cells, where infection relies on a complex molecular interplay potentially exploitable for drug targets. We previously identified naloxonazine, a compound specifically active against intracellular but not axenic Leishmania donovani. We evaluated here whether this compound could present a host cell-dependent mechanism of action. Microarray profiling of THP-1 macrophages treated with naloxonazine showed upregulation of vATPases, which was further linked to an increased volume of intracellular acidic vacuoles. Treatment of Leishmania-infected macrophages with the vATPase inhibitor concanamycin A abolished naloxonazine effects, functionally demonstrating that naloxonazine affects Leishmania amastigotes indirectly, through host cell vacuolar remodeling. These results validate amastigote-specific screening approaches as a powerful way to identify alternative host-encoded targets. Although the therapeutic value of naloxonazine itself is unproven, our results further demonstrate the importance of intracellular acidic compartments for host defense against Leishmania, highlighting the possibility of targeting this host cell compartment for anti-leishmanial therapy.	[De Muylder, Geraldine; Caljon, Guy; Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [De Muylder, Geraldine; Wolfe, Alan R.; McKerrow, James] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Vanhollebeke, Benoit] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, Gosselies, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, Antwerp, Belgium; [Caljon, Guy] Univ Antwerp, LMPH, Antwerp, Belgium; [McKerrow, James] Univ Calif San Diego, Skaggs Sch Pharm, San Diego, CA 92103 USA	De Muylder, G (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; De Muylder, G (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	gdemuylder@itg.be	Wolfe, Alan/A-6853-2009; Caljon, Guy/E-1310-2017	Wolfe, Alan/0000-0002-0932-4146; Caljon, Guy/0000-0002-4870-3202; Vanhollebeke, Benoit/0000-0002-0353-365X	Belgian Science Policy Office [TRIT P7/41]; Back-to-Belgium Return grant; Flemish Fund for Scientific Research [12Q8115N]; Center for Discovery and Innovation in Parasitic Diseases; EU/FP7 ERC starting grant [282312]	This work was supported by the Belgian Science Policy Office (TRIT P7/41 (BV, JCD) and Back-to-Belgium Return grant (GDM)) https.//www.belspo.be/belspo/index_fr.stm; the Flemish Fund for Scientific Research (12Q8115N (GDM)) www.fwo.be; and the Center for Discovery and Innovation in Parasitic Diseases. GC was supported by the EU/FP7 ERC starting grant (No.282312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; CHANG KP, 1978, J EXP MED, V147, P515, DOI 10.1084/jem.147.2.515; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; De Muylder G, 2011, PLOS NEGL TROP DIS, V5; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; Fernandez MM, 2011, ANTIMICROB AGENTS CH, V55, P86, DOI 10.1128/AAC.00506-10; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HAHN EF, 1982, LIFE SCI, V31, P1385, DOI 10.1016/0024-3205(82)90387-3; Haldar Arun Kumar, 2011, Mol Biol Int, V2011, P571242, DOI 10.4061/2011/571242; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771; Prussia A, 2011, INT J MOL SCI, V12, P4027, DOI 10.3390/ijms12064027; Roatt BM, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00272; Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Singh N, 2012, ASIAN PAC J TROP MED, V5, P485, DOI 10.1016/S1995-7645(12)60084-4; Singh OP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00296; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Vanaerschot M, 2013, CRIT REV MICROBIOL, V39, P384, DOI 10.3109/1040841X.2012.716818; Vinet AF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000628; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Zumla A, 2015, CLIN INFECT DIS, V61, P1432, DOI 10.1093/cid/civ631	30	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2016	10	12							e0005234	10.1371/journal.pntd.0005234				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0IX	WOS:000392158100077	28036391	DOAJ Gold, Green Published			2019-03-26
J	Vlaminck, J; Masure, D; Wang, T; Nejsum, P; Hokke, CH; Geldhof, P				Vlaminck, Johnny; Masure, Dries; Wang, Tao; Nejsum, Peter; Hokke, Cornelis H.; Geldhof, Peter			A Phosphorylcholine-Containing Glycolipid-like Antigen Present on the Surface of Infective Stage Larvae of Ascaris spp. Is a Major Antibody Target in Infected Pigs and Humans	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMITTED HELMINTH INFECTIONS; SUUM INFECTIONS; TRICHOSTRONGYLUS-COLUBRIFORMIS; INTESTINAL IMMUNITY; SERODIAGNOSIS; LUMBRICOIDES; GLYCOSPHINGOLIPIDS; SEROPOSITIVITY; EXPRESSION; RESISTANCE	Background The pig parasite Ascaris suum plays and important role in veterinary medicine and represents a suitable model for A. lumbricoides, which infects over 800 million people. In pigs, continued exposure to Ascaris induces immunity at the level of the gut, protecting the host against migrating larvae. The objective of this study was to identify and characterize parasite antigens targeted by this local immune response that may be crucial for parasite invasion and establishment and to evaluate their protective and diagnostic potential. Methodology/Principal Findings Pigs were immunized by trickle infection for 30 weeks, challenged with 2,000 eggs at week 32 and euthanized two weeks after challenge. At necropsy, there was a 100% reduction in worms recovered from the intestine and a 97.2% reduction in liver white spots in comparison with challenged non-immune control animals. Antibodies purified from the intestinal mucus or from the supernatant of cultured antibody secreting cells from mesenteric lymph nodes of immune pigs were used to probe L3 extracts to identify antibody targets. This resulted in the recognition of a 12kDa antigen (As12) that is actively shed from infective Ascaris L3. As12 was characterized as a phosphorylcholine-containing glycolipid-like antigen that is highly resistant to different enzymatic and chemical treatments. Vaccinating pigs with an As12 fraction did not induce protective immunity to challenge infection. However, serological analysis using sera or plasma from experimentally infected pigs or naturally infected humans demonstrated that the As12 ELISA was able to detect long-term exposure to Ascaris with a high diagnostic sensitivity (98.4% and 92%, respectively) and specificity (95.5% and 90.0%) in pigs and humans, respectively. Conclusions/Significance These findings show the presence of a highly stage specific, glycolipid-like component (As12) that is actively secreted by infectious Ascaris larvae and which acts as a major antibody target in infected humans and pigs.	[Vlaminck, Johnny; Masure, Dries; Wang, Tao; Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Nejsum, Peter] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Hokke, Cornelis H.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	Vlaminck, J (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	Vlaminck.johnny@gmail.com		Wang, Tao/0000-0003-1359-8913; Nejsum, Peter/0000-0002-6673-8505	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)	The Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) funded the work of JV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Z, 2015, REV INST MED TROP SP, V57, P47, DOI 10.1590/S0036-46652015000100007; Arizono N, 2010, JPN J INFECT DIS, V63, P447; Bendall RP, 2011, EMERG INFECT DIS, V17, P1964, DOI 10.3201/eid1710.101826; Bhattacharyya T, 2001, J CLIN MICROBIOL, V39, P2991, DOI 10.1128/JCM.39.8.2991-2994.2001; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; Chatterjee BP, 1996, TROP MED INT HEALTH, V1, P633; Deehan MR, 2002, PARASITE IMMUNOL, V24, P463, DOI 10.1046/j.1365-3024.2002.00489.x; Dell A, 1999, BBA-MOL BASIS DIS, V1455, P353, DOI 10.1016/S0925-4439(99)00064-2; EDWARDS MK, 1990, TROP MED PARASITOL, V41, P174; ERIKSEN L, 1992, VET PARASITOL, V41, P137, DOI 10.1016/0304-4017(92)90017-4; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P79, DOI 10.1046/j.1365-3024.2003.00606.x; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P45, DOI 10.1046/j.1365-3024.2003.00602.x; Hewitson JP, 2016, INT J PARASITOL, V46, P157, DOI 10.1016/j.ijpara.2015.10.004; Kean DE, 2006, PARASITE IMMUNOL, V28, P69, DOI 10.1111/j.1365-3024.2005.00801.x; Lamberton Poppy H L, 2015, Curr Trop Med Rep, V2, P189; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043; LYNCH NR, 1993, PARASITOL RES, V79, P547, DOI 10.1007/BF00932238; Maizels RM, 2013, VET PARASITOL, V193, P365, DOI 10.1016/j.vetpar.2012.12.032; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002138; Mekonnen Z, 2013, PATHOG GLOB HEALTH, V107, P207, DOI 10.1179/2047773213Y.0000000092; Miller LA, 2015, EMERG INFECT DIS, V21, P332, DOI 10.3201/eid2102.140048; Nejsum P, 2009, PARASITOLOGY, V136, P193, DOI 10.1017/S0031182008005349; Nejsum P, 2005, J CLIN MICROBIOL, V43, P1142, DOI 10.1128/JCM.43.3.1142-1148.2005; Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Pullan R.L, 2014, PARASITE VECTOR, V7, P37, DOI DOI 10.1186/1756-3305-7-37; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Roepstorff A, 1998, PARASITOL RES, V84, P537, DOI 10.1007/s004360050444; Santra A, 2001, T ROY SOC TROP MED H, V95, P289, DOI 10.1016/S0035-9203(01)90236-6; Slotved HC, 1996, J PARASITOL, V82, P612, DOI 10.2307/3283786; Smit CH, 2015, MOL CELL PROTEOMICS, V14, P1750, DOI 10.1074/mcp.M115.048280; SMITH HV, 1981, MOL BIOCHEM PARASIT, V4, P183, DOI 10.1016/0166-6851(81)90017-7; Supali T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002586; URBAN JF, 1981, P HELM SOC WASH, V48, P241; URBAN JF, 1988, EXP PARASITOL, V66, P66, DOI 10.1016/0014-4894(88)90051-3; Van Riet E, 2006, PARASITE IMMUNOL, V28, P363, DOI 10.1111/j.1365-3024.2006.00844.x; Vercruysse J, 2007, REV SCI TECH OIE, V26, P105, DOI 10.20506/rst.26.1.1728; Vlaminck J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004532; Vlaminck J, 2014, PARASITOLOGY, V141, P1904, DOI 10.1017/S0031182014000328; Vlaminck J, 2012, VET PARASITOL, V189, P267, DOI 10.1016/j.vetpar.2012.04.024; Vlaminck J, 2010, J PARASITOL, V96, P643, DOI 10.1645/GE-2276.1	42	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2016	10	12							e0005166	10.1371/journal.pntd.0005166				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0IX	WOS:000392158100036	27906979	DOAJ Gold, Green Published			2019-03-26
J	Ravinetto, R; De Weggheleire, A; Dorlo, TPC; Francque, S; Sokkab, A; Pouget, C; Meessen, B; Tabernero, P; Newton, PN; Lynen, L				Ravinetto, Raffaella; De Weggheleire, Anja; Dorlo, Thomas P. C.; Francque, Sven; Sokkab, An; Pouget, Corinne; Meessen, Bruno; Tabernero, Patricia; Newton, Paul N.; Lynen, Lut			Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material							SUBSTANDARD MEDICINES; DRUG; RESISTANCE		[Ravinetto, Raffaella; De Weggheleire, Anja; Lynen, Lut] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Ravinetto, Raffaella] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Dorlo, Thomas P. C.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Dorlo, Thomas P. C.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Francque, Sven] Univ Antwerp, Antwerp, Belgium; [Sokkab, An] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Pouget, Corinne] Inst Trop Med, QUAMED, Antwerp, Belgium; [Meessen, Bruno] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Tabernero, Patricia] INSERM, U1058, Montpellier, France; [Newton, Paul N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Newton, Paul N.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Newton, Paul N.] Univ Oxford, Churchill Hosp, Worldwide Antimalarial Resistance Network, Oxford, England; [Newton, Paul N.] London Sch Hyg & Trop Med, London, England	Ravinetto, R (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	rravinetto@itg.be	Tabernero, Patricia/O-8340-2017; De Weggheleire, Anja/C-7345-2018; Lynen, Lutgarde/A-1212-2014; Dorlo, Thomas/F-1339-2011	Tabernero, Patricia/0000-0002-1015-6207; De Weggheleire, Anja/0000-0001-9377-4766; Lynen, Lutgarde/0000-0001-7183-4895; Meessen, Bruno/0000-0002-0359-8621; Dorlo, Thomas/0000-0003-3076-8435			African Medicines Regulatory Harmonization Initiative (AMRHI), 2008, WHO DRUG INFORM, V22, P182; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; [Anonymous], 2015, NATION; [Anonymous], 2016, SOVALDI COUNTERFEITS; [Anonymous], 2015, FACTORY PRODUCING CO; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Consumers Protection Agency, 2016, WARN COUNT HEP C SOV; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorlo TPC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001544; Edlin Brian R, 2016, Lancet Infect Dis, V16, pe196, DOI 10.1016/S1473-3099(16)30005-6; Edwards DJ, 2015, B WORLD HEALTH ORGAN, V93, P799, DOI 10.2471/BLT.15.157784; Freeman J, 2016, EASL INT LIV C 2016, DOI LB03; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gray AL, 2015, LANCET, V386, P1601, DOI 10.1016/S0140-6736(15)00514-0; Hawkes N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5554; Hepatitis C, 2015, LANCET, V386, P1917; Hill A, 2016, J VIRUS ERAD, V2, P28; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Holmes JA, 2015, HEPATIC MED-EVID RES, V7, P51, DOI 10.2147/HMER.S55864; Jensen DM, 2016, LIVER INT, V36, P925, DOI 10.1111/liv.13120; Kamal-Yanni M, 2015, LANCET GLOB HEALTH, V3, pE73, DOI 10.1016/S2214-109X(14)70365-1; Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481; Maponga C, 2003, QUALITY ANTIMALARIAL; Medecins du Monde (MDM), 2014, NEW TREATM HEP C VIR; Minghetti P, 2010, J PHARM HEALTH SERV, V1, P107, DOI 10.1111/j.1759-8893.2010.00018.x; Newton PN, 2010, TRENDS PHARMACOL SCI, V31, P99, DOI 10.1016/j.tips.2009.11.005; Nishtar S, 2012, LANCET, V379, P1084, DOI 10.1016/S0140-6736(12)60277-3; Otte WM, 2015, LANCET NEUROL, V14, P1075, DOI 10.1016/S1474-4422(15)00255-0; Ravinetto R, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4524; Siederdissen CHZ, 2016, CLIN INFECT DIS, V62, P561, DOI 10.1093/cid/civ973; 't Hoen E, 2015, J PUBLIC HEALTH POL, V36, P384, DOI 10.1057/jphp.2015.22; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; Ward JW, 2015, NEW ENGL J MED, V3, pe676; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2010, WOR HEALT REP, P1; WHO, 2015, 19 WHO MOD LIST ESS; World Health Organization, DEF SSFFC MED PROD; World Health Organization (WHO), PREQ MED PROGR UN PR; World Health Organization (WHO), 2014, PREQ PROGR 12 INV MA	40	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2016	21	12					1490	1495		10.1111/tmi.12784				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EE1KZ	WOS:000389341700001	27671365	Green Published			2019-03-26
J	Kamga, GR; Dissak-Delon, FN; Nana-Djeunga, HC; Biholong, BD; Mbigha-Ghogomu, S; Souopgui, J; Zoure, HGM; Boussinesq, M; Kamgno, J; Robert, A				Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Nana-Djeunga, Hugues C.; Biholong, Benjamin D.; Mbigha-Ghogomu, Stephen; Souopgui, Jacob; Zoure, Honorat G. M.; Boussinesq, Michel; Kamgno, Joseph; Robert, Annie			Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment	PARASITES & VECTORS			English	Article						Onchocerciasis; Ivermectin; Persistence; Elimination; Bafia; Yabassi; Cameroon	AFRICAN PROGRAM; CLINICAL-MANIFESTATIONS; PARTICIPATING COUNTRIES; TREATED POPULATION; 1ST EVIDENCE; VOLVULUS; ELIMINATION; ENDEMICITY; TRANSMISSION; FEASIBILITY	Background: After more than a decade of community-directed treatment with ivermectin (CDTI) in Centre and Littoral Regions of Cameroon, onchocerciasis endemicity was still high in some communities according to the 2011 epidemiological evaluations. Some corrective measures were undertaken to improve the CDTI process and therefore reduce the burden of the disease. The objective of the present study was to assess the progress made towards the elimination of onchocerciasis in the Centre 1 and Littoral 2 CDTI projects where the worst performances were found in 2011. To this end, a cross-sectional survey was conducted in April 2015 in eight communities in two health districts (HD), Bafia in Centre 1 and Yabassi in Littoral 2, chosen because assessed at baseline and in 2011. All volunteers living for at least five years in the community, aged five years or more, underwent clinical and parasitological examinations. Individual compliance to ivermectin treatment was also assessed. Analyses of data were weighted proportionally to age and gender distribution in the population. Results: In the Bafia and Yabassi HD, 514 and 242 individuals were examined with a mean age of 35.1 (standard deviation, SD: 20.7) and 44.6 (SD: 16.3) years, respectively. In the Bafia HD, the weighted prevalences varied from 24.4 to 57.0 % for microfilaridermia and from 3.6 to 37.4 % for nodule presence across the surveyed communities. The community microfilarial load (CMFL), expressed in microfilariae/skin snip (mf/ss), significantly dropped from 20.84-114. 50 mf/ss in 1991 to 0.31-1.62 mf/ss in 2015 in all the surveyed communities. In the Yabassi HD, the weighted prevalences varied from 12.3 to 59.3 % for microfilaridermia and from 1.5 to 3.7 % for nodule presence across the surveyed communities, while a significant drop was observed in CMFL, from 20.40-28.50 mf/ss in 1999 to 0.48-1.74 mf/ss in 2015. The 2014 weighted therapeutic coverage of participants varied from 65.8 % (95 % CI: 58.4-73.2) in Yabassi HD, to 68.0 % (95 % CI: 63.3-72.7) in Bafia HD, with important variations among communities. Conclusions: After more than 15 years of CDTI, onchocerciasis is still mesoendemic in the surveyed communities. Further studies targeting therapeutic coverage, socio-anthropological considerations of CDTI implementation and entomological studies would bring more insights to the persistence of the disease as observed in the present study.	[Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Biholong, Benjamin D.] Minist Publ Hlth, 8 Rue 3038 Quartier Lac, Yaounde, Cameroon; [Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Nana-Djeunga, Hugues C.; Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis CRFilMT, POB 5797, Yaounde, Cameroon; [Kamga, Guy-Roger; Robert, Annie] Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Clos Chapelle Aux Champs 30 Bte B1-30-13, BE-1200 Brussels, Belgium; [Dissak-Delon, Fanny N.; Souopgui, Jacob] Univ Libre Bruxelles, Inst Biol Mol Med, Rue Prof Jeener & Brachet 12, BE-6041 Brussels, Belgium; [Nana-Djeunga, Hugues C.; Kamgno, Joseph] Univ Yaounde I, Fac Med & Biomed Sci, POB 1364, Yaounde, Cameroon; [Mbigha-Ghogomu, Stephen] Univ Buea, Dept Biochem & Mol Biol, Mol & Cell Biol Lab, POB 63, Buea, Cameroon; [Zoure, Honorat G. M.] WHO, APOC, 01 POB 549, Ouagadougou 01, Burkina Faso; [Boussinesq, Michel] Univ Montpellier, INSERM U1175, IRD UMI TransVIHMI 233, IRD, 911 Ave Agropolis,POB 64501, F-34394 Montpellier 5, France	Kamga, GR (reprint author), Minist Publ Hlth, 8 Rue 3038 Quartier Lac, Yaounde, Cameroon.; Kamga, GR (reprint author), Ctr Res Filariasis & Other Trop Dis CRFilMT, POB 5797, Yaounde, Cameroon.; Kamga, GR (reprint author), Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Clos Chapelle Aux Champs 30 Bte B1-30-13, BE-1200 Brussels, Belgium.	guyrogerkgr@gmail.com			Belgian university cooperation; University of Buea; Centre for Research on Filariasis and other Tropical Diseases (CRFilMT); Ministry of Public Health of Cameroon; Universite catholique de Louvain; Universite Libre de Bruxelles	This study was funded by the Belgian university cooperation (http://www.ares-ac.be/fr/cooperation-au-developpement) through the PRD2013 collaborative project between Universite catholique de Louvain, Universite Libre de Bruxelles, the University of Buea, the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT) and the Ministry of Public Health of Cameroon.	Albiez E J, 1988, Trop Med Parasitol, V39 Suppl 4, P331; ALBIEZ EJ, 1985, TROPENMED PARASITOL, V36, P17; Ameh GI, 2008, JOS J MED, V3, P33; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P381; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P382; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P23; [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P577; APOC, 2010, CONC OP FRAM ONCH EL, P24; Boussinesq M, 1992, B LIAISON DOCUMENTAT, V100, P26; Brieger WR, 2007, TROP MED INT HEALTH, V12, P260, DOI 10.1111/j.1365-3165.2006.01796.x; Brieger WR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-152; BUCREP, 2010, PROJ DEM TROIS REC G, P91; CDC, 2013, MMWR-MORBID MORTAL W, V62, P405; Commission of Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ, P1; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DUKE BOL, 1993, TROP MED PARASITOL, V44, P61; Elimination of onchocerciasis in the WHO Region of the Americas, 2014, WKLY EPIDEMIOL REC, V89, P401; EVANS TG, 1995, B WORLD HEALTH ORGAN, V73, P495; Gardon J, 2002, LANCET, V360, P203, DOI 10.1016/S0140-6736(02)09456-4; GTNO, 2015, RAPP TECHN ANN 2014, P70; Hoerauf A, 2003, BRIT MED J, V326, P207, DOI 10.1136/bmj.326.7382.207; Hopkins A, 2011, WATER SANITATION REL, V1, P133; Kamgno J, 2004, T ROY SOC TROP MED H, V98, P496, DOI 10.1016/j.trstmh.2003.10.018; Katabarwa M, 1999, E AFR MED J, V76, P440; Katabarwa M, 2014, LANCET INFECT DIS, V14, P373, DOI 10.1016/S1473-3099(14)70732-7; Katabarwa MN, 2011, AM J TROP MED HYG, V85, P1041, DOI 10.4269/ajtmh.2011.11-0333; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; Murdoch ME, 2010, CURR OPIN INFECT DIS, V23, P124, DOI 10.1097/QCO.0b013e328336a256; Nana-Djeunga HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002824; Newell ED, 1997, B SOC PATHOL EXOT, V90, P107; Newell ED, 1997, TROP MED INT HEALTH, V2, P218, DOI 10.1046/j.1365-3156.1997.d01-263.x; NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; PROST A, 1979, B WORLD HEALTH ORGAN, V57, P655; Prost A., 1978, Medecine Tropicale, V38, P519; Remme JHF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P433; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Rodriguez-Perez MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003922; Stolk WA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1159-9; Tchounkeu YFL, 2012, T ROY SOC TROP MED H, V106, P340, DOI 10.1016/j.trstmh.2012.02.009; Tekle AH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0160-7; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Wanji S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1283-6; WHO, 2014, WKLY EPIDEMIOL REC, V89, P551; World Health Organization (WHO), 2003, INV MENT HLTH, P1; Zoure HGM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-326	49	14	14	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 14	2016	9								581	10.1186/s13071-016-1868-8				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EC5AN	WOS:000388145600005	27842567	DOAJ Gold, Green Published			2019-03-26
J	Faway, E; Musset, L; Pelleau, S; Volney, B; Casteras, J; Caro, V; Menard, D; Briolant, S; Legrand, E				Faway, Emilie; Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Casteras, Jessica; Caro, Valerie; Menard, Didier; Briolant, Sebastien; Legrand, Eric			Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana	MALARIA JOURNAL			English	Article							RESISTANT PLASMODIUM-VIVAX; WESTERN BRAZILIAN AMAZON; MALARIA-ENDEMIC AREA; DRUG-RESISTANCE; CHLOROQUINE RESISTANCE; PVCRT-O; MULTIDRUG-RESISTANCE; FALCIPARUM; PVMDR1; AMPLIFICATION	Background: Plasmodium vivax malaria is a major public health problem in French Guiana. Some cases of resistance to chloroquine, the first-line treatment used against P. vivax malaria, have been described in the Brazilian Amazon region. The aim of this study is to investigate a possible dispersion of chloroquine-resistant P. vivax isolates in French Guiana. The genotype, polymorphism and copy number variation, of the P. vivax multidrug resistance gene-1 (pvmdr1) have been previously associated with modification of the susceptibility to chloroquine. Methods: The pvmdr1 gene polymorphism was evaluated by sequencing and copy number variation was assessed by real-time PCR, in P. vivax isolates obtained from 591 symptomatic patients from 1997 to 2013. Results: The results reveal that 1.0% [95% CI 0.4-2.2] of French Guiana isolates carry the mutations Y976F and F1076L, and that the proportion of isolates with multiple copies of pvmdr1 has significantly decreased over time, from 71.3% (OR = 6.2 [95% CI 62.9-78.7], p < 0.0001) in 1997-2004 to 12.8% (OR = 0.03 [95% CI 9.4-16.9], p < 0.0001) in 2009-2013. A statistically significant relationship was found between Guf-A (harboring the single mutation T958M) and Sal-1 (wild type) alleles and pvmdr1 copy number. Conclusions: Few P. vivax isolates harboring chloroquine-resistant mutations in the pvmdr1 gene are circulating in French Guiana. However, the decrease in the prevalence of isolates carrying multiple copies of pvmdr1 might indicate that the P. vivax population in French Guiana is evolving towards a decreased susceptibility to chloroquine.	[Faway, Emilie; Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Casteras, Jessica; Briolant, Sebastien; Legrand, Eric] Inst Pasteur, Lab Parasitol, Cayenne, French Guiana; [Faway, Emilie] Univ Namur, URPhyM NARILIS, Namur, Belgium; [Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Casteras, Jessica; Legrand, Eric] Inst Pasteur, Natl Reference Ctr Malaria, Cayenne, French Guiana; [Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Legrand, Eric] Inst Pasteur, World Hlth Org, Collaborating Ctr Surveillance Antimalarial Drug, Cayenne, French Guiana; [Caro, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Genotyping Pathogens Pole, Paris, France; [Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Menard, Didier] Inst Pasteur Cambodia, Malaria Translat Res Unit, Phnom Penh, Cambodia; [Briolant, Sebastien] Direct Interarmees Serv Sante, Cayenne, French Guiana; [Briolant, Sebastien] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Legrand, Eric] Inst Pasteur, Malaria Translat Res Unit, Paris, France; [Legrand, Eric] Inst Pasteur, Genet & Genom Insect Vectors Unit, Paris, France	Legrand, E (reprint author), Inst Pasteur, Genet & Genom Insect Vectors Unit, Paris, France.	eric.legrand@pasteur.fr	Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495; Legrand, Eric/0000-0003-4725-0712	Institut de Veille Sanitaire (French Ministry of Health); French Army [LR607e]; European grant [REGPOT-CT-2011-285837-STRONGER]; European Union (Lifelong Learning Programme)	This work benefited from funding from the Institut de Veille Sanitaire (French Ministry of Health) and the French Army (Grant LR607e). SP was financed by European grant managed by the European Commission (REGPOT-CT-2011-285837-STRONGER). EF was financed by the European Union (Lifelong Learning Programme).	ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Chehuan YF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-226; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; de Santi VP, 2016, EMERG INFECT DIS, V22, P903, DOI 10.3201/eid2205.151957; de Santi VP, 2016, EMERG INFECT DIS, V22, P344, DOI 10.3201/eid2202.151292; del Carmen R, 2012, AM J TROP MED HYG, V87, P813, DOI 10.4269/ajtmh.2012.12-0094; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020; Gama BE, 2009, MEM I OSWALDO CRUZ, V104, P1009, DOI 10.1590/S0074-02762009000700012; GARAVELLI PL, 1992, T ROY SOC TROP MED H, V86, P128, DOI 10.1016/0035-9203(92)90535-K; Gomes LR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1141-9; Graf Paul C F, 2012, Malar Res Treat, V2012, P936067, DOI 10.1155/2012/936067; Guthmann JP, 2008, TROP MED INT HEALTH, V13, P91, DOI 10.1111/j.1365-3156.2007.01978.x; Hupalo DN, 2016, NAT GENET, V48, P953, DOI 10.1038/ng.3588; Imwong M, 2008, ANTIMICROB AGENTS CH, V52, P2657, DOI 10.1128/AAC.01459-07; Jovel IT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-376; Ketema T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-177; Khatoon L, 2009, AM J TROP MED HYG, V81, P525, DOI 10.4269/ajtmh.2009.81.525; Khim N, 2014, EMERG INFECT DIS, V20, P1637, DOI 10.3201/eid2010.140411; Kim YK, 2011, AM J TROP MED HYG, V84, P532, DOI 10.4269/ajtmh.2011.10-0486; Kurcer MA, 2006, ANN TROP MED PARASIT, V100, P109, DOI 10.1179/136485906X86284; Legrand E, 2008, ANTIMICROB AGENTS CH, V52, P288, DOI 10.1128/AAC.00263-07; Legrand E, 2012, ANTIMICROB AGENTS CH, V56, P1382, DOI 10.1128/AAC.05280-11; Lekweiry KM, 2012, J ANTIMICROB CHEMOTH, V67, P367, DOI 10.1093/jac/dkr464; Lu F, 2011, ACTA TROP, V117, P69, DOI 10.1016/j.actatropica.2010.08.011; Marques MM, 2014, ANTIMICROB AGENTS CH, V58, P342, DOI 10.1128/AAC.02279-12; Melo GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105922; Musset L, 2014, MEM I OSWALDO CRUZ, V109, P525, DOI 10.1590/0074-0276140031; National Reference Centre for Malaria, 2015, NAT REF CTR MAL 2014; Orjuela-Sanchez P, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-65; Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09; Pearson RD, 2016, NAT GENET, V48, P959, DOI 10.1038/ng.3599; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171, DOI 10.1093/clinids/23.5.1171; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; RIECKMANN KH, 1989, LANCET, V2, P1183; Rungsihirunrat K, 2015, KOREAN J PARASITOL, V53, P43, DOI 10.3347/kjp.2015.53.1.43; Schousboe ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004196; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; World Health Organization, 2016, WORLD MALARIA REPORT, P1, DOI DOI 10.1017/CBO9781107415324.004	48	5	6	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 8	2016	15								540	10.1186/s12936-016-1595-9				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EC5AA	WOS:000388144300005	27825387	DOAJ Gold, Green Published			2019-03-26
J	Radin, K; Clement, F; Jongert, E; Sterckx, YGJ; Ockenhouse, C; Regules, J; Lemiale, F; Leroux-Roels, G				Radin, Kristina; Clement, Frederic; Jongert, Erik; Sterckx, Yann G. J.; Ockenhouse, Christian; Regules, Jason; Lemiale, Franck; Leroux-Roels, Geert			A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum	MALARIA JOURNAL			English	Article						Malaria; Competition ELISA; Enzyme-linked immunosorbent assay; Immunoassay; Circumsporozoite protein	CANDIDATE MALARIA VACCINE; DOUBLE-BLIND; IMMUNE-RESPONSE; NAIVE ADULTS; EFFICACY; SAFETY; TRIAL; IMMUNOGENICITY; IMMUNIZATION; INFECTION	Background: The malaria vaccine candidate RTS, S/AS01 (GSK Vaccines) induces high IgG concentration against the circumsporozoite protein (CSP) of Plasmodium falciparum. In human vaccine recipients circulating anti-CSP antibody concentrations are associated with protection against infection but appear not to be the correlate of protection. However, in a humanized mouse model of malaria infection prophylactic administration of a human monoclonal antibody (MAL1C), derived from a RTS, S/AS01-immunized volunteer, directed against the CSP repeat region, conveyed full protection in a dose-dependent manner suggesting that antibodies alone are able to prevent P. falciparum infection when present in sufficiently high concentrations. A competition ELISA was developed to measure the presence of MAL1C-like antibodies in polyclonal sera from RTS, S/AS01 vaccine recipients and study their possible contribution to protection against infection. Results: MAL1C-like antibodies present in polyclonal vaccine-induced sera were evaluated for their ability to compete with biotinylated monoclonal antibody MAL1C for binding sites on the capture antigen consisting of the recombinant protein encompassing 32 NANP repeats of CSP (R32LR). Serum samples were taken at different time points from participants in two RTS, S/AS01 vaccine studies (NCT01366534 and NCT01857869). Vaccine-induced protection status of the study participants was determined based on the outcome of experimental challenge with infected mosquito bites after vaccination. Optimal conditions were established to reliably detect MAL1C-like antibodies in polyclonal sera. Polyclonal anti-CSP antibodies and MAL1C-like antibody content were measured in 276 serum samples from RTS, S/AS01 vaccine recipients using the standard ELISA and MAL-1C competition ELISA, respectively. A strong correlation was observed between the results from these assays. However, no correlation was found between the results of either assay and protection against infection. Conclusions: The competition ELISA to measure MAL1C-like antibodies in polyclonal sera from RTS, S/AS01 vaccine recipients was robust and reliable but did not reveal the elusive correlate of protection.	[Radin, Kristina; Clement, Frederic; Leroux-Roels, Geert] Univ Ghent, Ctr Vaccinol CEVAC, Ghent, Belgium; [Jongert, Erik] GSK Vaccines, Rue Inst 89, B-1330 Rixensart, Belgium; [Sterckx, Yann G. J.] VIB, SBRC, Pl Laan 2, B-1050 Brussels, Belgium; [Sterckx, Yann G. J.] VUB, Res Unit Cellular & Mol Immunol CMIM, Pl Laan 2, B-1050 Brussels, Belgium; [Ockenhouse, Christian; Lemiale, Franck] PATH Malaria Vaccine Initiat MVI, 455 Massachusetts Ave NW, Washington, DC 20001 USA; [Regules, Jason] WRAIR, 503 Robert Grant Ave, Silver Spring, MD 20910 USA	Leroux-Roels, G (reprint author), Univ Ghent, Ctr Vaccinol CEVAC, Ghent, Belgium.	geert.lerouxroels@ugent.be	Sterckx, Yann/F-2269-2017; Clement, Frederic/B-2204-2009	Sterckx, Yann/0000-0002-7420-0983; Clement, Frederic/0000-0002-2720-3655	CEVAC; GlaxoSmithKline Biologicals SA	Funding for this work was provided by CEVAC and GlaxoSmithKline Biologicals SA. Experiments were reviewed and approved by the joint GSK-MVI RTS,S Immune Correlates of Protection Task Force.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Ballou RW, 2009, MALARIA J, V8, P312; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Birkett AJ, 2013, VACCINE, V31, pB233, DOI 10.1016/j.vaccine.2013.02.040; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Clinical S., 2015, LANCET, V386, P31; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Depraetere S, 2001, J IMMUNOL, V166, P2929, DOI 10.4049/jimmunol.166.5.2929; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; FOLENAWASSERMAN G, 1987, J CHROMATOGR, V411, P345, DOI 10.1016/S0021-9673(00)93985-2; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Leroux-Roels G, 2014, HUM VACC IMMUNOTHER, V10, P2211, DOI 10.4161/hv.29375; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571; Olotu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115126; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI [10.1016/S1473-3099(10)70262-0, 10.1016/51473-3099(10)70262-0]; Ramasamy R, 1998, BBA-MOL BASIS DIS, V1406, P10, DOI 10.1016/S0925-4439(97)00078-1; Reeder JC, 1996, IMMUNOL CELL BIOL, V74, P546, DOI 10.1038/icb.1996.88; Regules JA, 2016, J INFECT DIS, V214, P762, DOI 10.1093/infdis/jiw237; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; The RTS S Clinical Trials Partnership, 2012, NEW ENGL J MED, V367, P2284, DOI DOI 10.1056/NEJM0A1208394; World Health Organization, WORLD MAL REP 2015	35	3	3	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 8	2016	15								543	10.1186/s12936-016-1596-8				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EC5AA	WOS:000388144300008	27825382	DOAJ Gold, Green Published			2019-03-26
J	Lebbe, EKM; Tytgat, J				Lebbe, Eline K. M.; Tytgat, Jan			In the picture: disulfide-poor conopeptides, a class of pharmacologically interesting compounds	JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES			English	Review						Cone snail; Conopressin; Contryphan; Conantokin; Contulakin; Conorfamid; Conophan; Conomap; Conomarphin; Conolysin; ConoGAY; ConoCAP; Cono-NPY	ACID-CONTAINING CONTRYPHAN; NMDA RECEPTOR ANTAGONIST; CONTAINING CONUS PEPTIDE; D-ASPARTATE RECEPTORS; LYS-CONOPRESSIN-G; D-AMINO-ACID; GAMMA-CARBOXYGLUTAMATE; CONANTOKIN-G; D-TRYPTOPHAN; STRUCTURAL-CHARACTERIZATION	During evolution, nature has embraced different strategies for species to survive. One strategy, applied by predators as diverse as snakes, scorpions, sea anemones and cone snails, is using venom to immobilize or kill a prey. This venom offers a unique and extensive source of chemical diversity as it is driven by the evolutionary pressure to improve prey capture and/or to protect their species. Cone snail venom is an example of the remarkable diversity in pharmacologically active small peptides that venoms can consist of. These venom peptides, called conopeptides, are classified into two main groups based on the number of cysteine residues, namely disulfide-rich and disulfide-poor conopeptides. Since disulfide-poor conotoxins are minor components of this venom cocktail, the number of identified peptides and the characterization of these peptides is far outclassed by its cysteine-rich equivalents. This review provides an overview of 12 families of disulfide-poor peptides identified to date as well as the state of affairs.	[Lebbe, Eline K. M.; Tytgat, Jan] Katholieke Univ Leuven, Toxicol & Pharmacol, O&N2,Box 922,Herestr 49, B-3000 Leuven, Belgium	Tytgat, J (reprint author), Katholieke Univ Leuven, Toxicol & Pharmacol, O&N2,Box 922,Herestr 49, B-3000 Leuven, Belgium.	jan.tytgat@kuleuven.be			F.W.O. Vlaanderen [G.0433.12, GOE3414N]; EU-FP7-MAREX (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy) [IUAP 7/10]; KU Leuven [OT/12/081]	This work was supported by the following grants: G.0433.12, GOE3414N (F.W.O. Vlaanderen), EU-FP7-MAREX, IUAP 7/10 (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy) and OT/12/081 (KU Leuven).	Aguilar MB, 2008, PEPTIDES, V29, P186, DOI 10.1016/j.peptides.2007.09.022; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Banerjee P, 2017, GEN COMP ENDOCR, V241, P4, DOI 10.1016/j.ygcen.2016.04.025; Benarroch EE, 2009, NEUROLOGY, V72, P1016, DOI 10.1212/01.wnl.0000345258.18071.54; Bialer M, 2002, EPILEPSY RES, V51, P31, DOI 10.1016/S0920-1211(02)00106-7; Biggs JS, 2007, BIOCHEMISTRY-US, V46, P12586, DOI 10.1021/bi700775p; Brain SD, 2006, BRIT J PHARMACOL, V147, pS202, DOI 10.1038/sj.bjp.0706461; Chartrel N, 2011, FRONT NEUROENDOCRIN, V32, P387, DOI 10.1016/j.yfrne.2011.04.001; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Craik DJ, 2007, ACS CHEM BIOL, V2, P457, DOI 10.1021/cb700091j; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dockray GJ, 2004, EXP PHYSIOL, V89, P229, DOI 10.1113/expphysiol.2004.027169; Donevan SD, 2000, MOL PHARMACOL, V58, P614; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Elphick MR, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00093; Findeisen M, 2011, CHEMMEDCHEM, V6, P1081, DOI 10.1002/cmdc.201100089; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Gowd KH, 2008, TOXICON, V52, P203, DOI 10.1016/j.toxicon.2008.04.178; Grant MA, 2004, J BIOL CHEM, V279, P32464, DOI 10.1074/jbc.M313826200; HAACK JA, 1990, J BIOL CHEM, V265, P6025; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Han YH, 2008, FEBS J, V275, P1976, DOI 10.1111/j.1742-4658.2008.06352.x; Hansson K, 2004, J BIOL CHEM, V279, P32453, DOI 10.1074/jbc.M313825200; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; Hokfelt T, 2008, NUTRITION, V24, P860, DOI 10.1016/j.nut.2008.06.010; Huang FJ, 2009, TOXICON, V54, P153, DOI 10.1016/j.toxicon.2009.03.033; Jacobsen R, 1998, J PEPT RES, V51, P173; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Jimenez EC, 1997, BIOCHEMISTRY-US, V36, P989, DOI 10.1021/bi962840p; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; Jimenez EC, 2002, EPILEPSY RES, V51, P73, DOI 10.1016/S0920-1211(02)00101-8; Jimenez EC, 2001, TOXICON, V39, P803, DOI 10.1016/S0041-0101(00)00210-5; Kern SE, 2007, ANESTH ANALG, V104, P1514, DOI 10.1213/01.ane.0000262038.58546.e6; Layer RT, 2006, MAR DRUGS, V4, P119; Layer RT, 2004, CURR MED CHEM, V11, P3073, DOI 10.2174/0929867043363901; Lebbe EKM, 2016, DRUGS, V14, P199, DOI [10.3390/md14110199, DOI 10.3390/MD14110199]; Lee HK, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00011; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; LI KW, 1993, BIOCHEM BIOPH RES CO, V197, P1056, DOI 10.1006/bbrc.1993.2585; Maillo M, 2002, TOXICON, V40, P401, DOI 10.1016/S0041-0101(01)00176-3; Martinez-Mir I, 2002, INFLAMM RES, V51, P587, DOI 10.1007/PL00012433; Massilia GR, 2003, BIOCHEM BIOPH RES CO, V303, P238, DOI 10.1016/S0006-291X(03)00331-0; Massilia GR, 2001, BIOCHEM BIOPH RES CO, V288, P908, DOI 10.1006/bbrc.2001.5833; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; MCMASTER D, 1992, PEPTIDES, V13, P413, DOI 10.1016/0196-9781(92)90069-F; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; Moller C, 2007, BIOCHEM J, V404, P413, DOI 10.1042/BJ20061480; Moller C, 2010, J BIOL CHEM, V285, P40673, DOI 10.1074/jbc.M110.171397; MUIR KW, 1994, BRIT J CLIN PHARMACO, V38, P33, DOI 10.1111/j.1365-2125.1994.tb04318.x; Nepravishta R, 2014, AMINO ACIDS, V46, P2841, DOI 10.1007/s00726-014-1841-9; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Pallaghy PK, 1999, BIOCHEMISTRY-US, V38, P11553, DOI 10.1021/bi990685j; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Puillandre N, 2012, J MOL EVOL, V74, P297, DOI 10.1007/s00239-012-9507-2; Rajesh RP, 2015, J PEPT SCI, V21, P29, DOI 10.1002/psc.2715; RIVIER J, 1987, BIOCHEMISTRY-US, V26, P8508, DOI 10.1021/bi00400a002; Robinson SD, 2017, GEN COMP ENDOCR, V244, P11, DOI 10.1016/j.ygcen.2015.07.012; Robinson SD, 2015, J PROTEOMICS, V114, P38, DOI 10.1016/j.jprot.2014.11.003; Sabareesh V, 2006, PEPTIDES, V27, P2647, DOI 10.1016/j.peptides.2006.07.009; SALZET M, 1993, EUR J BIOCHEM, V217, P897, DOI 10.1111/j.1432-1033.1993.tb18319.x; Schrodinger L., PYMOL MOL GRAPHICS S; Skjaerbaek N, 1997, J BIOL CHEM, V272, P2291; SVEINBJORNSDOTTIR S, 1993, EPILEPSY RES, V16, P165, DOI 10.1016/0920-1211(93)90031-2; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Thakur SS, 2007, RAPID COMMUN MASS SP, V21, P3420, DOI 10.1002/rcm.3225; Twede VD, 2009, BIOCHEMISTRY-US, V48, P4063, DOI 10.1021/bi802259a; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Ukena K, 1997, CELL TISSUE RES, V288, P567, DOI 10.1007/s004410050842; van Kesteren RE, P NATL ACAD SCI US; VANKESTEREN RE, 1995, J NEUROSCI, V15, P5989; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; White HS, 2000, J PHARMACOL EXP THER, V292, P425; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu XC, 2010, ACTA BIOCH BIOPH SIN, V42, P502, DOI 10.1093/abbs/gmq042; Zhang L, 2010, PEPTIDES, V31, P177, DOI 10.1016/j.peptides.2009.10.017; Zhou LM, 1996, J NEUROCHEM, V66, P620	84	11	11	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1678-9199			J VENOM ANIM TOXINS	J. Venom. Anim. Toxins Trop. Dis.	NOV 7	2016	22								30	10.1186/s40409-016-0083-6				15	Toxicology; Tropical Medicine; Zoology	Toxicology; Tropical Medicine; Zoology	EB8EB	WOS:000387622700001	27826319	DOAJ Gold, Green Published			2019-03-26
J	Kerkhof, K; Sluydts, V; Willen, L; Kim, S; Canier, L; Heng, S; Tsuboi, T; Sochantha, T; Sovannaroth, S; Menard, D; Coosemans, M; Durnez, L				Kerkhof, Karen; Sluydts, Vincent; Willen, Laura; Kim, Saorin; Canier, Lydie; Heng, Somony; Tsuboi, Takafumi; Sochantha, Tho; Sovannaroth, Siv; Menard, Didier; Coosemans, Marc; Durnez, Lies			Serological markers to measure recent changes in malaria at population level in Cambodia	MALARIA JOURNAL			English	Article						Malaria; Serological markers; Malaria transmission; Half life	PLASMODIUM-FALCIPARUM TRANSMISSION; MASS-SPECTROMETRY DATA; MULTIPLEX ASSAY; ANTIBODY-RESPONSES; ERYTHROCYTE INVASION; QUANTILE REGRESSION; CLINICAL MALARIA; RISK-FACTORS; VIVAX; ANTIGENS	Background: Serological markers for exposure to different Plasmodium species have recently been used in multiplex immunoassays based on the Luminex technology. However, interpretation of the assay results requires consideration of the half-life of specific antibodies against these markers. Therefore, the aim of the present study was to document the half-life of malaria specific serological makers, as well as assessing the sensitivity of these markers to pick up recent changes in malaria exposure. Methods: A recently developed multiplex immunoassay was used to measure the intensity of antibody (Ab) responses against 19 different Plasmodium specific antigens, covering different human malaria parasites and two vector saliva antigens. Therefore, 8439 blood samples from five cross-sectional surveys in Ratanakiri, Cambodia, were analysed. These involve a random selection from two selected surveys, and an additional set of blood samples of individuals that were randomly re-sampled three, four or five times. A generalized estimating equation model and linear regression models were fitted on log transformed antibody intensity data. Results: Results showed that most (17/21) Ab-responses are higher in PCR positive than PCR negative individuals. Furthermore, these antibody-responses follow the same upward trend within each age group. Estimation of the half-lives showed differences between serological markers that reflect short-(seasonal) and long-term (year round) transmission trends. Ab levels declined significantly together with a decrease of PCR prevalence in a group of malaria endemic villages. Conclusion: For Plasmodium falciparum, antibodies against LSA3. RE, GLURP and Pf.GLURP.R2 are most likely to be a reflexion of recent (range from 6 to 8 months) exposure in the Mekong Subregion. PvEBP is the only Plasmodium vivax Ag responding reasonably well, in spite of an estimated Ab half-life of more than 1 year. The use of Ab intensity data rather dichotomizing the continuous Ab-titre data (positive vs negative) will lead to an improved approach for serological surveillance.	[Kerkhof, Karen; Sluydts, Vincent; Willen, Laura; Coosemans, Marc; Durnez, Lies] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kerkhof, Karen; Willen, Laura; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Kim, Saorin; Canier, Lydie; Menard, Didier] Inst Pasteur Cambodge, Mol Epidemiol Unit, Phnom Penh, Cambodia; [Heng, Somony; Sochantha, Tho; Sovannaroth, Siv] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Tsuboi, Takafumi] Ehime Univ, Div Malaria Res, Proteosci Ctr, Matsuyama, Ehime, Japan	Kerkhof, K; Durnez, L (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Kerkhof, K (reprint author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	kkerkhof@itg.be; ldurnez@itg.be	Willen, Laura/B-2977-2018; Menard, Didier/O-3294-2013	Willen, Laura/0000-0002-8027-8621; Kerkhof, Karen/0000-0002-2208-9902; Menard, Didier/0000-0003-1357-4495	Bill & Melinda Gates Foundation [OPP1032354]; association of Les Amis des Instituts Pasteur a Bruxelles	"This work is part of a larger project ""MalaResT"" funded by the Bill & Melinda Gates Foundation under the Global Health Grant number OPP1032354. This project aims to evaluate the effectiveness of topical repellents, in addition to long-lasting insecticidal nets, on malaria prevalence and incidence. Next, this work fits within the large-scale research project for the SOFI research program ""MalaSpot"" entitled 'Eco-epidemiology of asymptomatic malaria hotspots, a prerequisite for malaria elimination?'. Furthermore, KK was supported by the association of Les Amis des Instituts Pasteur a Bruxelles."	Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Andraud M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002418; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Badu K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-50; Bates D, 2015, J STAT SOFTW, V67, P1; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Cheng Y, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-323; Cho HJ, OUTLIERD OUTLIER DET; Cho HJ, 2008, BIOINFORMATICS, V24, P882, DOI 10.1093/bioinformatics/btn012; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; de Souza JB, 2002, INFECT IMMUN, V70, P5045, DOI 10.1128/IAI.70.9.5045-5051.2002; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Elliott Salenna R, 2014, F1000Prime Rep, V6, P100, DOI 10.12703/P6-100; Eo Soo-Heang, 2012, BMC Res Notes, V5, P236, DOI 10.1186/1756-0500-5-236; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fowkes FJI, 2012, J INFECT DIS, V206, P1612, DOI 10.1093/infdis/jis566; Frank Jr E. H., 2015, HMISC HARRELL MISCEL; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Halekoh U, 2006, J STAT SOFTW, V15, P1; Helb DA, 2015, P NATL ACAD SCI USA, V112, pE4438, DOI 10.1073/pnas.1501705112; Henry-Halldin CN, 2011, INFECT GENET EVOL, V11, P391, DOI 10.1016/j.meegid.2010.11.010; Hens N, 2012, STAT BIOL HLTH, V63, P316; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Hviid L, 2015, TRENDS PARASITOL, V31, P89, DOI 10.1016/j.pt.2014.12.009; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z; Khaireh BA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-395; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Koffi D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1043-2; Kusi KA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-103; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Ministry of Health, 2010, MIN HLTH STRAT MAST; Ondigo BN, 2014, J INFECT DIS, V210, P1123, DOI 10.1093/infdis/jiu225; Ondigo BN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-427; Orlandi-Pradines E, 2006, AM J TROP MED HYG, V74, P979; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; R Core Team, 2015, R LANG ENV STAT COMP; Rogier E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0955-1; Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-377; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Sutherland CJ, 2009, MOL BIOCHEM PARASIT, V166, P93, DOI 10.1016/j.molbiopara.2009.03.007; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; Theisen M, 2000, VACCINE, V19, P204, DOI 10.1016/S0264-410X(00)00181-X; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; van den Hoogen LL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0939-1; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; von Fricken ME, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-361; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; WHO, 2015, STRAT MAL EL GREAT M; WHO, 2015, WORLD MAL REP 2015; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wong J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-451; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2/3, P12; Yman V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19472; Zenonos ZA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-93; Zeyrek FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028126	82	8	8	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 4	2016	15								529	10.1186/s12936-016-1576-z				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EC4ZY	WOS:000388144100003	27809852	DOAJ Gold, Green Published			2019-03-26
J	Dieye, B; Affara, M; Sangare, L; Joof, F; Ndiaye, YD; Gomis, JF; Ndiaye, M; Mbaye, A; Diakite, M; Sy, N; Mbengue, B; Deme, AB; Daniels, R; Ahouidi, AD; Dieye, T; Abdullahi, A; Doumbia, S; Ndiaye, JL; Diarra, A; Ismaela, A; Coulibaly, M; Welty, C; Ngwa, AA; Shaffer, J; D'Alessandro, U; Volkman, SK; Wirth, DF; Krogstad, DJ; Koita, O; Nwakanma, D; Ndiayel, D				Dieye, Baba; Affara, Muna; Sangare, Lassana; Joof, Fatou; Ndiaye, Yaye D.; Gomis, Jules F.; Ndiaye, Mouhamadou; Mbaye, Aminata; Diakite, Mouhamadou; Sy, Ngayo; Mbengue, Babacar; Deme, Awa B.; Daniels, Rachel; Ahouidi, Ambroise D.; Dieye, Tandakha; Abdullahi, Ahmad; Doumbia, Seydou; Ndiaye, Jean L.; Diarra, Ayouba; Ismaela, Abubakar; Coulibaly, Mamadou; Welty, Clint; Ngwa, Alfred Amambua; Shaffer, Jeftley; D'Alessandro, Umberto; Volkman, Sarah K.; Wirth, Dyann F.; Krogstad, Donald J.; Koita, Ousmane; Nwakanma, Davis; Ndiayel, Daouda			West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIHYDROARTEMISININ-PIPERAQUINE; CHLOROQUINE SUSCEPTIBILITY; ARTEMISININ RESISTANCE; INCREASED SENSITIVITY; COMBINATION THERAPY; UGANDAN CHILDREN; RANDOMIZED-TRIAL; PFMDR1 GENE; TRANSMISSION	In 2006, artemether lumefantrine (AL) became the first-line treatment of uncomplicated malaria in Senegal, Mali, and the Gambia. To monitor its efficacy, between August 2011 and November 2014, children with uncomplicated Plasmodium falciparum malaria were treated with AL and followed up for 42 days. A total of 463 subjects were enrolled in three sites (246 in Senegal, 97 in Mali, and 120 in Gambia). No early treatment failure was observed and malaria infection cleared in all patients by day 3. Polymerase chain reaction (PCR)-adjusted adequate clinical and parasitological response (ACPR) was 100% in Mali, and the Gambia, and 98.8% in Senegal. However, without PCR adjustment, ACPR was 89.4% overall; 91.5% in Mali, 98.8% in Senegal, and 64.3% in the Gambia (the lower value in the Gambia attributed to poor compliance of the full antimalarial course). However, pfmdrl mutations were prevalent in Senegal and a decrease in parasite sensitivity to artesunate and lumefantrine (as measured by ex vivo drug assay) was observed at all sites. Recrudescent parasites did not show Kelch 13 (K13) mutations and AL remains highly efficacious in these west African sites.	[Dieye, Baba; Ndiaye, Yaye D.; Gomis, Jules F.; Ndiaye, Mouhamadou; Mbaye, Aminata; Sy, Ngayo; Mbengue, Babacar; Deme, Awa B.; Ahouidi, Ambroise D.; Dieye, Tandakha; Ndiaye, Jean L.; Ndiayel, Daouda] Cheikh Anta Diop Univ, Dakar, Fann, Senegal; [Welty, Clint; Shaffer, Jeftley; Krogstad, Donald J.] Tulane Univ, New Orleans, LA 70118 USA; [Sangare, Lassana; Diakite, Mouhamadou; Doumbia, Seydou; Diarra, Ayouba; Coulibaly, Mamadou; Koita, Ousmane] Univ Bamako, BP 1805, Bamako, Mali; [Affara, Muna; Joof, Fatou; Abdullahi, Ahmad; Ismaela, Abubakar; Ngwa, Alfred Amambua; D'Alessandro, Umberto; Nwakanma, Davis] MRC, Serekunda, Gambia; [Daniels, Rachel; Volkman, Sarah K.; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Volkman, Sarah K.; Wirth, Dyann F.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England; [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium; MRC Unit, Atlantic Blvd, Banjul, Gambia	Ndiayel, D (reprint author), Ave Cheikh Anta Diop Univ,POB 5005, Dakar, Senegal.	dieyebaba2004@yahoo.fr; maffara@mrc.gm; lansana.sangare@gmail.com; fajoof@mrc.gm; ydndiaye@gmail.com; jules.gomis@gmail.com; mouhamadou.ndiaye@ucad.edu.sn; natou5002@yahoo.fr; mdiakite@icermali.org; ngayosy50@hotmail.com; b.mbengue@yahoo.fr; deme.awa@gmail.com; rdaniels@broadinstitute.org; aahouidi@gmail.com; tandakha.dieye@ucad.edu.sn; angwa@mrc.gm; sdoumbi@gmail.com; jeanloab.ndiaye@ucad.edu.sn; adiarra@icemrwaf.org; udalessandro@mrc.gm; doudou@icermali.org; cwelty@icemrwaf.org; dnwakanma@mrc.gm; jshaffer@tulane.edu; svolkman@hsph.harvard.edu; dfwirth@hsph.harvard.edu; donkrogstad@gmail.com; okoita@icermali.org; dndiaye@hsph.harvard.edu		Nwakanma, Davis/0000-0002-6706-6069; Ndiaye, Jean/0000-0003-0450-5551	NIH/ICEMR, International Centre of Excellence for Malaria Research, west Africa [U19AI089696]; Medical Research Council [MC_UP_A900_1119, MC_EX_MR/K02440X/1]	The work was supported by the NIH/ICEMR, International Centre of Excellence for Malaria Research, west Africa (U19AI089696).	Adjuik M, 2004, LANCET, V363, P9; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI 10.1111/j.1365-3165.2006.01784.x; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Daniels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060780; Daniels R, 2012, ANTIMICROB AGENTS CH, V56, P2976, DOI 10.1128/AAC.05737-11; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorkenoo MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-338; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Dunyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017371; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Faye B, 2011, MALARIA J, V10, P237; Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80; Getnet G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0775-3; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Ly O, 2012, PARASITOL RES, V111, P1541, DOI 10.1007/s00436-012-2994-7; Mens PF, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-237; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Ndiaye M, 2012, AM J TROP MED HYG, V87, P640, DOI 10.4269/ajtmh.2012.11-0709; Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649; Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48; Sogoba N, 2007, ACTA TROP, V101, P232, DOI 10.1016/j.actatropica.2007.02.005; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Toure OA, 2011, TROP MED INT HEALTH, V16, P290, DOI 10.1111/j.1365-3156.2010.02701.x; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Tumwebaze P, 2015, ANTIMICROB AGENTS CH, V59, P3018, DOI 10.1128/AAC.05141-14; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153, DOI 10.4269/ajtmh.2007.77.153; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682; WHO, 2009, METH SURV ANT DRUG E; *WHO, 2005, WORLD MAL REP; Wilson PE, 2005, TRENDS PARASITOL, V21, P278, DOI 10.1016/j.pt.2005.04.007; World Health Organization, 2009, MAL MICR QUAL ASS MA; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985	45	2	3	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2016	95	5					1054	1060		10.4269/ajtmh.16-0053				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VC	WOS:000400206600020	27549635	Bronze, Green Published			2019-03-26
J	George, S; Geldhof, P; Albonico, M; Ame, SM; Bethony, JM; Engels, D; Mekonnen, Z; Montresor, A; Hem, S; Tchuem-Tchuente, LA; Huong, NT; Kang, G; Vercruysse, J; Levecke, B				George, Santosh; Geldhof, Peter; Albonico, Marco; Ame, Shaali M.; Bethony, Jeffrey M.; Engels, Dirk; Mekonnen, Zeleke; Montresor, Antonio; Hem, Sopheak; Tchuem-Tchuente, Louis-Albert; Nguyen Thu Huong; Kang, Gagandeep; Vercruysse, Jozef; Levecke, Bruno			The molecular speciation of soil-transmitted helminth eggs collected from school children across six endemic countries	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Ascaris lumbricoides; Trichiuris trichiura; Trichuris vulpis; Necator americanus; Ancylostoma duodenale; Zoonosis	ANCYLOSTOMA-CEYLANICUM; TRICHURIS-TRICHIURA; HOOKWORM INFECTION; RURAL-COMMUNITY; ASCARIS-SUUM; PCR-RFLP; HUMANS; TRANSMISSION; DOGS; IDENTIFICATION	Background: The diagnosis of soil-transmitted helminths (STHs; Ascaris, Trichuris and hookworms) is traditionally based on the demonstration of eggs in stool using microscopic techniques. While molecular techniques are more appropriate to speciate STH species they are seldom applied. In this study we speciated STH eggs from stool using molecular techniques to gain insights into the distribution of both human and animal STH species in the human host. Methods: We speciated 207 STH egg isolates from stool collected during the baseline survey of six drug efficacy trials conducted in Brazil, Cambodia, Cameroon, Ethiopia, Tanzania and Vietnam applying a PCR -restriction fragment length polymorphisms based approach. Results: DNA of Ascaris was detected in 71 (34.3%) samples, of which all were identified as the human roundworm Ascaris lumbricoides. In 87 (42.0%) samples, DNA of Trichuris spp. was found and further speciation demonstrated the presence of the human Trichuris trichiura (100%) and the canine Trichuris vulpis (n=7; 8.0%; in Cameroon only). Hookworms were identified in 104 (50.2%) samples, with Necator americanus (n=73; 70.2%) being the predominant species followed by Ancylostoma duodenale (n=40; 38.5%). Conclusions: Our study indicates that STH infections in humans are predominantly caused by human STH species. They also suggest that zoonotic transmission occurs on a local scale.	[George, Santosh; Geldhof, Peter; Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [George, Santosh; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Albonico, Marco] Sacro Cuore Hosp, Ctr Trop Dis, WHO Collaborating Ctr Strongyloidiasis & Other In, Negrar, Italy; [Albonico, Marco] Univ Turin, Turin, Italy; [Ame, Shaali M.] Ivo Carneri, Publ Hlth Lab, Chake Chake, Zanzibar, Tanzania; [Bethony, Jeffrey M.] George Washington Univ, Med Ctr, Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Engels, Dirk; Montresor, Antonio] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Mekonnen, Zeleke] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Hem, Sopheak] Pasteur Inst Cambodia, Clin Lab, Phnom Penh, Cambodia; [Tchuem-Tchuente, Louis-Albert] Univ Yaounde I, Ctr Schistosomiasis & Parasitol, Fac Sci, Yaounde, Cameroon; [Nguyen Thu Huong] Natl Inst Malariol Parasitol & Entomol, Dept Parasitol, Hanoi, Vietnam	Levecke, B (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	bruno.levecke@ugent.be		Levecke, Bruno/0000-0001-8912-5595; ALBONICO, Marco/0000-0002-7805-2391	Special Research Fund of Ghent University; World Health Organization [APW200432311]; Coordination Action Plan of FWO; Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India	This work was supported by a Special Research Fund of Ghent University (https://www.ugent.be/nl/onderzoek/financiering/bof). The multicentric drug efficacy trial was financially supported by World Health Organization ([grant no APW200432311]; http://apps.who.int/whocc/Detail.aspx?cc_ref=BEL-42&cc_code=bel). The coordination of the trial was supported by a Coordination Action Plan of FWO (www.fwo.be). SG is supported by the Special Research Fund of Ghent University and the Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India (www.cmcwtrl.in). BL is a postdoctoral fellow of FWO (Ref No. 0505 1.2.853.13; www.fwo.be).	ANDERSON TJC, 1995, PARASITOLOGY, V110, P215, DOI 10.1017/S0031182000063988; Areekul P, 2010, ASIAN BIOMED, V4, P49, DOI 10.2478/abm-2010-0006; Arizono N, 2010, JPN J INFECT DIS, V63, P447; Bendall RP, 2011, EMERG INFECT DIS, V17, P1964, DOI 10.3201/eid1710.101826; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Betson M, 2014, J INFECT DIS, V210, P932, DOI 10.1093/infdis/jiu193; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; Conlan JV, 2012, AM J TROP MED HYG, V86, P624, DOI 10.4269/ajtmh.2012.11-0413; CROESE J, 1994, ANN INTERN MED, V120, P369, DOI 10.7326/0003-4819-120-5-199403010-00003; Ng-Nguyen D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1015-y; George S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004891; George S, 2015, T ROY SOC TROP MED H, V109, P283, DOI 10.1093/trstmh/trv001; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Jiraanankul V, 2011, AM J TROP MED HYG, V84, P594, DOI 10.4269/ajtmh.2011.10-0189; Kaliappan SP, 2013, TROP MED INT HEALTH, V18, P1452, DOI 10.1111/tmi.12205; Landmann JK, 2003, MED J AUSTRALIA, V178, P69; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; *MIN AGR FISH FOOD, 1986, MAN VET PAR LAB TECH; Nejsum P, 2005, J CLIN MICROBIOL, V43, P1142, DOI 10.1128/JCM.43.3.1142-1148.2005; Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001522; Nissen S, 2012, VET PARASITOL, V188, P68, DOI 10.1016/j.vetpar.2012.03.004; Pullan R.L, 2014, PARASITE VECTOR, V7, P37, DOI DOI 10.1186/1756-3305-7-37; Sparks AM, 2015, J HELMINTHOL, V89, P512, DOI 10.1017/S0022149X14000431; Steinmann P, 2015, ACTA TROP, V141, P184, DOI 10.1016/j.actatropica.2014.08.018; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006; Traub RJ, 2004, VET PARASITOL, V123, P245, DOI 10.1016/j.vetpar.2004.05.026; Traversa D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-32; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; World Health Organization, 2012, SOIL TRANSM HELM EL; YOSHIKAWA H, 1989, PARASITOL RES, V75, P649, DOI 10.1007/BF00930964; Zhou CH, 2012, INFECT GENET EVOL, V12, P1172, DOI 10.1016/j.meegid.2012.04.016; Zhu XQ, 1999, INT J PARASITOL, V29, P469, DOI 10.1016/S0020-7519(98)00226-4	38	5	5	4	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	NOV	2016	110	11					657	663		10.1093/trstmh/trw078				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EQ9FU	WOS:000398390800005	28100811	Green Accepted			2019-03-26
J	Alirol, E; Horie, NS; Barbe, B; Lejon, V; Verdonck, K; Gillet, P; Jacobs, J; Buscher, P; Kanal, B; Bhattarai, NR; El Safi, S; Phe, T; Lim, K; Leng, L; Lutumba, P; Mukendi, D; Bottieau, E; Boelaert, M; Rijal, S; Chappuis, F				Alirol, Emilie; Horie, Ninon Seiko; Barbe, Barbara; Lejon, Veerle; Verdonck, Kristien; Gillet, Philippe; Jacobs, Jan; Buscher, Philippe; Kanal, Basudha; Bhattarai, Narayan Raj; El Safi, Sayda; Phe, Thong; Lim, Kruy; Leng, Long; Lutumba, Pascal; Mukendi, Deby; Bottieau, Emmanuel; Boelaert, Marleen; Rijal, Suman; Chappuis, Francois			Diagnosis of Persistent Fever in the Tropics: Set of Standard Operating Procedures Used in the NIDIAG Febrile Syndrome Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SCALE COLLABORATIVE PROJECT; ORIENTED RESEARCH CORE; TRAUMA PATIENT; CLINICAL CARE; MALARIA; INFLAMMATION; GUIDELINES; ILLNESS; INJURY	In resource-limited settings, the scarcity of skilled personnel and adequate laboratory facilities makes the differential diagnosis of fevers complex [1-5]. Febrile illnesses are diagnosed clinically in most rural centers, and both Rapid Diagnostic Tests (RDTs) and clinical algorithms can be valuable aids to health workers and facilitate therapeutic decisions [6,7]. The persistent fever syndrome targeted by NIDIAG is defined as presence of fever for at least one week. The NIDIAG clinical research consortium focused on potentially severe and treatable infections and therefore targeted the following conditions as differential diagnosis of persistent fever: visceral leishmaniasis (VL), human African trypanosomiasis (HAT), enteric (typhoid and paratyphoid) fever, brucellosis, melioidosis, leptospirosis, malaria, tuberculosis, amoebic liver abscess, relapsing fever, HIV/AIDS, rickettsiosis, and other infectious diseases (e.g., pneumonia). From January 2013 to October 2014, a prospective clinical phase III diagnostic accuracy study was conducted in one site in Cambodia, two sites in Nepal, two sites in Democratic Republic of the Congo (DRC), and one site in Sudan (clinicaltrials.gov no. NCT01766830). The study objectives were to (1) determine the prevalence of the target diseases in patients presenting with persistent fever, (2) assess the predictive value of clinical and first-line laboratory features, and (3) assess the diagnostic accuracy of several RDTs for the diagnosis of the different target conditions. In order to ensure consistency across study sites and compliance with Good Clinical (Laboratory) Practices (GC[L]P) and other applicable regulatory requirements, a robust quality assurance system was developed and implemented prior to recruitment start. This symposium describes the different components of the quality assurance system, introduces the set of standard operating procedures (SOPs) specifically developed for the NIDIAG persistent fever syndrome study, and identifies key challenges encountered by study sites in conducting the study in compliance with this quality framework.	[Alirol, Emilie; Horie, Ninon Seiko] Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland; [Horie, Ninon Seiko; Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Barbe, Barbara; Verdonck, Kristien; Gillet, Philippe; Jacobs, Jan; Buscher, Philippe; Bottieau, Emmanuel; Boelaert, Marleen] Inst Trop Med, Antwerp, Belgium; [Lejon, Veerle] IRD, Unite Mixte Rech IRD CIRAD 177, Montpellier, France; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Kanal, Basudha; Bhattarai, Narayan Raj; Rijal, Suman] BP Koirala Inst Hlth Sci, Dharan, Nepal; [El Safi, Sayda] Univ Khartoum, Fac Med, Khartoum, Sudan; [Phe, Thong; Lim, Kruy; Leng, Long] HOPE, Sihanouk Hosp Ctr, Phnom Penh, Cambodia; [Lutumba, Pascal; Mukendi, Deby] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal; Mukendi, Deby] Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO	Alirol, E (reprint author), Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland.	emilie.alirol@hcuge.ch		gillet, philippe/0000-0001-5878-6446; Buscher, Philippe/0000-0002-1926-7472; Boelaert, Marleen/0000-0001-8051-6776; Alirol, Emilie/0000-0001-8691-3991	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project) supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 89 TRIALS MEET ENROL; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Kleppinger CF, 2010, CLIN INFECT DIS, V51, pS111, DOI 10.1086/653058; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Nathens AB, 2005, J TRAUMA, V59, P764, DOI 10.1097/01.ta.0000177759.17704.35; Reyburn H, 2004, BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Shao AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132316; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	12	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004749	10.1371/journal.pntd.0004749				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400004	27812090	DOAJ Gold, Green Published			2019-03-26
J	Barbe, B; Verdonck, K; El-Safi, S; Khanal, B; Teav, S; Kalo, JRL; Ravinetto, R; Chappuis, F; Boelaert, M; Jacobs, J				Barbe, Barbara; Verdonck, Kristien; El-Safi, Sayda; Khanal, Basudha; Teav, Syna; Kalo, Jean-Roger Lilo; Ravinetto, Raffaella; Chappuis, Francois; Boelaert, Marleen; Jacobs, Jan			Rapid Diagnostic Tests for Neglected Infectious Diseases: Case Study Highlights Need for Customer Awareness and Postmarket Surveillance	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MEDICAL DEVICES; ACCURACY; QUALITY; AFRICA		[Barbe, Barbara; Verdonck, Kristien; Ravinetto, Raffaella; Boelaert, Marleen; Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [El-Safi, Sayda] Univ Khartoum, Fac Med, Khartoum, Sudan; [Khanal, Basudha] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Teav, Syna] HOPE, Sihanouk Hosp Ctr, Dept Infect Dis, Phnom Penh, Cambodia; [Kalo, Jean-Roger Lilo] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Ravinetto, Raffaella] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Chappuis, Francois] Univ Hosp Geneva, Geneva, Switzerland; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Verdonck, K (reprint author), Inst Trop Med, Antwerp, Belgium.	tverdonck@itg.be		Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project) supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, 210 ISOTC; [Anonymous], 2012, 212 ISOTC; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-39; Hopkins H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-30; Jacobs J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-505; Mori M, 2011, TROP MED INT HEALTH, V16, P1439, DOI 10.1111/j.1365-3156.2011.02852.x; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rugera SP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0524-2; World Health Organization, 2014, WHO PROC CHANG WHO P; World Health Organization, 2015, WHO POSTM SURV IN VI; World Health Organization, 2014, OV PREQ IN VITR DIAG; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	13	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004655	10.1371/journal.pntd.0004655				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400002	27812099	DOAJ Gold, Green Published			2019-03-26
J	Barbe, B; Verdonck, K; Mukendi, D; Lejon, V; Kalo, JRL; Alirol, E; Gillet, P; Horie, N; Ravinetto, R; Bottieau, E; Yansouni, C; Winkler, AS; van Loen, H; Boelaert, M; Lutumba, P; Jacobs, J				Barbe, Barbara; Verdonck, Kristien; Mukendi, Deby; Lejon, Veerle; Kalo, Jean-Roger Lilo; Alirol, Emilie; Gillet, Philippe; Horie, Ninon; Ravinetto, Raffaella; Bottieau, Emmanuel; Yansouni, Cedric; Winkler, Andrea S.; van Loen, Harry; Boelaert, Marleen; Lutumba, Pascal; Jacobs, Jan			The Art of Writing and Implementing Standard Operating Procedures (SOPs) for Laboratories in Low-Resource Settings: Review of Guidelines and Best Practices	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RAPID DIAGNOSTIC-TESTS; INSTRUCTIONS; TRANSLATE		[Barbe, Barbara; Verdonck, Kristien; Lejon, Veerle; Gillet, Philippe; Ravinetto, Raffaella; Bottieau, Emmanuel; van Loen, Harry; Boelaert, Marleen; Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Mukendi, Deby; Kalo, Jean-Roger Lilo; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lejon, Veerle] Inst Rech Dev, Montpellier, France; [Alirol, Emilie; Horie, Ninon] Univ Hosp Geneva, Geneva, Switzerland; [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Yansouni, Cedric] McGill Univ, Ctr Hlth, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkler, Andrea S.] Univ Oslo, Ctr Global Hlth, Oslo, Norway; [Lutumba, Pascal] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Barbe, B (reprint author), Inst Trop Med, Antwerp, Belgium.	bbarbe@itg.be		gillet, philippe/0000-0001-5878-6446; Alirol, Emilie/0000-0001-8691-3991; Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project) supported by the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Center for Medicare and Medicaid Services (US), 2011, CLIN LAB IMPR AM CLI; Clinical and laboratory Standards Institute (CLSI), 2013, QMS02A6 CLSI, V33; Clinical and laboratory Standards Institute (CLSI), 2011, QMS01A4 CLSI, V31; Cowgill J, 2003, JRC DESIGN SYMBOL US; Datema TAM, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.3; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; European Commission, 2009, ENTRF2SFJR2009D869 E; Hanrahan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133394; Hermans V., 2011, MALARIA J, V10, P10; International Organization for Standardization, 2012, 15189 ISO; International Organization for Standardization, 2005, 17025 ISO; Jacobs J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-505; Joint Commission International, 2010, ACCR STAND CLIN LAB; Luman ET, 2014, AFR J LAB MED, V3, DOI 10.4102/ajlm.v3i2.265; Nielsen J., 2015, READABILITY COMPREHE; Patel Ilesh, 2007, Community Eye Health, V20, P40; Patil S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7392; PETTERSSON R, 1982, ECTJ-EDUC COMMUN TEC, V30, P43; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Tavrow P, 2000, OPERATIONS RES RESUL, V1; U.S. Food and Drug Administration (FDA), 1993, WRIT IT RIGHT REC DE; U.S. Food and Drug Administration (FDA), 2001, GUID MED DEV PAT LAB; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2009, GOOD CLIN LAB PRACT; Wallace LS, 2008, BLOOD PRESS MONIT, V13, P219, DOI 10.1097/MBP.0b013e3283057b0a; Wallace LS, 2006, J ASTHMA, V43, P375, DOI 10.1080/02770900600709856; WHO, 2015, HARM RAP DIAGN TESTS; World Health Organization, 2008, PAT SAF WORKSH LEARN; World Health Organization Regional Office for Africa (WHO-AFRO) US Centers for Disease Control and Prevention (CDC) American Society for Clinical Pathology (ASCP) Clinton Foundation, 2009, STRENGTH LAB MAN ACC; World Health Organization (WHO), 2011, LAB QUAL MAN SYST HD	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0005053	10.1371/journal.pntd.0005053				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400016	27812100	DOAJ Gold, Green Published			2019-03-26
J	Becker, SL; Yap, P; Horie, NS; Alirol, E; Barbe, B; Bhatta, NK; Bhattarai, NR; Bottieau, E; Chatigre, JK; Coulibaly, JT; Fofana, HKM; Jacobs, J; Karki, P; Khanal, B; Knopp, S; Koirala, K; Mahendradhata, Y; Mertens, P; Meyanti, F; Murhandarwati, EH; N'Goran, EK; Peeling, RW; Pradhan, B; Ravinetto, R; Rijal, S; Sacko, M; Saye, R; Schneeberger, PHH; Schurmans, C; Silue, KD; Steinmann, P; van Loen, H; Verdonck, K; van Lieshout, L; von Muller, L; Yao, JA; Boelaert, M; Chappuis, F; Polman, K; Utzinger, J				Becker, Soren L.; Yap, Peiling; Horie, Ninon S.; Alirol, Emilie; Barbe, Barbara; Bhatta, Nisha K.; Bhattarai, Narayan R.; Bottieau, Emmanuel; Chatigre, Justin K.; Coulibaly, Jean T.; Fofana, Hassan K. M.; Jacobs, Jan; Karki, Prahlad; Khanal, Basudha; Knopp, Stefanie; Koirala, Kanika; Mahendradhata, Yodi; Mertens, Pascal; Meyanti, Fransiska; Murhandarwati, Elsa H.; N'Goran, Eliezer K.; Peeling, Rosanna W.; Pradhan, Bickram; Ravinetto, Raffaella; Rijal, Suman; Sacko, Moussa; Saye, Renion; Schneeberger, Pierre H. H.; Schurmans, Celine; Silue, Kigbafori D.; Steinmann, Peter; van Loen, Harry; Verdonck, Kristien; van Lieshout, Lisette; von Muller, Lutz; Yao, Joel A.; Boelaert, Marleen; Chappuis, Francois; Polman, Katja; Utzinger, Jurg			Experiences and Lessons from a Multicountry NIDIAG Study on Persistent Digestive Disorders in the Tropics	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NEED ASYMPTOMATIC CONTROLS; MIDDLE-INCOME COUNTRIES; RAPID DIAGNOSTIC-TESTS; MAL-ED COHORT; PATIENT RECRUITMENT; INFECTIOUS DIARRHEA; GUIDELINES; CHILDREN; ILLNESS; MANAGEMENT		[Becker, Soren L.; Yap, Peiling; Coulibaly, Jean T.; Knopp, Stefanie; Schneeberger, Pierre H. H.; Steinmann, Peter; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Becker, Soren L.; Yap, Peiling; Coulibaly, Jean T.; Knopp, Stefanie; Schneeberger, Pierre H. H.; Steinmann, Peter; Utzinger, Jurg] Univ Basel, Basel, Switzerland; [Becker, Soren L.; von Muller, Lutz] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Horie, Ninon S.; Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Alirol, Emilie] Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland; [Barbe, Barbara; Bottieau, Emmanuel; Jacobs, Jan; Ravinetto, Raffaella; Schurmans, Celine; van Loen, Harry] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Bhatta, Nisha K.] BP Koirala Inst Hlth Sci, Dept Paediat & Adolescent Med, Dharan, Nepal; [Bhattarai, Narayan R.; Khanal, Basudha] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Chatigre, Justin K.] Hop Methodiste Dabou, Dabou, Cote Ivoire; [Coulibaly, Jean T.; N'Goran, Eliezer K.; Silue, Kigbafori D.; Yao, Joel A.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Coulibaly, Jean T.; N'Goran, Eliezer K.; Silue, Kigbafori D.; Yao, Joel A.] Ctr Suisse Rech Sci Cote Ivoire, Dept Environm & Sante, Abidjan, Cote Ivoire; [Fofana, Hassan K. M.; Sacko, Moussa; Saye, Renion] Inst Natl Rech Sante Publ, Bamako, Mali; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Karki, Prahlad; Koirala, Kanika; Pradhan, Bickram; Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Knopp, Stefanie] Nat Hist Museum, Dept Life Sci, Wolfson Wellcome Biomed Labs, London, England; [Mahendradhata, Yodi; Meyanti, Fransiska; Murhandarwati, Elsa H.] Gadjah Mada Univ, Ctr Trop Med, Fac Med, Yogyakarta, Indonesia; [Mertens, Pascal] Coris BioConcept, Gembloux, Belgium; [Peeling, Rosanna W.] London Sch Hyg & Trop Med, London, England; [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Schneeberger, Pierre H. H.] Agroscope Changins Wadenswil, Dept Epidemiol & Mol Diagnost, Wadenswil, Switzerland; [Schneeberger, Pierre H. H.] Spiez Lab, Dept Virol, Fed Off Civil Protect, Spiez, Switzerland; [Verdonck, Kristien; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [van Lieshout, Lisette] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium	Utzinger, J (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Utzinger, J (reprint author), Univ Basel, Basel, Switzerland.	juerg.utzinger@unibas.ch		Alirol, Emilie/0000-0001-8691-3991; von Muller, Lutz/0000-0001-9013-4245; Knopp, Stefanie/0000-0001-5707-7963; Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; Adams M, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/1478-4505-13-8; ALAM N, 1989, INT J EPIDEMIOL, V18, P697, DOI 10.1093/ije/18.3.697; Becker SL, 2015, CLIN MICROBIOL INFEC, V21, pE53, DOI 10.1016/j.cmi.2015.04.024; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Bell-Syer SEM, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1093/ecam/nen044; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; Dixon J R Jr, 1998, Qual Assur, V6, P65; Dubourg G, 2015, CLIN MICROBIOL INFEC, V21, pE51, DOI 10.1016/j.cmi.2015.04.020; Ekwochi U, 2014, J TROP PEDIATRICS, V60, P249, DOI 10.1093/tropej/fmt111; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; KEMPER JT, 1978, B MATH BIOL, V40, P707, DOI 10.1016/S0092-8240(78)80003-2; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Murray-Kolb LE, 2014, CLIN INFECT DIS, V59, pS261, DOI 10.1093/cid/ciu437; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Platts-Mills JA, 2013, MUCOSAL IMMUNOL, V6, P876, DOI 10.1038/mi.2013.50; Platts-Mills JA, 2014, CLIN INFECT DIS, V59, pS233, DOI 10.1093/cid/ciu408; Polman K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1074-x; Raoult D, 2016, CLIN INFECT DIS, V62, P809, DOI 10.1093/cid/civ985; Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777; Thoma A, 2010, CAN J SURG, V53, P205; Thomas PD, 2003, GUT, V52, P1; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.02.016, 10.1016/j.cmi.2015.03.014]; Webair HH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-581; WEISS MG, 1988, SOC SCI MED, V27, P5, DOI 10.1016/0277-9536(88)90159-1; World Health Organization, 2009, DIARRH DIS FACT SHEE; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5; Yansouni CP, 2012, CLIN INFECT DIS, V55, P610, DOI 10.1093/cid/cis466	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004818	10.1371/journal.pntd.0004818				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400005	27812101	DOAJ Gold, Green Published			2019-03-26
J	Boelaert, M				Boelaert, Marleen		The NIDIAG Consortium	Clinical Research on Neglected Tropical Diseases: Challenges and Solutions	PLOS NEGLECTED TROPICAL DISEASES			English	Editorial Material							RAPID DIAGNOSTIC-TESTS; PERSISTENT DIGESTIVE DISORDERS; NEED ASYMPTOMATIC CONTROLS; MALARIAL FEBRILE ILLNESS; AFRICA; FEVER; GOVERNANCE; SETTINGS; CHILDREN; TANZANIA		[Boelaert, Marleen; The NIDIAG Consortium] Inst Trop Med, Antwerp, Belgium	Boelaert, M (reprint author), Inst Trop Med, Antwerp, Belgium.	mboelaert@itg.be		von Muller, Lutz/0000-0001-9013-4245; Vounatsou, Penelope/0000-0002-4904-5352; Lestari, Trisasi/0000-0002-4799-5338; Boelaert, Marleen/0000-0001-8051-6776; Surendra, Henry/0000-0002-6029-0623	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Alirol E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004749; Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004655; Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005053; Becker SL, 2015, CLIN MICROBIOL INFEC, V21, pE53, DOI 10.1016/j.cmi.2015.04.024; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Becker SL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004818; Bosu WK, 1999, TROP MED INT HEALTH, V4, P114, DOI 10.1046/j.1365-3156.1999.00360.x; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Clements ACA, 2010, TROP MED INT HEALTH, V15, P198, DOI 10.1111/j.1365-3156.2009.02440.x; Council for International Organization of Medical Sciences, 2002, INT ETH GUID BIOM RE; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Dubourg G, 2015, CLIN MICROBIOL INFEC, V21, pE51, DOI 10.1016/j.cmi.2015.04.020; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; El-Safi S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004736; Hildenwall H, 2016, TROP MED INT HEALTH, V21, P149, DOI 10.1111/tmi.12635; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Kiemde F, 2016, TROP MED IN IN PRESS; Laman M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-29; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450; Murphy SC, 2013, AM J TROP MED HYG, V89, P824, DOI 10.4269/ajtmh.12-0675; Polman K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1074-x; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Pratt B, 2016, AM J BIOETHICS, V16, P29, DOI 10.1080/15265161.2016.1214304; Ravinetto R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004654; Rosenberg M, 2016, PLOS NEGLECT TROP D, V10; ROUGEMONT A, 1991, LANCET, V338, P1292, DOI 10.1016/0140-6736(91)92592-P; Staunton C, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-35; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330; Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727; van den Bogaart E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001617; Walter ND, 2009, B WORLD HEALTH ORGAN, V87, P99, DOI 10.2471/BLT.08.050740; World Health Organization, 2008, PAT SAF WORKSH LEARN; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5; Yansouni CP, 2012, CLIN INFECT DIS, V55, P610, DOI 10.1093/cid/cis466	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004853	10.1371/journal.pntd.0004853				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400006	27812095	DOAJ Gold, Green Published			2019-03-26
J	Carneiro, MW; Fukutani, KF; Andrade, BB; Curvelo, RP; Cristal, JR; Carvalho, AM; Barral, A; Van Weyenbergh, J; Barral-Netto, M; de Oliveira, CI				Carneiro, Marcia W.; Fukutani, Kiyoshi F.; Andrade, Bruno B.; Curvelo, Rebecca P.; Cristal, Juqueline R.; Carvalho, Augusto M.; Barral, Aldina; Van Weyenbergh, Johan; Barral-Netto, Manoel; de Oliveira, Camila I.			Gene Expression Profile of High IFN-gamma Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MUCOSAL LEISHMANIASIS; IMMUNE-RESPONSE; TEGUMENTARY LEISHMANIASIS; DIFFERENTIAL REGULATION; T-CELLS; INFECTION; ALPHA; AMAZONENSIS; NEUTROPHILS; INHIBITION	Background The initial response to Leishmania parasites is essential in determining disease development or resistance. In vitro, a divergent response to Leishmania, characterized by high or low IFN-gamma production has been described as a potential tool to predict both vaccine response and disease susceptibility in vivo. Methods and findings We identified uninfected and healthy individuals that were shown to be either high-or low IFN-gamma producers (HPs and LPs, respectively) following stimulation of peripheral blood cells with Leishmania braziliensis. Following stimulation, RNA was processed for gene expression analysis using immune gene arrays. Both HPs and LPs were shown to upregulate the expression of CXCL10, IFI27, IL6 and LTA. Genes expressed in HPs only (CCL7, IL8, IFI44L and IL1B) were associated with pathways related to IL17 and TREM 1 signaling. In LPs, uniquely expressed genes (for example IL9, IFI44, IFIT1 and IL2RA) were associated with pathways related to pattern recognition receptors and interferon signaling. We then investigated whether the unique gene expression profiles described here could be recapitulated in vivo, in individuals with active Cutaneous Leishmaniasis or with subclinical infection. Indeed, using a set of six genes (TLR2, JAK2, IFI27, IFIT1, IRF1 and IL6) modulated in HPs and LPs, we could successfully discriminate these two clinical groups. Finally, we demonstrate that these six genes are significantly overexpressed in CL lesions. Conclusion Upon interrogation of the peripheral response of naive individuals with diverging IFN-gamma production to L. braziliensis, we identified differences in the innate response to the parasite that are recapitulated in vivo and that discriminate CL patients from individuals presenting a subclinical infection.	[Carneiro, Marcia W.; Fukutani, Kiyoshi F.; Andrade, Bruno B.; Curvelo, Rebecca P.; Cristal, Juqueline R.; Carvalho, Augusto M.; Barral, Aldina; Barral-Netto, Manoel; de Oliveira, Camila I.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil; [Andrade, Bruno B.] Fundacao Jose Silveira, Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil; [Van Weyenbergh, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium; [Barral, Aldina; Barral-Netto, Manoel] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil; [Carneiro, Marcia W.] Univ Catolica Salvador, Salvador, BA, Brazil	de Oliveira, CI (reprint author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil.	camila@bahia.fiocruz.br	Van Weyenbergh, Johan/B-4187-2009	Van Weyenbergh, Johan/0000-0003-3234-8426; Barral Netto, Manoel/0000-0002-5823-7903; Fukutani, Kiyoshi/0000-0003-2223-0918	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302464/2009-3]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Coordenacao de Apoio a Pesquisa e Ensino Superior (CAPES)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant 302464/2009-3 to M.BN and fellowship to MWC and KFF), Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (fellowship to KFF) and Coordenacao de Apoio a Pesquisa e Ensino Superior (CAPES) (fellowship to JRC). AB, MBN, and MO are senior researchers at CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bacellar O, 2009, J INFECT DIS, V200, P75, DOI 10.1086/599380; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Campanelli AP, 2010, HUM IMMUNOL, V71, P1220, DOI 10.1016/j.humimm.2010.09.002; Carneiro MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052296; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; Carvalho LP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00301; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; Castes M, 1993, Biol Res, V26, P233; Coelho ZCB, 2010, BRAZ J INFECT DIS, V14, P476, DOI 10.1590/S1413-86702010000500009; DaCruz AM, 1996, MEM I OSWALDO CRUZ, V91, P225, DOI 10.1590/S0074-02761996000200019; DAVIES CR, 1995, EPIDEMIOL INFECT, V114, P297, DOI 10.1017/S0950268800057964; de Oliveira CI, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00145; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Follador I, 2002, CLIN INFECT DIS, V34, pE54, DOI 10.1086/340261; Franca-Costa J, 2016, J INFECT DIS, V213, P1143, DOI 10.1093/infdis/jiv548; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Huang L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003546; Khouri R, 2014, J INFECT DIS, V210, P306, DOI 10.1093/infdis/jiu087; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martensen PM, 2001, EUR J BIOCHEM, V268, P5947, DOI 10.1046/j.0014-2956.2001.02545.x; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Murray HW, 2008, INFECT IMMUN, V76, P4088, DOI 10.1128/IAI.00490-08; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; NANDAN D, 1995, INFECT IMMUN, V63, P4495; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Novais FO, 2014, J INVEST DERMATOL; Oliveira PRS, 2015, J IMMUNOL, V194, P2664, DOI 10.4049/jimmunol.1402047; Pompeu MML, 2001, INFECT IMMUN, V69, P7453, DOI 10.1128/IAI.69.12.7453-7460.2001; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Rogers KA, 2004, AM J TROP MED HYG, V71, P568, DOI 10.4269/ajtmh.2004.71.568; Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601; Schnorr D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001947; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Weber B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003900	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							5116	10.1371/journal.pntd.0005116				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400038	27870860	DOAJ Gold, Green Published			2019-03-26
J	El-Safi, S; Chappuis, F; Boelaert, M				El-Safi, Sayda; Chappuis, Francois; Boelaert, Marleen			The Challenges of Conducting Clinical Research on Neglected Tropical Diseases in Remote Endemic Areas in Sudan	PLOS NEGLECTED TROPICAL DISEASES			English	Article							FEVER		[El-Safi, Sayda] Univ Khartoum, Khartoum, Sudan; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium	El-Safi, S (reprint author), Univ Khartoum, Khartoum, Sudan.	shelsafi@yahoo.com		Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004749; [Anonymous], 2008, J ONCOL PRACT, V4, P233, DOI 10.1200/JOP.0854601; Ax J., 2014, REUTERS; Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004655; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Mendelson M, 2015, LANCET	8	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004736	10.1371/journal.pntd.0004736				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400003	27812094	DOAJ Gold, Green Published			2019-03-26
J	Ravinetto, R; Alirol, E; Mahendradhata, Y; Rijal, S; Lutumba, P; Sacko, M; El-Safi, S; Lim, K; van Loen, H; Jacobs, J; Peeling, RW; Chappuis, F; Boelaert, M				Ravinetto, Raffaella; Alirol, Emilie; Mahendradhata, Yodi; Rijal, Suman; Lutumba, Pascal; Sacko, Moussa; El-Safi, Sayda; Lim, Kruy; van Loen, Harry; Jacobs, Jan; Peeling, Rosanna W.; Chappuis, Francois; Boelaert, Marleen			Clinical Research in Neglected Tropical Diseases: The Challenge of Implementing Good Clinical (Laboratory) Practices	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRIALS; PARTICIPANTS; CONSENT; AFRICA		[Ravinetto, Raffaella; van Loen, Harry; Jacobs, Jan] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [Ravinetto, Raffaella] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Alirol, Emilie] Medecins Sans Frontieres United Kingdom, London, England; [Alirol, Emilie] Hop Univ Geneve, Ctr Rech Clin, Geneva, Switzerland; [Mahendradhata, Yodi] Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Yogyakarta, Indonesia; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Sacko, Moussa] Inst Natl Rech Sante Publ, Bamako, Mali; [El-Safi, Sayda] Univ Khartoum, Khartoum, Sudan; [Lim, Kruy] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Peeling, Rosanna W.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium	Ravinetto, R (reprint author), Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium.; Ravinetto, R (reprint author), Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium.	rravinetto@itg.be		Alirol, Emilie/0000-0001-8691-3991; Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi MO, 2014, TROP MED INT HEALTH, V19, P625, DOI 10.1111/tmi.12288; Afolabi MO, 2015, B WORLD HEALTH ORGAN, V93, P320, DOI 10.2471/BLT.14.146159; [Anonymous], 2009, GOOD CLIN LAB PRACT; [Anonymous], 2015, B WORLD HEALTH ORGAN, V93, P70, DOI [10.2471/BLT.15.020215, DOI 10.2471/BLT.15.020215]; [Anonymous], 1995, WHO TECHN REP SER, V850; Chen H, 2015, B WORLD HEALTH ORGAN, V93, P113, DOI 10.2471/BLT.14.138420; Chilengi R, 2010, WEBMEDCENTRAL CLIN T, V1; Council for International Organization of Medical Sciences, 2002, INT ETH GUID BIOM RE; Guindo MA, 2012, AM J TROP MED HYG, V86, P573, DOI 10.4269/ajtmh.2012.11-0691; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; International Conference of Harmonization (ICH), 1996, ICH TRIP GUID GOOD C; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Mavoko HM, 2015, TROP MED INT HEALTH, V20, P163; Newton PN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h602; Tam NT, 2015, B WORLD HEALTH ORGAN, V93, P186, DOI 10.2471/BLT.14.141390; PEDRIQUE B, 2000, LANCET GLOB HEALTH, V1, P371, DOI DOI 10.1016/S2214-109X(13)70078-0; PLOS Medicine Editors, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001949, DOI 10.1371/JOURNAL.PMED.1001949]; Ravinetto R, BMC INT HLT IN PRESS; Ravinetto RM, 2013, TROP MED INT HEALTH, V18, P237, DOI 10.1111/tmi.12036; Singh Jerome Amir, 2009, Acta Trop, V112 Suppl 1, pS71, DOI 10.1016/j.actatropica.2009.07.032; Stevens W, 2003, Qual Assur, V10, P83; Thupasi T, 2016, B WORLD HEALTH ORGAN, V94, P147, DOI [10.2471/BLT.15.154997, DOI 10.2471/BLT.15.154997]; Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330; World Health Organization-Special Programme for Research and Training in Tropical Diseases (WHO-TDR), 2007, ETH CHALL STUD DES I	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004654	10.1371/journal.pntd.0004654				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400001	27812089	DOAJ Gold, Green Published			2019-03-26
J	Delamou, A; Utz, B; Delvaux, T; Beavogui, AH; Shahabuddin, A; Koivogui, A; Leveque, A; Zhang, WH; De Brouwere, V				Delamou, Alexandre; Utz, Bettina; Delvaux, Therese; Beavogui, Abdoul Habib; Shahabuddin, Asm; Koivogui, Akoi; Leveque, Alain; Zhang, Wei-Hong; De Brouwere, Vincent			Pregnancy and childbirth after repair of obstetric fistula in sub-Saharan Africa: Scoping Review	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						pregnancy; childbirth; post-repair; obstetric fistula; sub-Saharan Africa	FEMALE GENITAL FISTULA; FOLLOW-UP; WOMEN; OUTCOMES; PREVALENCE; FERTILITY; COUNTRIES; PROGRAM; HEALTH; IMPACT	OBJECTIVE To synthesise the evidence on pregnancy and childbirth after repair of obstetric fistula in sub-Saharan Africa and to identify the existing knowledge gaps. METHODS A scoping review of studies reporting on pregnancy and childbirth in women who underwent repair for obstetric fistula in sub-Saharan Africa was conducted. We searched relevant articles published between 1 January 1970 and 31 March 2016, without methodological or language restrictions, in electronic databases, general Internet sources and grey literature. RESULTS A total of 16 studies were included in the narrative synthesis. The findings indicate that many women in sub-Saharan Africa still desire to become pregnant after the repair of their obstetric fistula. The overall proportion of pregnancies after repair estimated in 11 studies was 17.4% (ranging from 2.5% to 40%). Among the 459 deliveries for which the mode of delivery was reported, 208 women (45.3%) delivered by elective caesarean section (CS), 176 women (38.4%) by emergency CS and 75 women (16.3%) by vaginal delivery. Recurrence of fistula was a common maternal complication in included studies while abortions/miscarriage, stillbirths and neonatal deaths were frequent foetal consequences. Vaginal delivery and emergency C-section were associated with increased risk of stillbirth, recurrence of the fistula or even maternal death. CONCLUSION Women who get pregnant after repair of obstetric fistula carry a high risk for pregnancy complications. However, the current evidence does not provide precise estimates of the incidence of pregnancy and pregnancy outcomes post-repair. Therefore, studies clearly assessing these outcomes with the appropriate study designs are needed.	[Delamou, Alexandre; Leveque, Alain; Zhang, Wei-Hong] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Delamou, Alexandre; Beavogui, Abdoul Habib] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Utz, Bettina; Delvaux, Therese; Shahabuddin, Asm; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Koivogui, Akoi] Assoc Depistage Organise Canc, Dept Saone & Loire, Charnay Les Macon, France	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	adelamou@gmail.com		Zhang, Wei-Hong/0000-0003-0380-770X; Utz, Bettina/0000-0002-7263-3320; KOIVOGUI, AKOI/0000-0001-9097-3006			Adler AJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-246; AIMAKHU VE, 1974, FERTIL STERIL, V25, P586; Andreucci CB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0742-6; Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616; Barone MA, 2012, OBSTET GYNECOL, V120, P524, DOI 10.1097/AOG.0b013e31826579e8; Benfield N, 2011, INT J GYNECOL OBSTET, V114, P265, DOI 10.1016/j.ijgo.2011.02.024; Browning A, 2008, BJOG-INT J OBSTET GY, V115, P1564, DOI 10.1111/j.1471-0528.2008.01900.x; Browning A, 2009, BJOG-INT J OBSTET GY, V116, P1265, DOI 10.1111/j.1471-0528.2009.02182.x; de Bernis L, 2007, INT J GYNECOL OBSTET, V99, pS117, DOI 10.1016/j.ijgo.2007.06.032; Delamou A, 2015, TROP MED INT HEALTH, V20, P1454, DOI 10.1111/tmi.12584; Delamou A, 2015, TROP MED INT HEALTH, V20, P813, DOI 10.1111/tmi.12489; Docquier J, 1988, Acta Urol Belg, V56, P535; Donnay F, 2006, INT J GYNECOL OBSTET, V94, P254, DOI 10.1016/j.ijgo.2006.04.005; Donnelly K, 2015, CULT HEALTH SEX, V17, P150, DOI 10.1080/13691058.2014.964320; Drew LB, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0755-1; EMEMBOLU J, 1992, INT J GYNECOL OBSTET, V39, P205, DOI 10.1016/0020-7292(92)90658-6; EVOH NJ, 1978, ANN CLIN RES, V10, P303; Fistula C., 2013, PROJECT REPORT OCT 1; Ford CCM, 2013, BJOG-INT J OBSTET GY, V120, P332; Frajzyngier V, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.02.006; Genadry RR, 2007, INT J GYNECOL OBSTET, V99, pS51, DOI 10.1016/j.ijgo.2007.06.026; Gottvall K, 2002, BJOG-INT J OBSTET GY, V109, P254, DOI 10.1016/S1470-0328(02)01200-4; Gupta NP, 2012, UROL INT, V88, P259, DOI 10.1159/000331503; Hawkins L, 2013, INT J GYNECOL OBSTET, V120, P178, DOI 10.1016/j.ijgo.2012.08.014; Khisa W, 2017, BJOG-INT J OBSTET GY, V124, P503, DOI 10.1111/1471-0528.13902; Landry E, 2013, GLOB PUBLIC HEALTH, V8, P926, DOI 10.1080/17441692.2013.824018; Lawani LO, 2015, INT J GYNECOL OBSTET, V129, P256, DOI 10.1016/j.ijgo.2014.11.028; Lombard L, 2015, TROP MED INT HEALTH, V20, P554, DOI 10.1111/tmi.12469; MacDonald P, 2007, INT J GYNECOL OBSTET, V99, pS112, DOI 10.1016/j.ijgo.2007.06.031; Maheu-Giroux M, 2015, LANCET GLOB HEALTH, V3, pE271, DOI 10.1016/S2214-109X(14)70348-1; Maulet N, 2013, TROP MED INT HEALTH, V18, P524, DOI 10.1111/tmi.12086; Maulet NBE, 2012, INT J GYNECOL OBSTET, V119, pS841; Miller S, 2005, J MIDWIFERY WOM HEAL, V50, P286, DOI 10.1016/j.jmwh.2005.03.009; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Muleta M, 2010, ACTA OBSTET GYN SCAN, V89, P945, DOI 10.3109/00016341003801698; Muleta M, 2008, J OBSTET GYNAECOL CA, V30, P44, DOI 10.1016/S1701-2163(16)32712-8; Nielsen HS, 2009, BJOG-INT J OBSTET GY, V116, P1258, DOI 10.1111/j.1471-0528.2009.02200.x; Osotimehin B., 2016, COMMUNICATION; Osotimehin B, 2013, LANCET, V381, P1702, DOI 10.1016/S0140-6736(13)61001-6; OTUBU JA, 1982, INT J GYNECOL OBSTET, V20, P163, DOI 10.1016/0020-7292(82)90032-7; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Ruminjo JK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-220; Siddle K, 2013, INT UROGYNECOL J, V24, P1215, DOI 10.1007/s00192-012-1994-6; Tayler-Smith K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-164; Tembely A, 2014, Prog Urol, V24, P876, DOI 10.1016/j.purol.2014.08.202; Turan Janet Molzan, 2007, Glob Public Health, V2, P64, DOI 10.1080/17441690600648728; Wilson AL, 2011, INT J GYNECOL OBSTET, V113, P196, DOI 10.1016/j.ijgo.2011.01.006	47	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2016	21	11					1348	1365		10.1111/tmi.12771				18	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EC6YZ	WOS:000388283900002	27596732	Bronze			2019-03-26
J	Cikomola, JC; Vandepoele, K; Katchunga, PB; Kishabongo, AS; Padalko, EY; Speeckaert, MM; Delanghe, JR				Cikomola, Justin C.; Vandepoele, Karl; Katchunga, Philippe B.; Kishabongo, Antoine S.; Padalko, Elizaveta Y.; Speeckaert, Marijn M.; Delanghe, Joris R.			The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South Kivu	ACTA TROPICA			English	Article						Diabetes meliitus; Ferroportin Q248H mutation; Fructosamine-3 kinase 900C/G polymorphism; Human herpes virus-8; TF polymorphism	FERROPORTIN Q248H POLYMORPHISM; KAPOSIS-SARCOMA; AFRICAN-AMERICANS; SERUM FERRITIN; IRON HOMEOSTASIS; HEPCIDIN; MUTATION; GENE; HEMOCHROMATOSIS; VARIABILITY	Prevalences of human herpesvirus-8 (HHV-8) infection and diabetes mellitus are very common in certain parts of Africa, containing iron-rich soils. We hypothesized that some genetic factors could have a link with susceptibility to HHV-8 infection. We focused on ferroportin Q248H mutation (rs11568350), transferrin (TF) polymorphism and fructosamine-3 kinase (FN3K) 900C/G polymorphism (rs1056534). The study population consisted of 210 type 2 diabetic adults and 125 healthy controls recruited in Bukavu (South Kivu). In the whole study population (diabetics + healthy controls), ferroportin Q248H mutation was detected in 47 subjects (14.0%) with 43 heterozygotes and 4 homozygotes. TF phenotype frequencies were 88.1% (CC), 10.4% (CD) and 1.5% (BC). Genotype frequencies of FN3K 900C/G polymorphism were respectively 9,3% (CC), 43.3% (GC) and 47.4% (GG). Prevalence of HHV8-infection in the study population was 77.3%. HHV-8 infection rate and HHV-8 IgG antibody titer were significantly higher in diabetics then in controls (p < 0.0001). Significant differences were observed in HHV-8 infection rate and in HHV-8 IgG antibody titer according to FN3K rs1056534 (p < 0.05 and p < 0.05, respectively) and TF polymorphism (p < 0.05 and p = 0.005, respectively). No significant differences in HHV-8 infection rate and in HHV-8 IgG antibody titer were observed in the ferroportin Q248H mutation carriers (rs11568350) in comparison with ferroportin wild type. In a multiple regression analysis, FN3K rs1056534, TF polymorphism and presence of diabetes mellitus were predictors for HHV-8 infection. In contrast to these findings, ferroportin Q248H mutation (rs11568350) did not influence the susceptibility for an HHV-8 infection in sub-Saharan Africans. (C) 2016 Elsevier B.V. All rights reserved.	[Cikomola, Justin C.; Katchunga, Philippe B.] Catholic Univ Bukavu, Dept Internal Med, Bukavu, Zaire; [Cikomola, Justin C.; Delanghe, Joris R.] Ghent Univ Hosp, Dept Clin Chem, De Pintelaan 185, B-9000 Ghent, Belgium; [Vandepoele, Karl] Ghent Univ Hosp, Lab Mol Diagnost & Hematol, Ghent, Belgium; [Kishabongo, Antoine S.] Catholic Univ Bukavu, Dept Lab Med, Bukavu, Zaire; [Padalko, Elizaveta Y.] Ghent Univ Hosp, Dept Virol, Ghent, Belgium; [Speeckaert, Marijn M.] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium	Delanghe, JR (reprint author), Ghent Univ Hosp, Dept Clin Chem, De Pintelaan 185, B-9000 Ghent, Belgium.	Joris.Delanghe@ugent.be	Vandepoele, Karl/C-1197-2009	Vandepoele, Karl/0000-0002-0025-5594; Speeckaert, Marijn/0000-0001-9183-4390; Delanghe, Joris/0000-0002-5702-6792			Albuquerque D, 2011, ANN HUM BIOL, V38, P378, DOI 10.3109/03014460.2010.541496; American, 2012, DIABETES CARE S1, V35, pS64, DOI DOI 10.2337/DC12-S064; Buysschaert M, 1997, DIABETES METAB, V23, P308; Caselli E, 2014, J MED VIROL, V86, P1745, DOI 10.1002/jmv.23771; Cavalli-Sforza L, 1994, HIST GEOGRAPHY HUMAN, P188; Collard FO, 2003, DIABETES, V52, P2888, DOI 10.2337/diabetes.52.12.2888; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.660745; Defrere S, 2011, HISTOL HISTOPATHOL, V26, P1083, DOI 10.14670/HH-26.1083; Delpierre G, 2006, DIABETES METAB, V32, P31, DOI 10.1016/S1262-3636(07)70244-6; DMOCHOWSKI K, 1993, J CLIN ENDOCR METAB, V77, P478, DOI 10.1210/jc.77.2.478; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; GIBLETT ER, 1959, NATURE, V183, P1589, DOI 10.1038/1831589a0; Gordeuk VR, 2008, ALCOHOL CLIN EXP RES, V32, P1947, DOI 10.1111/j.1530-0277.2008.00782.x; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Hang H., 2015, DIABETES-METAB RES, V31, P127; Ingianni A, 2007, AM J INFECT DIS, V3, P123, DOI 10.3844/ajidsp.2007.123.127; Ingianni A, 2013, NEW MICROBIOL, V36, P257; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; KAMBOH MI, 1987, HUM HERED, V37, P65, DOI 10.1159/000153680; Kasvosve I, 2000, CLIN CHEM, V46, P1535; Kasvosve I, 2005, AM J CLIN NUTR, V82, P1102; Kasvosve I, 2002, AM J CLIN NUTR, V75, P321; Kasvosve I, 2015, CLIN CHIM ACTA, V444, P257, DOI 10.1016/j.cca.2015.02.037; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kasvosve I, 2010, CLIN CHIM ACTA, V411, P1248, DOI 10.1016/j.cca.2010.04.031; Katchunga PB, 2013, DIABETES METAB SYND, V7, P112, DOI 10.1016/j.dsx.2013.02.017; Masaisa F, 2012, ANN HEMATOL, V91, P911, DOI 10.1007/s00277-011-1400-3; Mayr R, 2010, J HEPATOL, V53, P941, DOI 10.1016/j.jhep.2010.05.016; Mohas M, 2010, EXP CLIN ENDOCR DIAB, V118, P209, DOI 10.1055/s-0029-1238319; Monnier Vincent M, 2006, Biochem J, V399, pe11; Mosca L, 2011, CLIN CHEM LAB MED, V49, P803, DOI 10.1515/CCLM.2011.133; Nekhai S, 2013, HAEMATOLOGICA, V98, P455, DOI 10.3324/haematol.2012.066530; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; River CA, 2007, BLOOD CELL MOL DIS, V38, P247, DOI 10.1016/j.bcmd.2006.12.002; Rose PP, 2007, ONCOGENE, V26, P1995, DOI 10.1038/sj.onc.1210006; Schulz TF, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.suppl_4.15; Schwager J., 2015, MOL NUTR FOOD RES, P1; Simonart T, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-1; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; Smithies O., 1959, GENETIC CONTROL TRAN; Sobngwi E, 2008, JAMA-J AM MED ASSOC, V299, P2770, DOI 10.1001/jama.299.23.2770; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Szwergold BS, 2001, DIABETES, V50, P2139, DOI 10.2337/diabetes.50.9.2139; Weissmann A, 2000, J EUR ACAD DERMATOL, V14, P91, DOI 10.1046/j.1468-3083.2000.00022.x; ZIEGLER JL, 1993, LANCET, V342, P1348, DOI 10.1016/0140-6736(93)92252-O	50	3	3	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2016	163						14	19		10.1016/j.actatropica.2016.07.011				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DW3FO	WOS:000383527700004	27461879				2019-03-26
J	Kerkhof, K; Sluydts, V; Heng, S; Kim, S; Pareyn, M; Willen, L; Canier, L; Sovannaroth, S; Menard, D; Sochantha, T; Coosemans, M; Durnez, L				Kerkhof, Karen; Sluydts, Vincent; Heng, Somony; Kim, Saorin; Pareyn, Myrthe; Willen, Laura; Canier, Lydie; Sovannaroth, Siv; Menard, Didier; Sochantha, Tho; Coosemans, Marc; Durnez, Lies			Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia	MALARIA JOURNAL			English	Article						Malaria; Serological markers; Geographical patterns; Malaria pockets; Heterogeneous transmission; Cambodia	RANDOMIZED CONTROLLED-TRIAL; THAILAND-MYANMAR BORDER; PLASMODIUM-FALCIPARUM; RISK-FACTORS; CLINICAL MALARIA; EPIDEMIOLOGY; ELIMINATION; INFECTIONS; AREAS; HOTSPOTS	Background: Malaria transmission is highly heterogeneous, especially in low endemic countries, such as Cambodia. This results in geographical clusters of residual transmission in the dry, low transmission season, which can fuel the transmission to wider areas or populations during the wet season. A better understanding of spatial clustering of malaria can lead to a more efficient, targeted strategy to reduce malaria transmission. This study aims to evaluate the potential of the use of serological markers to define spatial patterns in malaria exposure. Methods: Blood samples collected in a community-based randomized trial performed in 98 high endemic communities in Ratanakiri province, north-eastern Cambodia, were screened with a multiplex serological assay for five serological markers (three Plasmodium falciparum and two Plasmodium vivax). The antibody half-lives range from approximately six months until more than two years. Geographical heterogeneity in malaria transmission was examined using a spatial scan statistic on serology, PCR prevalence and malaria incidence rate data. Furthermore, to identify behavioural patterns or intrinsic factors associated with malaria exposure (antibody levels), risk factor analyses were performed by using multivariable random effect logistic regression models. The serological outcomes were then compared to PCR prevalence and malaria incidence data. Results: A total of 6502 samples from two surveys were screened in an area where the average parasite prevalence estimated by PCR among the selected villages is 3.4 %. High-risk malaria pockets were observed adjacent to the 'Tonle San River' and neighbouring Vietnam for all three sets of data (serology, PCR prevalence and malaria incidence rates). The main risk factors for all P. falciparum antigens and P. vivax MSP1.19 are age, ethnicity and staying overnight at the plot hut. Conclusion: It is possible to identify similar malaria pockets of higher malaria transmission together with the potential risk factors by using serology instead of PCR prevalence or malaria incidence data. In north-eastern Cambodia, the serological markers show that malaria transmission occurs mainly in adults staying overnight in plot huts in the field. Pf.GLURP.R2 showed a shrinking pocket of malaria transmission over time, and Pf.MSP1.19, CSP, PvAMA1 were also informative for current infection to a lesser extent. Therefore, serology could contribute in future research. However, further in-depth research in selecting the best combination of antigens is required.	[Kerkhof, Karen; Sluydts, Vincent; Pareyn, Myrthe; Willen, Laura; Coosemans, Marc; Durnez, Lies] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kerkhof, Karen; Pareyn, Myrthe; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Heng, Somony; Sovannaroth, Siv; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Kim, Saorin; Canier, Lydie; Menard, Didier] Inst Pasteur Cambodge, Mol Epidemiol Unit, Phnom Penh, Cambodia	Kerkhof, K (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	kkerkhof@itg.be	Willen, Laura/B-2977-2018; Menard, Didier/O-3294-2013	Willen, Laura/0000-0002-8027-8621; Kerkhof, Karen/0000-0002-2208-9902; Menard, Didier/0000-0003-1357-4495	Bill & Melinda Gates Foundation under the Global Health Grant [OPP1032354]; association of Les Amis des Instituts Pasteur a Bruxelles	"This work is part of a larger project ""MalaResT"" funded by the Bill & Melinda Gates Foundation under the Global Health Grant number OPP1032354. This project aims to evaluate the effectiveness of topical repellents, in addition to long-lasting insecticidal nets, on malaria prevalence and incidence. Next, this work fits within the large-scale research project for the SOFI research program ""MalaSpot"" entitled 'Eco-epidemiology of asymptomatic malaria hotspots, a prerequisite for malaria elimination?'. Furthermore, KK was supported by the association of Les Amis des Instituts Pasteur a Bruxelles."	Aamodt Geir, 2006, Int J Health Geogr, V5, P15, DOI 10.1186/1476-072X-5-15; Bates D, 2015, J STAT SOFTW, V67, P1; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cui LW, 2012, ACTA TROP, V121, P240, DOI 10.1016/j.actatropica.2011.04.006; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Fox J, 2011, R COMPANION APPL REG; Gamage-Mendis AC, 2010, AM J TROP MED HYG, V82, P185; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259; Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0; Guyant P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0773-5; Heng T, 2015, J STAT SOFTW, V5, P1; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Hviid L, 2015, TRENDS PARASITOL, V31, P89, DOI 10.1016/j.pt.2014.12.009; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kangoye DT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1260-3; Kerkhof K, 2016, MALAR J; Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z; Khaireh BA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-395; Kleinman K, 2016, RSATSCAN TOOLS CLASS; Kulldorf M, 2015, SATSCAN SOFTWARE SPA; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kumar S, 2015, PROTOPLASMA, V252, P717, DOI 10.1007/s00709-014-0697-x; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Lynch CA, 2016, AM J TROP MED HYG, V94, P1251, DOI 10.4269/ajtmh.15-0653; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Ministry of Health, 2016, CAMB MAL EL ACT FRAM; Mosha JF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-53; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0712-5; R Core Team, 2015, R LANG ENV STAT COMP; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Souza-Silva FA, 2010, AM J TROP MED HYG, V185, P193; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Venabled W, 2002, MODERN APPL STAT S; WHO, 2015, STRAT MAL EL GREAT M; WHO, 2015, WORLD MAL REP 2015; WHO, 2010, MAL GREAT MEK SUBR R	50	6	6	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 19	2016	15								510	10.1186/s12936-016-1558-1				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DZ5CX	WOS:000385880700001	27756395	DOAJ Gold, Green Published			2019-03-26
J	Abduselam, N; Zeynudin, A; Berens-Riha, N; Seyoum, D; Pritsch, M; Tibebu, H; Eba, K; Hoelscher, M; Wieser, A; Yewhalaw, D				Abduselam, Nuredin; Zeynudin, Ahmed; Berens-Riha, Nicole; Seyoum, Dinberu; Pritsch, Michael; Tibebu, Habtewold; Eba, Kasahun; Hoelscher, Michael; Wieser, Andreas; Yewhalaw, Delenasaw			Similar trends of susceptibility in Anopheles arabiensis and Anopheles pharoensis to Plasmodium vivax infection in Ethiopia	PARASITES & VECTORS			English	Article						Experimental infection; Anopheles arabiensis; Anopheles pharoensis; Anopheles coustani; Plasmodium vivax; Direct membrane feeding assay; Malaria	SOUTH-CENTRAL ETHIOPIA; GAMBIAE COMPLEX; MALARIA TRANSMISSION; FALCIPARUM-MALARIA; INOCULATION RATES; POPULATION; MOSQUITOS; AREA; PREVALENCE; DYNAMICS	Background: Around half of the global population is living in areas at risk of malaria infection. Plasmodium vivax malaria has become increasingly prevalent and responsible for a high health and socio-economic burden in Ethiopia. The availability of gametocyte carriers and mosquito species susceptible to P. vivax infection are vital for malaria transmission. Determining the susceptibility of vector species to parasite infection in space and time is important in vector control programs. This study assesses the susceptibility of Anopheles arabiensis, An. pharoensis and An. coustani group to Plasmodium vivax infection in Ethiopia. Methods: Larvae of An. arabiensis, An. pharoensis and An. coustani group were collected from an array of breeding sites and reared to adult under controlled conditions. Batches of adult female mosquitoes of the three species were allowed to feed in parallel on the same infected blood with gametocytes drawn from Plasmodium vivax infected patients by Direct Membrane Feeding Assays (DMFA). Fed mosquitoes were kept in an incubator under controlled laboratory conditions. Seven days after each feeding assay, mosquitoes were dissected for midgut oocyst microscopy and enumeration. Data were analysed using R statistical software package version 3.1.0. Results: Over all, 8,139 adult female mosquitoes were exposed to P. vivax infection. Of the exposed mosquitoes 16. 64 % (95 % CI: 1,354-8,139) were properly fed and survived until dissection. The infection rate in An. arabiensis and An. pharoensis was 31.72 % (95 % CI: 28.35-35.08) and 28.80 % (95 % CI: 25.31-32.28), respectively. The intensity of infection for An. arabiensis and An. pharoensis was 2.5 (95 % CI: 1.9-3.2) and 1.4 (95 % CI: 1.1-1.8), respectively. Gametocyte density was positively correlated to infection rate and intensity of infection in An. arabiensis as well as An. pharoensis. No An. coustani group mosquitoes were found infected, though almost four hundred mosquitoes were successfully fed and dissected. All groups received blood from the same infected blood source containing gametocytes in parallel. There was no significant difference in susceptibility rates between An. arabiensis and An. pharoensis (P = 0.215). Conclusions: Anopheles arabiensis and An. pharoensis showed similar susceptibility to P. vivax infection. However, An. coustani group was not permissive for the development of P. vivax parasites.	[Abduselam, Nuredin; Zeynudin, Ahmed; Yewhalaw, Delenasaw] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Zeynudin, Ahmed; Pritsch, Michael; Wieser, Andreas] Max von Pettenkofer Inst LMU, Dept Bacteriol, Munich, Germany; [Berens-Riha, Nicole; Pritsch, Michael; Hoelscher, Michael; Wieser, Andreas] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Seyoum, Dinberu] Jimma Univ, Dept Stat, Coll Nat Sci, Jimma, Ethiopia; [Pritsch, Michael; Hoelscher, Michael; Wieser, Andreas] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Tibebu, Habtewold] Imperial Coll London, Div Cell & Mol Biol, Dept Life Sci, London, England; [Eba, Kasahun; Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia; [Seyoum, Dinberu] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium	Wieser, A (reprint author), Max von Pettenkofer Inst LMU, Dept Bacteriol, Munich, Germany.; Wieser, A (reprint author), Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany.; Wieser, A (reprint author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.	wieser@mvp.uni-muenchen.de	Hoelscher, Michael/D-3436-2012		Jimma University; German Center for Infection Research (DZIF); Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU); German Center for Infection Research	The study was partly funded by Jimma University funds allocated to NA, as well as by funds given by the German Center for Infection Research (DZIF), partner site Munich given to AW as well as by funds of the Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU) given to AW, MP and MH. This study was supported by Clinical Leave Scholarships from the German Center for Infection Research (to MP and AW).	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Animut A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-76; Animut A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-117; Bayoh NM, 2010, MALARIA J, V9, P62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bousema T, 2011, INT J PARASITOL, V41, P293, DOI 10.1016/j.ijpara.2010.09.908; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Degefa T, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0532-z; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Federal Democratic Ethiopia MoH, 2014, NAT MAL STRAT PLAN 2; Federal Democratic Ethiopia MoH, 2006, NAT 5 YEAR STRAT PLA; Federal Democratic Ethiopia MoH, 2012, ETH NAT MAL IND SURV; Fornadel CM, 2010, AM J TROP MED HYG, V83, P838, DOI 10.4269/ajtmh.2010.10-0088; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gerberg EJ, 1970, AM MOSQ CONTROL ASS, V5, P109; Gillies MT, 1987, JOHANNESBURG S AFR I, V55, P1; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kibret S, 2010, TROP MED INT HEALTH, V15, P41, DOI 10.1111/j.1365-3156.2009.02423.x; KRAFSUR ES, 1978, T ROY SOC TROP MED H, V72, P348, DOI 10.1016/0035-9203(78)90125-6; Lensen A, 1996, T ROY SOC TROP MED H, V90, P20, DOI 10.1016/S0035-9203(96)90464-2; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Massebo F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-44; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Nyanjom SRG, 2003, J HERED, V94, P457, DOI 10.1093/jhered/esg100; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Rios-Velasquez CM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-460; Sinden R, 2007, METHODS MOL MED, V72, P25; Snow RW, 2002, ESSENTIAL MALARIOLOG, P85; Stone WJR, 2013, SCI REP-UK, V3, DOI 10.1038/srep03418; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; WHITE GB, 1980, T ROY SOC TROP MED H, V74, P683; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2015, CONTR EL PLASM VIV; World Health Organization, 2015, WORLD MALARIA REPORT; Woyessa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-84; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21; Zhu GD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-176	47	1	1	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 18	2016	9								552	10.1186/s13071-016-1839-0				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DZ5DZ	WOS:000385883500003	27756355	DOAJ Gold, Green Published			2019-03-26
J	Lempereur, L; Martinelle, L; Marechal, F; Bayrou, C; Dalemans, AC; Schnyder, M; Losson, B				Lempereur, Laetitia; Martinelle, Ludovic; Marechal, Francoise; Bayrou, Calixte; Dalemans, Anne Catherine; Schnyder, Manuela; Losson, Bertrand			Prevalence of Angiostrongylus vasorum in southern Belgium, a coprological and serological survey	PARASITES & VECTORS			English	Article						Angiostrongylus vasorum; Crenosoma vulpis; Serology; Coprology; Dog; Belgium	CANINE ANGIOSTRONGYLOSIS; SEROEPIDEMIOLOGICAL SURVEY; CRENOSOMA-VULPIS; INFECTED-DOGS; ANTIGEN; ANTIBODIES; HEARTWORM; GERMANY; EUROPE	Background: Canine angiostrongylosis, a gastropod-borne helminthic infection, is increasingly being described in North America and is now reported in many European countries. In dogs, Angiostrongylus vasorum may cause a wide spectrum of clinical signs. Respiratory distress such as coughing and dyspnoea are the most frequently described manifestations. The aim of the present study was to gain additional information on the distribution, prevalence and risk factors associated with A. vasorum infection in dog from southern Belgium through the combined used of a commercially available in-clinic assay for detection of circulating antigen (Angio Detect (TM), IDEXX, Westbrook, USA) and coprology in two different canine populations: dogs with clinical signs compatible with angiostrongylosis and asymptomatic dogs or dogs presented for unrelated conditions (control). Results: A total of 979 dogs were enrolled in the study from November 2014 until February 2016. Seven hundred fiftyseven dogs were included in the control group, whereas 222 dogs had clinical signs compatible with angiostrongylosis. Forty-six dogs out of 979 (4.7 %) had A. vasorum circulating antigen. There was a highly significant difference between the two populations (3.6 % (27/747) and 8.6 % (19/222) in control and symptomatic dogs, respectively) (P = 0.00379). First stage larvae (L1) of A. vasorum were found in seven out of 24 serologically positive control dogs and in six out of 17 serologically positive symptomatic dogs. Interestingly, L1 of Crenosoma vulpis were detected by Baermann technique in one control and nine symptomatic dogs, respectively. Out of 17 Angio Detect (TM) (IDEXX, Westbrook, USA) positive dogs with negative (14) or not performed Baermann test (three), one dog was positive in both in-house ELISAs (Ag and Ab) and one dog was positive for Ag. Statistical analysis was unable to detect any risk factors associated with the direct and/or indirect detection of A. vasorum. Conclusions: This seroepidemiological study demonstrated for the first time a high seroprevalence in Southern Belgium for A. vasorum. The Angio Detect (TM) was found to be suitable in this context as the collection, preservation and examination of stools were difficult. Nevertheless, discrepancies were observed between the different available tests. Additional research is clearly needed. Also, coproscopy remains a very useful tool in dogs infected for less than nine weeks and for the identification of other canine lung nematodes such as C. vulpis. This study also demonstrates that asymptomatic dogs may shed A. vasorum L1 in their faeces and therefore contribute to the maintenance of A. vasorum life-cycle.	[Lempereur, Laetitia; Marechal, Francoise; Losson, Bertrand] Univ Liege, Lab Parasitol & Parasit Dis, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium; [Martinelle, Ludovic] Univ Liege, Expt Stn CARE FePex, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium; [Bayrou, Calixte] Univ Liege, Pathol Unit, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium; [Dalemans, Anne Catherine] Bayer Anim Hlth Benelux, Diegem, Belgium; [Schnyder, Manuela] Univ Zurich, Vetsuisse Fac, Inst Parasitol, Zurich, Switzerland	Lempereur, L (reprint author), Univ Liege, Lab Parasitol & Parasit Dis, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium.	llempereur@ulg.ac.be	Schnyder, Manuela/J-3188-2015	Schnyder, Manuela/0000-0002-6523-7952	Bayer Animal Health; IDEXX Laboratories	This study was performed with the financial support of Bayer Animal Health and IDEXX Laboratories.	Alho AM, 2016, PARASITOL RES, V115, P2567, DOI 10.1007/s00436-016-5001-x; Barutzki D, 2003, PARASITOL RES, V90, pS148, DOI 10.1007/s00436-003-0922-6; Barutzki D, 2009, PARASITOL RES, V105, pS39, DOI 10.1007/s00436-009-1494-x; Blehaut TRW, 2014, VET REC, V175, P148, DOI 10.1136/vr.102186; BOLT G, 1994, VET REC, V135, P447, DOI 10.1136/vr.135.19.447; Canonne AM, 2016, J SMALL ANIM PRACT, V57, P130, DOI 10.1111/jsap.12419; Caron Y., 2014, VET RECORD CASE REPO, V2, P1; Chapman PS, 2004, J SMALL ANIM PRACT, V45, P435, DOI 10.1111/j.1748-5827.2004.tb00261.x; Colella V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1440-6; Conboy GA, 2011, VET PARASITOL, V176, P382, DOI 10.1016/j.vetpar.2011.01.025; Di Cesare A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1047-3; Drake J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0698-4; ESCCAP, 2010, WORM CONTR DOGS CATS; Ferdushy T, 2009, J HELMINTHOL, V83, P379, DOI 10.1017/S0022149X09377706; Guardone L, 2013, VET PARASITOL, V192, P192, DOI 10.1016/j.vetpar.2012.10.016; GUILHON J, 1973, Annales de Parasitologie Humaine et Comparee, V48, P567; Helm JR, 2010, J VET EMERG CRIT CAR, V20, P98, DOI 10.1111/j.1476-4431.2009.00494.x; Jolly S, 2015, PARASITOL INT, V64, P97, DOI 10.1016/j.parint.2014.10.008; Koch J, 2009, VET J, V179, P348, DOI 10.1016/j.tvjl.2007.11.014; Little SE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0710-z; Lurati L, 2015, VET PARASITOL, V212, P219, DOI 10.1016/j.vetpar.2015.08.017; McGarry JW, 2009, VET REC, V165, P258, DOI 10.1136/vr.165.9.258; Morgan ER, 2010, VET PARASITOL, V173, P255, DOI 10.1016/j.vetpar.2010.06.037; Morgan ER, 2009, PARASITOL INT, V58, P406, DOI 10.1016/j.parint.2009.08.003; Oliveira SD, 2006, VET PARASITOL, V141, P101, DOI 10.1016/j.vetpar.2006.05.003; Sarre C, 2015, VLAAMS DIERGEN TIJDS, V84, P243; Schnyder M, 2015, PARASITOLOGY, V142, P1270, DOI 10.1017/S0031182015000554; Schnyder M, 2013, PARASITOLOGY, V140, P1442, DOI 10.1017/S0031182013001091; Schnyder M, 2011, VET PARASITOL, V179, P152, DOI 10.1016/j.vetpar.2011.01.054; Schnyder M, 2015, PARASITOL RES, V114, pS145, DOI 10.1007/s00436-015-4520-1; Schnyder M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-72; Schnyder M, 2013, PARASITOL RES, V112, P109, DOI 10.1007/s00436-013-3285-7; Schucan A, 2012, VET PARASITOL, V185, P216, DOI 10.1016/j.vetpar.2011.09.040; Serres E, 1854, J VET MIDI, V7, P70; Tolnai Z, 2015, VET PARASITOL, V207, P355, DOI 10.1016/j.vetpar.2014.12.008; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-62	36	7	7	2	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 6	2016	9								533	10.1186/s13071-016-1820-y				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DY1IB	WOS:000384847000002	27716374	DOAJ Gold, Green Published			2019-03-26
J	Grandesso, F; Nabasumba, C; Nyehangane, D; Page, AL; Bastard, M; De Smet, M; Boum, Y; Etard, JF				Grandesso, Francesco; Nabasumba, Carolyn; Nyehangane, Dan; Page, Anne-Laure; Bastard, Mathieu; De Smet, Martin; Boum, Yap; Etard, Jean-Francois			Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings	MALARIA JOURNAL			English	Article						Malaria; Fever; Diagnostic; Rapid diagnostic test; Sensitivity; Specificity; Performance; Negativity	UNCOMPLICATED FALCIPARUM-MALARIA; LACTATE-DEHYDROGENASE; CHILDREN; TANZANIA; AREA; INFECTIONS; PFHRP2; FEVER; BLOOD; ASSAY	Background: The performance of different malaria rapid diagnostic tests (RDT) may be influenced by transmission intensity and by the length of time each test requires to become negative after treatment and patient's recovery. Methods: Results of three RDTs (two HRP2 and one pLDH antigen-based tests) were compared to blood smear microscopy (the gold standard method) in children under 5 years of age living in a high versus low malaria intensity setting in southwestern Uganda. In each setting, 212 children, who tested positive by at least one RDT and by microscopy, were treated with artemether-lumefantrine. RDTs and microscopy were then repeated at fixed intervals to estimate each test's time to negativity after treatment and patient recovery. Results: In the two settings, sensitivities ranged from 98.4 to 99.2 % for the HRP2 tests and 94.7 to 96.1 % for the pLDH test. Specificities were 98.9 and 98.8 % for the HRP2 tests and 99.7 % for the pLDH test in the low-transmission setting and 79.7, 80.7 and 93.9 %, respectively, in the high-transmission setting. Median time to become negative was 35-42 or more days for the HRP2 tests and 2 days for the pLDH test. Conclusions: High transmission contexts and a long time to become negative resulted in considerably reduced specificities for the HRP2 tests. Choice of RDT for low-versus high-transmission settings should balance risks and benefits of over-treatment versus missing malaria cases.	[Grandesso, Francesco; Page, Anne-Laure; Bastard, Mathieu; Etard, Jean-Francois] Epicentre, 8 Rue Saint Sabin, Paris, France; [Nabasumba, Carolyn; Nyehangane, Dan; Boum, Yap] Epicentre, Mbarara Res Ctr, Mbarara, Uganda; [De Smet, Martin] Med Sans Frontieres, Brussels, Belgium; [Boum, Yap] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Etard, Jean-Francois] Univ Montpellier I, UMI TransVIHMI 233, Inst Rech Dev, F-34000 Montpellier, France	Grandesso, F (reprint author), Epicentre, 8 Rue Saint Sabin, Paris, France.	francesco.GRANDESSO@epicentre.msf.org		Grandesso, Francesco/0000-0001-9909-0285	MSF International through the International Innovation Fund; MSF Operational Centre Paris	This study was sponsored by MSF International through the International Innovation Fund and by MSF Operational Centre Paris.	[Anonymous], 2013, WHO FIND CDC TDR MAL; [Anonymous], 2011, WHO FIND CDC TDR MAL; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132; Desakorn V, 1997, T ROY SOC TROP MED H, V91, P479, DOI 10.1016/S0035-9203(97)90292-3; Gerstl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-28; Hawkes M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-43; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Laurent A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-294; Mahende C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1450-z; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Moody A, 2000, BRIT J HAEMATOL, V109, P891, DOI 10.1046/j.1365-2141.2000.01974.x; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Njama-Meya D, 2013, 6 MIM PAN AFR MAL C; Nyunt MH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-123; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Oduola AMJ, 1997, EXP PARASITOL, V87, P283, DOI 10.1006/expr.1997.4251; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Olaleye BO, 1998, T ROY SOC TROP MED H, V92, P300, DOI 10.1016/S0035-9203(98)91021-5; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WHO, 2009, WORLD MALARIA REPORT	23	16	16	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 4	2016	15								496	10.1186/s12936-016-1529-6				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DY1HU	WOS:000384846300001	27716244	DOAJ Gold, Green Published			2019-03-26
J	Altare, C; Delbiso, TD; Mutwiri, GM; Kopplow, R; Guha-Sapir, D				Altare, Chiara; Delbiso, Tefera Darge; Mutwiri, George Mutembei; Kopplow, Regine; Guha-Sapir, Debarati			Factors Associated with Stunting among Pre-school Children in Southern Highlands of Tanzania	JOURNAL OF TROPICAL PEDIATRICS			English	Article						stunting; growth; maternal support; child care; diet diversity; Tanzania	DEVELOPING-COUNTRIES; DEVELOPED-COUNTRIES; EARLY-CHILDHOOD; UNDERNUTRITION; GROWTH; INTERVENTIONS; CONSEQUENCES; METAANALYSIS; ADOLESCENTS; OVERWEIGHT	Methods: A cross-sectional two-stage cluster sampling survey was conducted among children aged 6-59 months. The sample included 1360 children aged 6-23 months and 1904 children aged 24-59 months. Descriptive statistics and binary and multivariate logistic regression analyses were used. Results: Our main results are: in the younger group, stunting was associated with male sex (adjusted odds ratio [AOR]: 2.17; confidence interval [CI]: 1.52-3.09), maternal absence (AOR: 1.93; CI: 1.21-3.07) and household diet diversity (AOR: 0.61; CI: 0.41-0.92). Among older children, stunting was associated with male sex (AOR: 1.28; CI: 1.00-1.64), age of 4 and 5 (AOR: 0.71; CI: 0.54-0.95; AOR: 0.60; CI: 0.44-0.83), access to improved water source (AOR: 0.70; CI: 0.52-0.93) and to a functioning water station (AOR: 0.63; CI: 0.40-0.98) and mother breastfeeding (AOR: 1.97; CI: 1.18-3.29). Conclusions: Interventions that increase household wealth and improve water and sanitation conditions should be implemented to reduce stunting. Family planning activities and programmes supporting mothers during pregnancy and lactation can positively affect both newborns and older siblings.	[Altare, Chiara; Delbiso, Tefera Darge; Guha-Sapir, Debarati] Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Clos Chapelle Aux Champs 30,Bte B1-30-15, B-1200 Brussels, Belgium; [Altare, Chiara] Act Faim, Res & Anal Unit, 14-16 Blvd Douaumont, F-75854 Paris, France; [Mutwiri, George Mutembei] Concern Worldwide Tanzania, 169 Regent Estate, Dar Es Salaam, Tanzania; [Kopplow, Regine] Concern Worldwide, 52-55 Camden St, Dublin 2, Ireland	Altare, C (reprint author), Clos Chapelle Aux Champs 30,Bte B1-30-15, B-1200 Brussels, Belgium.	chiara.altare@uclouvain.be			Irish Aid; UNICEF; Concern Worldwide; Fond National de Recherche Scientifique [PDR 14692731]; Universite catholique de Louvain; Association pour l'epidemiologie des desastres	This work was supported by Irish Aid, UNICEF, Concern Worldwide, Fond National de Recherche Scientifique (PDR 14692731), Universite catholique de Louvain and Association pour l'epidemiologie des desastres.	Abubakar A, 2012, INT J ENV RES PUB HE, V9, P3506, DOI 10.3390/ijerph9103506; Action Contre la Faim International, 2012, EM NUTR ASS STAND MO; Adair LS, 2013, LANCET; Arimond M, 2004, J NUTR, V134, P2579; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dror DK, 2014, NUTR REV, V72, P68, DOI 10.1111/nure.12078; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fink G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102391; Greene M, 2005, INVOLVING MEN REPROD; Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Keino S, 2014, FOOD NUTR BULL, V35, P167, DOI 10.1177/156482651403500203; Kennedy G, 2010, GUIDELINES MEASURING; Mamiro PS, 2005, J HEALTH POPUL NUTR, V23, P222; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Martorell R, 2012, ADV NUTR, V3, P227, DOI 10.3945/an.111.001107; Masanja H, 2005, HEALTH POLICY PLANN, V20, pI77, DOI 10.1093/heapol/czi054; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; McDonald CM, 2013, J NUTR, V143, P204, DOI 10.3945/jn.112.168682; Mussa R, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0011-9; Onyango AW, 2014, PUBLIC HEALTH NUTR, V17, P1975, DOI 10.1017/S1368980013002401; Petrou S, 2010, SOC SCI MED, V71, P1366, DOI 10.1016/j.socscimed.2010.06.038; Prendergast AJ, 2014, PAEDIAT INT CHILD HL; Sania A, 2014, MATERN CHILD NUTR; Shrimpton R, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e75; Smith LC, 2002, ECON DEV CULT CHANGE, V51, P55, DOI 10.1086/345313; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; Tanzania Commission for AIDS Zanzibar AIDS Commission National Bureau of Statistics Office of the Chief Government Statistician ICF International, 2013, TANZ HIV AIDS MAL IN; The SMART Project, 2006, MEAS MORT NUTR FOOD; The Sphere Project, 2011, HUM CHART MIN STAND; *UN CHILDR FUND, 1990, STRAT IMPR NUTR CHIL; UNICEF, 2012, LOOK MBEYA CIT CIT C; United Nations Children's Fund World Health Organization World Bank, 2013, JOINT CHILD MALN EST; United Republic of Tanzania, 2014, TANZ NAT NUTR SURV 2; United Republic of Tanzania, 2010, TANZ DEM HLTH SURV; United Republic of Tanzania, 2012, POP HOUS CENS; Ververs M, 2013, PLOS CURR; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wamani Henry, 2007, BMC Pediatr, V7, P17, DOI 10.1186/1471-2431-7-17; WHO, 2006, WHO ANTHR 2005 PERS	44	5	5	3	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	OCT	2016	62	5					390	408		10.1093/tropej/fmw024				19	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	EC1YE	WOS:000387904500007	27122480	Bronze, Green Published			2019-03-26
J	Belaid, L; Dumont, A; Chaillet, N; Zertal, A; De Brouwere, V; Hounton, S; Ridde, V				Belaid, L.; Dumont, A.; Chaillet, N.; Zertal, A.; De Brouwere, V.; Hounton, S.; Ridde, V.			Effectiveness of demand generation interventions on use of modern contraceptives in low- and middle-income countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						Systematic review; low- and middle-income countries; family planning; demand intervention; effectiveness; costs; contraception	FAMILY-PLANNING PROGRAMS; COMPLEX INTERVENTIONS; SERVICE DELIVERY; POOR WOMEN; HEALTH; VOUCHERS; TRIAL; CARE; EDUCATION; BEHAVIOR	OBJECTIVES To synthesise evidence on the implementation, costs and cost-effectiveness of demand generation interventions and their effectiveness in improving uptake of modern contraception methods. METHODS A Cochrane systematic review was conducted. Searches were performed in electronic databases (MEDLINE, EMBASE) and the grey literature. Randomised controlled trials, cluster randomised trials and quasi-experimental studies, including controlled before-after studies (CBAs) and cost and cost-effectiveness studies that aimed to assess demand interventions (including community-and facility-based interventions, financial mechanisms and mass media campaigns) in low-and middle-income countries were considered. Meta-analyses and narrative synthesis were conducted. RESULTS In total, 20 papers meeting the inclusion criteria were included in this review. Of those, 13 were used for meta-analysis. Few data were available on implementation and on the influence of context on demand interventions. Involving family members during counselling, providing education activities and increasing exposure to those activities could enhance the success of demand interventions. Demand generation interventions were positively associated with increases in current use (pooled OR 1.57; 95% CI: 1.46-1.69, P < 0.01). Financial mechanism interventions (vouchers) appeared effective to increase use of modern contraceptive methods (pooled OR 2.16; 95% CI: 1.91-2.45, P < 0.01; I-2 = 0%). Demand interventions improved knowledge (pooled OR 1.02; 95% CI 0.63-1.64, P = 0.93) and attitudes towards family planning and improved discussion with partners/husbands around modern contraceptive methods. However, given the limited number of studies included in each category of demand generation interventions, the dates of publication of the studies and their low quality, caution is advised in considering the results. Very limited evidence was available on costs; studies including data on costs were old and inconsistent. CONCLUSION Demand generation interventions contribute to increases in modern contraceptive methods use. However, more studies with robust designs are needed to identify the most effective demand generation intervention to increase uptake of modern contraceptive methods. More evidence is also needed about implementation, costs and cost-effectiveness to inform decisions on sustainability and scaling-up.	[Belaid, L.] Univ Montreal, Sch Publ Hlth ESPUM, Montreal, PQ, Canada; [Dumont, A.] Univ Paris 05, UMR IRD 216, Paris, France; [Chaillet, N.] Ctr Hosp Univ Laval, CHU Quebec, Ctr Rech, Ville De Quebec, PQ, Canada; [Zertal, A.] CHU St Justine, Montreal, PQ, Canada; [De Brouwere, V.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Hounton, S.] United Nations Populat Fund, Tech Div, New York, NY USA; [Ridde, V.] Univ Montreal, IRSPUM, ESPUM, Sch Publ Hlth, Montreal, PQ, Canada	Belaid, L (reprint author), Univ Montreal, Sch Publ Hlth, 7101 Ave Parc, Montreal, PQ H3N 1X9, Canada.	belaid.loubna@gmail.com		Ridde, Valery/0000-0001-9299-8266			Akman M, 2010, J INT MED RES, V38, P1243, DOI 10.1177/147323001003800405; Azmat SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074260; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barberis M, 1997, J BIOSOC SCI, V29, P219, DOI 10.1017/S0021932097002198; Belaid L, 2015, SYST REV, V4, P1; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Bertrand JT, 1982, STUD FAM PLAN, V18, P361; Chirwa Y, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-197; Cochrane IKMD, 2011, REV MAN REVMAN VERS; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Dureab F, 2013, TROP MED INT HEALTH, V18, P179; Durlak JA, 2015, PREV SCI, V16, P1123, DOI 10.1007/s11121-015-0606-3; Effective Practice and Organisation of Care (EPOC), 2015, SUGG RISK BIAS CRIT; Eva G, 2015, INT J GYNAECOL OB S3, V130, P15; FISEK NH, 1978, STUD FAMILY PLANN, V9, P280, DOI 10.2307/1965765; Fonner VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089692; George AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138116; Guse K, 2012, J ADOLESCENT HEALTH, V51, P535, DOI 10.1016/j.jadohealth.2012.03.014; Hawe P, 2015, ANNU REV PUBL HEALTH, V36, P307, DOI [10.1146/annurev-publhealth-031912-114421, 10.1146/annurev-publhealth-031914-114421]; Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; HUBER SC, 1989, J BIOSOC SCI, V21, P267; Hurst TE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0727-5; Ir P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-1; Ireland M, 2011, B WORLD HEALTH ORGAN, V89, P695, DOI 10.2471/BLT.11.087379; Kagesten A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138647; Kanya L, 2014, HEALTH POLICY PLANN, V29, pI4, DOI 10.1093/heapol/czt079; Katz KR, 1998, INT FAM PLAN PERSPEC, V24, P104, DOI 10.2307/3038206; Luck M, 2000, STUD FAMILY PLANN, V31, P325, DOI 10.1111/j.1728-4465.2000.00325.x; Lutalo T, 2010, STUD FAMILY PLANN, V41, P55, DOI 10.1111/j.1728-4465.2010.00224.x; Mahamed Fariba, 2012, Glob J Health Sci, V4, P110, DOI 10.5539/gjhs.v4n2p110; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; Osotimehin B, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29978; Pazol K, 2015, AM J PREV MED, V49, pS46, DOI 10.1016/j.amepre.2015.03.031; Popay J, 2006, GUIDANCE CONDUCT NAR; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; Saeed GA, 2008, CONTRACEPTION, V77, P377, DOI 10.1016/j.contraception.2008.01.011; Schwandt HM, 2013, CONTRACEPTION, V88, P281, DOI 10.1016/j.contraception.2013.03.008; Sebastian MP, 2012, INT PERSPECT SEX R H, V38, P68, DOI 10.1363/3806812; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Sinding SW., 2007, GLOBAL FAMILY PLANNI; Soliman M H, 1999, East Mediterr Health J, V5, P1002; STEVENS JR, 1992, STUD FAMILY PLANN, V23, P171, DOI 10.2307/1966726; TEREFE A, 1993, AM J PUBLIC HEALTH, V83, P1567, DOI 10.2105/AJPH.83.11.1567; UNFPA, 2014, DEV UNFPA PROGR GUID; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; Weeden D, 1986, Asia Pac Popul J, V1, P31; Wells M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-95; World Bank, 2016, DAT COUNTR LEND GROU; Zapata LB, 2015, AM J PREV MED, V49, pS31, DOI 10.1016/j.amepre.2015.03.023	52	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2016	21	10					1240	1254		10.1111/tmi.12758				15	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EB7TF	WOS:000387592800003	27465589	Other Gold			2019-03-26
J	Lafort, Y; Greener, R; Roy, A; Greener, L; Ombidi, W; Lessitala, F; Haghparast-Bidgoli, H; Beksinska, M; Gichangi, P; Reza-Paul, S; Smit, JA; Chersich, M; Delva, W				Lafort, Yves; Greener, Ross; Roy, Anuradha; Greener, Letitia; Ombidi, Wilkister; Lessitala, Faustino; Haghparast-Bidgoli, Hassan; Beksinska, Mags; Gichangi, Peter; Reza-Paul, Sushena; Smit, Jenni A.; Chersich, Matthew; Delva, Wim			HIV prevention and care-seeking behaviour among female sex workers in four cities in India, Kenya, Mozambique and South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						female sex workers; HIV prevention and care; care-seeking behaviour; condom use; peer education; Sub-Saharan Africa; India	SEXUALLY-TRANSMITTED INFECTIONS; REPRODUCTIVE HEALTH-SERVICES; SUB-SAHARAN AFRICA; VAGINAL PRACTICES; TETE PROVINCE; CONDOM USE; DRY SEX; INTERVENTIONS; COUNTRIES; RISK	OBJECTIVE To identify gaps in the use of HIV prevention and care services and commodities for female sex workers, we conducted a baseline cross-sectional survey in four cities, in the context of an implementation research project aiming to improve use of sexual and reproductive health services. METHODS Using respondent-driven sampling, 400 sex workers were recruited in Durban, 308 in Tete, 400 in Mombasa and 458 in Mysore and interviewed face-to-face. RDS-adjusted proportions were estimated by nonparametric bootstrapping and compared across cities using post hoc pairwise comparison. RESULTS Condom use with last client ranged from 88.3% to 96.8%, ever female condom use from 1.6% to 37.9%, HIV testing within the past 6 months from 40.5% to 70.9%, receiving HIV treatment and care from 35.5% to 92.7%, care seeking for last STI from 74.4% to 87.6% and having had at least 10 contacts with a peer educator in the past year from 5.7% to 98.1%. Many of the differences between cities remained statistically significant (P < 0.05) after adjusting for differences in FSWs' socio-demographic characteristics. CONCLUSION The use of HIV prevention and care by FSWs is often insufficient and differed greatly between cities. Differences could not be explained by variations in socio-demographic sex worker characteristics. Models to improve use of condoms and HIV prevention and care services should be tailored to the specific context of each site. Programmes at each site must focus on improving availability and uptake of those services that are currently least used.	[Lafort, Yves; Gichangi, Peter; Chersich, Matthew; Delva, Wim] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Greener, Ross; Greener, Letitia; Beksinska, Mags; Smit, Jenni A.] Univ Witwatersrand, MatCH Res Unit, Durban, South Africa; [Roy, Anuradha] Ashodaya Samithi, Mysore, Karnataka, India; [Ombidi, Wilkister] Int Ctr Reprod Hlth Kenya, Mombasa, Kenya; [Lessitala, Faustino] Int Ctr Reprod Hlth Mozambique, Maputo, Mozambique; [Haghparast-Bidgoli, Hassan] UCL, Inst Global Hlth, London, England; [Gichangi, Peter] Univ Nairobi, Nairobi, Kenya; [Reza-Paul, Sushena] Univ Manitoba, Winnipeg, MB, Canada; [Smit, Jenni A.] Univ KwaZulu Natal, Coll Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa; [Chersich, Matthew] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Delva, Wim] Univ Stellenbosch, South African DST NRF Ctr Excellence Epidemiol Mo, Stellenbosch, South Africa; [Delva, Wim] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium	Lafort, Y (reprint author), Pintelaan 185 UZP114, B-9000 Ghent, Belgium.	yves.lafort@ugent.be		chersich, matthew/0000-0002-4320-9168; Delva, Wim/0000-0001-8054-1904	European Union [Health-F3-2011-282542]; International Department Flanders (DIV) [A11/TT/0382]	The research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement number Health-F3-2011-282542. In Mozambique, funding was received from the International Department Flanders (DIV) under agreement A11/TT/0382.	[Anonymous], 2014, CONS GUID HIV PREV D; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Civic D, 1996, SOC SCI MED, V42, P91, DOI 10.1016/0277-9536(95)00081-X; Consortium D, 2013, REP SIT AN REPR HLTH; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Dinno A, 2015, STATA J, V15, P292, DOI 10.1177/1536867X1501500117; [FHI360 WHO U], 2012, FHI360 WHO UNFPA; Francois I, 2012, INT J SEX HEALTH, V24, P205, DOI 10.1080/19317611.2012.691443; Gabbay M, 1996, CONTRACEPTION, V53, P155, DOI 10.1016/0010-7824(96)00001-7; Ghimire L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-79; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Guerra FM, 2014, AIDS BEHAV, V18, P146, DOI 10.1007/s10461-013-0580-3; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Johnston L.G., 2010, METHODOLOGICAL INNOV, V5, P38, DOI DOI 10.4256/MI0.2010.0017; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Laga M, 2010, SEX TRANSM INFECT, V86, pI6, DOI 10.1136/sti.2009.039255; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Luchters S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068855; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Moore L, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-47; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; O'Brien N, 2011, SEX TRANSM INFECT, V87, pA234, DOI 10.1136/sextrans-2011-050108.313; Peters A, 2014, AFR J REPROD HEALTH, V18, P34; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Richter M, 2014, J IMMIGR MINOR HEALT, V16, P7, DOI 10.1007/s10903-012-9758-4; Rojanapithayakorn W, 1995, J Med Assoc Thai, V78, P350; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Scorgie F, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-33; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Steen R, 2003, REPROD HEALTH MATTER, V11, P74, DOI 10.1016/S0968-8080(03)02295-X; UNAIDS, 2014, THE GAP REP; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Vuylsteke B, 2001, SEX TRANSM INFECT, V77, P351, DOI 10.1136/sti.77.5.351; WHO, 2012, PREV TREATM HIV OTH; WHO, 2012, 989241503839 WHO; Williams BG, 2015, CURR HIV-AIDS REP, V12, P196, DOI 10.1007/s11904-015-0264-x	41	5	5	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2016	21	10					1293	1303		10.1111/tmi.12761				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EB7TF	WOS:000387592800008	27479236				2019-03-26
J	Abello, JE; Cuesta, JG; Cerro, BR; Guha-Sapir, D				Abello, Jason Echavez; Cuesta, Julita Gil; Cerro, Boyd Roderick; Guha-Sapir, Debarati			Factors Associated with the Time of Admission among Notified Dengue Fever Cases in Region VIII Philippines from 2008 to 2014	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BRAZIL; CLASSIFICATION; EPIDEMIC; CAMBODIA; CHILDREN; CARE	In cases of Dengue fever, late hospital admission can lead to treatment delay and even death. In order to improve early disease notification and management, it is essential to investigate the factors affecting the time of admission of Dengue cases. This study determined the factors associated with the time of admission among notified Dengue cases. The study covered the period between 2008 and 2014 in Region VIII, Philippines. The factors assessed were age, sex, hospital sector, hospital level, disease severity based on the 1997 WHO Dengue classification, and period of admission (distinguishing between the 2010 Dengue epidemic and non-epidemic time). We analysed secondary data from the surveillance of notified Dengue cases. We calculated the association through chi-square test, ordinal logistic regression and linear regression at p value <0.05. The study included 16,357 admitted Dengue cases. The reported cases included a majority of children (70.09%), mild cases of the disease (64.00%), patients from the public sector (69.82%), and non-tertiary hospitals (62.76%). Only 1.40% of cases had a laboratory confirmation. The epidemic period in 2010 comprised 48.68% of all the admitted cases during this period. Late admission was more likely among adults than children (p<0.05). The severe type of the disease was more likely to be admitted late than the mild type (p<0.05). Late admission was also more likely in public hospitals than in private hospitals (p<0.05); and within tertiary level hospitals than non-tertiary hospitals (p<0.05). Late admission was more likely during the non-epidemic period than the 2010 epidemic period (p<0.05). A case fatality rate of 1 or greater was significantly associated with children, severe diseases, tertiary hospitals and public hospitals when admitted late (p<0.05). Data suggests that early admission among child cases was common in Region VIII. This behavior is encouraging, and should be continued. However, further study is needed on the late admission among tertiary, public hospitals and non-epidemic period with reference to the quality of care, patient volume, out of pocket expense, and accessibility We recommend the consistent use of the 2009 WHO Dengue guidelines in order to standardize the admission criteria and time across hospitals.	[Abello, Jason Echavez; Cuesta, Julita Gil; Guha-Sapir, Debarati] Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Brussels, Belgium; [Cerro, Boyd Roderick] Reg Epidemiol & Surveillance Unit VIII, Dept Hlth, Tacloban City, Philippines	Abello, JE (reprint author), Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Brussels, Belgium.	jasonabello@yahoo.com		Gil Cuesta, Julita/0000-0002-8291-9701	Education, Audiovisual and Culture Executive Agency (EACEA) of the European Commission	Our gratitude to the Education, Audiovisual and Culture Executive Agency (EACEA) of the European Commission for supporting Jason Echavez Abello in completing the Erasmus Mundus Master Course in Public Health in Disasters (EMMPHID). We wish to acknowledge the Philippines-Department of Health (DOH), Region VIII Epidemiology and Surveillance Unit (RESU) for sharing the data through the authorization of Jose Llacuna, Jr. and Minerva Molon, and helping us interpret with assistance from Grace Jusayan Campo, Arlene Gomez Pallones-Lim, Elsie Jaca and Ezra Valido. We extend our gratitude to Tefera Darge Delbiso and Jose Rodriguez-Llanes who assisted in the data analysis, and Eleanor Hegarty who assisted in the manuscript revision.	Asia Pacific Dengue Prevention Board, 2009, ACC PROGR DENG CONTR; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Department of Health, 2013, HOSP DISTR CY 2012; Department of Health, 2012, 20120012 DEP HLTH RE; Department of Health, 2012, 20120006 DEP HLTH RE; Department of Health-National Epidemiology Center, 2015, DENG CAS AG SEX DIST; Department of Health-Regional Epidemiology and Surveillance Unit VIII, MORBIDITY WEEK, V23, P1; Edillo FE, 2015, AM J TROP MED HYG, V92, P360, DOI 10.4269/ajtmh.14-0139; Gibson G, 2013, CAD SAUDE PUBLICA, V29, P82, DOI 10.1590/S0102-311X2013000100010; Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Herrera M. E., 2007, PREPRINT; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Mendez Angela, 2003, Biomedica, V23, P180; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; NImmanutya S., 2002, J PAEDIATR CHILD H, V1, P1; Pan American Health Organization, 1994, SCI PUBLICATION, V548; Philippine Statistics Authority, 2014, POP ANN GROWTH RAT P; Vicente CR, 2013, REV SOC BRAS MED TRO, V46, P629, DOI 10.1590/0037-8682-1579-2013; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; UCLA, 2015, R DAT AN ORD LOG REG; United Nations International Strategy for Disaster Reduction, 2013, IRP182013 UN INT STR; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Velasco JMS, 2014, SE ASIAN J TROP MED, V45, P337; World Health Organization, 2009, DENG GUID DIAGN TREA; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2014, SURV SYST PHIL	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2016	10	10							e0005050	10.1371/journal.pntd.0005050				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EA5QH	WOS:000386676200036	27780199	DOAJ Gold, Green Published			2019-03-26
J	Avau, B; Borra, V; Vandekerckhove, P; De Buck, E				Avau, Bert; Borra, Vere; Vandekerckhove, Philippe; De Buck, Emmy			The Treatment of Snake Bites in a First Aid Setting: A Systematic Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							APPLY PRESSURE IMMOBILIZATION; ENVENOMATION; MANAGEMENT; MORTALITY; SEVERITY; BANDAGE; 1ST-AID; BURDEN; TRENDS; VENOM	Background The worldwide burden of snakebite is high, especially in remote regions with lesser accessibility to professional healthcare. Therefore, adequate first aid for snakebite is of the utmost importance. A wide range of different first aid techniques have been described in literature, and are being used in practice. This systematic review aimed to summarize the best available evidence concerning effective and feasible first aid techniques for snakebite. Methods A systematic literature screening, performed independently by two authors in the Cochrane Library, MEDLINE and Embase resulted in 14 studies, fulfilling our predefined selection criteria, concerning first aid techniques for snakebite management. Data was extracted and the body of evidence was appraised according to the GRADE approach. Principal findings The pressure immobilization technique was identified as the only evidence-based first aid technique with effectiveness on venom spread. However, additional studies suggest that proper application of this technique is not feasible for laypeople. Evidence concerning other first aid measures, such as the application of a tourniquet, suggests avoiding the use of these techniques. Conclusions The practical recommendation for the treatment of snakebite in a first aid setting is to immobilize the victim, while awaiting the emergency services. However, given the low to very low quality of the data collected, high quality randomized controlled trials concerning the efficacy and feasibility of different variations of the pressure immobilization technique are warranted.	[Avau, Bert; Borra, Vere; Vandekerckhove, Philippe; De Buck, Emmy] Belgian Red Cross Flanders, Ctr Evidence Based Practice CEBaP, Mechelen, Belgium; [Vandekerckhove, Philippe; De Buck, Emmy] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Vandekerckhove, Philippe] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium	Avau, B (reprint author), Belgian Red Cross Flanders, Ctr Evidence Based Practice CEBaP, Mechelen, Belgium.	bert.avau@rodekruis.be		Borra, Vere/0000-0001-7320-9698	Foundation for Scientific Research of the Belgian Red Cross-Flanders	This work was made possible through funding from the Foundation for Scientific Research of the Belgian Red Cross-Flanders. All authors are employees at the Belgian Red Cross Flanders and were involved in the development of this systematic review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAS S, 1969, COMPR PSYCHIAT, V10, P151, DOI 10.1016/0010-440X(69)90022-4; Amaral CFS, 1998, TOXICON, V36, P805, DOI 10.1016/S0041-0101(97)00132-3; Anker R L, 1983, Aust Fam Physician, V12, P365; ANKER RL, 1982, MED J AUSTRALIA, V1, P212; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Australia Healthdirect, 2015, SNAK BIT; Bhat R N, 1974, J Indian Med Assoc, V63, P383; Bush SP, 2004, ANN EMERG MED, V44, P599, DOI 10.1016/j.annemergmed.2004.06.007; Canale E, 2009, EMERG MED AUSTRALAS, V21, P184, DOI 10.1111/j.1742-6723.2009.01180.x; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; De Buck E, 2014, INT J EVID-BASED HEA, V12, P39, DOI 10.1097/01.XEB.0000444637.88465.a3; Feitosa ES, 2015, REV SOC BRAS MED TRO, V48, P34, DOI 10.1590/0037-8682-0105-2013; Franca FOS, 2003, T ROY SOC TROP MED H, V97, P312, DOI 10.1016/S0035-9203(03)90158-1; Habib AG, 2011, INT HEALTH, V3, P50, DOI 10.1016/j.inhe.2010.08.001; Habib AG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004088; Halesha BR, 2013, J CLIN DIAGN RES, V7, P122, DOI [10.7860/JCDR/2012/4842.2685, 10.7860/JCOR/2012/4842.2685]; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; HOWARTH DM, 1994, MED J AUSTRALIA, V161, P695, DOI 10.5694/j.1326-5377.1994.tb126923.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Khin Ohn Lwin, 1984, Trans R Soc Trop Med Hyg, V78, P165; Madaki JKA, 2005, NIG MED PRACT, V48, P10; Gutierrez JM, 2007, CURR PHARM DESIGN, V13, P2935, DOI 10.2174/138161207782023784; McKinney PE, 2001, ANN EMERG MED, V37, P168, DOI 10.1067/mem.2001.111574; Michael GC, 2011, T ROY SOC TROP MED H, V105, P95, DOI 10.1016/j.trstmh.2010.09.005; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; MURRELL G, 1981, MED J AUSTRALIA, V2, P295; Norris RL, 2005, WILD ENVIRON MED, V16, P16, DOI 10.1580/PR12-04.1; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; PEARN J, 1981, MED J AUSTRALIA, V2, P293; Seifert SA, 2011, J MED TOXICOL, V7, P324, DOI 10.1007/s13181-011-0188-9; Simpson ID, 2008, T ROY SOC TROP MED H, V102, P451, DOI 10.1016/j.trstmh.2008.01.014; St John Ambulance Australia, 2014, FACT SHEET SNAK BIT; SUTHERLAND SK, 1979, LANCET, V1, P183, DOI 10.1016/S0140-6736(79)90580-4; Tun-Pe, 1994, Southeast Asian J Trop Med Public Health, V25, P349; Vaiyapuri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080090; Van de Velde S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001059; Van Strien JW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00691; Wang W, 2014, ENVIRON TOXICOL PHAR, V37, P648, DOI 10.1016/j.etap.2013.12.018; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; World Health Organization (WHO), 2010, VEN SNAK DISTR SPEC	40	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2016	10	10							e0005079	10.1371/journal.pntd.0005079				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EA5QH	WOS:000386676200055	27749906	DOAJ Gold, Green Published			2019-03-26
J	Delamou, A; Haba, NY; Mari-Saez, A; Gallian, P; Rouse, M; Jacobs, J; Camara, BS; Kadio, KJJO; Guemou, A; Kolie, JP; De Crop, M; Chavarin, P; Jacquot, C; Lazaygues, C; De Weggheleire, A; Lynen, L; van Griensven, J				Delamou, Alexandre; Haba, Nyankoye Yves; Mari-Saez, Almudena; Gallian, Pierre; Rouse, Maya; Jacobs, Jan; Camara, Bienvenu Salim; Kadio, Kadio Jean-Jacques Olivier; Guemou, Achille; Kolie, Jean Pe; De Crop, Maaike; Chavarin, Patricia; Jacquot, Chantal; Lazaygues, Catherine; De Weggheleire, Anja; Lynen, Lutgarde; van Griensven, Johan		Ebola-Tx Consortium	Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SUB-SAHARAN AFRICA; BLOOD	Although convalescent plasma (CP) transfusion was prioritized among potential Ebola treatments by the World Health Organization, there were concerns on the feasibility of its implementation. We report on the successful organization of donor mobilization and plasma collection as part of the Ebola-Tx clinical trial from November 2014 to July 2015 in Conakry, Guinea. Project implementation registers, tools and reports, mission reports, and minutes of research team meetings were used to reconstruct the sequence of events on how donor mobilization was organized, plasmapheresis was set up, and how effective this approach was in collecting CP. An initial needs assessment of the Guinean National Blood Transfusion Center resulted in targeted training of staff on site, resulting in autonomy and independent production of CP within 3 months. The Conakry Ebola Survivors Association played a direct role in donor mobilization and organization of CP donations. A total of 98 Ebola survivors were screened for plasma donation, of which 84 were found eligible for plasmapheresis. Of these, 26 (30.9%) were excluded. The remaining 58 donors made a total of 90 donations, corresponding to 50.9 L of CP. This sufficed to treat the 99 eligible patients enrolled in the trial. Within a poor resource emergency context, transfusion capacity could be rapidly improved through the strengthening of local capacities and gradual transfer of skills coupled with active involvement of Ebola survivors. However, large-scale plasma collection or multisite studies may require further adaptations of both strategy and logistics. The Ebola-Tx trial was funded by the European Union and others.	[Delamou, Alexandre] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Mari-Saez, Almudena; Rouse, Maya; Jacobs, Jan; De Crop, Maaike; De Weggheleire, Anja; Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, Antwerp, Belgium; [Haba, Nyankoye Yves; Camara, Bienvenu Salim; Kadio, Kadio Jean-Jacques Olivier] Ctr Natl Transfus Sanguine, Conakry, Guinea; [Gallian, Pierre; Jacquot, Chantal] Etab Francais Sang, Plaine Stade De France, France; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Guemou, Achille; Kolie, Jean Pe] Assoc Personnes Gueries & Affectees Ebola Guinee, Conakry, Guinea; [Chavarin, Patricia] Etab Francais Sang Auvergne Loire, St Etienne, France; [Lazaygues, Catherine] Etab Francais Sang Alpes Mediterranee, Marseille, France	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	adelamou@gmail.com; nyankoyeh@yahoo.fr; almudena.mari-saez@charite.de; Pierre.gallian@efs.sante.fr; mronse@itg.be; jjacobs@itg.be; bienvenusalimcamara@gmail.com; drkadiojolivier@gmail.com; guem_achille@yahoo.fr; santekolie2000@yahoo.fr; maaikedecrop@telenet.be; patricia.chavarin@efs.sante.fr; chantal.jacquot@efs.sante.fr; catherine.lazaygues@efs.sante.fr; adeweggheleire@itg.be; llynen@itg.be; jvangriensven@itg.be	De Weggheleire, Anja/C-7345-2018; Lynen, Lutgarde/A-1212-2014	De Weggheleire, Anja/0000-0001-9377-4766; Lynen, Lutgarde/0000-0001-7183-4895	European Union [666094]; Department of Economy, Science and Innovation (EWI) of the Flemish government; Bill and Melinda Gates Foundation	The Ebola-Tx project was funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 666094. Additional funding and support was provided by the Department of Economy, Science and Innovation (EWI) of the Flemish government and the Bill and Melinda Gates Foundation. The funders of the study had no role in study design, data collection, data analysis, interpretation of the data, or in the writing of the report. The corresponding author had full access to data and has the final responsibility to submit for publication.	Ali R, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17288; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bagot KL, 2013, TRANSFUSION, V53, P1108, DOI 10.1111/j.1537-2995.2012.03891.x; Bannister-Tyrrell M, 2015, LANCET, V385, P420, DOI 10.1016/S0140-6736(14)62392-8; Burnouf T, 2014, LANCET, V384, P1347, DOI 10.1016/S0140-6736(14)61693-7; Colebunders RL, 2015, J INFECT DIS, V211, P1208, DOI 10.1093/infdis/jiv043; Coordination Nationale Ebola in Guinee OMS, 2015, 350 OMS COORD NAT EB; Enserink M, 2015, SCIENCE, V348, P742, DOI 10.1126/science.348.6236.742; Falero F, 2015, RAPID EVALUATION CON; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5539; Lund TC, 2013, TRANSFUS APHER SCI, V49, P416, DOI 10.1016/j.transci.2013.06.014; Nielsen CF, 2015, MMWR-MORBID MORTAL W, V64, P20; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Tagny CT, 2008, TRANSFUSION, V48, P1256, DOI 10.1111/j.1537-2995.2008.01697.x; Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; van Griensven J, 2016, CLIN INFECT DIS, V62, P69, DOI 10.1093/cid/civ680; Wong HK, 2010, TRANSFUSION, V50, P1967, DOI 10.1111/j.1537-2995.2010.02651.x; World Health Organization, 2015, US CONV WHOL BLOOD P; World Health Organization, 2015, COMM ENG ED RECR RET	20	2	2	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	SEP	2016	95	3					647	653		10.4269/ajtmh.15-0890				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VA	WOS:000400206400029	27430546	Other Gold, Green Published			2019-03-26
J	Brizzi, K; Pelden, S; Tshokey, T; Nirola, DK; Diamond, MB; Klein, JP; Tshering, L; Deki, S; Nidup, D; Bruno, V; Dorny, P; Garcia, HH; Mateen, FJ				Brizzi, Kate; Pelden, Sonam; Tshokey, Tshokey; Nirola, Damber K.; Diamond, Megan B.; Klein, Joshua P.; Tshering, Lhab; Deki, Sonam; Nidup, Dechen; Bruno, Veronica; Dorny, Pierre; Hugo Garcia, Hector; Mateen, Farrah J.		Bhutan Epilepsy Project	Neurocysticercosis in Bhutan: a cross-sectional study in people with epilepsy	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Bhutan; Enzyme-linked immunoelectrotransfer blot; Epilepsy; Magnetic resonance imaging; Neurocysticercosis; Seizure	CYSTICERCOSIS TAENIA-SOLIUM; SEIZURES; PERU; COMMUNITY; DIAGNOSIS; CHILDREN; PROFILE; ELISA; ASSAY	Background: We sought to provide an assessment of the burden of neurocysticercosis among people with epilepsy (PWE) in Bhutan and evaluate the yield of various tests for Taenia solium. Methods: PWE were enrolled at the National Referral Hospital in Thimphu (2014-2015). Serum was tested for anti-Taenia solium IgG using ELISA (Ab-ELISA), enzyme-linked immunoelectrotransfer blot (EITB), and parasite antigen. Results were compared to brain MRI. Participants were categorized as definite neurocysticercosis (MRI and EITB positive), probable neurocysticercosis (MRI or EITB positive), or without neurocysticercosis. Logistic regression models were constructed to explore clinicodemographic associations. Results: There were 12/205 (6%, 95% CI 2%, 9%) definite and 40/205 (20%, 95% CI 14%, 25%) probable neurocysticercosis cases. 25/205 (12%) with positive EITB did not have neurocysticercosis on MRI, and 15/205 (7%) participants with positive MRI had negative EITB. Participants with neurocysticercosis-suggestive lesions on MRI had an average of 1.2 cysts (parenchymal 26/27; nodular/calcified stage 21/27). In a multivariable analysis, present age (OR 1.05, 95% CI 1.01,1.09, p=0.025) was positively associated with (combined probable or definite) neurocysticercosis while mesial temporal sclerosis on MRI (OR 0.294, 95% CI 0.144, 0.598, p=0.001) was negatively associated. Conclusions: Neurocysticercosis was associated with 6-25% of epilepsy in a Bhutanese cohort. Combining EITB and MRI would aid the diagnosis of neurocysticercosis among PWE since no test identified all cases.	[Brizzi, Kate; Diamond, Megan B.; Bruno, Veronica; Mateen, Farrah J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Pelden, Sonam; Tshokey, Tshokey] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Lab Med, Thimphu, Bhutan; [Nirola, Damber K.; Tshering, Lhab; Deki, Sonam] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Psychiat, Thimphu, Bhutan; [Klein, Joshua P.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Klein, Joshua P.; Mateen, Farrah J.] Harvard Med Sch, Boston, MA 02115 USA; [Nidup, Dechen] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Radiol, Thimphu, Bhutan; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Hugo Garcia, Hector] Univ Peruana Cayetan Heredia, Dept Microbiol, Inst Ciencias Neurol, Cysticercosis Unit, Lima, Peru	Mateen, FJ (reprint author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Mateen, FJ (reprint author), Harvard Med Sch, Boston, MA 02115 USA.	fmateen@partners.org			Grand Challenges Canada; Government of Canada [338-04]; Partners Center for Expertise in Global Health Travel Grant; Massachusetts General Hospital Center for Global Health Travel Grant	This work was supported by Grand Challenges Canada, funded by the Government of Canada (338-04); Partners Center for Expertise in Global Health Travel Grant; Massachusetts General Hospital Center for Global Health Travel Grant.	Adhikari S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-43; Bhutan Health Management Information System, 2013, ANN HLTH B MIN HLTH, V2013; Brizzi K, 2016, INT HEALTH, V8, P286, DOI 10.1093/inthealth/ihw017; Carabin Helene, 2014, Curr Trop Med Rep, V1, P181; Del Brutto Oscar H, 2014, Handb Clin Neurol, V121, P1445, DOI 10.1016/B978-0-7020-4088-7.00097-3; Del Brutto OH, 2015, J NEUROL SCI, V359, P392, DOI 10.1016/j.jns.2015.08.011; Del Brutto OH, 2012, PATHOG GLOB HEALTH, V106, P299, DOI 10.1179/2047773212Y.0000000025; DIAZ JF, 1992, AM J TROP MED HYG, V46, P610, DOI 10.4269/ajtmh.1992.46.610; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Fleury A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002096; Garcia HH, 2016, NEW ENGL J MED, V374, P2335, DOI 10.1056/NEJMoa1515520; Garcia HH, 2014, LANCET NEUROL, V13, P1202, DOI 10.1016/S1474-4422(14)70094-8; Garcia HH, 2012, TROP MED INT HEALTH, V17, P1014, DOI 10.1111/j.1365-3156.2012.03037.x; Garcia HH, 2004, NEW ENGL J MED, V350, P249, DOI 10.1056/NEJMoa031294; Garcia HH, 2003, ACTA TROP, V87, P71, DOI 10.1016/S0001-706X(03)00057-3; Gekeler F, 2002, EUR J CLIN MICROBIOL, V21, P227, DOI 10.1007/s10096-002-0695-3; Hosmer DW, 1997, STAT MED, V16, P965; Kafle D R, 2014, Kathmandu Univ Med J (KUMJ), V12, P202; Lerner A, 2012, NEUROIMAG CLIN N AM, V22, P659, DOI 10.1016/j.nic.2012.05.004; Michelet L, 2011, J CLIN MICROBIOL, V49, P195, DOI 10.1128/JCM.01554-10; Moyano LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002692; O'Neal SE, 2012, EMERG INFECT DIS, V18, P431, DOI 10.3201/eid1803.111367; Ojha R, 2015, NEUROIMMUNOL NEUROIN, V2, P167; Poudel P, 2013, J NEPAL MED ASSOC, V52, P260, DOI 10.31729/jnma.572; Prasad KN, 2011, T ROY SOC TROP MED H, V105, P531, DOI 10.1016/j.trstmh.2011.06.001; Prasad KN, 2009, T ROY SOC TROP MED H, V103, P144, DOI 10.1016/j.trstmh.2008.07.015; Rodriguez S, 2012, PATHOG GLOB HEALTH, V106, P286, DOI 10.1179/2047773212Y.0000000048; Singh G, 2010, NEUROLOGY, V75, P2236, DOI 10.1212/WNL.0b013e31820202dc; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50	29	6	6	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	SEP	2016	110	9					517	526		10.1093/trstmh/trw066				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EA6SI	WOS:000386758800004	27794094	Green Accepted			2019-03-26
J	Osbak, KK; Houston, S; Lithgow, KV; Meehan, CJ; Strouhal, M; Smajs, D; Cameron, CE; Van Ostade, X; Kenyon, CR; Van Raemdonck, GA				Osbak, Kara K.; Houston, Simon; Lithgow, Karen V.; Meehan, Conor J.; Strouhal, Michal; Smajs, David; Cameron, Caroline E.; Van Ostade, Xaveer; Kenyon, Chris R.; Van Raemdonck, Geert A.			Characterizing the Syphilis-Causing Treponema pallidum ssp pallidum Proteome Using Complementary Mass Spectrometry	PLOS NEGLECTED TROPICAL DISEASES			English	Article							OUTER-MEMBRANE PROTEINS; PENICILLIN-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; GENOME-SCALE IDENTIFICATION; BARREL ASSEMBLY MACHINERY; SUBSP PALLIDUM; MOONLIGHTING PROTEINS; ANTIGENIC VARIATION; SIGNAL PEPTIDES; SUBCELLULAR-LOCALIZATION	Background The spirochete bacterium Treponema pallidum ssp. pallidum is the etiological agent of syphilis, a chronic multistage disease. Little is known about the global T. pallidum proteome, therefore mass spectrometry studies are needed to bring insights into pathogenicity and protein expression profiles during infection. Methodology/Principal Findings To better understand the T. pallidum proteome profile during infection, we studied T. pallidum ssp. pallidum DAL-1 strain bacteria isolated from rabbits using complementary mass spectrometry techniques, including multidimensional peptide separation and protein identification via matrix-assisted laser desorption ionization-time of flight (MALDI-TOF/TOF) and electrospray ionization (ESI-LTQ-Orbitrap) tandem mass spectrometry. A total of 6033 peptides were detected, corresponding to 557 unique T. pallidum proteins at a high level of confidence, representing 54% of the predicted proteome. A previous gel-based T. pallidum MS proteome study detected 58 of these proteins. One hundred fourteen of the detected proteins were previously annotated as hypothetical or uncharacterized proteins; this is the first account of 106 of these proteins at the protein level. Detected proteins were characterized according to their predicted biological function and localization; half were allocated into a wide range of functional categories. Proteins annotated as potential membrane proteins and proteins with unclear functional annotations were subjected to an additional bioinformatics pipeline analysis to facilitate further characterization. A total of 116 potential membrane proteins were identified, of which 16 have evidence supporting outer membrane localization. We found 8/12 proteins related to the paralogous tpr gene family: TprB, TprC/D, TprE, TprG, TprH, TprI and TprJ. Protein abundance was semi-quantified using label-free spectral counting methods. A low correlation (r = 0.26) was found between previous microarray signal data and protein abundance. Conclusions This is the most comprehensive description of the global T. pallidum proteome to date. These data provide valuable insights into in vivo T. pallidum protein expression, paving the way for improved understanding of the pathogenicity of this enigmatic organism.	[Osbak, Kara K.; Kenyon, Chris R.; Van Raemdonck, Geert A.] Inst Trop Med, HIV STI Unit, Antwerp, Belgium; [Houston, Simon; Lithgow, Karen V.; Cameron, Caroline E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Meehan, Conor J.] Inst Trop Med, Unit Mycobacteriol, Antwerp, Belgium; [Strouhal, Michal; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Van Ostade, Xaveer; Van Raemdonck, Geert A.] Univ Antwerp, Lab Prot Sci Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Van Ostade, Xaveer; Van Raemdonck, Geert A.] Univ Antwerp, Ctr Prote CFP, Antwerp, Belgium; [Kenyon, Chris R.] Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa	Osbak, KK (reprint author), Inst Trop Med, HIV STI Unit, Antwerp, Belgium.	kosbak@hotmail.com	Van Ostade, Xaveer/D-1702-2015	Van Ostade, Xaveer/0000-0003-4078-3014; Osbak, Kara/0000-0002-8612-8413	Flanders Research Foundation; National Institutes of Health [AI-051334]; Grant Agency of the Czech Republic [P302/12/0574, GP14-29596P]	This work was supported by the grants from the Flanders Research Foundation, SOFI-B Grant to CRK, http://www.fwo.be/, a Public Health Service Grant from the National Institutes of Health to CEC, (grant # AI-051334), https://www.nih.gov/ and a grant from the Grant Agency of the Czech Republic to DS and MS (P302/12/0574, GP14-29596P), https://gacr.cz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2015, J BIOL CHEM, V290, P12313, DOI 10.1074/jbc.M114.629188; Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Babolin C, 2011, J IMMUNOL, V187, P1377, DOI 10.4049/jimmunol.1100615; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Brinkman MB, 2006, REACTIVITY ANTIBODIE; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Cameron CE, 2004, J BACTERIOL, V186, P7019, DOI 10.1128/JB.186.20.7019-7022.2004; Carlson JA, 2011, AM J DERMATOPATH, V33, P433, DOI 10.1097/DAD.0b013e3181e8b587; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Cejkova D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004110; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002222; Cha JY, 2004, J BIOL CHEM, V279, P14917, DOI 10.1074/jbc.M400666200; Chu Q, 2015, CRIT REV BIOCHEM MOL, V50, P134, DOI 10.3109/10409238.2015.1016215; COVER WH, 1982, SEX TRANSM DIS, V9, P1, DOI 10.1097/00007435-198201000-00001; COX CD, 1974, INFECT IMMUN, V10, P123; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; COX DL, 1990, APPL ENVIRON MICROB, V56, P3063; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI 10.1093/nar/gkj040; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eshghi A, 2009, GLOBAL PROTEOME ANAL, P4564; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Giacani L, 2005, INFECT IMMUN, V73, P3817, DOI 10.1128/IAI.73.6.3817-3822.2005; Giacani L, 2007, FEMS IMMUNOL MED MIC, V51, P289, DOI 10.1111/j.1574-695X.2007.00303.x; Giacani L, 2007, INFECT IMMUN, V75, P104, DOI 10.1128/IAI.01124-06; Giacani L, 2015, INFECT IMMUN, V83, P2275, DOI 10.1128/IAI.00360-15; Giacani L, 2012, J BACTERIOL, V194, P4208, DOI 10.1128/JB.00863-12; Giacani L, 2010, J IMMUNOL, V184, P3822, DOI 10.4049/jimmunol.0902788; HANFF PA, 1984, SEX TRANSM DIS, V11, P275, DOI 10.1097/00007435-198410000-00003; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kelesidis T., 2014, FRONT IMMUNOL, V5, P85; Kelkar YD, 2013, GENETICS, V193, P303, DOI 10.1534/genetics.112.145656; Khan I, 2014, BIOL DIRECT, V9, DOI 10.1186/s13062-014-0030-9; Khan IK, 2014, BIOCHEM SOC T, V42, P1780, DOI 10.1042/BST20140214; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; LaFond RE, 2006, INFECT IMMUN, V74, P1896, DOI 10.1128/IAI.74.3.1896-1906.2006; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Leader BT, 2003, INFECT IMMUN, V71, P6054, DOI 10.1128/IAI.71.10.6054-6057.2003; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Lukehart Sheila A, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12a01s7; Luthra A, 2015, METHODS MOL BIOL, V1329, P67, DOI 10.1007/978-1-4939-2871-2_6; Luthra A, 2015, J BACTERIOL, V197, P1906, DOI 10.1128/JB.00086-15; Lyu ZX, 2015, BIOCHEM SOC T, V43, P133, DOI 10.1042/BST20140217; Maass S, 2016, J PROTEOMICS, V136, P222, DOI 10.1016/j.jprot.2016.01.015; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; McGill MA, 2010, INFECT IMMUN, V78, P2631, DOI 10.1128/IAI.00173-10; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Morgan CA, 2002, J IMMUNOL, V169, P952, DOI 10.4049/jimmunol.169.2.952; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Naqvi AAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124177; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; NORRIS SJ, 1986, INFECT IMMUN, V53, P534; NORRIS SJ, 1993, MICROBIOL REV, V57, P750; Ou Y-Y, 2013, PLOONE PUBLIC LIB, V8, DOI [10.1371/journal.pone.0046572, DOI 10.1371/JOURNAL.PONE]; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1995, J IMMUNOL, V154, P2866; Read P, 2015, SEX HEALTH, V12, P155, DOI 10.1071/SH14153; Reid TB, 2014, INFECT IMMUN, V82, P4959, DOI 10.1128/IAI.02236-14; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Schouls L., 1992, MOL BIOL SEXUALLY TR; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Semanjski M, 2015, EXPERT REV PROTEOMIC, DOI 10.1586/14789450.2016.1132168; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; Smajs D, 2005, TRANSCRIPTOME TREPON; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Soufi B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00103; Stamm LV, 2000, INFECT IMMUN, V68, P6482, DOI 10.1128/IAI.68.11.6482-6486.2000; STRUGNELL RA, 1986, GENITOURIN MED, V62, P4; Tomson FL, 2007, MICROBES INFECT, V9, P1267, DOI 10.1016/j.micinf.2007.05.018; Tsiatsiani L, 2015, FEBS J, V282, P2612, DOI 10.1111/febs.13287; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; WALKER EM, 1989, J BACTERIOL, V171, P5005, DOI 10.1128/jb.171.9.5005-5011.1989; WEIGEL LM, 1994, P NATL ACAD SCI USA, V91, P11611, DOI 10.1073/pnas.91.24.11611; Weinstock GM, 2000, RES MICROBIOL, V151, P151, DOI 10.1016/S0923-2508(00)00115-7; Weinstock GM, 1998, FEMS MICROBIOL REV, V22, P323, DOI 10.1111/j.1574-6976.1998.tb00373.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	111	5	5	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2016	10	9							e0004988	10.1371/journal.pntd.0004988				29	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DZ1UZ	WOS:000385627900043	27606673	DOAJ Gold, Green Published			2019-03-26
J	Wong, VK; Holt, KE; Okoro, C; Baker, S; Pickard, DJ; Marks, F; Page, AJ; Olanipekun, G; Munir, H; Alter, R; Fey, PD; Feasey, NA; Weill, FX; Le Hello, S; Hart, PJ; Kariuki, S; Breiman, RF; Gordon, MA; Heyderman, RS; Jacobs, J; Lunguya, O; Msefula, C; MacLennan, CA; Keddy, KH; Smith, AM; Onsare, RS; De Pinna, E; Nair, S; Amos, B; Dougan, G; Obaro, S				Wong, Vanessa K.; Holt, Kathryn E.; Okoro, Chinyere; Baker, Stephen; Pickard, Derek J.; Marks, Florian; Page, Andrew J.; Olanipekun, Grace; Munir, Huda; Alter, Roxanne; Fey, Paul D.; Feasey, Nicholas A.; Weill, Francois-Xavier; Le Hello, Simon; Hart, Peter J.; Kariuki, Samuel; Breiman, Robert F.; Gordon, Melita A.; Heyderman, Robert S.; Jacobs, Jan; Lunguya, Octavie; Msefula, Chisomo; MacLennan, Calman A.; Keddy, Karen H.; Smith, Anthony M.; Onsare, Robert S.; De Pinna, Elizabeth; Nair, Satheesh; Amos, Ben; Dougan, Gordon; Obaro, Stephen		Int Typhoid Consortium	Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa	PLOS NEGLECTED TROPICAL DISEASES			English	Article							COMMUNITY-ACQUIRED BACTEREMIA; RESISTANT SALMONELLA-ENTERICA; ANTIBIOTIC-RESISTANCE; INTERACTIVE TREE; CHILDREN; MUTATIONS; SEQUENCE; FEVER; PREVALENCE; ANNOTATION	Background The burden of typhoid in sub-Saharan African (SSA) countries has been difficult to estimate, in part, due to suboptimal laboratory diagnostics. However, surveillance blood cultures at two sites in Nigeria have identified typhoid associated with Salmonella enterica serovar Typhi (S. Typhi) as an important cause of bacteremia in children. Methods A total of 128 S. Typhi isolates from these studies in Nigeria were whole-genome sequenced, and the resulting data was used to place these Nigerian isolates into a worldwide context based on their phylogeny and carriage of molecular determinants of antibiotic resistance. Results Several distinct S. Typhi genotypes were identified in Nigeria that were related to other clusters of S. Typhi isolates from north, west and central regions of Africa. The rapidly expanding S. Typhi clade 4.3.1 (H58) previously associated with multiple antimicrobial resistances in Asia and in east, central and southern Africa, was not detected in this study. However, antimicrobial resistance was common amongst the Nigerian isolates and was associated with several plasmids, including the IncHI1 plasmid commonly associated with S. Typhi. Conclusions These data indicate that typhoid in Nigeria was established through multiple independent introductions into the country, with evidence of regional spread. MDR typhoid appears to be evolving independently of the haplotype H58 found in other typhoid endemic countries. This study highlights an urgent need for routine surveillance to monitor the epidemiology of typhoid and evolution of antimicrobial resistance within the bacterial population as a means to facilitate public health interventions to reduce the substantial morbidity and mortality of typhoid.	[Wong, Vanessa K.; Okoro, Chinyere; Pickard, Derek J.; Page, Andrew J.; Kariuki, Samuel; MacLennan, Calman A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Wong, Vanessa K.; Okoro, Chinyere] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Holt, Kathryn E.] Univ Melbourne, Ctr Syst Genom, Parkville, Vic, Australia; [Baker, Stephen] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Baker, Stephen] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Marks, Florian] Int Vaccine Inst, Dept Epidemiol, Seoul, South Korea; [Olanipekun, Grace] Int Fdn Infect Dis Nigeria, Abuja, Nigeria; [Munir, Huda] Aminu Kano Teaching Hosp, Dept Med Microbiol, Kano, Nigeria; [Alter, Roxanne; Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Feasey, Nicholas A.] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Weill, Francois-Xavier; Le Hello, Simon] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Hart, Peter J.; MacLennan, Calman A.] Univ Birmingham, Inst Biomed Res, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Hart, Peter J.] St Georges Univ London, London, England; [Kariuki, Samuel; Breiman, Robert F.; Onsare, Robert S.] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA; [Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Gordon, Melita A.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Heyderman, Robert S.; Msefula, Chisomo] UCL, Div Infect & Immun, London, England; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Msefula, Chisomo] Univ Malawi, Dept Microbiol, Coll Med, Blantyre, Malawi; [MacLennan, Calman A.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Natl Inst Communicable Dis, Ctr Enter Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [De Pinna, Elizabeth; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London, England; [Amos, Ben] St Augustines Hosp, Muheza, Tanzania; [Obaro, Stephen] Univ Nebraska Med Ctr, Div Pediat Infect Dis, Omaha, NE USA; [Obaro, Stephen] Univ Abuja Teaching Hosp, Gwagwalada, Nigeria; [Obaro, Stephen] Bingham Univ, Karu, Nassarawa State, Nigeria	Wong, VK (reprint author), Wellcome Trust Sanger Inst, Cambridge, England.; Wong, VK (reprint author), Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Cambridge, England.	vw1@sanger.ac.uk	Le Hello, Simon/K-6584-2018; Hatta, Mochammad/D-3742-2019; Holt, Kathryn/A-8108-2012; Gordon, Melita/F-5563-2012	Le Hello, Simon/0000-0001-7993-4305; Cain, Amy/0000-0002-4230-6572; Heyderman, Robert/0000-0003-4573-449X; Watson, Conall/0000-0002-2469-791X; Hatta, Mochammad/0000-0002-8456-4203; Nair, Satheesh/0000-0002-7297-1485; Marks, Florian/0000-0002-6043-7170; Weill, Francois-Xavier/0000-0001-9941-5799; Connor, Thomas/0000-0003-2394-6504; Amos, Benjamin/0000-0002-8569-1650; Okoro, Chinyere/0000-0002-2466-304X; Thwaites, Guy/0000-0002-2858-2087; Holt, Kathryn/0000-0003-3949-2471; Gordon, Melita/0000-0002-0629-0884; Dufour, Muriel/0000-0003-3638-4918	"Wellcome Trust [098051, WT092152MA, 101113/Z/13/Z, 100087/Z/12/Z]; NHMRC of Australia [1061409]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council; IP; Institut de Veille Sanitaire; French Government ""Investissement d'Avenir"" program [ANR-10-LABX-62-IBEID]; Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in DR Congo; Belgian Directorate General of Development Cooperation [2.01]; Institute of Tropical Medicine, Antwerp, Belgium [2.01]; Bill & Melinda Gates Foundation; NIH [R01 AI099525-02]; Royal Society; National Institute Of Allergy And Infectious Diseases (NIAID) of the National Institutes of Health [R01AI097493]"	"This work was supported by a number of organizations. The Wellcome Trust Sanger Institute authors were funded by Wellcome Trust Award 098051; NAF was supported by the Wellcome Trust Research Fellowship WT092152MA. NAF, RSH and this work were supported by a strategic award from the Wellcome Trust for the MLW Clinical Research Programme (101113/Z/13/Z). KEH was supported by the NHMRC of Australia (fellowship #1061409) and the Victorian Life Sciences Computation Initiative (VLSCI) (grant #VR0082). CAM was supported by a Clinical Research Fellowship from GlaxoSmithKline and PJH by a UK Medical Research Council PhD studentship. This work forms part of an EU FP7 Marie Curie Actions Industry Academia Partnerships and Pathways (IAPP) Consortium Programme, entitled GENDRIVAX (Genome-driven vaccine development for bacterial infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and Novartis Vaccines Institute for Global Health. The Institut Pasteur (IP) authors were funded by the IP, the Institut de Veille Sanitaire, and by the French Government ""Investissement d'Avenir"" program (Integrative Biology of Emerging Infectious Diseases"" Laboratory of Excellence, grant no. ANR-10-LABX-62-IBEID). CO was supported by Society in Science, The Branco Weiss Fellowship, administered by the ETH Zurich. JJ was supported by the antibiotic resistance surveillance project in DR Congo, funded by Project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine, Antwerp, Belgium. FM was supported by a research grant from the Bill & Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. SK was supported by the NIH Grant Number R01 AI099525-02. SB is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). SO was supported by the National Institute Of Allergy And Infectious Diseases (NIAID) of the National Institutes of Health (#R01AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	[Anonymous], 2011, ABUJA BEAUTIFUL CAPI; Arulogun OS, 2012, INT Q COMMUNITY HEAL, V32, P219, DOI 10.2190/IQ.32.3.e; Baucheron S, 2005, ANTIMICROB AGENTS CH, V49, P862, DOI 10.1128/AAC.49.2.862-863.2005; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; CLSI, 2014, PERF STAND ANT SUSC; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Federal Republic of Nigeria NAftCoA, GLOB AIDS RESP COUNT; Federal Republic of Nigeria NBoSpc, 2010, KAN STAT STAT TABL; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herrera-Leon S, 2004, J CLIN MICROBIOL, V42, P2581, DOI 10.1128/JCM.42.6.2581-2586.2004; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; IBM Corp. Released, 2013, IBM SPSS STAT MAC VA; Inouye MD, 2014, GENOME MED, V6; Isendahl J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0715-9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Obaro S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-137; Obaro SK, 2015, CLIN INFECT DIS, V61, pS325, DOI 10.1093/cid/civ745; Olayemi I K, 2011, Pak J Biol Sci, V14, P293, DOI 10.3923/pjbs.2011.293.299; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281	37	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2016	10	9							e0004781	10.1371/journal.pntd.0004781				22	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DZ1UZ	WOS:000385627900002	27657909	DOAJ Gold, Green Published			2019-03-26
J	Falq, G; Van Den Bergh, R; De Smet, M; Etienne, W; Nguon, C; Rekol, H; Imwong, M; Dondorp, A; Kindermans, JM				Falq, Gregoire; Van Den Bergh, Rafael; De Smet, Martin; Etienne, William; Nguon, Chea; Rekol, Huy; Imwong, Mallika; Dondorp, Arjen; Kindermans, Jean-Marie			Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum	MALARIA JOURNAL			English	Article						Malaria; Plasmodium falciparum; Epidemiology; Artemisinin resistance; Polymerase chain reaction; k13-propeller; Cambodia	WESTERN CAMBODIA; MALARIA; INFECTIONS; PREVALENCE; PROVINCE	Background: In Cambodia, elimination of artemisinin resistance through direct elimination of the Plasmodium falciparum parasite may be the only strategy. Prevalence and incidence at district and village levels were assessed in Chey Saen district, Preah Vihear province, North of Cambodia. Molecular and clinical indicators for artemisinin resistance were documented. Methods: A cross sectional prevalence survey was conducted at village level in the district of Chey Saen from September to October 2014. Plasmodium spp. was assessed with high volume quantitative real-time polymerase chain reaction (qPCR). Plasmodium falciparum-positive samples were screened for mutations in the k13-propeller domain gene. Treatment effectiveness was established after 28 days (D28) using the same qPCR technique. Data from the provincial surveillance system targeting symptomatic cases, supported by Medecins Sans Frontieres (MSF), were used to assess incidence. Results: District P. falciparum prevalence was of 0.74 % [0.41; 1.21]; village prevalence ranged from 0 to 4.6 % [1.4; 10.5]. The annual incidence of P. falciparum was 16.8 cases per 1000 inhabitants in the district; village incidence ranged from 1.3 to 54.9 for 1000 inhabitants. Two geographical clusters with high number of cases were identified by both approaches. The marker for artemisinin resistance was found in six samples out of the 11 tested (55 %). 34.9 % of qPCR blood analysis of symptomatic patients were still positive at D28. Conclusions: The overall low prevalence of P. falciparum was confirmed in Chey Saen district in Cambodia, while there were important variations between villages. Symptomatic cases had a different pattern and were likely acquired outside the villages. It illustrates the importance of prevalence surveys in targeting interventions for elimination. Mutations in the k13-propeller domain gene (C580Y), conferring artemisinin resistance, were highly prevalent in both symptomatic and asymptomatic cases (realizing the absolute figures remain low). Asymptomatic individuals could be an additional reservoir for artemisinin resistance. The low effectiveness of dihydroartemisinin-piperaquine (DHA-PPQ) for symptomatic cases indicates that PPQ is no longer able to complement the reduced potency of DHA to treat falciparum malaria and highlights the need for an alternative first-line treatment.	[Falq, Gregoire; De Smet, Martin; Etienne, William; Kindermans, Jean-Marie] Med Sans Frontieres, 46 Rue Arbre Benit, B-1050 Brussels, Belgium; [Van Den Bergh, Rafael] Med Sans Frontieres, 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg; [Nguon, Chea; Rekol, Huy] Ctr Parasitol Entomol & Malaria Control, 477 Betong St, Khan Sen Sok, Phnom Penh, Cambodia; [Imwong, Mallika] Mahidol Univ, Dept Mol Trop Med & Genet, Fac Trop Med, 3-F,60th Anniversary Chalermprakiat Bldg, Bangkok 10400, Thailand; [Dondorp, Arjen] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Res Unit, Bangkok, Thailand	Kindermans, JM (reprint author), Med Sans Frontieres, 46 Rue Arbre Benit, B-1050 Brussels, Belgium.	jean-marie.kindermans@brussels.msf.org		Van den Bergh, Rafael/0000-0001-6277-8713	Medecins Sans Frontieres	Funding was provided by Medecins Sans Frontieres.	Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2016, ART ART BAS COMB THE; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Chaorattanakawee S, 2015, ANTIMICROB AGENTS CH, V59, P4631, DOI 10.1128/AAC.00366-15; DEVILLE JC, 1993, J AM STAT ASSOC, V88, P1013, DOI 10.2307/2290793; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Maude RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037166; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353; Tripura R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1224-7; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, GLOB PLAN ART RES CO; World Health Organization, 2010, GLOB REP ANT DRUG EF; World health Organization, 2012, DIS SURV MAL CONTR O	24	7	7	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 1	2016	15								446	10.1186/s12936-016-1487-z				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU9KP	WOS:000382536200001	27585957	DOAJ Gold, Green Published			2019-03-26
J	Stassijns, J; van den Boogaard, W; Pannus, P; Nkunzimana, A; Rosanas-Urgell, A				Stassijns, Jorgen; van den Boogaard, Wilma; Pannus, Pieter; Nkunzimana, Alphonse; Rosanas-Urgell, Anna			Prevalence and diagnostics of congenital malaria in rural Burundi, a cross-sectional study	MALARIA JOURNAL			English	Article						Congenital malaria; Prevalence; Diagnosis; Rapid diagnostic test; Burundi	PLASMODIUM-FALCIPARUM MALARIA; NIGERIA; PREGNANCY; INFANTS; INFECTIONS; CALABAR; AREA	Background: Congenital malaria, defined as the presence of asexual forms of malaria parasites in the peripheral blood during the first 7 days of life, remains a neglected area of research. Knowledge gaps exist about prevalence and management of malaria in this age group. The objective of this study was to evaluate the prevalence of congenital malaria and the validity of a rapid diagnostic test (RDT) for its diagnosis in rural Burundi. Methods: A cross-sectional study was conducted in a meso-endemic malaria context in Burundi among 290 mothers, and their newborns (n = 303), who delivered at the maternity departments of Kirundo and Mukenke Hospitals during March and April 2014. Peripheral blood samples were collected from all mothers/newborns pairs in order to examine the presence of malaria parasites with two RDT (SD-Bioline HRP2 and Carestart pan-pLDH) and a blood slide. In addition, quantitative real-time polymerase chain reaction (PCR) was performed from the newborn peripheral sample. Frequencies and proportions were calculated for categorical variables. Sensitivity and specificity were calculated with a 95 % confidence interval (CI). Results: None of the newborns were found positive by PCR (0/303; 95 % CI 0.0-1.3). The prevalence in newborns born from microscopy-positive mothers was 0 % (0/44; 95 % CI 0.0-8.0). Two newborns were positive with SD-Bioline HRP2 (0.7 %, 95 % CI 0.2-2.4) but none with Carestart pan-pLDH or microscopy. Sensitivity of the diagnostic tests could not be evaluated as no congenital malaria was detected. Specificity of SD-Bioline HRP2, Carestart pan-pLDH and microscopy to detect congenital malaria was 99.3 % (95 % CI 97.6-99.8), 100.0 % (95 % CI 98.3-100.0) and 100.0 % (95 % CI 98.8-100.0), respectively. Conclusion: In Burundi or the Central African region, no recent prevalence studies for congenital malaria have been carried out. This study found that the prevalence of congenital malaria in two hospitals in Kirundo province is zero. RDT showed to have an excellent specificity and, therefore, can be used to rule out congenital malaria: the risk of overtreatment is low. However, as no cases of congenital malaria were detected, the study was not able to draw conclusions about the sensitivity of the RDT, nor about risk factors for congenital malaria. Further studies evaluating the sensitivity of RDT for diagnosis of congenital malaria are needed.	[Stassijns, Jorgen] Med Sans Frontieres, Brussels Operat Ctr, 46 Rue Arbre Benit, B-1050 Brussels, Belgium; [van den Boogaard, Wilma] Med Sans Frontieres, Brussels Operat Ctr, Operat Res Unit, Luxembourg, Luxembourg; [van den Boogaard, Wilma; Pannus, Pieter] Med Sans Frontieres, Brussels Operat Ctr, Kirundo, Kirundo Provinc, Burundi; [Pannus, Pieter; Rosanas-Urgell, Anna] Inst Trop Med, Antwerp, Belgium; [Nkunzimana, Alphonse] Minist Hlth, Prov Sanit Kirundo, Kirundo, Kirundo Provinc, Burundi	Stassijns, J (reprint author), Med Sans Frontieres, Brussels Operat Ctr, 46 Rue Arbre Benit, B-1050 Brussels, Belgium.	jorgenstassijns@gmail.com			MSF Brussels Operational Centre; Ministry of Foreign Affairs, Luxembourg	This study was funded by MSF Brussels Operational Centre and the Ministry of Foreign Affairs, Luxembourg.	Coll O, 2008, J PERINAT MED, V36, P15, DOI 10.1515/JPM.2008.002; D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400; Enweronu-Laryea CC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-17; EZEOKE ACJ, 1985, CENT AFR J MED, V31, P241; Falade C, 2007, TROP MED INT HEALTH, V12, P1279, DOI 10.1111/j.1365-3156.2007.01931.x; Lamikanra O T, 1993, West Afr J Med, V12, P213; LARKIN GL, 1991, AM J TROP MED HYG, V45, P587, DOI 10.4269/ajtmh.1991.45.587; Malhotra I, 2006, J INFECT DIS, V194, P176, DOI 10.1086/505150; Menendez C, 2007, SEMIN FETAL NEONAT M, V12, P207, DOI 10.1016/j.siny.2007.01.018; [MSPLS ICF International ISTEEBU], 2013, BUR ENQ IND PAL 2012; MSPLS, 2014, ANN STAT DONN CTR SA; Mukhtar MY, 2006, J TROP PEDIATRICS, V52, P19, DOI 10.1093/tropej/fmi044; NYIRJESY P, 1993, CLIN INFECT DIS, V16, P127, DOI 10.1093/clinids/16.1.127; Obiajunwa PO, 2005, J TROP PEDIATRICS, V51, P219, DOI 10.1093/tropej/fmi003; Oduwole OA, 2011, AM J TROP MED HYG, V84, P386, DOI 10.4269/ajtmh.2011.10-0253; Ojukwu JU, 2004, NIG J PAEDIAT, V31, P48; Orogade AA, 2008, J PEDIAT INFECT DISE, V3, P181; Ouedraogo A, 2012, J TROP MED, V2012; Pengsaa K, 2007, ANN TROP PAEDIATR, V27, P133, DOI 10.1179/146532807X192507; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361; Uneke CJ, 2007, PARASITOL RES, V101, P835, DOI 10.1007/s00436-007-0577-9; Wagner G, 1998, AM J TROP MED HYG, V59, P115, DOI 10.4269/ajtmh.1998.59.115	24	1	1	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 30	2016	15								443	10.1186/s12936-016-1478-0				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU9KM	WOS:000382535900004	27577552	DOAJ Gold, Green Published			2019-03-26
J	Korba, RA; Alayat, MS; Bouiba, L; Boudrissa, A; Bouslama, Z; Boukraa, S; Francis, F; Failloux, AB; Boubidi, SC				Korba, Raouf Amara; Alayat, Moufida Saoucen; Bouiba, Lazhari; Boudrissa, Abdelkarim; Bouslama, Zihad; Boukraa, Slimane; Francis, Frederic; Failloux, Anna-Bella; Boubidi, Said Chaouki			Ecological differentiation of members of the Culex pipiens complex, potential vectors of West Nile virus and Rift Valley fever virus in Algeria	PARASITES & VECTORS			English	Article						Culex pipiens complex; Molestus; CQ11; Hybrid; Algeria; Autogeny; Stenogamy	DIPTERA-CULICIDAE; EXPERIMENTAL TRANSMISSION; POPULATION-STRUCTURE; AEDES-AEGYPTI; MOSQUITOS; MOLESTUS; METHYLATION; FORMS; HYBRIDIZATION; AUTOGENY	Background: We investigated the ecological differentiation of two members of the Culex pipiens complex, Cx. p. pipiens form pipiens and Cx. p. pipiens form molestus in three sites, El-Kala, M'Sila and Tinerkouk in Algeria. These two forms are the most widespread mosquito vectors in temperate regions exhibiting important behavioural and physiological differences. Nevertheless, this group of potential vectors has been poorly studied, particularly in North Africa. Methods: Ten larval populations of Cx. p. pipiens were sampled from various above-and underground habitats in three zones representing the three bioclimatic regions in Algeria. The reproduction characteristics were also investigated in the laboratory to define the rates of autogeny and stenogamy. Identification of Cx. p. pipiens members present in Algeria was achieved using a molecular analysis with the microsatellite CQ11 locus. Results: We detected larvae of Cx. p. pipiens in all areas suggesting that the species is a ubiquitous mosquito well adapted to various environments. To our knowledge, this study provides the first molecular evidence of the presence of the Cx. p. pipiens form molestus and hybrids (molestus/pipiens) in Algeria with a high proportion of molestus form (48.3 %) in comparison with hybrids (36.8 %) and pipiens form (14.9 %). Conclusions: Some unexpected correlations between the proportion of forms pipiens, molestus and hybrids, and mosquito biological characteristics were observed suggesting some epigenetic effects controlling Cx. p. pipiens mating and reproduction. Consequences for pathogen transmission are discussed.	[Korba, Raouf Amara; Bouslama, Zihad] Univ Badji Mokhtar, Lab Ecol Syst Terr & Aquat, Dept Biol, Fac Sci, Annaba, Algeria; [Korba, Raouf Amara; Bouiba, Lazhari; Boudrissa, Abdelkarim; Boubidi, Said Chaouki] Inst Pasteur Alger, Unite Entomol Med, Serv Ecoepidemiol Parasit & Genet Populat, Algiers, Algeria; [Alayat, Moufida Saoucen] Univ Badji Mokhtar, Lab Biol Anim Appl, Fac Sci, Dept Biol, Annaba, Algeria; [Boukraa, Slimane; Francis, Frederic] Univ Liege, Unit Funct & Evolutionary Entomol, Gembloux Agro Bio Tech, Passage Deportes 2, B-5030 Gembloux, Belgium; [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France	Korba, RA (reprint author), Univ Badji Mokhtar, Lab Ecol Syst Terr & Aquat, Dept Biol, Fac Sci, Annaba, Algeria.; Korba, RA (reprint author), Inst Pasteur Alger, Unite Entomol Med, Serv Ecoepidemiol Parasit & Genet Populat, Algiers, Algeria.	amarakorbaraouf@hotmail.com			"Institut Pasteur (ACIP grant) [A-08-2009]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence ""Integrative Biology of Emerging Infectious Diseases"" [ANR-10-LABX-62-IBEID]; PhD fellowship ""Biodiversity, Evolution and Ecology of Health"" from the Algerian Ministry of Higher Education and Scientific Research"	"This work was funded by the Institut Pasteur (ACIP grant A-08-2009) and the French Government's Investissement d'Avenir program, Laboratoire d'Excellence ""Integrative Biology of Emerging Infectious Diseases"" (grant no ANR-10-LABX-62-IBEID). AKR was supported by PhD fellowship ""Biodiversity, Evolution and Ecology of Health"" from the Algerian Ministry of Higher Education and Scientific Research."	Alto BW, 2012, MED VET ENTOMOL, V26, P396, DOI 10.1111/j.1365-2915.2012.01010.x; Amraoui F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-83; Amraoui F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036757; Arsevska E, 2015, TRANSBOUND EMERG DIS, V2; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53; Ben Hassine T, 2015, TRANSBOUND EMERG DIS, P29; CHEVILLON C, 1995, GENET RES, V66, P147, DOI 10.1017/S0016672300034492; Christophers S. R., 1945, TRANS ROY ENT SOC LONDON, V95, P25; Christophers SR, 1951, T R ENTOMOL SOC LOND, V102, P372; DIGOUTTE JP, 1989, RES VIROLOGY, V140, P27, DOI 10.1016/S0923-2516(89)80081-0; El Harrak M, 1997, VIROLOGIE, V1, P248; Emberger L., 1955, RECUEIL TRAV LAB BOT, V7, P3; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; FOSTER WA, 1987, ANN ENTOMOL SOC AM, V80, P103, DOI 10.1093/aesa/80.2.103; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Garbouj M., 2003, B EPIDEMIOLOGIQUE, V3, P4; Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006; Gomes B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-93; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Huang SM, 2008, AM J TROP MED HYG, V79, P518, DOI 10.4269/ajtmh.2008.79.518; Ishii T., 1983, Journal of Science College of General Education University of Tokushima, V16, P27; Kamura T., 1959, ENDEMIC DIS B NAGASA, V1, P51; Kassim NFA, 2012, AUST J ENTOMOL, V51, P67, DOI 10.1111/j.1440-6055.2011.00834.x; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Knight K. L., 1951, Bulletin de la Societe Fouad ler d'Entomologie, V35, P175; Korba Raouf Amara, 2015, Advances in Environmental Biology, V9, P288; Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031; Krida G, 2015, MED VET ENTOMOL, V29, P124, DOI 10.1111/mve.12107; Krida G, 2011, Bull Soc Pathol Exot, V104, P250, DOI 10.1007/s13149-010-0122-4; LeGuenno B, 1996, LANCET, V348, P1315; LOUNIBOS LP, 1991, MEM I OSWALDO CRUZ, V86, P57, DOI 10.1590/S0074-02761991000100010; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; MEEGAN JM, 1980, AM J TROP MED HYG, V29, P1405, DOI 10.4269/ajtmh.1980.29.1405; Menzel S, 2011, AQUAT TOXICOL, V105, P640, DOI 10.1016/j.aquatox.2011.08.025; MITCHELL CJ, 1989, J MED ENTOMOL, V26, P332, DOI 10.1093/jmedent/26.4.332; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Nelms BM, 2013, AM J TROP MED HYG, V89, P1168, DOI 10.4269/ajtmh.13-0219; PASTEUR N, 1977, ANN PARASIT HUM COMP, V52, P205; Pilo-Moron E, 1970, Arch Inst Pasteur Alger, V48, P181; Reusken CBEM, 2010, J VECTOR ECOL, V35, P210, DOI 10.1111/j.1948-7134.2010.00050.x; Rudolf M, PLOS ONE, V8; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817; Senevet G., 1958, Arch Inst Pasteur Alger Algiers, V36, P70; SENEVET G, 1959, MOUSTIQUES AFRIQUE N; Senevet G, 1960, ARCH I PASTEUR ALGER, V38, P306; Shute PG, 1951, T R ENT SOC LOND, V102, P380; Silver J, 2008, MOSQUITO ECOLOGY FIE; Spielman A, 2001, ANN NY ACAD SCI, V951, P220; SPIELMAN A, 1967, B WORLD HEALTH ORGAN, V37, P271; STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459; TAHORI AS, 1955, AM J TROP MED HYG, V4, P1015, DOI 10.4269/ajtmh.1955.4.1015; Tate P., 1936, Parasitology Cambridge, V28, P115; Triki H, 2001, Med Trop (Mars), V61, P487; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; URBANELLI S, 1985, B ENTOMOL RES, V75, P291; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Vinogradova EB, 1992, AKAIEKA NEWSLETTER, V15, P1	62	3	4	1	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 17	2016	9								455	10.1186/s13071-016-1725-9				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DW7NA	WOS:000383836500001	27534938	DOAJ Gold, Green Published			2019-03-26
J	Knols, BGJ; Farenhorst, M; Andriessen, R; Snetselaar, J; Suer, RA; Osinga, AJ; Knols, JMH; Deschietere, J; Ng'habi, KR; Lyimo, IN; Kessy, ST; Mayagaya, VS; Sperling, S; Cordel, M; Sternberg, ED; Hartmann, P; Mnyone, LL; Rose, A; Thomas, MB				Knols, Bart G. J.; Farenhorst, Marit; Andriessen, Rob; Snetselaar, Janneke; Suer, Remco A.; Osinga, Anne J.; Knols, Johan M. H.; Deschietere, Johan; Ng'habi, Kija R.; Lyimo, Issa N.; Kessy, Stella T.; Mayagaya, Valeriana S.; Sperling, Sergej; Cordel, Michael; Sternberg, Eleanore D.; Hartmann, Patrick; Mnyone, Ladslaus L.; Rose, Andreas; Thomas, Matthew B.			Eave tubes for malaria control in Africa: an introduction	MALARIA JOURNAL			English	Editorial Material						Vector control; Resistance; Eave tube; House modification; Africa; Malaria elimination	HOUSE-ENTRY; PYRETHROID RESISTANCE; MOSQUITOS; TRANSMISSION; BEHAVIOR; VECTORS; RISK; NETS	In spite of massive progress in the control of African malaria since the turn of the century, there is a clear and recognized need for additional tools beyond long-lasting insecticide-treated bed nets (LLINs) and indoor residual spraying (IRS) of insecticides, to progress towards elimination. Moreover, widespread and intensifying insecticide resistance requires alternative control agents and delivery systems to enable development of effective insecticide resistance management strategies. This series of articles presents a novel concept for malaria vector control, the 'eave tube', which may fulfil these important criteria. From its conceptualization to laboratory and semi-field testing, to demonstration of potential for implementation, the stepwise development of this new vector control approach is described. These studies suggest eave tubes (which comprise a novel way of delivering insecticides plus screening to make the house more 'mosquito proof') could be a viable, cost-effective, and acceptable control tool for endophilic and endophagic anophelines, and possibly other (nuisance) mosquitoes. The approach could be applicable in a wide variety of housing in sub-Saharan Africa, and possibly beyond, for vectors that use the eave as their primary house entry point. The results presented in these articles were generated during an EU-FP7 funded project, the mosquito contamination device (MCD) project, which ran between 2012 and 2015. This was a collaborative project undertaken by vector biologists, product developers, modellers, materials scientists, and entrepreneurs from five different countries.	[Knols, Bart G. J.; Farenhorst, Marit; Andriessen, Rob; Snetselaar, Janneke; Suer, Remco A.; Osinga, Anne J.; Knols, Johan M. H.] In2Care BV, Marijkeweg 22, NL-6709 PG Wageningen, Netherlands; [Deschietere, Johan; Hartmann, Patrick] CTF2000, Baaikensstr 11, B-9240 Zele, Belgium; [Ng'habi, Kija R.; Lyimo, Issa N.; Kessy, Stella T.; Mayagaya, Valeriana S.; Mnyone, Ladslaus L.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, POB 53, Ifakara, Tanzania; [Sperling, Sergej; Cordel, Michael; Rose, Andreas] Biogents AG, Weissenburgstr 22, D-93055 Regensburg, Germany; [Sternberg, Eleanore D.; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Sternberg, Eleanore D.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Knols, BGJ (reprint author), In2Care BV, Marijkeweg 22, NL-6709 PG Wageningen, Netherlands.	bart@in2care.org	Knols, Bart/C-5765-2017				Anderson L, 2014, DURABLE HOUSING IMPR; Andriessen R, 2015, P NATL ACAD SCI USA, V112, P12081, DOI 10.1073/pnas.1510801112; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626; Celli A, 1900, LANCET, V2, P1603; Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7; Diallo DA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P377; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hemingway J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0431; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Lengeler C., 2004, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD000363.pub2/abstract;jsessionid=23CE1FBBFA0C06D2841A1BBC3EE93F02.f02t02, DOI 10.1002/14651858.CD000363.PUB2]; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Manson P, 1900, Br Med J, V2, P949; Menger DJ, 2016, AM J TROP MED HYG, V94, P868, DOI 10.4269/ajtmh.15-0632; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Spitzen J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1293-7; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Toe KH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1342-6; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; United Nations, MILL DEV GOALS REP 2; von Seidlein L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-200; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396; WERNSDORFER WH, 1988, MALARIA PRINCIPLES P; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2013, LARV SOURC MAN SUPPL; WHO, 2012, HDB INT VECT MAN; World Health Organization, 1997, VECTOR CONTROL METHO	40	18	18	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 11	2016	15								404	10.1186/s12936-016-1452-x				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DT3CI	WOS:000381357700003	27515306	DOAJ Gold, Green Published			2019-03-26
J	van As, J; Cook, CA; Netherlands, EC; Smit, NJ				van As, Johann; Cook, Courtney A.; Netherlands, Edward C.; Smit, Nico J.			A new lizard malaria parasite Plasmodium intabazwe n. sp (Apicomplexa: Haemospororida: Plasmodiidae) in the Afromontane Pseudocordylus melanotus (Sauria: Cordylidae) with a review of African saurian malaria parasites	PARASITES & VECTORS			English	Article						Plasmodiid taxonomy; Molecular characterisation; Morphological description; Plasmodium zonuriae; Haematozoa; Haemosporids; Malaria	CYTOCHROME-B; ADELEORINA HEPATOZOIDAE; SPECIES CONCEPTS; SOUTH-AFRICA; LIFE-CYCLE; REDESCRIPTION; HAEMOPROTEIDAE; PHYLOGENY; DIVERSITY; EVOLUTION	Background: Saurian malaria parasites are diverse apicomplexan blood parasites including the family Plasmodiidae Mesnil, 1903, and have been studied since the early 1900s. Currently, at least 27 species of Plasmodium are recorded in African lizards, and to date only two species, Plasmodium zonuriae (Pienaar, 1962) and Plasmodium cordyli Telford, 1987, have been reported from the African endemic family Cordylidae. This paper presents a description of a new malaria parasite in a cordylid lizard and provides a phylogenetic hypothesis for saurian Plasmodium species from South Africa. Furthermore, it provides a tabular review of the Plasmodium species that to date have been formally described infecting species of African lizards. Methods: Blood samples were collected from 77 specimens of Pseudocordylus melanotus (A. Smith, 1838) from Platberg reserve in the Eastern Free State, and two specimens of Cordylus vittifer (Reichenow, 1887) from the Roodewalshoek conservancy in Mpumalanga (South Africa). Blood smears were Giemsa-stained, screened for haematozoa, specifically saurian malaria parasites, parasite stages were photographed and measured. A small volume was also preserved for TEM studies. Plasmodium and Haemoproteus primer sets, with a nested-polymerase chain reaction (PCR) protocol, were employed to target a fragment of the cytochrome-b (cyt-b) gene region. Resulting sequences of the saurian Plasmodium species' isolates were compared with each other and to other known Plasmodium spp. sequences in the GenBank database. Results: The presence of P. zonuriae in both specimens of the type lizard host C. vittifer was confirmed using morphological characteristics, which subsequently allowed for the species' molecular characterisation. Of the 77 P. melanotus, 44 were parasitised by a Plasmodium species, which when compared morphologically to other African saurian Plasmodium spp. and molecularly to P. zonuriae, supported its description as a new species Plasmodium intabazwe n. sp. Conclusions: This is the first morphological and molecular account of Plasmodium species within the African endemic family Cordylidae from South Africa. The study highlights the need for molecular analysis of other cordylid Plasmodium species within Africa. Future studies should also include elucidating of the life-cycles of these species, thus promoting the use of both morphological and molecular characteristics in species descriptions of saurian malaria parasites.	[van As, Johann] Univ Free State, Dept Zool & Entomol, QwaQwa Campus, Bloemfontein, Free State, South Africa; [Cook, Courtney A.; Netherlands, Edward C.; Smit, Nico J.] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Netherlands, Edward C.] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, B-3000 Leuven, Belgium	Cook, CA (reprint author), North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa.	apicomplexan@yahoo.co.za	J, Nico/L-4905-2013	J, Nico/0000-0001-7950-193X; Netherlands, Edward/0000-0003-1856-0586	National Research Foundation (NRF) of South Africa (NRF Thutuka) [TTK: 14042266483]; CAC (NRF Scarce Skills Postdoctoral Scholarship) [SFP13090332476]; ECN (NRF Scarce Skills Masters Scholarship) [UID: 89924]	The National Research Foundation (NRF) of South Africa provided funding to JVA (NRF Thutuka - Grant TTK: 14042266483), CAC (NRF Scarce Skills Postdoctoral Scholarship - Grant SFP13090332476), and ECN (NRF Scarce Skills Masters Scholarship - Grant UID: 89924). The role of the funding body was in the collection and analyses of data in this study. Opinions expressed and conclusions arrived at, are those of the authors and are not necessarily to be attributed to the NRF.	BALL GH, 1965, J PROTOZOOL, V12, P479, DOI 10.1111/j.1550-7408.1965.tb03246.x; BALL GH, 1967, J PROTOZOOL, V14, P198, DOI 10.1111/j.1550-7408.1967.tb01983.x; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; BRAY RS, 1959, J PROTOZOOL, V6, P13, DOI 10.1111/j.1550-7408.1959.tb03920.x; Cook CA, 2010, J PARASITOL, V96, P1168, DOI 10.1645/GE-2527.1; Cook CA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1600-8; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davies AJ, 2000, ADV PARASIT, V45, P1, DOI 10.1016/S0065-308X(00)45003-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Falk BG, 2015, EVOLUTION, V69, P1584, DOI 10.1111/evo.12683; GARNHAM P. C. C., 1966, MALARIA PARASITES OT; GARNHAM PCC, 1950, PARASITOLOGY, V40, P328, DOI 10.1017/S0031182000018205; GARNHAM PCC, 1984, J PROTOZOOL, V31, P518, DOI 10.1111/j.1550-7408.1984.tb05494.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; HOARE CECIL A., 1932, PARASITOLOGY, V24, P210; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1; Javanbakht H, 2015, J EUKARYOT MICROBIOL, V62, P670, DOI 10.1111/jeu.12227; Lawrence RF, 1935, PARASITOLOGY, V37, P1; Martinsen ES, 2006, PARASITOLOGY, V133, P279, DOI 10.1017/S0031182006000424; Netherlands EC, 2015, INT J PARASITOL-PAR, V4, P135, DOI 10.1016/j.ijppaw.2015.01.003; Netherlands EC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0552-0; PAPERNA I, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P309; Perkins SL, 2000, P ROY SOC B-BIOL SCI, V267, P2345, DOI 10.1098/rspb.2000.1290; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.2307/3285540; Perkins SL, 2009, J PARASITOL, V95, P424, DOI 10.1645/GE-1750.1; PETIT G, 1983, PROTISTOLOGICA, V19, P537; PIENAAR UDV, 1962, HAEMATOLOGY SOME S A; Pineda-Catalan O, 2013, J PARASITOL, V99, P1089, DOI 10.1645/13-296.1; PRINGLE G., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P411, DOI 10.1016/0035-9203(60)90085-7; Riding D., 1930, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V23, P635, DOI 10.1016/S0035-9203(30)80029-4; SCHALL JJ, 1990, PARASITOL TODAY, V6, P264, DOI 10.1016/0169-4758(90)90188-A; Schwetz J., 1931, Annales de Parasitologie Paris, V9, P193; Telford Jr SR, 2009, HEMOPARASITES REPTIL; Telford S.R. Jr, 1984, P385; Telford Sam R. Jr, 1994, P1; TELFORD SR, 1988, INT J PARASITOL, V18, P197, DOI 10.1016/0020-7519(88)90061-6; Telford SR, 2005, J PARASITOL, V91, P135, DOI 10.1645/GE-3395; TELFORD SR, 1987, ANN PARASIT HUM COMP, V62, P395, DOI 10.1051/parasite/1987625395; TELFORD SR, 1987, ANN PARASIT HUM COMP, V62, P405, DOI 10.1051/parasite/1987625405; TELFORD SR, 1986, J PARASITOL, V72, P271, DOI 10.2307/3281603; TELFORD SR, 1983, J PARASITOL, V69, P1146, DOI 10.2307/3280880; THEILER M, 1930, AFRICAN REPUBLIC LIB, P490; Valkiunas G, 2009, PARASITOL RES, V104, P1061, DOI 10.1007/s00436-008-1289-5; Van As J, 2015, FOLIA PARASIT, V62; Van As J, 2013, ZOOTAXA, V3608, P345, DOI 10.11646/zootaxa.3608.5.3; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wenyon C.M., 1909, REP WELL TROP RES LA, V3, P121	50	2	2	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 8	2016	9								437	10.1186/s13071-016-1702-3				15	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DT0TD	WOS:000381195000001	27502045	DOAJ Gold, Green Published			2019-03-26
J	Kmentova, N; Gelnar, M; Koblmuller, S; Vanhove, MPM				Kmentova, Nikol; Gelnar, Milan; Koblmuller, Stephan; Vanhove, Maarten P. M.			Deep-water parasite diversity in Lake Tanganyika: description of two new monogenean species from benthopelagic cichlid fishes	PARASITES & VECTORS			English	Article						Benthochromis horii; Cichlidae; Cichlidogyrus; Monogenea; Trematocara unimaculatum	ADAPTIVE RADIATION; SEXUAL SELECTION; ANCYROCEPHALIDAE MONOGENEA; GILL PARASITES; HOST-SPECIFICITY; ANCIENT LAKE; PLATYHELMINTHES; SPECIATION; TELEOSTEI; PHYLOGENY	Background: Lake Tanganyika is the world's second deepest lake. Its diverse cichlid assemblage offers a unique opportunity for studying a deep-water host-parasite model in freshwater. Low host specificity and a broad host range including representatives of the Bathybatini tribe in the only monogenean parasite described from this habitat, Cichlidogyrus casuarinus Pariselle, Muterezi Bukinga & Vanhove, 2015 suggest a link between lower specificity and lower host density. Conversely, high host specificity and species richness are reported for monogeneans of the lake's littoral cichlids. We further investigated whether the deep-water environment in Lake Tanganyika is really monogenean species-depauperate by investigating the monogenean fauna of Trematocara unimaculatum (a representative of the tribe Trematocarini, the sister lineage of the Bathybatini) and Benthochromis horii, a member of the tribe Benthochromini, found in the same deep-water habitat as the already known hosts of C. casuarinus. Methods: Sclerotised structures of the collected monogenean individuals were characterised morphologically using light microscopy and morphometrics. Results: Both examined cichlid species are infected by a single monogenean species each, which are new to science. They are described as Cichlidogyrus brunnensis n. sp., infecting T. unimaculatum, and Cichlidogyrus attenboroughi n. sp., parasitising on B. horii. Diagnostic characteristics include the distal bifurcation of the accessory piece in C. brunnensis n. sp. and the combination of long auricles and no heel in C. attenboroughi n. sp. In addition C. brunnensis n. sp. does not resemble C. casuarinus, the only species of Cichlidogyrus thus far reported from the Bathybatini. Also Cichlidogyrus attenboroughi n. sp. does not resemble any of the monogenean species documented from the pelagic zone of the lake and is among the few described species of Cichlidogyrus without heel. Conclusions: As two new and non-resembling Cichlidogyrus species are described from T. unimaculatum and B. horii, colonisation of the deep-water habitat by more than one morphotype of Cichlidogyrus is evident. Based on morphological comparisons with previously described monogenean species, parasite transfers with the littoral zone are possible. Therefore, parasites of pelagic cichlids in the lake do not seem to only mirror host phylogeny and the evolutionary history of this host-parasite system merits further attention.	[Kmentova, Nikol; Gelnar, Milan; Vanhove, Maarten P. M.] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic; [Koblmuller, Stephan] Graz Univ, Inst Zool, Univ Pl 2, A-8010 Graz, Austria; [Koblmuller, Stephan] Acad Sci Czech Republic, Inst Vertebrate Biol, Kvetna 8, CS-60365 Brno, Czech Republic; [Vanhove, Maarten P. M.] Royal Museum Cent Africa, Biol Dept, Leuvensesteenweg 13, B-3080 Tervuren, Belgium; [Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Ch Deberiotstr 32, B-3000 Leuven, Belgium; [Vanhove, Maarten P. M.] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Capac Biodivers & Sustainable Dev, Vautierstr 29, B-1000 Brussels, Belgium	Kmentova, N (reprint author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic.	kmentovan@mail.muni.cz		Vanhove, Maarten/0000-0003-3100-7566; Koblmuller, Stephan/0000-0002-1024-3220	Czech Science Foundation [GBP505/12/G112-ECIP]	This study was financially supported by the Czech Science Foundation (GBP505/12/G112-ECIP).	Barlow G. W., 2000, CICHLID FISHES NATUR; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Boeger WA, 1997, INT J PARASITOL, V27, P1495, DOI 10.1016/S0020-7519(97)00140-9; Brown KJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-188; Bukinga FM, 2012, PARASITOL RES, V111, P2049, DOI 10.1007/s00436-012-3052-1; CAMPBELL RA, 1980, MAR BIOL, V57, P301, DOI 10.1007/BF00387573; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; Ergens R., 1970, CAUSATIVE AGENTS FIS; Erpenbeck D, 2011, MOL PHYLOGENET EVOL, V61, P231, DOI 10.1016/j.ympev.2011.05.021; FRYER G, 1991, HYDROBIOLOGIA, V211, P137, DOI 10.1007/BF00037369; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; Glaubrecht Matthias, 2008, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V84, P71, DOI 10.1002/mmnz.200700016; Humason G.L., 1979, ANIMAL TISSUE TECHNI; Husemann M, 2011, BIODIVERSITY HOTSPOT, P333, DOI DOI 10.1007/978-3-642-20992-5_18; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1; Justine Jean-Lou, 2012, Aquat Biosyst, V8, P22, DOI 10.1186/2046-9063-8-22; Kirchberger Paul C, 2012, Int J Evol Biol, V2012, P716209, DOI 10.1155/2012/716209; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Marijnissen SAE, 2006, MOL PHYLOGENET EVOL, V40, P628, DOI 10.1016/j.ympev.2006.03.025; Meixner MJ, 2007, MOL PHYLOGENET EVOL, V45, P875, DOI 10.1016/j.ympev.2007.09.007; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Michel E, 1995, EVOLUTIONARY DIVERSI; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; PAPERNA I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; PARISELLE A, 1995, PARASITE, V2, P203, DOI 10.1051/parasite/199502s2203; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; Pariselle A., 2011, INT J EVOL BIOL, V2011, DOI DOI 10.4061/2011/471480; Pariselle A, 2015, CONTRIB ZOOL, V84, P25; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Peart CR, 2014, MOL PHYLOGENET EVOL, V73, P119, DOI 10.1016/j.ympev.2014.01.013; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Pugachev ON, 2009, GUIDE MONOGENOIDEA F; Rehulkova E, 2013, PARASITOL RES, V112, P1399, DOI 10.1007/s00436-013-3291-9; Santos ME, 2012, SCIENCE, V338, P619, DOI 10.1126/science.1224818; Schoelinck C, 2012, PARASITOL INT, V61, P356, DOI 10.1016/j.parint.2012.01.009; Schon I, 2012, HYDROBIOLOGIA, V682, P91, DOI 10.1007/s10750-011-0935-6; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P367; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Sirnkova A, 2004, EVOLUTION, V58, P1001; Sturmbauer C, 1998, J FISH BIOL, V53, P18; Takahashi T, 2014, J FISH BIOL, V84, P929, DOI 10.1111/jfb.12309; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Takahashi T, 2016, MOL PHYLOGENET EVOL, V100, P234, DOI 10.1016/j.ympev.2016.04.012; Van Steenberge M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124474; Vanhove MPM, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P401; Vanhove MPM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13669; Vanhove MPM, 2013, ZOOTAXA, V3608, P398, DOI 10.11646/zootaxa.3608.5.8; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Weiss JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125043	61	4	4	1	30	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 3	2016	9								426	10.1186/s13071-016-1696-x				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DT0SO	WOS:000381193500001	27488497	DOAJ Gold, Green Published			2019-03-26
J	Staedke, SG; Maiteki-Sebuguzi, C; DiLiberto, DD; Webb, EL; Mugenyi, L; Mbabazi, E; Gonahasa, S; Kigozi, SP; Willey, BA; Dorsey, G; Kamya, MR; Chandler, CIR				Staedke, Sarah G.; Maiteki-Sebuguzi, Catherine; DiLiberto, Deborah D.; Webb, Emily L.; Mugenyi, Levi; Mbabazi, Edith; Gonahasa, Samuel; Kigozi, Simon P.; Willey, Barbara A.; Dorsey, Grant; Kamya, Moses R.; Chandler, Clare I. R.			The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-FALCIPARUM; ANTIMALARIAL THERAPY; 3 SITES; AFRICA; ACCESS; TRANSMISSION; MANAGEMENT; INFECTION; PROTOCOL	Optimizing quality of care for malaria and other febrile illnesses is a complex challenge of major public health importance. To evaluate the impact of an intervention aiming to improve malaria case management on the health of community children, a cluster-randomized trial was conducted from 2010-2013 in Tororo, Uganda, where malaria transmission is high. Twenty public health centers were included; 10 were randomized in a 1:1 ratio to intervention or control. Households within 2 km of health centers provided the sampling frame for the evaluation. The PRIME intervention included training in fever case management using malaria rapid diagnostic tests (mRDTs), patient-centered services, and health center management; plus provision of mRDTs and artemether lumefantrine. Cross-sectional community surveys were conducted at baseline and endline (N = 8,766), and a cohort of children was followed for approximately 18 months (N = 992). The primary outcome was prevalence of anemia (hemoglobin < 11.0 g/dL) in children under 5 years of age in the final community survey. The intervention was delivered successfully; however, no differences in prevalence of anemia or parasitemia were observed between the study arms in the final community survey or the cohort. In the final survey, prevalence of anemia in children under 5 years of age was 62.5% in the intervention versus 63.1% in control (adjusted risk ratio = 1.01; 95% confidence interval = 0.91-1.13; P = 0.82). The PRIME intervention, focusing on training and commodities, did not produce the expected health benefits in community children in Tororo. This challenges common assumptions that improving quality of care and access to malaria diagnostics will yield health gains.	[Staedke, Sarah G.; DiLiberto, Deborah D.; Webb, Emily L.; Willey, Barbara A.; Chandler, Clare I. R.] London Sch Hyg & Trop Med, Dept Clin Res, Dept Infect Dis Epidemiol, Dept Med Stat,Dept Global Hlth & Dev, London, England; [Staedke, Sarah G.; Maiteki-Sebuguzi, Catherine; Mugenyi, Levi; Mbabazi, Edith; Gonahasa, Samuel; Kigozi, Simon P.; Kamya, Moses R.] Infect Dis Res Collaborat, POB 7475, Kampala, Uganda; [Mugenyi, Levi] Hasselt Univ, Biostat 1, Diepenbeek, Belgium; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Staedke, Sarah G.; Chandler, Clare I. R.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [DiLiberto, Deborah D.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Webb, Emily L.; Willey, Barbara A.] London Sch Hyg & Trop Med, Dept Infect Dis, London, England; [Chandler, Clare I. R.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	Staedke, SG (reprint author), Infect Dis Res Collaborat, POB 7475, Kampala, Uganda.	sarah.staedke@lshtm.ac.uk; cmaiteki@yahoo.com; deborah.diliberto@lshtm.ac.uk; emily.webb@lshtm.ac.uk; lmugenyi005@gmail.com; edithmbabazi@yahoo.com; sgonahasa1983@gmail.com; skigozi@yahoo.com; barbara.willey@lshtm.ac.uk; grant.dorsey@ucsf.edu; mkamya@infocom.co.ug; clare.chandler@lshtm.ac.uk		DiLiberto, Deborah/0000-0003-0528-5773	ACT Consortium through Bill & Melinda Gates Foundation; Medical Research Council [MR/K012126/1]	This work was supported by the ACT Consortium (http://www.actconsortium.org/) through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine.	Abba K, 2011, COCHRANE DB SYST REV, V7; [Anonymous], 2012, T3 TEST TREAT TRACK; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Chandler CIR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-113; Chandler CIR, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-13; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Cundill B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0346-z; DiLiberto DD, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29067; Greenwood B, 2014, LANCET, V383, P1703, DOI 10.1016/S0140-6736(14)60044-1; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hopkins H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2606; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kigozi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042857; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Klemick H, 2008, DEFINING ACCESS HLTH; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-695; Mbabazi P, 2015, AM J TROP MED HYG, V92, P530, DOI 10.4269/ajtmh.14-0180; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; National Academies of Sciences Engineering and Medicine, 2015, IMPR QUAL CAR LAW MI; Nayiga S, 2014, EVALUATION-US, V20, P471, DOI 10.1177/1356389014551484; Odaga J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008998.pub2; Okwaro FM, 2015, SOC SCI MED, V131, P10, DOI 10.1016/j.socscimed.2015.02.032; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Staedke SG, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-114; Staedke SG, 2009, LANCET, V373, P1623, DOI 10.1016/S0140-6736(09)60328-7; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2007, EV BUS STRENGTH HLTH	36	4	4	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	AUG	2016	95	2					358	367		10.4269/ajtmh.16-0103				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3UY	WOS:000400206200018	27273646	Other Gold, Green Published			2019-03-26
J	Vischer, N; Pfeiffer, C; Joller, A; Klingmann, I; Ka, A; Kpormegbe, SK; Burri, C				Vischer, N.; Pfeiffer, C.; Joller, A.; Klingmann, I.; Ka, A.; Kpormegbe, S. K.; Burri, C.			The Good Clinical Practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						clinical trials; Africa South of the Sahara; good clinical practice; qualitative research; guideline; essais cliniques; Afrique subsahararienne; bonnes pratiques cliniques; recherche qualitative; directive; Ensayos clinicos; africa al sur del Sahara; buenas practicas clinicas; investigacion cualitativa; guias	DEVELOPING-COUNTRIES; INFORMED-CONSENT; VACCINE TRIALS; IMPACT; RECOMMENDATIONS; DISEASES	ObjectivesTo explore the advantages and challenges of working with the Good Clinical Practice (GCP)-International Conference of Harmonization (ICH) E6 guideline and its interpretation from the perspective of clinical trial teams based in sub-Saharan Africa. MethodsWe conducted 60 key informant interviews with clinical trial staff at different levels in clinical research centres in Kenya, Ghana, Burkina Faso and Senegal and thematically analysed the responses. ResultsClinical trial teams perceived working with ICH-GCP as highly advantageous and regarded ICH-GCP as applicable to their setting and efficiently applied. Only for informed consent did some clinical trial staff (one-third) perceive the guideline as insufficiently applicable. Specific challenges included meeting the requirements for written and individual consent, conditions for impartial witnesses for illiterates or legally acceptable representatives for children, guaranteeing voluntary participation and ensuring full understanding of the consent given. It was deemed important to have ICH-GCP compliance monitored by relevant ethics committees and regulatory authorities, without having guidelines applied overcautiously. ConclusionClinical trial teams in sub-Saharan Africa perceived GCP as a helpful guideline, despite having been developed by northern organisations and despite the high administrative burden of implementing it. To mitigate consent challenges, we suggest adapting GCP and making use of the flexibility it offers. ObjectifsExplorer les avantages et les defis du travail selon la directive des bonnes pratiques cliniques (BPC) de l'ICH E6 (ICH-GCP) et son interpretation du point de vue des equipes d'essais cliniques en Afrique subsaharienne. MethodesNous avons mene 60 entretiens d'information cles avec le personnel a differents niveaux des essais cliniques dans les centres de recherche clinique au Kenya, au Ghana, au Burkina-Faso et au Senegal, et avons thematiquement analyse les reponses. ResultatsLes equipes d'essais cliniques percoivent le travail selon l'ICH-GCP comme tres avantageux et considerent l'ICH-GCP applicable a leur situation et efficacement appliquee. Seul pour le consentement eclaire, certains membres du personnel d'essai clinique (un tiers) percoivent la directive comme insuffisamment applicable. Les defis specifiques comprennent: repondre aux exigences du consentement ecrit et individuel, les conditions des temoins impartiaux pour les analphabetes ou les representants legalement acceptables pour les enfants, garantir la participation volontaire et assurer la pleine comprehension du consentement donne. Il a ete juge important de veiller a ce que le respect de l'ICH-GCP soit surveille par les comites d'ethique et les autorites reglementaires, pour ne pas avoir des directives appliquees de facon trop precautionneuse. ConclusionLes equipes d'essais cliniques en Afrique subsaharienne percoivent la directive sur les BPC comme utile, bien qu'ayant ete mise au point par des organismes du Nord et malgre la charge administrative elevee pour son implementation. Afin d'attenuer les defis lies au consentement, nous suggerons d'adapter la directive et de faire usage de la flexibilite qu'elle offre. ObjetivosExplorar las ventajas y los retos de trabajar con las guias ICH E6 de Buenas Practicas Clinicas (BPC) y su interpretacion desde la perspectiva de los equipos trabajando en ensayos clinicos en africa subsahariana. MetodosHemos llevado a cabo 60 entrevistas con informantes claves de personal de ensayos clinicos de diferentes niveles en centros de investigacion clinica de Kenia, Ghana, Burkina Faso y Senegal, y analizado tematicamente las respuestas. ResultadosLos equipos de ensayos clinicos percibian el trabajar con las guias de BPC ICH-GCP como algo altamente ventajoso y veian las ICH-GCP como pertinentes para su emplazamiento y posibles de aplicar eficientemente. Solo en el caso del consentimiento informado, una tercera parte del personal clinico percibia las guias como insuficientemente aplicables. Los retos especificos incluian el alcanzar los requerimientos para el consentimiento informado escrito e individual, condiciones de un testigo imparcial para analfabetos o representantes legalmente aceptables para ninos, garantizando la participacion voluntaria y asegurando el completo entendimiento del consentimiento que se da. Se considero importante monitorizar el cumplimiento de las guias ICH-GCP por los comites de etica relevantes y las autoridades regulatorias, sin tener que aplicar las guias de forma excesivamente cautelosa. ConclusionLos equipos de ensayos clinicos en africa subsahariana percibian las BPC como unas guias utiles, a pesar de haber sido desarrolladas por organizaciones del norte y de la alta carga administrativa para implementarlas. Para mitigar los retos del consentimiento informado, sugerimos adaptar las BPC y hacer uso de la flexibilidad que ofrece.	[Vischer, N.; Pfeiffer, C.; Joller, A.; Burri, C.] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4051 Basel, Switzerland; [Vischer, N.; Pfeiffer, C.; Joller, A.; Burri, C.] Univ Basel, Basel, Switzerland; [Klingmann, I.] European Forum Good Clin Practice, Brussels, Belgium; [Ka, A.] Univ Cheikh Anta Diop Dakar, Dept Sociol, Dakar, Senegal; [Kpormegbe, S. K.] Univ Ghana, Dept Sociol, Legon, Ghana	Vischer, N (reprint author), Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4051 Basel, Switzerland.	nerina.vischer@unibas.ch			Rudolf Geigy Foundation; Swiss Tropical and Public Health Institute; Freiwillige Akademische Gesellschaft	We thank the clinical research centres which participated in our study and especially the study participants. Thanks to Andrea Bianchin for designing the graphic and to Julie Catusse for helping with the translation. We thank Amena Briet and Benjamin Berger for editing. The work was funded by the Rudolf Geigy Foundation, the Swiss Tropical and Public Health Institute and the Freiwillige Akademische Gesellschaft.	Acosta CJ, 2007, VACCINE, V25, P2852, DOI 10.1016/j.vaccine.2006.09.079; [Anonymous], 2014, CTR DRUG EVALUATION; Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Bompart F, 2008, THERAPIE, V63, P83, DOI [10.2515/therapie:2008023, 10.2515/therapie:2008022]; Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP0630A]; Charmaz K., 2006, CONSTRUCTING GROUNDE; Clark J, 2003, QUALITATIVE RES REV; DeMets DL, 2006, CLIN TRIALS, V3, P142, DOI 10.1191/1740774506cn137oa; Department of Health Republic of South Africa, 2015, ETH HLTH RES; Fekadu A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-493; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Hanna M, 2013, CLIN TRIALS, V10, P300, DOI 10.1177/1740774512470765; Hartmann M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-53; Hearn J, 2007, EUR J CANCER, V43, P8, DOI 10.1016/j.ejca.2006.09.016; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, INT C HARMONISATION; Kalabuanga M, 2016, DEV WORLD BIOETH, V16, P64, DOI 10.1111/dewb.12090; Kuepfer I, 2009, INT J PARASITOL, V39, P947, DOI 10.1016/j.ijpara.2009.02.021; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Lang T, 2011, LANCET, V377, P1553, DOI 10.1016/S0140-6736(10)62052-1; Lang TA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000619; Lorell BH, 2015, CLIN TRIALS, V12, P692, DOI 10.1177/1740774515594362; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; O'Leary E, 2013, CLIN TRIALS, V10, P624, DOI 10.1177/1740774513491337; Owens S, 2007, TROP MED INT HEALTH, V12, P472; Singh JA, 2006, RES ETHICS REV, V2, P63; Sweatman J, 2003, BRIT J CLIN PHARMACO, V55, P1, DOI 10.1046/j.1365-2125.2003.01713.x; Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340; Vijayananthan A, 2008, Biomed Imaging Interv J, V4, pe5, DOI 10.2349/biij.4.1.e5; Vray Muriel, 2007, Therapie, V62, P217, DOI 10.2515/therapie:2007044; Walker L, 2004, SOC SCI MED, V59, P1251, DOI 10.1016/j.socscimed.2003.12.020; White NJ, 2006, TROP MED INT HEALTH, V11, P1483, DOI 10.1111/j.1365-3156.2006.01765.x; Yusuf S, 2010, CLIN TRIALS, V7, P622, DOI 10.1177/1740774510387850	34	5	5	2	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2016	21	8					1040	1048		10.1111/tmi.12734				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DU9UN	WOS:000382563500012		Green Published			2019-03-26
J	George, S; Levecke, B; Kattula, D; Velusamy, V; Roy, S; Geldhof, P; Sarkar, R; Kang, G				George, Santosh; Levecke, Bruno; Kattula, Deepthi; Velusamy, Vasanthakumar; Roy, Sheela; Geldhof, Peter; Sarkar, Rajiv; Kang, Gagandeep			Molecular Identification of Hookworm Isolates in Humans, Dogs and Soil in a Tribal Area in Tamil Nadu, India	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMITTED HELMINTH INFECTIONS; TRICHURIS-VULPIS; ANCYLOSTOMA-CEYLANICUM; LARVA MIGRANS; GASTROINTESTINAL PARASITES; EOSINOPHILIC ENTERITIS; COMMUNITY; PREVALENCE; CANINUM; SCHISTOSOMIASIS	Background Hookworms (Necator americanus and Ancylostoma duodenale) remain a major public health problem worldwide. Infections with hookworms (e.g., A. caninum, A. ceylanicum and A. braziliense) are also prevalent in dogs, but the role of dogs as a reservoir for zoonotic hookworm infections in humans needs to be further explored. Methodology/Principal Findings As part of an open-label community based cluster-randomized trial in a tribal area in Tamil Nadu (India; 2013-2015), a total of 143 isolates of hookworm eggs from human stool were speciated based on a previously described PCR-RFLP methodology. The presence of hookworm DNA was confirmed in 119 of 143 human samples. N. americanus (100%) was the most prevalent species, followed by A. caninum (16.8%) and A. duodenale (8.4%). Because of the high prevalence of A. caninum in humans, dog samples were also collected to assess the prevalence of A. caninum in dogs. In 68 out of 77 canine stool samples the presence of hookworms was confirmed using PCR-RFLP. In dogs, both A. caninum (76.4%) and A. ceylanicum (27.9%) were identified. Additionally, to determine the contamination of soil with zoonotic hookworm larvae, topsoil was collected from defecating areas. Hookworm DNA was detected in 72 out of 78 soil samples that revealed presence of hook-worm-like nematode larvae. In soil, different hookworm species were identified, with animal hookworms being more prevalent (A. ceylanicum: 60.2%, A. caninum: 29.4%, A. duodenale: 16.6%, N. americanus: 1.4%, A. braziliense: 1.4%). Conclusions/Significance In our study we regularly detected the presence of A. caninum DNA in the stool of humans. Whether this is the result of infection is currently unknown but it does warrant a closer look at dogs as a potential reservoir.	[George, Santosh; Kattula, Deepthi; Velusamy, Vasanthakumar; Roy, Sheela; Sarkar, Rajiv; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [George, Santosh; Levecke, Bruno; Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Kang, G (reprint author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	gkang@cmcvellore.ac.in		Levecke, Bruno/0000-0001-8912-5595; Kang, Gagandeep/0000-0002-3656-564X	Wellcome Trust/DBT India Alliance trough an Early Career Fellowship; Special Research Fund of Ghent University [01W01511]; FWO [1285316N]	This study is supported by the Wellcome Trust/DBT India Alliance trough an Early Career Fellowship to RS. SG is supported by the Special Research Fund of Ghent University (scholarship code - 01W01511) (http://www.ugent.be/nl/onderzoek/financiering/bof). BL is a postdoctoral fellow of FWO (Grant number - 1285316N) (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002027; Areekul P, 2010, ASIAN BIOMED, V4, P49, DOI 10.2478/abm-2010-0006; Bowman DD, 2010, TRENDS PARASITOL, V26, P162, DOI 10.1016/j.pt.2010.01.005; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; CROESE J, 1994, ANN INTERN MED, V120, P369, DOI 10.7326/0003-4819-120-5-199403010-00003; de Silva NR, 2003, ACTA TROP, V86, P197, DOI 10.1016/S0001-706X(03)00035-4; Diemert DJ, 2008, CLIN INFECT DIS, V46, P282, DOI 10.1086/524070; Ng-Nguyen D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1015-y; Dunn JJ, 2002, J CLIN MICROBIOL, V40, P2703, DOI 10.1128/JCM.40.7.2703-2704.2002; Engleberg N. C., 2013, SCHAECHTERS MECH MIC; Farthing MJG, 1995, HUMAN HOOKWORM INFEC; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; George S, 2015, T ROY SOC TROP MED H, V109, P283, DOI 10.1093/trstmh/trv001; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Hotez PJ, 2013, VACCINE, V31, pB227, DOI 10.1016/j.vaccine.2012.11.034; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Kaliappan SP, 2013, TROP MED INT HEALTH, V18, P1452, DOI 10.1111/tmi.12205; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Landmann JK, 2003, MED J AUSTRALIA, V178, P69; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Liu D, 2012, MOL DETECTION HUMAN; MASUDA Y, 1987, THORAX, V42, P990, DOI 10.1136/thx.42.12.990; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngui R, 2014, AM J TROP MED HYG, V91, P86, DOI 10.4269/ajtmh.13-0756; Ngui R, 2013, ACTA TROP, V128, P154, DOI [10.1016/Lactatropica.2013.06.003, 10.1016/j.actatropica.2013.06.003]; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; PROCIV P, 1990, LANCET, V335, P1299, DOI 10.1016/0140-6736(90)91186-E; Ranganathan RV, 2012, ASIAN J PHARM CLIN R, V5; SAKANO T, 1980, ARCH DIS CHILD, V55, P631, DOI 10.1136/adc.55.8.631; Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Traub RJ, 2014, VET PARASITOL, V205, P233, DOI 10.1016/j.vetpar.2014.06.037; Traub RJ, 2005, TRENDS PARASITOL, V21, P42, DOI 10.1016/j.pt.2004.10.011; Traub RJ, 2004, TROP MED INT HEALTH, V9, P688, DOI 10.1111/j.1365-3156.2004.01252.x; Traub RJ, 2002, AM J TROP MED HYG, V67, P539, DOI 10.4269/ajtmh.2002.67.539; Tun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142231; UDONSI JK, 1987, EXP PARASITOL, V63, P136, DOI 10.1016/0014-4894(87)90154-8; Ugbomoiko Uade Samuel, 2008, BMC Vet Res, V4, P49, DOI 10.1186/1746-6148-4-49; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, pe948, DOI DOI 10.1371/J0URNAL.PNTD.0000948; WALKER NI, 1995, AM J SURG PATHOL, V19, P328, DOI 10.1097/00000478-199503000-00011; *WHO, 1991, BAS LAB METH MED PAR	44	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2016	10	8							e0004891	10.1371/journal.pntd.0004891				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU7JR	WOS:000382390800034	27486798	DOAJ Gold, Green Published			2019-03-26
J	Hirve, S; Boelaert, M; Matlashewski, G; Mondal, D; Arana, B; Kroeger, A; Olliaro, P				Hirve, Siddhivinayak; Boelaert, Marleen; Matlashewski, Greg; Mondal, Dinesh; Arana, Byron; Kroeger, Axel; Olliaro, Piero			Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							AZAR DERMAL LEISHMANIASIS; LIPOSOMAL AMPHOTERICIN-B; DIRECT AGGLUTINATION-TEST; CLUSTER-RANDOMIZED-TRIAL; RECOMBINANT K-39 ANTIGEN; ORGAN TRANSPLANT RECIPIENTS; LINKED-IMMUNOSORBENT-ASSAY; LASTING INSECTICIDAL NETS; PHLEBOTOMINE SAND FLIES; LONG-TERM EFFECTIVENESS	Background mAs Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination, it is important to understand the role of asymptomatic Leishmania infection (ALI), VL treatment relapse and post kala-azar dermal leishmaniasis (PKDL) in transmission. Methodology/Principal Finding We reviewed evidence systematically on ALI, relapse and PKDL. We searched multiple databases to include studies on burden, risk factors, biomarkers, natural history, and infectiveness of ALI, PKDL and relapse. After screening 292 papers, 98 were included covering the years 1942 through 2016. ALI, PKDL and relapse studies lacked a reference standard and appropriate biomarker. The prevalence of ALI was 4-17-fold that of VL. The risk of ALI was higher in VL case contacts. Most infections remained asymptomatic or resolved spontaneously. The proportion of ALI that progressed to VL disease within a year was 1.5-23%, and was higher amongst those with high antibody titres. The natural history of PKDL showed variability; 3.8-28.6% had no past history of VL treatment. The infectiveness of PKDL was 32-53%. The risk of VL relapse was higher with HIV co-infection. Modelling studies predicted a range of scenarios. One model predicted VL elimination was unlikely in the long term with early diagnosis. Another model estimated that ALI contributed to 82% of the overall transmission, VL to 10% and PKDL to 8%. Another model predicted that VL cases were the main driver for transmission. Different models predicted VL elimination if the sandfly density was reduced by 67% by killing the sandfly or by 79% by reducing their breeding sites, or with 4-6y of optimal IRS or 10y of sub-optimal IRS and only in low endemic setting. Conclusion/Significance There is a need for xenodiagnostic and longitudinal studies to understand the potential of ALI and PKDL as reservoirs of infection.	[Hirve, Siddhivinayak] World Hlth Org, Global Influenza Programme, Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med, Epidemiol & Control Trop Dis, Antwerp, Belgium; [Matlashewski, Greg] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Mondal, Dinesh] Int Ctr Diarrheal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Arana, Byron] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Kroeger, Axel; Olliaro, Piero] World Hlth Org, Special Programme Res & Training Trop Dis, Geneva, Switzerland	Hirve, S (reprint author), World Hlth Org, Global Influenza Programme, Geneva, Switzerland.	hirves@who.int		Hirve, Siddhivinayak/0000-0002-9651-7789; Boelaert, Marleen/0000-0001-8051-6776	Special Program for Research and Training in Tropical Diseases, World Health Organization through an APW contract [2015/572330]; WHO/TDR	The study was supported by the Special Program for Research and Training in Tropical Diseases, World Health Organization through an APW contract no. 2015/572330 with SH. AK and PO from WHO TDR contributed to the design of the study, data analysis and preparation of the manuscript. SH is a staff member of WHO, Global Influenza Programme; AK is at the Center for Medicine and Society, University of Freiburg, Germany and also a consultant to WHO TDR, TDR programme; PO is a staff member of WHO, TDR programme. WHO/TDR funded SH to conduct the systematic review, (ii) defined the objectives and terms of the review; (iii) funded a workshop of experts where the results were reviewed; (iv) both TDR and the experts participated in the interpretation of results and writing up of the paper.	Adams ER, 2013, J TROP MED, DOI 10.1155/2013/150746; ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ansari NA, 2007, CLIN IMMUNOL, V122, P343, DOI 10.1016/j.clim.2006.11.008; Antinori S, 2008, LANCET INFECT DIS, V8, P191, DOI 10.1016/S1473-3099(08)70043-4; Basset D, 2005, MICROBES INFECT, V7, P1370, DOI 10.1016/j.micinf.2005.06.002; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2007, AM J TROP MED HYG, V76, P909; Bern C, 2006, AM J TROP MED HYG, V75, P744, DOI 10.4269/ajtmh.2006.75.744; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657; Bhattacharya SK, 2004, CLIN INFECT DIS, V38, P217, DOI 10.1086/380638; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003273; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x; Bhunia GS, 2012, GEOSPATIAL HEALTH, V7, P51, DOI 10.4081/gh.2012.104; Bhunia GS, 2012, GEOSPATIAL HEALTH, V6, P177, DOI 10.4081/gh.2012.136; Bimal S, 2005, ANN TROP MED PARASIT, V99, P743, DOI 10.1179/136485905X65107; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Boettcher JP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0767-5; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003053; Burza S, 2014, CLIN INFECT DIS, V59, P552, DOI 10.1093/cid/ciu333; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002611; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002536; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002603; Burza S, 2013, CLIN INFECT DIS, V57, P1363, DOI 10.1093/cid/cit508; Chapman LAC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1136-3; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; CHOWDHURY MS, 1993, PARASITOL RES, V79, P444, DOI 10.1007/BF00931580; Chowdhury R, 2011, AM J TROP MED HYG, V84, P662, DOI 10.4269/ajtmh.2011.10-0682; Clements MF, 2010, AM J TROP MED HYG, V82, P801, DOI 10.4269/ajtmh.2010.09-0336; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Cruz I, 2002, LANCET, V359, P1124, DOI 10.1016/S0140-6736(02)08160-6; Das ML, 2010, ACTA TROP, V113, P162, DOI 10.1016/j.actatropica.2009.10.012; Das M. L., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P619; Das VNR, 2011, T ROY SOC TROP MED H, V105, P661, DOI 10.1016/j.trstmh.2011.08.005; Das VNR, 2012, AM J TROP MED HYG, V86, P959, DOI 10.4269/ajtmh.2012.11-0467; de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14; Dey A, 2006, Indian J Med Microbiol, V24, P165; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2; ELTOUM IA, 1992, AM J TROP MED HYG, V46, P57, DOI 10.4269/ajtmh.1992.46.57; Ganguly S, 2010, INT J DERMATOL, V49, P921, DOI 10.1111/j.1365-4632.2010.04558.x; Ganguly S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004138; Garg VK, 2001, INT J DERMATOL, V40, P179, DOI 10.1046/j.1365-4362.2001.01198.x; GHOSH K N, 1990, Journal of Communicable Diseases, V22, P67; Ghosh S, 2015, AM J TROP MED HYG, V93, P767, DOI 10.4269/ajtmh.14-0721; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Gidwani K, 2009, AM J TROP MED HYG, V80, P345, DOI 10.4269/ajtmh.2009.80.345; Gonzalez U, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008736.pub2; Goswami R P, 2003, J Assoc Physicians India, V51, P759; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; Hati A K, 1984, J Indian Med Assoc, V82, P1; HATI AK, 1991, INDIAN J MED RES-A, V93, P388; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; Higgins J. P., 2011, COCHRANE HANDBOOK FO; Huda MM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-62; Islam MZ, 2012, AM J TROP MED HYG, V87, P658, DOI 10.4269/ajtmh.2012.12-0168; Islam S, 2013, AM J TROP MED HYG, V89, P345, DOI 10.4269/ajtmh.12-0711; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Joshi A B, 2006, Kathmandu Univ Med J (KUMJ), V4, P488; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Kesari S., 2009, Journal of Communicable Diseases, V41, P211; Kesari S, 2013, MEM I OSWALDO CRUZ, V108, P197, DOI 10.1590/0074-0276108022013012; Kesari S, 2011, MEM I OSWALDO CRUZ, V106, P515, DOI 10.1590/S0074-02762011000500001; Khan AM, 2014, EMERG INFECT DIS, V20, P487, DOI 10.3201/eid2003.130260; Khanal B, 2010, PARASITOLOGY, V137, P1597, DOI 10.1017/S0031182010000521; Khanal B, 2010, TROP MED INT HEALTH, V15, P1390, DOI 10.1111/j.1365-3156.2010.02631.x; Kip AE, 2015, ANTIMICROB AGENTS CH, V59, P1, DOI 10.1128/AAC.04298-14; Koirala S, 2004, TROP MED INT HEALTH, V9, P533, DOI 10.1111/j.1365-3156.2004.01212.x; Kumar R, 2006, TROP MED INT HEALTH, V11, P41, DOI 10.1111/j.1365-3156.2005.01538.x; Kumar R, 2001, CLIN DIAGN LAB IMMUN, V8, P1220, DOI 10.1128/CDLI.8.6.1220-1224.2001; Kumar V., 2001, Journal of Communicable Diseases, V33, P102; KUMAR V, 1995, INDIAN J MED RES, V101, P154; Le Rutte EA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1292-0; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Mathur P, 2006, J MED MICROBIOL, V55, P919, DOI 10.1099/jmm.0.46574-0; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; Medley GF, 2015, NATURE, V528, pS102, DOI 10.1038/nature16042; Miller E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003288; Moher David, 2009, Open Med, V3, pe123; MOLINA R, 1994, AIDS, V8, P277, DOI 10.1097/00002030-199402000-00024; Mondal D, 2010, Proceedings 2010 Annual IEEE India Conference (INDICON 2010), DOI 10.1109/INDCON.2010.5712633; Mondal D, 2010, TROP MED INT HEALTH, V15, P1382, DOI 10.1111/j.1365-3156.2010.02635.x; Mubayi A, 2010, J THEOR BIOL, V262, P177, DOI 10.1016/j.jtbi.2009.09.012; Mukhopadhyay A. K., 1996, Journal of Communicable Diseases, V28, P171; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; MUKHOPADHYAY AK, 1991, INDIAN J MED RES-A, V93, P152; Mukhopadhyay D, 2014, TRENDS PARASITOL, V30, P65, DOI 10.1016/j.pt.2013.12.004; Muniaraj Mayilsamy, 2014, Trop Parasitol, V4, P10, DOI 10.4103/2229-5070.129143; NANDY A, 1987, ANN TROP MED PARASIT, V81, P693, DOI 10.1080/00034983.1987.11812172; Nandy A, 1998, TROP MED INT HEALTH, V3, P76, DOI 10.1046/j.1365-3156.1998.00176.x; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Ostyn B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003966; Ostyn B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100220; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Palit A, 2005, INT J ENVIRON HEAL R, V15, P449, DOI 10.1080/09603120500392525; Pandey BD, 2011, AM J TROP MED HYG, V84, P107, DOI 10.4269/ajtmh.2011.10-0291; PANDYA AP, 1983, INDIAN J MED RES, V77, P817; Patole S, 2014, INT J INFECT DIS, V25, P204, DOI 10.1016/j.ijid.2014.02.015; Picado A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087641; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Poche D, 2011, J VECTOR ECOL, V36, pS106, DOI 10.1111/j.1948-7134.2011.00119.x; Rahman KM, 2010, CLIN INFECT DIS, V50, P73, DOI 10.1086/648727; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; RAI R N, 1989, Journal of Communicable Diseases, V21, P214; Ramesh V, 2007, TROP MED INT HEALTH, V12, P848, DOI 10.1111/j.1365-3156.2007.01854.x; Ramesh V, 2011, BRIT J DERMATOL, V165, P411, DOI 10.1111/j.1365-2133.2011.10402.x; RAMESH V, 1995, INT J DERMATOL, V34, P85, DOI 10.1111/j.1365-4362.1995.tb03584.x; Rao J. S., 2001, Journal of Communicable Diseases, V33, P7; Rao J S, 1992, J Commun Dis, V24, P116; Ready PD, 2014, CLIN EPIDEMIOL, V6, P147, DOI 10.2147/CLEP.S44267; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Rijal S, 2010, TROP MED INT HEALTH, V15, P21, DOI 10.1111/j.1365-3156.2010.02518.x; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; Saha S, 2009, T ROY SOC TROP MED H, V103, P737, DOI 10.1016/j.trstmh.2008.10.006; Salotra P, 2002, CLIN DIAGN LAB IMMUN, V9, P370, DOI 10.1128/CDLI.9.2.370-373.2002; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Saran R., 1992, Journal of Communicable Diseases, V24, P242; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Seblova V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002187; Sen Gupta P C, 1968, J Indian Med Assoc, V50, P1; Singh DP, 2010, J HEALTH POPUL NUTR, V28, P281; Singh R, 2005, CLIN DIAGN LAB IMMUN, V12, P1191, DOI 10.1128/CDLI.12.10.1191-1194.2005; Singh RP, 2012, TROP MED INT HLTH; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh S, 2014, INT J INFECT DIS, V29, P103, DOI 10.1016/j.ijid.2014.07.011; Singh SP, 2010, TROP MED INT HEALTH, V15, P12, DOI 10.1111/j.1365-3156.2010.02519.x; Singh Utpal Kant, 2006, Indian Journal of Pediatrics, V73, P1077, DOI 10.1007/BF02763048; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Sinha PK, 2008, ANN TROP MED PARASIT, V102, P119, DOI 10.1179/136485908X252278; Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521; Sinha PK, 2010, AM J TROP MED HYG, V83, P357, DOI 10.4269/ajtmh.2010.10-0156; Srivastava P, 2013, TROP MED INT HEALTH, V18, P548, DOI 10.1111/tmi.12085; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Stauch A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001973; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Sudarshan M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003366; Sudarshan M, 2014, DIAGN MICR INFEC DIS, V80, P40, DOI 10.1016/j.diagmicrobio.2014.01.031; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2003, PEDIATR INFECT DIS J, V22, P434; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar Shyam, 2015, ScientificWorldJournal, V2015, P414378, DOI 10.1155/2015/414378; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; Swaminath CS, 2006, INDIAN J MED RES, V123, pA473; THAKUR CP, 1992, ANN TROP MED PARASIT, V86, P355, DOI 10.1080/00034983.1992.11812678; Tiwary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061370; Tiwary P, 2012, VECTOR-BORNE ZOONOT, V12, P467, DOI 10.1089/vbz.2011.0808; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; Uranw S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-21; Uranw S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001433; Vallur AC, 2014, CLIN MICROBIOL INFEC, V20, pO374, DOI 10.1111/1469-0691.12421; van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556; Wells GA, THE NEWCASTLEOTTAWA; World Health Organization, 2005, REGIONAL STRATEGIC F; World Health Organization, 2015, MEETING OF MINISTERS; World Health Organization, 2010, INDICATORS FOR MONIT; World Health Organization, 2015, KALA AZAR ELIMINATIO; World Health Organization ROfS-EA, 2016, REGIONAL STRATEGIC F; Yangzom T, 2012, AM J TROP MED HYG, V87, P1028, DOI 10.4269/ajtmh.2012.12-0211; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6	175	25	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2016	10	8							e0004896	10.1371/journal.pntd.0004896				28	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU7JR	WOS:000382390800039	27490264	DOAJ Gold, Green Published			2019-03-26
J	Terryn, S; Francart, A; Rommelaere, H; Stortelers, C; Van Gucht, S				Terryn, Sanne; Francart, Aurelie; Rommelaere, Heidi; Stortelers, Catelijne; Van Gucht, Steven			Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SINGLE-DOMAIN ANTIBODIES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; HALF-LIFE; VIRUS; PROPHYLAXIS; THERAPEUTICS; REGIMENS; DISEASE; BURDEN	Post-exposure prophylaxis (PEP) against rabies infection consists of a combination of passive immunisation with plasma-derived human or equine immune globulins and active immunisation with vaccine delivered shortly after exposure. Since anti-rabies immune globulins are expensive and scarce, there is a need for cheaper alternatives that can be produced more consistently. Previously, we generated potent virus-neutralising VHH, also called Nanobodies, against the rabies glycoprotein that are effectively preventing lethal disease in an in vivo mouse model. The VHH domain is the smallest antigen-binding functional fragment of camelid heavy chain-only antibodies that can be manufactured in microbial expression systems. In the current study we evaluated the efficacy of half-life extended anti-rabies VHH in combination with vaccine for PEP in an intranasal rabies infection model in mice. The PEP combination therapy of systemic anti-rabies VHH and intramuscular vaccine significantly delayed the onset of disease compared to treatment with anti-rabies VHH alone, prolonged median survival time (35 versus 14 days) and decreased mortality (60% versus 19% survival rate), when treated 24 hours after rabies virus challenge. Vaccine alone was unable to rescue mice from lethal disease. As reported also for immune globulins, some interference of anti-rabies VHH with the antigenicity of the vaccine was observed, but this did not impede the synergistic effect. Post exposure treatment with vaccine and human anti-rabies immune globulins was unable to protect mice from lethal challenge. Anti-rabies VHH and vaccine act synergistically to protect mice after rabies virus exposure, which further validates the possible use of anti-rabies VHH for rabies PEP.	[Terryn, Sanne; Francart, Aurelie; Van Gucht, Steven] Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Viral Dis, Brussels, Belgium; [Terryn, Sanne; Van Gucht, Steven] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Ghent, Belgium; [Rommelaere, Heidi; Stortelers, Catelijne] Ablynx NV, Ghent, Belgium	Van Gucht, S (reprint author), Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Viral Dis, Brussels, Belgium.; Van Gucht, S (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Ghent, Belgium.	steven.vangucht@wiv-isp.be			WIV-ISP; Belgian Ministry of Social Affairs through a fund from the Health Insurance System	ST received a fellowship from the WIV-ISP (https://www.wiv-isp.be/). The National Reference Centre of Rabies is partially supported by the Belgian Ministry of Social Affairs through a fund from the Health Insurance System (http://nrchmweb.wiv-isp.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WHO CONS RAB MON ANT; ARCHER BG, 1968, B WORLD HEALTH ORGAN, V39, P407; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Bourhy H, 2009, EUROPE EURO, V14; Chomchay P, 2000, J TRAVEL MED, V7, P187; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Dimaano EM, 2011, INT J INFECT DIS, V15, pE495, DOI 10.1016/j.ijid.2011.03.023; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3; Hooper DC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000535; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; IWASAKI Y, 1977, INFECT IMMUN, V18, P220; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Lang J, 1998, BIOLOGICALS, V26, P299, DOI 10.1006/biol.1998.0156; Law M, 2008, CURR OPIN IMMUNOL, V20, P486, DOI 10.1016/j.coi.2008.06.005; Lewis CE, 2013, J VIROL METHODS, V190, P49, DOI 10.1016/j.jviromet.2013.03.020; Lewis P, 2000, MUSCLE NERVE, V23, P720, DOI 10.1002/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Niewiesk S., 2014, FRONT IMMUNOL, P5; PHANUPHAK P, 1987, ASIAN PAC J ALLERGY, V5, P33; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Rosseels V, 2011, J VIROL METHODS, V173, P127, DOI 10.1016/j.jviromet.2011.01.019; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SCHUMACHER CL, 1992, VACCINE, V10, P754, DOI 10.1016/0264-410X(92)90510-Q; Servat A, 2003, VACCINE, V22, P244, DOI 10.1016/S0264-410X(03)00559-0; Shantavasinkul P, 2010, CLIN INFECT DIS, V50, P77, DOI 10.1086/649873; Shuangshoti S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-31; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Sudarshan MK, 2007, INT J INFECT DIS, V11, P29, DOI 10.1016/j.ijid.2005.10.007; Suin V, 2014, BIOMED RES INT, DOI 10.1155/2014/256175; SUNTHARASAMAI P, 1986, J HYG-CAMBRIDGE, V96, P483, DOI 10.1017/S0022172400066286; SUNTHARASAMAI P, 1987, EPIDEMIOL INFECT, V99, P755, DOI 10.1017/S0950268800066619; Terryn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109367; Tinsa Faten, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-206191; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WIKTOR TJ, 1971, B WORLD HEALTH ORGAN, V45, P747; Wilde H, 2002, CLIN INFECT DIS, V34, P477, DOI 10.1086/324628; Wilde H, 2007, VACCINE, V25, P7605, DOI 10.1016/j.vaccine.2007.08.054; World Health Organisation, 2007, 4950 WHO	45	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2016	10	8							e0004902	10.1371/journal.pntd.0004902				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU7JR	WOS:000382390800044	27483431	DOAJ Gold, Green Published			2019-03-26
